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RESUMEN EN INGLÉS - SUMMARY 
Alphaviruses are positive polarity single-stranded RNA viruses responsible for 
several human and other animal diseases, causing usually arthrosis or encephalitis that 
continue to be a worldwide health threat. They are usually transmitted by blood-sucking 
arthropods to vertebrate hosts. Sindbis virus (SINV) is a well-characterized member of 
this group and is usually employed as a model system in molecular virology. SINV RNA 
genome contains two open reading frames (ORFs) that correspond to the translation of 
the genomic RNA (gRNA) and subgenomic RNA (sgRNA), translated at early or late times 
post-infection, respectively. SINV infection profoundly blocks cellular protein synthesis 
while sgRNA translation occurs, which follows a non-canonical mechanism, independent 
of several eukaryotic initiation factors (eIFs), which involves the scanning of 5’-UTR. 
In this work, we have studied the requirement of different eIFs for SINV mRNAs 
translation. We have examined the role of the RNA helicase eIF4A using the selective 
inhibitor pateamine A. Translation of SINV gRNA involves the participation of eIF4A, 
while translation of sgRNA is independent of this factor in infected cells but dependent 
in transfected cells or in cell-free systems, indicating a dual mechanism of translation. 
Moreover, sgRNA translation does not require eIF2, and the identification of substitute 
factors has been the object of intensive research in the past few years. eIF2A and eIF2D 
were proposed as candidates by several studies. However, we have demonstrated that 
eIF2A and eIF2D are not required for the translation of SINV mRNAs, even when eIF2α 
is phosphorylated. In addition, eIF2A and eIF2D do not participate in the translation of 
SINV sgRNA bearing non-AUG codons. The initiation on non-AUG codons for sgRNA 
translation is highly dependent on the integrity of a downstream stable hairpin (DSH) 
structure located in the coding region of capsid protein.   
Furthermore, in collaboration with Dr. A. Castelló (University of Oxford), we have 
demonstrated that the loss of cellular mRNAs and the emergence of viral RNA induced 
by SINV infection alters the dynamics and activity of the compendium of RNA-biding 
proteins (RBPs) of the host cell. Many of the RBPs whose activity is stimulated by SINV 
redistribute to viral replication factories and regulate the capacity of the virus to infect.  
Finally, we examined the involvement of several eIFs in hepatitis C virus (HCV) 
IRES-driven translation in human cells in a comparative analysis with mRNAs bearing the 
encephalomyocarditis virus or the Cricket paralysis virus IRES elements. We concluded 
that eIF2, eIF2A, eIF2D, eIF4A and eIF4G are not involved in the initiation of translation 
driven by HCV IRES. 
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RESUMEN  
Los alfavirus se caracterizan por presentar un genoma constituido por una cadena 
de RNA de polaridad positiva. Estos virus suponen una amenaza para la salud a nivel 
mundial ya que pueden causar enfermedades fatales en humanos y otros animales. El 
virus Sindbis (SINV) es uno de los alfavirus mejor estudiado y suele emplearse como 
sistema modelo en virología molecular. El genoma de SINV contiene dos marcos de 
lectura abiertos (ORFs) que dirigen la traducción del RNA genómico (gRNA) y 
subgenómico (sgRNA), a tiempo temprano o tardío después de la infección, 
respectivamente. La infección por SINV bloquea la síntesis de proteínas celulares al 
tiempo que se produce la traducción del sgRNA, que sigue un mecanismo no canónico, 
independiente de varios factores de iniciación eucarióticos (eIFs), que incluye el 
scanning de la 5’-UTR. 
En este trabajo, hemos estudiado el requerimiento de diferentes eIFs para la 
traducción de los mRNAs de SINV. Empleando el inhibidor selectivo pateamina A, se 
determinó que la traducción del gRNA de SINV implica la participación de eIF4A. En 
cambio, la traducción del sgRNA es independiente de este factor en células infectadas, 
pero dependiente de eIF4A en células transfectadas o en sistemas de traducción in vitro, 
lo que indica un mecanismo dual de traducción. Además, la traducción del sgRNA no 
requiere eIF2, por lo que varios estudios propusieron como sustitutos de este factor al 
eIF2A o al eIF2D. En este trabajo, demostramos que eIF2A y eIF2D no son necesarios 
para la traducción de los mRNAs de SINV, incluso cuando eIF2α está fosforilado. 
Asimismo, eIF2A y eIF2D no participan en la traducción de variantes del sgRNA de SINV 
que inician en codones no-AUG. La iniciación de la traducción del sgRNA en codones 
no-AUG depende en gran medida de la integridad del downstream stable hairpin (DSH) 
situado en la región codificante de la proteína de la cápsida. 
En colaboración con el Dr. A. Castelló (Universidad de Oxford), hemos 
demostrado que la pérdida de los mRNAs celulares y la aparición del RNA viral tras la 
infección por SINV altera la dinámica y la actividad de las proteínas de unión al RNA 
(RBPs). Muchas de estas RBPs cuya actividad es estimulada por SINV se redistribuyen a 
las fábricas de replicación viral y regulan la capacidad del virus para infectar. 
Finalmente, examinamos en células humanas la participación de varios eIFs en la 
traducción dirigida por el IRES del virus de la hepatitis C (HCV) concluyendo que eIF2, 
eIF2A, eIF2D, eIF4A y eIF4G no participan en el inicio de la traducción dirigida por IRES 
de HCV. 
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ABREVIATURAS  
 
AUGi   AUG iniciador 
BHK   Célula de riñón de hámster neonato 
C   Proteína de la cápsida 
C6/36   Célula de larva del mosquito Aedes albopictus 
CITE   Potenciador de la traducción cap-independiente 
cRIC   Captura comparativa del RNA interactoma  
CrPV   Virus de la Parálisis del grillo 
DLP / DSH Downstream loop / Downstream stable hairpin  
eEF   Factor de elongación de traducción eucariótico 
eIF   Factor de iniciación de la traducción eucariótico 
EMCV   Virus de la encefalomiocarditis 
G3BP    Proteína de unión al dominio SH3 de Ras-GAP 
GDP   Guanosina difosfato 
GTP   Guanosina trifosfato 
gRNA / gmRNA RNA genómico 49S 
HAP1 Célula semi-haploide humana derivada de leucemia mielógena 
crónica  
HEK293 Célula embrionaria de riñón humano 
Huh-7 Célula derivada de hepatocarcinoma humano 
hipp   Hippuristanol 
hpi   Hora post-infección 
hpt   Hora post-transfección 
IGR   Región intergénica 
IRES   Sitio de entrada interna del ribosoma 
KO   Knock out 
L26S   Secuencia leader  del sgRNA o mRNA 26S 
Leu   Leucina 
Luc   Luciferasa 
MEF   Fibroblasto de ratón 
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Met   Metionina 
Met-Cis  Metionina-Cisteína 
Met-tRNAiMet  tRNA iniciador unido a metionina 
mRNA   RNA mensajero 
nsP   Proteína no estructural 
nt   nucleótidos 
ORF   Fase abierta de lectura 
PABP   Proteína de unión a la cola poli(A) 
PKR   Proteína quinasa R 
PTB    Proteína de unión al tracto de polipirimidina 
RBP   Proteína de unión al RNA 
rep   Replicón 
RE   Retículo endoplasmático 
RLU   Unidades relativas de luz 
RRL   Lisado de reticulocitos de conejo 
rRNA   RNA ribosómico 
sfRNA   RNA subgenómico de flavivirus  
SG   Gránulo de estrés 
sgRNA / sgmRNA RNA subgenómico 26S 
SINV   Virus Sindbis 
siRNA   RNA pequeño de interferencia 
sP   Proteína estructural 
TIA-1   Antígeno intracelular 1 restringido a linfocitos T  
tRNA   RNA de transferencia 
UTR   Región no traducida 
Val   Valina 
wt   Tipo salvaje o estándar (“wild type”) 
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INTRODUCCIÓN  
 
Una característica general de todos los virus es su completa dependencia de la 
maquinaria celular de síntesis de proteínas para la traducción de los RNAs mensajeros 
(mRNAs) virales. Pese a que la complejidad de los virus es extremadamente variable, 
ninguno de ellos codifica en su genoma los componentes necesarios para la traducción 
de mensajeros virales, por lo que han evolucionado sofisticados mecanismos para 
secuestrar la maquinaria celular de síntesis de proteínas. Estos mecanismos pueden ser 
muy complejos y tienen como finalidad dirigir la maquinaria celular a la traducción de 
proteínas virales y, a su vez, bloquear la respuesta antiviral innata evitando el acceso de 
los mRNAs celulares a los ribosomas (Gale et al., 2000). Curiosamente, existen ciertas 
similitudes entre estos mecanismos y los empleados por las células en respuesta a estrés 
fisiológico (Jan et al., 2016). Generalmente, el control de la traducción para sintetizar 
proteínas virales implica subvertir los factores de traducción celular y las vías de 
señalización que controlan el aparato de síntesis de proteínas en la célula. Los virus, 
debido a la rápida evolución de sus mecanismos de control de la traducción y a la alta 
densidad de secuencias reguladoras localizadas en sus genomas, constituyen 
excelentes modelos para el estudio de mecanismos de expresión, como la transcripción, 
el procesamiento del RNA, el transporte y la traducción. De hecho, fue en sistemas 
virales donde se describieron los principios esenciales de varios procesos como la 
regulación de la expresión génica por RNAs de interferencia (Haasnoot and Berkhout, 
2011, Pager et al., 2009), la compactación de la traducción de mRNAs virales y celulares 
(Martin and Ephrussi, 2009, Besse and Ephrussi, 2008), los mecanismos de iniciación de 
la traducción como el leaky scanning, el shunting, la traducción mediada por IRES 
(Internal Ribosome Entry Site) o CITEs (Cap-Independent Translation Enhancer) (Firth 
and Brierley, 2012), el descubrimiento de nuevos factores eucarióticos de iniciación de 
la traducción (eIFs) y los diferentes requisitos de participación de estos factores (Kim et 
al., 2011, Redondo et al., 2011, Sanz et al., 2009, Skabkin et al., 2010, Dmitriev et al., 2010, 
Parsyan et al., 2011), la regulación de la traducción mediada por gránulos de RNA 
(Thomas et al., 2011), la iniciación desde codones no-AUG (Zu et al., 2011, Pearson, 2011) 
y la regulación de la expresión génica por uORFs (Upstream Open Reading Frame) 
localizados antes del AUG iniciador (AUGi) (Wethmar et al., 2010). Por lo tanto, la 
investigación sobre el control de la traducción en células infectadas por virus ha 
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descubierto mecanismos claves en la patogénesis viral, y ha definido paradigmas del 
control de la traducción celular en células no infectadas.  
Nuestro grupo de investigación ha realizado diversas aportaciones en el campo 
de la regulación de la iniciación de la traducción como la demostración de que los 
factores eIF4G y eIF2 no eran necesarios para la traducción del RNA subgenómico 
(sgRNA) del virus Sindbis (SINV) y que además presenta un mecanismo dual de 
traducción dependiente del contexto celular (Sanz et al., 2009, Castello et al., 2006, 
Ventoso et al., 2006). También hemos mostrado que la proteasa 2A de poliovirus es 
capaz de conferir traducibilidad a los mRNAs virales cuando el factor eIF2 está inactivo 
(Redondo et al., 2011). Esta tesis doctoral está enfocada en el estudio de los mecanismos 
de iniciación de la traducción de los RNAs virales, con especial interés en el 
requerimiento de factores y en la relación entre estructura y función de estos RNAs. Se 
desconocen aún muchos aspectos de la dinámica de los RNAs virales que pudieran estar 
implicados en provocar efectos citopatogénicos, por lo que el estudio de la interacción 
de estos RNAs con proteínas constituirá un nuevo campo de investigación para 
desentrañar la patología viral a nivel molecular. Para poder determinar los mecanismos 
implicados en la infección viral resulta necesario identificar las proteínas celulares que 
se unen a los RNAs virales, y también aquellas que interfieren con los mRNAs celulares 
bloqueando su traducción. La importancia del estudio de estas cuestiones crece con la 
aparición de nuevas epidemias de gran relevancia médica y veterinaria donde el diseño 
de estrategias selectivas para inhibir la traducción viral podría derivar en potentes 
terapias antivirales.  
 
1. EL VIRUS SINDBIS  
 
El virus Sindbis (SINV) pertenece al género Alfavirus dentro de la familia 
Togaviridae (Griffin, 2007). Este género comprende unas 30 especies de virus que se 
transmiten en su mayoría por vectores artrópodos hematófagos, generalmente 
mosquitos, a gran variedad de hospedadores vertebrados tales como aves, roedores, 
cerdos, caballos y primates, incluyendo humanos (Forrester et al., 2012, Nasar et al., 
2012). Existen excepciones respecto al vector de trasmisión, como es el caso de los 
alfavirus acuáticos que afectan a especies de salmónidos o al elefante marino del sur 
(Strauss and Strauss, 1994, Brown and Hernandez, 2012, Weaver et al., 2012). También 
se ha descrito el caso de un alfavirus que sólo replica en insectos y no en vertebrados, 
el virus Eilat (Nasar et al., 2012). Los alfavirus presentan una amplia distribución 
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geográfica, lo cual apunta a un origen antiguo y a una gran diversificación posterior 
(Novella et al., 2011, Weaver et al., 2012). Los alfavirus se pueden dividir en dos grupos 
según su origen geográfico: virus del Viejo Mundo y virus del Nuevo Mundo. Algunos 
ejemplos de los alfavirus del Viejo Mundo son el virus del Bosque Semliki (SFV), el virus 
Chikungunya (CHIKV), el virus del Río Ross (RRV) y el virus o’nyong’nyong (ONNV). El 
grupo del Nuevo Mundo incluye a SINV, y a los virus de encefalitis equinas occidental, 
oriental y venezolana (WEEV, EEEV y VEEV) (Forrester et al., 2012, Carrasco et al., 2018). 
Los alfavirus son responsables de numerosas enfermedades humanas y veterinarias en 
todo el mundo y su estudio tiene gran relevancia sanitaria y económica. En mamíferos, 
los alfavirus producen enfermedades que se desarrollan generalmente mediante una 
infección aguda, de corta duración, que cursa con variedad de síntomas dependiendo 
del virus y su hospedador. Estos síntomas pueden ser: encefalitis, poliartritis, mialgia, 
artritis, artralgia, sarpullidos y fiebre (Griffin, 2007). En concreto, los virus de las encefalitis 
equinas pueden causar enfermedades neurológicas fatales en humanos y animales 
domésticos. A su vez, el virus Chikungunya, que produce una artralgia intensa, ha 
resurgido como una seria amenaza para la salud humana causando grandes pandemias 
principalmente en África, Asia y América (Brown and Hernandez, 2012). Al contrario de 
lo que ocurre en vertebrados, los insectos superan la fase aguda de la infección y quedan 
persistentemente infectados sin consecuencias patológicas aparentes (Karpf et al., 1997, 
Mudiganti et al., 2006), aunque también se ha observado apoptosis en células de 
mosquito en cultivo infectadas con SINV (Mudiganti et al., 2006).  
SINV ha sido utilizado ampliamente en investigación como modelo en estudios de 
síntesis de proteínas, transcripción y replicación viral, y para comprender la patogénesis 
viral y la interacción entre virus y hospedador. Estos estudios han revelado aspectos 
fundamentales de la regulación de la traducción en células infectadas por virus (Carrasco 
et al., 2018). Por ejemplo, los mRNAs de SINV han ayudado a comprender la relación 
existente entre la estructura y la función de los mRNAs virales. Por otra parte, SINV ha 
sido utilizado en la investigación de campos tan diversos como la terapia oncológica o 
la inmunidad adaptativa antiviral (Suzme et al., 2012, Tassetto et al., 2017).  
1.1 Ciclo viral de SINV 
El virión de SINV tiene aproximadamente 70 nm de diámetro y está formado por 
una nucleocápsida de estructura icosaédrica compuesta por 240 copias de la proteína 
de la cápsida (proteína C). Esta estructura contiene en su interior el RNA genómico 
(gRNA) también conocido como 49S, que es un RNA monocatenario de polaridad 
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positiva y de 11,7 Kb de longitud (Figura 1) (Fuller, 1987, Strauss and Strauss, 1994). La 
nucleocápsida está envuelta por una bicapa lipídica derivada de la membrana 
plasmática de la célula hospedadora, que tiene ancladas las glicoproteínas virales E1 y 
E2 (Chen et al., 2018). Estas glicoproteínas interaccionan con receptores de la membrana 
de las células diana y propician la fusión de las membranas celular y viral. Las partículas 
virales de SINV pueden llegar al citoplasma por diferentes vías, siendo la más común la 
endocitosis mediada por clatrina. Tras la endocitosis, los viriones acaban en endosomas  
(Perez and Carrasco, 1994, Mayor and Pagano, 2007, Leung et al., 2011). 
Alternativamente los viriones también pueden fusionar su membrana con la membrana 
plasmática celular liberando el gRNA directamente al citosol (Vancini et al., 2013). En 
cualquier caso, para que la infección sea eficaz, el gRNA debe mantener el contacto con 
la proteína C tras su liberación al citoplasma (Sokoloski et al., 2017).  
 
Cuando el genoma viral alcanza el citoplasma, comienza su traducción. El genoma 
de SINV contiene dos marcos de lectura abierta u ORFs (Open Reading Frame) que se 
expresan en dos mRNAs distintos: el gRNA y el sgRNA. El gRNA se traduce en las 
Figura 1. Ciclo infectivo y organización del genoma de SINV. Abreviaturas: gRNA, RNA genómico; 
sgRNA, RNA subgenómico; C, proteína de la cápsida; nsP, proteína no estructural; ORF, fase abierta de 
lectura; RE, retículo endoplasmático; ◊, codón de terminación opal 1897. 
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proteínas no estructurales (nsPs), y el sgRNA codifica para las proteínas estructurales 
(sPs) (Figura 1). Mientras el gRNA es traducido preferentemente tras la liberación del 
genoma viral al citosol (fase temprana de la infección), el sgRNA se traduce 
preferencialmente durante la fase tardía (Shin et al., 2012). Ambos RNAs presentan una 
estructura cap en el extremo 5’ y una cola poli(A) en su extremo 3’. Como excepción a 
esto, se ha encontrado una pequeña porción de gRNA que no presenta la estructura 
cap en su extremo 5’ (Sokoloski et al., 2015).  
El primer paso en la replicación del virus SINV es la síntesis de las proteínas no 
estructurales nsP1-4 codificadas en el gRNA, que participan en la replicación y 
transcripción viral (Strauss and Strauss, 1994). Las nsPs se traducen desde un único codón 
iniciador AUG (AUGi) generándose dos tipos de poliproteínas precursoras: P123 y P1234, 
que serán posteriormente procesados mediante la proteólisis llevada a cabo por la nsP2 
(Figura 1) (de Groot et al., 1990, Ahola et al., 2000). En la traducción de estos precursores, 
la mayoría de los ribosomas (90-95%) se detienen en el primer codón de parada que 
encuentran (UGA) – un codón opal, lo que genera el precursor P123 (Li and Rice, 1993). 
Sin embargo, y con escasa frecuencia, ocurre un fenómeno read-through de este codón 
de parada y se produce el precursor P1234. La función de cada una de las nsPs derivadas 
de estos precursores ha sido intensamente investigada (Laakkonen et al., 1996, Ahola et 
al., 1999, Ahola et al., 2000, Rupp et al., 2015). nsP1 es una proteína palmitoilada capaz 
de interaccionar con las membranas celulares a través de una hélice anfipática localizada 
en su región central (Peranen et al., 1995). De este modo, sirve de anclaje a la membrana 
para los complejos replicativos virales de los que forma parte (Salonen et al., 2003). nsP1 
participa junto a nsP4, la RNA polimerasa viral, en la iniciación y elongación de la cadena 
de RNA de polaridad negativa complementario al RNA genómico de SINV (Shirako et 
al., 2000, Fata et al., 2002). El motivo N-terminal de nsP1 tiene actividad metiltransferasa 
y guanililtransferasa, que están implicadas en el proceso de “capping” (Mi et al., 1989, 
Ahola et al., 1997, Peranen et al., 1995). La proteína nsP2 también presenta varios 
dominios: (1) la región amino-terminal, con actividad RNA helicasa, (2) la región central, 
con actividad proteasa que cataliza todas las reacciones de escisión que darán lugar a 
las diferentes nsPs, y (3) un motivo inactivo tipo RNA metiltransferasa (Russo et al., 2006, 
Gomez de Cedron et al., 1999). nsP2 también participa en el bloqueo de las actividades 
de síntesis de macromoléculas celulares, tales como la transcripción y la traducción, 
antagonizando de esta forma la respuesta antiviral celular (Garmashova et al., 2006, 
Breakwell et al., 2007). Se ha observado que una fracción de la proteína nsP2 se localiza 
en el núcleo celular donde bloquea la exportación de RNAs al citoplasma (Breakwell et 
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al., 2007, Rikkonen et al., 1994). Además, nsP2 induce la degradación mediante 
ubiquitinación de Rpb1, que es una subunidad catalítica esencial de la RNA polimerasa II 
(Akhrymuk et al., 2012). La nsP3 presenta tres dominios: (1) un macrodominio amino-
terminal, (2) una región central específica de alfavirus, y (3) una región de secuencia 
hipervariable en el extremo carboxilo con multitud de sitios susceptibles de fosforilación 
(Lark et al., 2017, Lulla et al., 2012). nsP3 bloquea la formación de gránulos de estrés 
(SGs) en la célula hospedadora, ya que estos participan en los mecanismos de respuesta 
antiviral innata, mediante la interacción de su dominio carboxi-terminal con G3BP 
(proteína de unión al dominio SH3 de Ras-GAP). De esta forma, nsP3 impide la función 
nucleadora de G3BP en la formación de SGs (Panas et al., 2012, Fros et al., 2012). 
Finalmente, nsP4 es una RNA polimerasa RNA-dependiente que lleva a cabo la síntesis 
de los diferentes RNAs virales – gRNA, sgRNA y el RNA monocatenario de polaridad 
negativa complementario al genoma (Rubach et al., 2009, Pietila et al., 2017). Cabe 
señalar que el complejo P123 + nsP4 sintetiza preferencialmente la cadena de RNA de 
polaridad negativa, mientras que el complejo nsP1 + P23 + nsP4 sintetiza tanto la cadena 
de polaridad positiva como la de polaridad negativa (Shirako and Strauss, 1994, Lemm 
et al., 1994). La escisión final de P23 en P2+P3 supone la maduración completa de todas 
las nsPs, que a partir ese momento priorizarán su función hacia la síntesis de los gRNAs 
y sgRNAs. 
Las moléculas de gRNA de SINV participan en tres funciones: (1) síntesis de nsPs; 
(2) síntesis de la cadena de RNA de polaridad negativa; y (3) formación de la 
nucleocápsida durante el ensamblaje y la generación de nuevas partículas virales. Por 
otro lado, la cadena de RNA de polaridad negativa sirve como molde para que la 
maquinaria replicativa viral sintetice los dos mRNAs virales – gRNA y sgRNA (Lemm et 
al., 1994, LaStarza et al., 1994). En el caso de virus RNA citoplasmáticos, como SINV, la 
síntesis de RNA viral ocurre en estrecha asociación con las membranas celulares (Perez 
et al., 1994, Carrasco, 2002, Hellstrom et al., 2017). Los complejos replicativos de SINV 
se encuentran concentrados en regiones específicas del citoplasma formando las 
factorías de replicación viral. Estas factorías están asociadas a unas estructuradas 
denominadas esférulas, que son invaginaciones de la membrana de las vacuolas 
citopáticas, que a su vez se forman a partir de endosomas celulares modificados por la 
infección viral (Harak and Lohmann, 2015). El análisis del proteoma de los complejos 
replicativos ha conseguido la identificación de varias proteínas celulares cuya actividad 
puede estimular o inhibir la síntesis de RNA viral (Varjak et al., 2013). Varios factores 
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celulares pueden interaccionar con las nsPs, como se ha visto para nsP2 y nsP3, y así 
modular la replicación del RNA de SINV (Cristea et al., 2010).  
Para iniciar la síntesis del sgRNA (también conocido como 26S) es necesario el 
reconocimiento de un promotor interno en la cadena de RNA de polaridad negativa. 
Este sgRNA es el mRNA más abundante durante la fase tardía de la infección y dirige la 
síntesis de la poliproteína C-E3-E2-6K-E1, que dará lugar a las sPs. La traducción de este 
sgRNA coincide con una drástica inhibición de la traducción de los mRNAs celulares. La 
secuencia codificante del sgRNA está flanqueada por dos regiones no traducibles, UTRs 
(UnTranslated Regions): la 5’-UTR contiene la estructura cap en su extremo 5’, y la 3’-
UTR termina en una cola poli(A). Cuando los ribosomas interaccionan con el sgRNA, 
avanzan sobre él mediante un proceso de scanning hasta alcanzar el primer codón AUG, 
donde inician la traducción. Primero se sintetiza la proteína de la cápsida (C), que se 
libera de la poliproteína naciente mediante autoproteólisis (Figura 2) (Strauss and 
Strauss, 1994). Tras este evento, la proteína C se une al gRNA para formar las 
nucleocápsidas. El nuevo extremo N-terminal de la poliproteína, que se corresponde 
con la proteína E3, tiene un péptido señal que dirige la traducción al retículo 
endoplasmático (RE). Una vez en el RE, la traducción continúa asociada a su membrana 
generándose el precursor de las tres glicoproteínas E3, E2 y E1, y la viroporina 6K. La 
translocación de las glicoproteínas virales a través de la membrana del RE está regulada 
por varias secuencias señal. Las glicoproteínas y la viroporina 6K son procesadas y 
cortadas por proteasas celulares, como la furina y la signalasa, del sistema vesicular 
celular (Sariola et al., 1995). Hace algunos años, fue descubierto un sitio de deslizamiento 
(slip site) de siete nucleótidos (UUUUUUA) dentro del gen que codifica para la proteína 
6K, y se observó que, en aproximadamente el 10% de los casos, produce un 
desplazamiento del ribosoma a una posición -1 en el marco de lectura. En estos casos, 
se produce una forma transframe (TF) de 6K que acaba en un codón de parada próximo 
y, por tanto, no continúa con la traducción de E1 (Firth et al., 2008, Chung et al., 2010). 
La proteína 6K, con sólo 55 aminoácidos, pertenece a la familia de las viroporinas y se 
encuentra generalmente en forma palmitoilada, lo cual le permite interaccionar con las 
membranas (Gaedigk-Nitschko and Schlesinger, 1990, Sanz et al., 1994, Sanz et al., 2003, 
Nieva et al., 2012, Ramsey and Mukhopadhyay, 2017). 6K está implicada en el transporte 
de las glicoproteínas virales a través del sistema vesicular hacia la membrana plasmática 
(Sanz and Carrasco, 2001, Sanz, 2005), y en el ensamblaje de las partículas virales, aunque 
no se incorpora en los viriones, salvo en pequeñas proporciones (Nieva et al., 2012, 
Melton et al., 2002). Por el contrario, la proteína TF es preferencialmente incorporada 
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dentro de los viriones liberados (Snyder et al., 2013). pE2 y E1 interaccionan entre sí 
formando heterodímeros que migran hacia la membrana plasmática de tal forma que su 
extremo carboxi-terminal queda orientado hacia la cara citoplasmática de la membrana. 
Cuando el complejo pE2-E1 alcanza el trans-Golgi, pE2 es procesada para formar E3 y 
E2 mediante la acción de furinas. Este procesamiento de pE2 es necesario para generar 
partículas virales activas que inicien un nuevo ciclo infectivo (Jose et al., 2009, Weaver et 
al., 2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figura 2. Representación esquemática de la traducción del sgRNA de SINV para producir las proteínas de la cápsida
(C), pE2, 6K y E1. 
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2. MECANISMOS DE INICIACION DE LA TRADUCCIÓN EN EUCARIOTAS 
 
La expresión de los genes está regulada a múltiples niveles, incluyendo la 
traducción de los mRNAs. El control a nivel de traducción permite cambios rápidos en 
la concentración de proteínas y, por eso, se emplea para regular la homeostasis y los 
cambios fisiológicos de la célula. El proceso de traducción se divide en las fases de 
iniciación, elongación, terminación y reciclado de ribosomas (Hinnebusch, 2014). La fase 
más regulada es la iniciación, durante la cual el codón de iniciación es identificado y 
decodificado por el RNA transferente especializado en iniciación: Met-tRNAi. Existen 
gran variedad de mecanismos de iniciación de la traducción (Jackson et al., 2010). 
2.1 Mecanismo canónico de iniciación de la traducción 
En eucariotas, el mecanismo canónico de iniciación comienza con el 
reconocimiento de la estructura cap metilada m7GpppN en el extremo 5’ de los mRNAs 
por el factor eIF4E (Figura 3) (Gingras et al., 1999). eIF4E, junto con la helicasa tipo 
DEAD-box eIF4A y la proteína de andamiaje eIF4G, forma el complejo multiproteico 
eIF4F (Jackson et al., 2010, Sonenberg and Hinnebusch, 2009). La proteína PABP (Poly(A) 
Binding Protein) se asocia con el complejo eIF4F, a través del factor eIF4G, a la vez que 
une la cola poli(A) del mensajero promoviendo su circularización y facilitando el 
reciclado de los ribosomas (Gingras et al., 1999, Derry et al., 2006, Wells et al., 1998). Por 
otro lado, el factor eIF2 unido a GTP interacciona con el tRNAi asociado con metionina 
formando el complejo ternario Met-tRNAiMet-eIF2-GTP. La subunidad pequeña 
ribosómica 40S es precargada con el complejo ternario y, junto con los factores eIF1, 
eIF1A, eIF3, y eIF5, forma el complejo de preiniciación 43S (43S PIC) (Lorsch and Dever, 
2010). El complejo eIF4F, unido al mRNA, recluta al 43S PIC mediante la interacción de 
eIF3 con el dominio central de eIF4G. De esta forma, el 43S PIC, que se encuentra en 
conformación “abierta”, se desplazará desde el cap sobre el 5’-UTR del mRNA en 
dirección 5’ 3‘, en un proceso de scanning, hasta reconocer el codón iniciador AUG 
en un contexto de secuencia adecuado. Desde hace muchos años, el contexto de Kozak 
RCCAUGG se ha considerado el óptimo para señalar el sitio de iniciación de los mRNAs 
en mamíferos (Kozak, 1991, Hinnebusch, 2011, Asano and Sachs, 2007, Pestova and 
Kolupaeva, 2002, Kozak, 1999). Para que el mecanismo de scanning sea eficiente es 
necesario que eIF4A, mediante su actividad helicasa y ATPasa, deshaga la estructura 
secundaria de la secuencia leader del mRNA (Parsyan et al., 2011). Otras helicasas como 
DHX29 y Ded1/DDX3 también pueden participar en este proceso (Parsyan et al., 2011, 
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Abaeva et al., 2011, Pisareva et al., 2008). El proceso de scanning finaliza con el 
reconocimiento del AUGi, que se lleva a cabo mediante el apareamiento de bases entre 
el anticodón del Met-tRNAiMet y el codón AUGi en el sitio P ribosómico, y desencadena 
la hidrólisis de GTP liberándose eIF2-GDP y otros factores unidos a la subunidad 40S 
(Figura 3). Estas reestructuraciones moleculares y conformacionales conducen a la 
formación “cerrada” de la subunidad 40S del ribosoma, quedando ésta ya 
comprometida a continuar la traducción del mRNA (Pisareva et al., 2008, Shatsky et al., 
2010). El papel de la proteína eIF5 es central en la regulación de estos eventos. eIF5 
participa en la formación del complejo de preiniciación mediante la interacción de su 
extremo carboxilo-terminal con el eIF1 y el eIF2β (Asano et al., 2001, Yamamoto et al., 
2005). También induce la disociación del eIF1 tras el reconocimiento codón-anticodón, 
lo cual permite que eIF5 catalice la hidrolisis de GTP a GDP del complejo ternario (Luna 
et al., 2012, Cheung et al., 2007). La salida de eIF1 despeja el sitio P, permitiendo que el 
 
Figura 3. Esquema del mecanismo canónico de iniciación de la traducción en eucariotas. 
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Met-tRNAiMet se una con más fuerza a este sitio (Lomakin et al., 2003). Simultáneamente, 
eIF5B-GTP interacciona con la subunidad 40S promoviendo la salida de eIF2-GDP y los 
demás factores, excepto eIF1A y eIF5B, y a su vez, estimula la unión de la subunidad 60S 
con la 40S (Pestova et al., 2000). eIF2-GDP debe reciclarse a eIF2-GTP mediante la acción 
del eIF2B para poder participar en el siguiente proceso de iniciación. Por último, eIF5B 
hidroliza GTP liberando eIF1A y eIF5B-GDP de los ribosomas 80S ensamblados y 
competentes para la elongación. Cuando el Met-tRNAiMet queda anclado al sitio P, 
dejando libre el sitio A, finaliza la fase de iniciación de la traducción dando paso a la fase 
de elongación, que comienza en el momento en el que el primer aminoacil-tRNAe-eEF1-
GTP se une al sitio A ribosómico. 
2.2 Otros mecanismos de iniciación dependientes de cap 
Aunque la mayoría de los mRNAs eucarióticos inician su traducción por el 
mecanismo canónico, hay otros mecanismos dependientes de cap que siguen un 
proceso de scanning diferente al canónico. Estos mecanismos alternativos suelen estar 
implicados en la traducción de mensajeros con regiones 5’-UTR extremadamente cortas 
o de gran complejidad estructural, y son ventajosos bajo determinadas condiciones 
fisiológicas, por lo que han sido descritos principalmente para mRNAs virales.  
 Leaky scanning : mecanismo por el cual la subunidad ribosómica 40S escanea la 
región 5’-UTR, pero no reconoce el primer AUG que encuentra, por estar éste 
en un contexto de secuencia subóptimo. Por tanto, la iniciación se produce en 
un codón AUG posterior (Lopez-Lastra et al., 2010).  
 Mecanismo de salto o shunting : los ribosomas inician el scanning desde el cap 
en la 5’-UTR, pero al encontrar determinadas secuencias son traslocados 
directamente a una región posterior, saltando segmentos amplios de la 5’-UTR 
que pueden contener AUGs y estructuras secundarias fuertes (Yueh and 
Schneider, 1996, Yueh and Schneider, 2000). 
 Mecanismo de terminación-reiniciación: tras alcanzar el codón de parada de 
traducción, la subunidad 40S no se separa del mRNA y reanuda el proceso de 
scanning en un segundo ORF (Lopez-Lastra et al., 2010).  
2.3 Mecanismo de iniciación de la traducción dependiente de IRES 
Este mecanismo no canónico independiente de cap dirige la iniciación de la 
traducción de muchos mRNAs virales y celulares que presentan elementos internos de 
entrada al ribosoma o IRES en sus regiones 5’-UTR (Kieft, 2008, Balvay et al., 2009, 
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Lozano and Martinez-Salas, 2015, Komar et al., 2012). Estos elementos presentan 
estructuras terciarias o secundarias particulares, ricas en “stem-loops”, y son capaces de 
reclutar los ribosomas a posiciones internas del mRNA cercanas al AUGi o directamente 
sobre él (Jackson et al., 2010). El requerimiento de eIFs varía según el IRES que dirige la 
traducción.  
Los IRES se clasifican según su origen, estructura secundaria y funcionalidad 
(Belsham, 2009, Fitzgerald and Semler, 2009). Existen IRES celulares e IRES virales. Estos 
últimos aparecen en todos los picornavirus y en otros virus RNA como flavivirus, 
retrovirus, pestivirus y dicistrovirus (Balvay et al., 2009, Khawaja et al., 2015, Jang, 2006, 
Nakashima and Uchiumi, 2009, Lee et al., 2017). Los IRES de picornavirus se clasifican en 
cuatro tipos: tipo I (virus de la polio, rinovirus) requiere de todos los eIFs salvo de eIF4E 
y, tras posicionar el RNA en el ribosoma, encuentra el AUGi mediante scanning; tipo II 
(virus de la fiebre aftosa, virus de la encefalomiocarditis) difiere del tipo I en que sitúa al 
ribosoma directamente sobre el AUGi; tipo III (virus de la hepatitis A) el IRES se une 
directamente a la subunidad 40S y sólo requiere de eIF2 y eIF3; y tipo IV (teschovirus 
porcino) tras la unión a la 40S, la pseudotranslocación por eEF2 es necesaria para 
posicionar el codón de iniciación en el sitio A; sólo requiere de eIF2 (Balvay et al., 2009, 
Hertz and Thompson, 2011, Yamamoto et al., 2017). 
El mecanismo de iniciación de la traducción dependiente de IRES es empleado 
también por el virus de la hepatitis C (HCV). HCV es responsable de la mayoría de las 
hepatitis crónicas de origen viral e induce hepatocarcinomas en humanos (Hajarizadeh 
et al., 2013, Khullar and Firpi, 2015). HCV pertenece a la familia Flaviridae y contiene un 
genoma compuesto por RNA monocatenario de polaridad positiva de unos 9,6 Kb. Este 
genoma constituye su único mensajero conocido y presenta una sola ORF que dirige la 
traducción de la poliproteína que, tras el procesamiento proteolítico, genera las 
proteínas virales maduras (Paul et al., 2014). La traducción del mRNA de HCV está 
promovida y regulada por un elemento IRES que media la interacción de los 
componentes que participan en la síntesis de proteínas (Hellen and Pestova, 1999, 
Khawaja et al., 2015). Varios trabajos realizados en sistemas in vitro sugieren que el factor 
eIF2 es necesario para la iniciación de la traducción de este mRNA viral (Pestova et al., 
1998, Otto and Puglisi, 2004). Aunque se ha postulado que la traducción de HCV puede 
emplear eIF2 cuando este factor está activo en condiciones normales, su traducción, 
dirigida por IRES, ocurre tras la inactivación de este factor por fosforilación. Además, la 
interacción de este IRES viral con los complejos de preiniciación parece desplazar al eIF2 
fuera de ellos (Jaafar et al., 2016). Esto ha suscitado que varios factores se hayan 
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propuesto como candidatos para reemplazar eIF2 en la traducción de HCV: eIF5B 
(Terenin et al., 2008), eIF2D (Dmitriev et al., 2010, Skabkin et al., 2010), y eIF2A (Kim et 
al., 2011). A pesar de que eIF2A y eIF2D pueden formar un complejo con el Met-tRNAiMet 
e interaccionar con la subunidad 40S o con la 80S, resultados recientes parecen indicar 
que el silenciamiento de eIF2A, eIF2D o ambos no tiene efecto en la traducción de HCV 
(Jaafar et al., 2016). Se ha especulado que bajo condiciones en las que eIF2 no es 
funcional, el Met-tRNAiMet puede unirse directamente con el ribosoma mediante un 
mecanismo que no requiere el complejo ternario, pero que es dirigido por el IRES de 
HCV (Jaafar et al., 2016). 
2.4 Otros mecanismos de iniciación de la traducción independientes de cap 
Existen otros mecanismos independientes de cap que utilizan secuencias 
conocidas como CITEs (Cap-Independent Translation Enhancer) que se encuentran en 
diversas regiones del genoma RNA de algunos virus de plantas, aunque 
preferentemente en la 3’-UTR (Simon and Miller, 2013). Estas secuencias parecen ser 
necesarias para reclutar diversos componentes de la maquinaria de traducción, que 
serán posteriormente transferidos a la secuencia 5’ leader  mediante la interacción de 
las 5’- y 3’-UTR, antes de iniciarse el proceso de scanning (Shatsky et al., 2010, Kraft et 
al., 2013, Kneller et al., 2006). Otros virus emplean mecanismos donde el RNA viral se 
une covalentemente a una proteína viral que recluta diferentes factores de iniciación de 
la traducción actuando de manera parecida a la estructura cap del mecanismo canónico 
(Lopez-Lastra et al., 2010, Kneller et al., 2006).  
 
3. INICIACIÓN DE LA TRADUCCIÓN EN SINV   
 
3.1 Iniciación de la traducción del sgRNA de SINV 
Numerosos elementos estructurales han sido identificados en el sgRNA de SINV 
que lo hacen particularmente eficiente para la traducción durante la infección en dos 
hospedadores distintos: células de mamífero y de insecto. Este sgRNA está formado por 
4105 nucleótidos (nt), sin incluir la secuencia de la cola poli(A), y dedica la mayor parte 
de su secuencia (3738 nt) a codificar la poliproteína estructural C-E3-E2-6K-E1. La 
secuencia codificante está flanqueada por dos UTRs (Hyde et al., 2015). La región 5’-UTR 
(49 nt) representa la secuencia leader y contiene una estructura cap de tipo 0 (N7mGppp) 
en su extremo 5’ (Hyde et al., 2015). La región 3’-UTR (323 nt) está organizada en tres 
dominios diferentes: una secuencia conservada de 19 nt cerca de la cola poli(A), una 
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secuencia rica en AU de unos 60 nt, y tres estructuras repetidas stem-loop que están 
presentes no sólo en los alfavirus, sino también en otros virus transmitidos por 
artrópodos y que parecen conferir traducibilidad a los mRNAs de manera específica de 
huésped (Dickson et al., 2012, Sokoloski et al., 2010, Barnhart et al., 2013, Hardy, 2006, 
Ou et al., 1982, Pfeffer et al., 1998, Gritsun and Gould, 2006, Garneau et al., 2008, Garcia-
Moreno et al., 2016). 
 Además de las 5’- y 3’-UTRs, otra estructura en forma de horquilla (hairpin) 
presente en la secuencia codificante desde la posición 77 a la 139 resulta fundamental 
para la traducción del sgRNA en células infectadas. Esta estructura hairpin, previamente 
denominada downstream loop (DLP) y actualmente renombrada como downstream 
stable hairpin (DSH), parece estar implicada en: 
 La independencia de eIF2 en la traducción del sgRNA en células de mamífero 
infectadas (McInerney et al., 2005, Ventoso et al., 2006, Sanz et al., 2017).  
 La colonización de hospedadores vertebrados y la consecuente expansión 
geográfica de los alfavirus por todo el mundo (Sokoloski et al., 2010, Ventoso, 
2012).  
 La señalización del codón exacto de iniciación para la traducción (Sanz et al., 2009, 
Frolov and Schlesinger, 1996, Sanz et al., 2019). 
El mecanismo de iniciación de la traducción del sgRNA y la selección del codón 
AUGi han sido estudiados en profundidad. En común con los mRNAs celulares, la 
iniciación de la traducción del sgRNA de SINV también ocurre siguiendo el mecanismo 
de scanning (Garcia-Moreno et al., 2013, Garcia-Moreno et al., 2015). Se ha sugerido que 
el primer evento en esta iniciación podría ser la interacción del eIF3, mediante su 
subunidad eIF3D, con la estructura cap en el extremo 5’, sin la participación del eIF4E ni 
del complejo eIF4F (Skabkin et al., 2010, Lee et al., 2016, Castello et al., 2006). Después 
del reconocimiento de la estructura cap, la subunidad ribosómica 40S puede 
interaccionar con el mRNA. A pesar de que no se conoce exactamente que eIFs se unen 
con la subunidad ribosómica 40S, el complejo ternario conteniendo eIF2 activo no se 
requiere para esta interacción, ni tampoco para el scanning de la secuencia leader 
(Garcia-Moreno et al., 2016). Igualmente, la potente inhibición del eIF4A mediante 
inhibidores específicos, como el hippuristanol (hipp), no afecta a la traducción del 
sgRNA, reforzando la idea de que el complejo eIF4F no está implicado en ella durante 
la fase tardía de la infección (Cencic et al., 2012, Castello et al., 2006, Garcia-Moreno et 
al., 2013, Sanz et al., 2013).  
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3.2 Inhibición de la traducción celular por SINV 
La mayoría de los virus animales con ciclo citolítico inducen una profunda 
inhibición de la síntesis de proteínas celulares en las células infectadas, especialmente 
durante la fase tardía de la infección, que podría interferir con la respuesta antiviral 
innata y facilitar que la maquinaria de síntesis de proteínas se dedique 
preferencialmente a traducir RNAs virales (Bushell and Sarnow, 2002, Fros and Pijlman, 
2016). En el caso de SINV, se ha observado que esta inhibición puede comenzar 
aproximadamente a partir de las 3 horas post-infección (hpi), aunque este punto 
depende de la línea celular y puede variar entre 3-8 hpi. Curiosamente, la inhibición de 
la síntesis de proteínas celulares es más fuerte en células de vertebrado que en células 
de mosquito (Garcia-Moreno et al., 2013, Sanz et al., 2015). La inhibición de la traducción 
de los mensajeros celulares y del gRNA viral ocurre en fases tardías de la infección, 
cuando el sgRNA dirige la síntesis de proteínas estructurales (Strauss and Strauss, 1994).  
Distintos mecanismos han sido sugeridos para explicar la inhibición de la síntesis 
de proteínas celulares mediada por SINV: (1) la fosforilación de la subunidad α del factor 
eIF2; (2) la competición de los mRNAs virales por la maquinaria de traducción celular; y 
(3) las modificaciones del entorno iónico. Atendiendo a la primera, eIF2 tiene un papel 
central en la traducción y su reciclaje de eIF2-GDP a eIF2-GTP se realiza por la acción de 
eIF2B. La actividad de eIF2 está altamente regulada por cuatro quinasas que responden 
a diferentes estímulos de estrés: (1) PKR (Protein Kinase R) se activa por la presencia del 
RNA de doble cadena en el citoplasma; (2) PERK (PKR-like ER Kinase) detecta proteínas 
no plegadas en el RE; y (3) GCN2 y (4) HRI (Heme-Regulated Inhibitor) se activan por 
falta de nutrientes o deficiencia en iones hemo, respectivamente (Koromilas, 2015). La 
fosforilación de la serina 51 de la subunidad α de eIF2 provoca la inactivación de este 
factor, ya que forma un complejo estable con eIF2B impidiendo el reciclado de 
eIF2-GDP a eIF2-GTP (Proud, 2005, Donnelly et al., 2013). Debido a que la cantidad de 
eIF2B en la célula es unas 10 ó 20 veces menor que la de eIF2, un pequeño porcentaje 
de eIF2 fosforilado basta para secuestrar todo el eIF2B, bloqueando el reciclaje de eIF2 
y, por tanto, la iniciación de la traducción (Hershey, 1989). La moléculas de RNA de doble 
cadena viral de SINV en el citoplasma se unen a PKR provocando cambios 
conformacionales que inducen su actividad quinasa y autofosforilación (Berglund et al., 
2007). En células de mamífero, PKR, una vez activada, fosforila también a eIF2α, 
bloqueando la traducción de los mRNAs celulares (McInerney et al., 2005, Ventoso et 
al., 2006, Sanz et al., 2009, Sanz et al., 2013). Sin embargo, en células deficientes en PKR, 
como en fibroblastos embrionarios de ratón (MEFs) PKR–/–, la infección por SINV también 
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produce este bloqueo a pesar de no observarse un aumento de la fosforilación de eIF2α, 
lo que sugiere que podría estar activándose otro mecanismo de inhibición (Gorchakov 
et al., 2004, Ventoso et al., 2006). 
La competición directa del sgRNA por la maquinaria de traducción celular no 
parece ser realmente necesaria para la inhibición de síntesis de proteínas celulares, ya 
que replicones de SINV que codifican sólo para nsPs y carecen de la secuencia 
correspondiente al sgRNA también logran inducir una profunda inhibición de la síntesis 
de proteínas celulares comparable a la observada en células infectadas con el virus wild-
type (wt) (Frolov and Schlesinger, 1994, Sanz et al., 2007, Patel et al., 2013). Por otra parte, 
como se ha descrito para varios virus, el desequilibrio de las concentraciones iónicas en 
el citoplasma de células infectadas por SINV podría estar implicado en el shut-off  de la 
traducción celular (Garry, 1994, Garry et al., 1979, Carrasco, 1978, Contreras and 
Carrasco, 1979, Nieva et al., 2012, Sanz et al., 2009, Sanz et al., 2007). 
Varios trabajos apuntan a que el proceso de replicación de RNAs virales en el 
citoplasma podría ser el responsable de inducir esta inhibición. De hecho, el shut-off 
celular disminuye en presencia de inhibidores que reducen la replicación de RNA viral o 
en infecciones con virus mutantes defectivos en replicación (Sanz et al., 2015). La 
replicación de RNA viral genera altos niveles de secuencias virales en el citoplasma que 
inducen una redistribución de las proteínas nucleares, especialmente de proteínas que 
se unen al RNA (Sanz et al., 2015, Patel et al., 2013, Barnhart et al., 2013). La salida de 
proteínas nucleares, como TIA-1 (T-cell restricted intracelular antigen-1 ) o PTB 
(polypyrimidine tract binding protein ), claramente puede detectarse en células 
infectadas por SINV, pero no en contextos de replicación viral reducida (Sanz et al., 
2015). Por tanto, una alta tasa de replicación viral es necesaria para que se induzca la 
inhibición de la síntesis de proteínas celulares, y es probable que uno de los factores 
con mayor relevancia en este evento sea la relocalización de las proteínas nucleares. 
Esta relocalización puede implicar tanto la salida de proteínas nucleares que activen 
rutas para el bloqueo de la síntesis de proteínas celulares, como el secuestro de 
componentes nucleares necesarios para la expresión de proteínas celulares, debido a la 
actividad tipo esponja de los mRNAs virales (Barnhart et al., 2013). La futura 
caracterización de las proteínas que interaccionan específicamente con los mRNAs 
virales o celulares a tiempos tardíos de la infección por SINV podría esclarecer este tipo 
de inhibición. Recientemente se ha caracterizado mediante la técnica de comparative 
RNA-interactome capture (cRIC) el compendio de proteínas de unión al RNA (RBPs) cuya 
actividad de unión al RNA se ve estimulada o disminuida en respuesta a la infección por 
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SINV. Esta infección parece alterar la actividad de 245 RBPs mediante cambios en la 
localización subcelular de estas proteínas o en la disponibilidad de los mRNAs. Esta 
remodelación de las RBPs resulta esencial para que la infección viral sea efectiva (Garcia-
Moreno et al., 2019). 
3.3 La traducción sin eIF2 
Como se ha mencionado anteriormente, la infección por SINV induce la 
inactivación del factor eIF2 mediante la fosforilación de su subunidad α por la quinasa 
PKR, sin embargo, la traducción del sgRNA no depende de eIF2. Varios trabajos apuntan 
a que el DSH, localizado entre 27 y 89 nt downstream del AUGi, es crucial para traducir 
este mRNA cuando eIF2 está inactivado (Garcia-Moreno et al., 2013, McInerney et al., 
2005, Ventoso et al., 2006, Sanz et al., 2013). También se ha especulado que, a pesar de 
que la mayoría del eIF2α está fosforilado en las células infectadas por SINV, una pequeña 
porción de eIF2 permanece activo en cercana proximidad a la maquinaria de traducción 
asociada a los sgRNA. En discordancia con esta hipótesis, se confirmó que en variantes 
del sgRNA de SINV con dos codones de iniciación AUG seguidos y en correcto marco 
de lectura, tras la fosforilación de eIF2 sólo la traducción dirigida por el AUG más 
cercano al DSH fue resistente (Garcia-Moreno et al., 2015). 
En trabajos anteriores se propuso que la función del eIF2 en células infectadas por 
SINV podría ser reemplazada por otros factores celulares como el eIF2A (Ventoso et al., 
2006). A pesar de que el eIF2A se descubrió hace varios años, su actividad en células de 
mamífero continúa siendo desconocida, y en levaduras la deleción de su ortólogo no 
tiene efecto en la viabilidad celular (Zoll et al., 2002). Inicialmente se demostró que eIF2A 
puede interaccionar con el Met-tRNAiMet y transportarlo al ribosoma (Merrick and 
Anderson, 1975). Sin embargo, empleando sistemas artificiales se comprobó que esta 
unión con el tRNA era independiente de GTP y mucho menos eficiente que la observada 
con eIF2 (Golovko 2016). Por otra parte, se observó que eIF2A tampoco consigue 
promover la unión del Met-tRNAiMet al mRNA de globina (Adams et al., 1975). 
Descubrimientos recientes sugieren que eIF2A está implicado en la traducción de 
algunos mRNAs celulares especializados que inician su traducción en codones no-AUG, 
como UUG y CUG (Liang et al., 2014, Starck et al., 2016). Resulta de interés que la 
participación de eIF2A en la iniciación de la traducción en ORFs upstream (uORFs) 
no-convencionales ha hecho que se relacione este factor con la progresión de algunos 
procesos cancerosos (Sendoel et al., 2017). Sorprendentemente, el desarrollo de ratones 
con el gen eIF2A delecionado es completamente normal, lo cual indica que eIF2A no es 
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requerido para la traducción de mRNAs normales ni especializados en ratones (Golovko 
et al., 2016).  
Otro posible factor sustitutivo del eIF2 en la iniciación de la traducción del sgRNA 
de SINV es el eIF2D (Skabkin et al., 2010). Inicialmente se asoció este factor con el 
desplazamiento del tRNA deacetilado y del mRNA de la subunidad ribosómica 40S para 
su reciclaje. Además, eIF2D podría interferir con la formación del complejo de iniciación 
48S promovida por eIF2 (Skabkin et al., 2010). eIF2D puede formar un complejo con el 
Met-tRNAiMet de forma independiente de GTP, y después interaccionar con la subunidad 
40S ribosómica para llevar el tRNAi al sitio P ribosómico (Dmitriev et al., 2010). Tras 
determinarse la estructura cristalográfica de este factor, se observaron dos dominios 
diferentes: el dominio SUI1 que presenta una estructura similar a un dominio del eIF1 
(factor crucial para el scanning y la selección del codón iniciador), y el dominio 
SWIB/MDM2 (Vaidya et al., 2017). A pesar de estos esfuerzos, aún existe mucha 
controversia en cuanto al papel de estos factores en la traducción. 
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OBJETIVOS 
Los objetivos desarrollados en esta tesis doctoral han sido: 
1. Estudio del efecto de inhibidores selectivos de eIFs, en concreto del eIF4A y del 
eIF2, sobre el requerimiento de factores para la traducción de SINV en células de 
mamífero en diferentes fases del ciclo infectivo. 
 
2. Caracterización de la implicación de la estructura y la secuencia del mRNA en la 
traducción viral y el requerimiento de factores celulares. Determinar especialmente 
la estructura y función del DSH del sgRNA de SINV.  
 
3. Descripción del papel de los factores eIF2A y eIF2D como posibles sustitutos del 
eIF2 para la traducción de los mRNAs virales de SINV.  
 
4. Caracterización de los requerimientos de estructura del RNA y factores para la 
iniciación de la traducción en codones no-AUG, empleando como modelo el sgRNA 
de SINV.  
 
5. Determinación del requerimiento de factores eucarióticos para la traducción del 
mRNA de HCV en células de origen humano. 
 
6. Identificación de las proteínas que interaccionan con los mRNAs virales y celulares 
en células de mamífero infectadas por SINV y su dinámica durante el ciclo infectivo. 
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ARTÍCULO 1:  
Differential action of pateamine A on translation of genomic and subgenomic 
mRNAs from Sindbis virus 
El estudio de los eIFs implicados en la traducción de RNAs virales es clave en la 
identificación de dianas potenciales para bloquear la infección viral. En células de 
mamífero, SINV inhibe la traducción de los mRNAs celulares para favorecer la expresión 
de sus mRNAs, especialmente del sgRNA, y esta inhibición está estrechamente 
relacionada con la replicación viral (Sanz, Garcia-Moreno et al. 2015). En este trabajo se 
estudió en profundidad el papel del factor eIF4A y su implicación en la traducción tanto 
del gRNA como del sgRNA, con especial interés en el cambio de requerimiento de 
factores de iniciación para la traducción del sgRNA, que sucede a la par que el shut-off 
de la expresión de los mRNAs celulares. Con este objetivo, se empleó un compuesto 
inhibidor del eIF4A, la pateamina A (Pat A).  
En este artículo, se determinó el efecto de la Pat A en la traducción del gRNA, a 
tiempos tempranos de la infección por SINV, en células de riñón de hámster BHK (Baby 
Hamster Kidney ). Además, se estudió el efecto de este inhibidor sobre la traducción del 
gRNA viral fuera del contexto de infección. Para ello, se transfectaron células BHK con 
construcciones de RNA no replicativas, obtenidas mediante transcripción in vitro, que 
contenían luciferasa como gen reportero. En ambos casos, la Pat A induce una fuerte 
supresión de la traducción del gRNA de SINV. Por otra parte, la traducción del sgRNA 
de SINV se analizó en dos condiciones diferentes: (1) cuando deriva de la replicación 
viral - en células infectadas y en células transfectadas con replicones, y (2) fuera del 
contexto de replicación - en sistemas de traducción in vitro (lisado de reticulocitos de 
conejo, RRL) y en células transfectadas con sgRNAs obtenidos mediante transcripción in 
vitro. En el contexto replicativo, la traducción del sgRNA se vio escasamente inhibida 
tras el tratamiento con Pat A. Por el contrario, fuera del contexto de replicación viral, la 
Pat A sí inhibe la traducción del sgRNA.  
Finalmente, se comprobó que, al inicio de la fase tardía, el sgRNA necesita eIF4A 
para su traducción, pero a medida que avanza esta fase, se va volviendo más 
independiente de este factor. Esta independencia sólo ocurre en contextos donde el 
RNA de SINV está siendo replicado. Para examinar en qué momento ocurre este 
cambio, células BHK infectadas con SINV fueron tratadas con Pat A y la síntesis de 
proteínas fue determinada a diferentes hpi mediante la incorporación de metionina 
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marcada radiactivamente. A partir de las 4 hpi, se observó una mayor resistencia de la 
traducción del sgRNA de SINV a la Pat A. 
En este artículo, se demostró que la Pat A inhibe potentemente la traducción del 
gRNA de SINV, como se observa en la reducción de la síntesis de nsP1 y nsP2. Por otro 
lado, la síntesis de proteínas dirigida por el sgRNA es resistente a la acción de la Pat A 
a tiempos tardíos del ciclo infectivo. Curiosamente, el sgRNA es sensible a Pat A fuera 
del contexto de infección, como se ha observado en células transfectadas o sistemas in 
vitro, lo cual parece indicar que el sgRNA de SINV presenta un mecanismo dual de 
traducción.  
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a b s t r a c t
Pateamine A (Pat A) is a natural marine product that interacts speciﬁcally with the translation initiation
factor eIF4A leading to the disruption of the eIF4F complex. In the present study, we have examined the
activity of Pat A on the translation of Sindbis virus (SINV) mRNAs. Translation of genomic mRNA is
strongly suppressed by Pat A, as shown by the reduction of nsP1 or nsP2 synthesis. Notably, protein
synthesis directed by subgenomic mRNA is resistant to Pat A inhibition when the compound is added at
late times following infection; however, subgenomic mRNA is sensitive to Pat A in transfected cells or in
cell free systems, indicating that this viral mRNA exhibits a dual mechanism of translation. A detailed
kinetic analysis of Pat A inhibition in SINV-infected cells demonstrates that a switch occurs approxi-
mately 4 h after infection, rendering subgenomic mRNA translation more resistant to Pat A inhibition.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Translation of cellular and viral mRNAs can take place by a
number of mechanisms depending on the mRNA and the context
of its translation. The vast majority of cellular mRNAs contain a cap
structure at their 5ʹ end and are translated following the canonical
mechanism that involves the recognition of the cap structure by
the heterotrimeric factor eIF4F followed by the interaction of the
preinitiation 43S complex with the mRNA (Sonenberg and
Hinnebusch, 2009). The eIF4F complex is composed of the cap-
binding factor eIF4E, the helicase and ATPase enzyme eIF4A and
the scaffolding protein eIF4G (Gingras et al., 1999). Unwinding of
the secondary structure present in the mRNA leader sequence is
accomplished by eIF4AI or eIF4AII, which are functionally inter-
changeable isoforms with 90% similarity (Parsyan et al., 2011).
After RNA unwinding, the 40S ribosomal subunit containing
several initiation factors linearly scans the leader sequence until
an AUG codon is encountered in a good sequence context (Kozak,
1991). Initiation of translation can also occur by a mechanism
which is independent of the cap structure whereby initiation takes
place at an internal sequence located at the 5ʹ untranslated region
(5ʹ-UTR) of the mRNA, known as the Internal Ribosome Entry Site
(IRES) (Au and Jan, 2014; Komar et al., 2012; Niepmann, 2009).
This element promotes the direct interaction of preinitiation
complexes, or even 40S ribosomal subunits, to an internal region
of the mRNA leader sequence that can be followed by scanning
until the initiation codon is reached (Au and Jan, 2014; Chamond
et al., 2014). The number of eIFs that participate in this initiation
mechanism, as well as the molecular events that occur to build up
the 80S initiation complex, depends on the particular IRES
analyzed. Yet another mechanism of translation has been observed
with Sindbis virus (SINV) subgenomic mRNA (sgmRNA), which
contains a cap structure and is translated by a scanning mechan-
ism of its leader sequence, where cap recognition and linear
scanning are accomplished without the participation of crucial
eIFs, such as eIF2 or eIF4A (Garcia-Moreno et al., 2014). SINV
belongs to the alphavirus genus in the Togaviridae family and
contains a positive-stranded RNA as genome, which is delivered to
the cytoplasm after virus entry (Brown and Hernandez, 2012;
Schlesinger and Schlesinger, 1996; Strauss and Strauss, 1994). This
genomic mRNA (gmRNA) directs the synthesis of early nonstruc-
tural proteins (nsP1-4), which are involved in RNA replication and
transcription. In contrast, the sgmRNA is transcribed and trans-
lated in the late phase of the virus life cycle and gives rise to the
production of structural proteins concomitant with the inhibition
of cellular mRNA translation (Sanz et al., 2014). Interestingly, SINV
sgmRNA exhibits a dual mechanism of translation depending on
the context in which it is translated. Thus, translation of this mRNA
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does not require eIF2, eIF4G nor eIF4A in infected cells (Castelló
et al., 2006; Garcia-Moreno et al., 2013; Sanz et al., 2009; Ventoso
et al., 2006). In contrast, these factors are necessary to initiate
protein synthesis on sgmRNA in cell free systems or in trans-
fected cells.
Inhibitors of cellular functions are very valuable as therapeutic
agents, but they also represent important tools to help unravel the
molecular events involved in a given cellular or viral process. This
is the case for translation inhibitors, which have been widely
employed to explore the processes of mRNA translation (Lindqvist
and Pelletier, 2009; Vázquez, 1979). More recently, high through-
put screening methods have led to the discovery of a number of
new translation inhibitors with promising applications in mole-
cular biology (Cencic et al., 2011, 2012). One such molecule is
pateamine A (Pat A), a natural marine compound synthesized by
the sponge Mycale sp. (Hood et al., 2001; Low et al., 2007). Pat A
targets eIF4A and enhancing its helicase and ATPase activities
disrupts its interaction with eIF4G while promoting the formation
of a stable complex between eIF4A and eIF4B (Bordeleau et al.,
2005, 2006; Low et al., 2005). This disruption may lead to an
inhibition of the interaction of the preinitiation complexes with
mRNA (Bordeleau et al., 2006), or to the stalling of initiation
complexes at the leader region of mRNA in vitro (Low et al., 2005).
Thus, translation of capped mRNAs that require the eIF4F complex
is blocked. In contrast, hepatitis C virus (HCV) mRNA is not
inhibited by Pat A, although other mRNAs bearing picornavirus
IRES elements are blocked by this compound (Bordeleau et al.,
2006; Low et al., 2005). Additionally, Pat A induces the formation
of stress granules (SG) by a pathway independent of eIF2α
phosphorylation (Dang et al., 2006). In the present work, we have
tested the activity of Pat A on the translation of SINV gmRNA and
sgmRNA, both of which contain a cap-structure at the 5ʹ end. Our
results show that protein synthesis directed by sgmRNA is resis-
tant to Pat A inhibition, whereas gmRNA translation is blocked.
Moreover, resistance of sgmRNA to Pat A is only observed in SINV-
infected cells, but not when this mRNA is translated out of the
infection context. This represents the ﬁrst example of a capped
mRNA that is resistant to Pat A.
Results
Early translation of SINV gmRNA. Inhibition of nsP synthesis by Pat A
The ﬁrst step in the SINV replication cycle after virus entry is
the translation of the input gmRNA that has been delivered to the
cytoplasm (Hernandez et al., 2014). The schematic representation
of gmRNA, sgmRNA and the different constructs used in this work
are shown in Fig. 1a. To analyze the action of Pat A on translation,
BHK cells were initially infected with SINV for 1 h to allow virus
entry. Then, increasing amounts of the inhibitor were added and
cells were incubated for one additional hour. Synthesis of nsP1and
nsP2 was analyzed by immunoblotting using speciﬁc polyclonal
antibodies. Used at a concentration of 100 nM, Pat A markedly
inhibited the synthesis of nsP1 and nsP2 (Fig. 1b and c). Next,
translation of gmRNA was assayed by transfection of a non-
replicative RNA lacking most of the coding region of nsP4 and
bearing the luciferase gene embedded within the nsP3 sequence
(see SV-Luc ΔnsP4 scheme in Fig. 1a). Synthesis of luciferase
directed by this mRNA was strongly inhibited by Pat A in
transfected BHK cells (Fig. 1d). The extent of inhibition was similar
to that observed with a control cap-Luc mRNA, whereas synthesis
of luciferase directed by CrPV IGR-Luc mRNA was moderately
stimulated by Pat A. The cap-Luc contains the cellular leader
sequence of luciferase mRNA, while CrPV IGR IRES has the
intergenic region (IGR) from cricket paralysis virus (CrPV) genome
that confers translatability in the absence of any eIFs (Jan and
Sarnow, 2002). This ﬁnding indicated that Pat A has no effect on
the elongation or termination steps of translation and is consistent
with the idea that Pat A is a selective inhibitor of eIF4A. Therefore,
SINV gmRNA requires this initiation factor for its translation early
during infection.
To further analyze the synthesis of nsPs and to test the
formation of SG by Pat A, BHK cells were treated with Pat A or
sodium arsenite, an inducer of oxidative stress, and immunocy-
tochemistry was used to analyze SG formation. Treatment of
control uninfected BHK cells with Pat A (400 nM) resulted in
TIA-1 release from the nucleus to the cytoplasm and stimulated
formation of SGs at a level similar to that observed with sodium
arsenite (Fig. 2). As expected, the synthesis of nsP2 was dimin-
ished by Pat A in SINV infected cells, as assessed by reduced
staining with an antibody against nsP2 (Fig. 2). The amount of
nsP2 observed in presence of 200 μM sodium arsenite may
correspond to partial inhibition by this compound. Formation of
SG was abrogated in SINV-infected cells at 3 h post infection (hpi),
perhaps due to the production of nsP3 before treatment with the
inhibitors (Panas et al., 2012).
Previous observations indicated that Pat A blocks eIF4A in an
irreversible manner (Bordeleau et al., 2005; Low et al., 2005). Thus,
we tested the potential irreversibility of Pat A inhibition directly
on protein synthesis in SINV infected cells in order to assess the
blockade of other steps of SINV replication, such as the synthesis of
late viral proteins. To this end, BHK cells were infected with SINV
(10 pfu/cell) and cells were treated from 2 to 3 hpi with 200 nM
Pat A. Subsequently, the inhibitor was extensively washed out and
cells were replenished with fresh medium and protein synthesis
monitored for several hours after washing. As shown in Fig. 3, the
application of Pat A in uninfected cells for only 1 h potently
blocked cellular mRNA translation even several hours after wash-
ing off the inhibitor. On the other hand, Pat A strongly blocked the
remaining cellular mRNA translation, and also late viral proteins in
SINV-infected BHK cells treated from 2–3 hpi. This blockade
extended over the ensuing hours even in the absence of Pat A,
demonstrating that this compound exerts an irreversible inhibi-
tion of translation.
Translation of SINV sgmRNA to produce late viral proteins. Action of
Pat A
Viral RNA replication gives rise to the negative-stranded RNA,
which contains two promoters: one located at the 3ʹ-end and one
located internally. Viral transcription using this internal promoter
on negative RNA generates sgmRNA. Translation of this messenger
gives rise to the structural viral proteins, which are synthesized as
a large precursor that is proteolytically cleaved to render the
mature viral proteins. The initiation of translation of sgmRNA at
late stages of infection is carried out by a mechanism that does not
require certain eIFs (Garcia-Moreno et al., 2013, 2014; Sanz et al.,
2009, 2013). The inhibition of the synthesis of SINV structural
proteins was examined by radioactive labeling from 5 to 6 hpi
using different concentrations of Pat A. Translation of cellular
mRNAs was blocked by 32.5% with 100 nM Pat A and this
inhibition increased to 70% with 200 nM Pat A (Fig. 4a and b). At
these concentrations, the translation of SINV sgmRNA was only
marginally affected and a concentration of 400 nM Pat A was
required to provoke a reduction of viral protein synthesis of 50%.
However, this inhibition may not have been due solely to the
blockade of eIF4A activity, but perhaps also to side-effects of the
inhibitor on other cellular functions. Nevertheless, it can be
concluded that a concentration of Pat A that reduced cellular
protein synthesis by approximately 70% inhibited SINV sgmRNA
translation by only 20%, suggesting that initiation of translation
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of this viral messenger does not require eIF4A or intact eIF4F
complex at later times of the viral life cycle. Of note, the inhibition
of endogenous translation was less efﬁcient when compared with
transfected cap-Luc mRNA (Fig. 1c). This result is consistent with
the idea that disruption of the eIF4F complex has a greater impact
on de novo translation of mRNAs as compared to protein synthesis
directed by preexisting mRNAs already engaged in the polysome
(Novoa and Carrasco, 1999).
As with most alphaviruses, SINV is an arthropod borne virus
(arbovirus) that has two natural hosts for its transmission. Thus,
aside from vertebrate cells, SINV also infects insect cells, giving rise
to a productive infection without apparent inhibition of host
protein synthesis. Therefore, we next explored the action of Pat
A on translation in mosquito C6/36 cells infected of SINV (10 pfu/
cell) and treated with different concentrations of the compound.
As a control, the activity of Pat A was also examined in uninfected
Fig. 1. Translation of SINV gmRNA. Effect of Pat A. (a) Schematic representation of the RNAs employed in this work. (b) BHK cells were mock-infected or infected with SINV at
a multiplicity of infection (MOI) of 10 pfu/cell. At 1 hpi, cells were treated with vehicle or Pat A for 1 h at the indicated concentrations. SINV proteins nsP2 (upper panel) and
nsP1 (lower panel) were analyzed by western blot. The results shown are representative of three independent experiments. (c) Densitometric values of western blots of the
viral proteins nsP1 and nsP2 are expressed as the percentage of untreated samples. The results represent the mean7SD of three independent experiments. (d) In vitro
synthesized RNAs gmRNA SV-Luc ΔnsP4, RNA cap-Luc and CrPV IGR-Luc were transfected into BHK cells with Lipofectamine 2000. Different concentrations of Pat A (50, 100,
200 and 400 nM) or cycloheximide (100 mg ml1) were added at 1 hpt and cells were incubated for 1 h before analysis of luciferase activity. Values obtained from
cycloheximide-treated cells were used to subtract the amount of luciferase synthesized prior to Pat A addition. Luciferase activity values of Pat A-treated cells are expressed
as percentage of untreated samples. The results represent the mean7SD of three independent experiments.
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mosquito cells. Analogous to vertebrate cells, protein synthesis
was also inhibited by Pat A in insect cells (Fig. S1). In contrast,
sgmRNA translation at 7 hpi was more resistant to inhibition by
Pat A than cellular protein synthesis, even though the shut-off of
host translation does not occur in mosquito cells. Therefore, the
translation of sgmRNA appears to be more eIF4A/eIF4F-dependent
in insect cells than in vertebrate settings. This result indicates that
the resistance to Pat A in infected cells is speciﬁc for sgmRNA
translation and does not occur with other mRNAs that are
translated in the same cell.
It should be possible that Pat A resistance of SINV sgmRNA was
due to the fact that it is synthesized in large amounts from SINV
replicons and that these newly-synthesized mRNAs are located in
speciﬁc foci in close proximity to components of the protein
synthesizing machinery (Sanz et al., 2009). To test this possibility,
the sequence of luciferase gene preceded by a cellular IRES
element was cloned in place of SINV sgmRNA (see rep BiP-Luc
scheme Fig. 1a). The sgmRNA that is rendered after transfection of
rep BiP-Luc bears the IRES from the cellular mRNA that encodes for
the chaperone BiP (binding immunoglobulin protein). Translation
of this mRNA is independent of eIF2α phosphorylation (Fernandez
et al., 2002) and therefore can be translated in BHK cells that
replicate SINV RNA. Interestingly, Pat A strongly blocked luciferase
synthesis directed by this mRNA, indicating that it requires eIF4A
for translation under these conditions (Fig. 5). As a control SINV
rep Cþ luc was tested. In this case, the inhibition of sgmRNA
translation by Pat A was lower as compared to rep BiP-Luc.
Luciferase synthesis was assayed by measuring its activity
(Fig. 5). In conclusion, only protein synthesis directed by SINV
sgmRNA was resistant to Pat A, whereas under the same condi-
tions translation driven by a cellular IRES was sensitive to this
inhibitor.
Pat A inhibits sgmRNA translation out of the viral infection context
We next questioned whether the resistance of sgmRNA trans-
lation to Pat A was an intrinsic property of the RNA structure or
whether such a resistance was due to conditions existing in cells
Fig. 2. Pat A-induced formation of stress granules. Blockade by SINV infection. BHK cells seeded on glass coverslips were mock-infected or infected with SINV (MOI of 10 pfu/
cell). At 2 hpi, cells were treated or not with Pat A (400 nM) or sodium arsenite (200 mM) for 1 h. At 3 hpi, cells were ﬁxed, permeabilized and processed for
immunoﬂuorescence using anti-TIA-1 (red), anti-nsP2 (green) and DAPI (blue). Images were acquired with a confocal microscope and subsequently processed with Zeiss Zen
2010B sp1 and Zen 2008 software (Zeiss). Merged images show the simultaneous visualization of TIA-1, nsP2 and nucleic acids. Scale bar represents 30 mm. The results
shown are representative of three independent experiments.
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replicating SINV RNA. Initially, different mRNAs, including
sgmRNA, were transfected into BHK cells and luciferase synthesis
was measured after addition of increasing concentrations of Pat A.
Cycloheximide was added at the same time and served to establish
the amount of luciferase synthesized before the addition of Pat A,
and this was subtracted from these samples. As positive controls of
Fig. 3. Pat A blocks protein synthesis in an irreversible manner. (a) BHK cells were infected with SINV at a MOI of 10 pfu/cell for 1 h. Cells were then treated or not with Pat A
(200 nM) from 1 to 2 hpi. Subsequently, Pat A was washed out and replaced by fresh medium. At the indicated times, cells were labeled with [35S]MetCys for 1 h.
Radiolabeled proteins were separated by SDS-PAGE, followed by autoradiography. The results shown are representative of three independent experiments. (b) The
percentage of cellular (actin) and (c) viral C protein synthesis in cells treated or not with Pat A (200 nM) were calculated from values obtained by densitometric scanning of
the corresponding bands. The results are mean7SD of three independent experiments.
Fig. 4. Action of Pat A on the translation of SINV sgmRNA. (a) BHK cells were either mock-infected or infected with SINV (MOI of 10 pfu/cell). From 5 to 6 hpi, cells were
treated or not with the indicated concentrations of Pat A while they were labeled with [35S]MetCys. Radiolabeled proteins were separated by SDS-PAGE, followed by
autoradiography. The results shown are representative of three independent experiments. (b) Values of cellular and viral protein synthesis were obtained by densitometric
scanning of the radioactive signal and are expressed as the percentage of untreated samples. The results represent the mean7SD of three independent experiments.
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mRNAs that utilize eIF4A, we employed the eIF4A-dependent cap-
Luc and IRES EMC-Luc mRNAs. CrPV IGR-Luc and IRES HCV-Luc
mRNAs served as negative controls as these are not dependent on
eIF4A for initiation. As shown in Fig. 6a, SINV sgmRNAwas blocked
by Pat A in transfected BHK cells to an extent similar to that
observed with cap-Luc mRNA, while CrPV IGR-Luc and IRES HCV-
Luc mRNAs were in fact stimulated by Pat A. This stimulation was
presumably due to the fact that the inhibition of cellular mRNA
translation avoids the competition with translation driven by CrPV
or HCV IRES. In contrast, IRES EMC-Luc mRNA was partially
inhibited by Pat A, in agreement with in vitro results (Bordeleau
et al., 2005; Low et al., 2005). Further evidence that Pat A could
inhibit sgmRNA translation out of the context of active infection
was obtained through in vitro translation assays using rabbit
reticulocyte lysates (RRL). Increasing concentrations of Pat A
inhibited in vitro translation directed by sgmRNA CþLuc as well
as by cap-Luc or IRES EMC-Luc mRNAs (Fig. 6b). Interestingly, the
optimal translation of sgmRNA CþLuc required high concentra-
tions of KCl (Fig. 6c), as occurs with a variety of viral mRNAs which
are translated late during infection (Koch et al., 1980). Moreover,
the inhibition of sgmRNA CþLuc translation by Pat A was higher at
the optimal concentration of KCl (Fig. 6c). Collectively, these
ﬁndings indicate that the structure of sgmRNA is not responsible
for its resistance to inhibition by Pat A in infected cells; instead,
this viral messenger requires eIF4A for initiation of protein synth-
esis in uninfected cells.
Determination of the stage during SINV infection when translation
becomes resistant to eIF4A
To further assess the activity of Pat A on sgmRNA translation in
BHK cells that replicate SINV RNA, we made use of rep CþLuc (see
scheme, Fig. 1a). This SINV replicon was ﬁrstly synthesized by
in vitro transcription from the corresponding plasmid. After
transfection of rep CþLuc, C protein was analyzed at two distinct
time points in order to assess viral C production early during the
late phase or at later times. The activity of Pat A on the production
of C protein from 3 to 5 or from 6 to 8 h post transfection (hpt) was
estimated by western blotting using speciﬁc rabbit polyclonal
antibodies (Fig. S2). As a control, we measured in parallel the
amount of protein C synthesized prior to Pat A treatment by
adding cycloheximide. Surprisingly, 100 nM Pat A was strongly
inhibitory (91%) for C production at early times of the late phase,
whereas this inhibition was lower (20%) as replication progressed
(Fig. S2). These ﬁndings suggested that sgmRNA translation
requires eIF4A at early times and becomes less dependent on this
factor at later infection times.
Additionally, the above results indicated that gmRNA transla-
tion was sensitive to inhibition by Pat A very early during SINV
infection (Fig. 1), whereas at late times sgmRNA translation was
more resistant to the inhibition of eIF4A (Fig. 4). This behavior of
sgmRNA to Pat A only occurs in SINV-infected cells or in cells
replicating SINV RNA (Fig. S2), suggesting that when viral infection
progresses there is a switch from a mechanism of initiation of
protein synthesis dependent on eIF4A to a mode of translation that
is less dependent of this factor. To determine more accurately
when this switch takes place, SINV-infected cells were treated
with 200 nM Pat A at different hpi and protein synthesis was
analyzed by radioactive labeling followed by SDS PAGE and
ﬂuorography. During the initial hours of infection, cellular transla-
tion was potently blocked by Pat A (Fig. 7a and b). Conversely, the
synthesis of viral C protein was observed from 2 hpi and was
concomitant with the increased shut-off of cellular protein synth-
esis. Notably, from 2–3 and 3–4 hpi, the synthesis of C protein was
drastically reduced by Pat A, whereas from 4 hpi sgmRNA transla-
tion became more resistant to the inhibitor (Fig. 7a–c). Therefore,
at early periods during the late phase sgmRNA translation was
sensitive to Pat A, suggesting that a change occurs after that time
which confers less dependency on eIF4A for the initiation of
translation of sgmRNA in infected cells (Fig. 7c). Thus, Pat A
constitutes a good tool for future studies to investigate the
molecular nature of this switch. Further support to the concept
that sgmRNA translation is more dependent on eIF4A at early
times of the late phase was obtained by hippuristanol, the other
selective inhibitor of eIF4A (Garcia-Moreno et al., 2013). Indeed,
analysis of the inhibition of sgmRNA translation at different times
p.i. by hippuristanol clearly indicates that this inhibition varies and
becomes more resistant as infection progresses (Fig. S3).
Discussion
From the perspective of therapeutic agents and molecular tools,
marine organisms are providing a very interesting number of natural
compounds for investigation (Singh and Pelaez, 2008; Stonik and
Fedorov, 2014; Vera and Joullié, 2002). Since the discovery of didem-
nins, the ﬁrst marine natural products administered to humans (Lee
et al., 2012), the number of new inhibitors of cellular functions from
marine sources continues to rise (Skropeta and Wei, 2014). This is the
case for hippuristanol and Pat A, two natural compounds produced by
invertebrate marine organisms (Lindqvist and Pelletier, 2009). These
Fig. 5. Luciferase synthesis from rep CþLuc and rep BiP-Luc. Action of Pat A. BHK cells were transfected with in vitro synthesized RNAs rep CþLuc and rep BiP-Luc with
Lipofectamine 2000. Different concentrations of Pat A (25, 50 and 100 nM) or cycloheximide (100 μg ml1) were added at 5 hpt and cells were incubated for 2 h before
analysis of luciferase activity. Values obtained from cycloheximide-treated cells were used to subtract the amount of luciferase synthesized prior to Pat A addition. Luciferase
activity values of Pat A-treated cells are expressed as percentage of untreated samples. The RLU values obtained once the luciferase obtained in presence of cycloheximide
was subtracted were rep CþLuc: 48644047359965.9; rep BiPþLuc: 15918187135304.5. These luciferase values were taken as 100% of control. The results represent the
mean7SD of three independent experiments.
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Fig. 6. Translation of sgmRNA outside the viral infection context. Activity of Pat A. (a) In vitro synthesized sgmRNA CþLuc and control RNAs eIF4A-dependent (RNA cap-Luc
and IRES EMCV-Luc (left panel)) and eIF4A-independent (IRES HCV-Luc and CrPV IGR-Luc (right panel)) were transfected into BHK cells with Lipofectamine 2000. Cells were
then incubated with different concentrations of Pat A (50, 100, 200 and 400 nM) or cycloheximide (100 μg ml1) for 1 h before analysis of luciferase activity. Values obtained
from cycloheximide-treated cells were used to subtract the amount of luciferase synthesized prior to Pat A addition. Luciferase activity values of Pat A-treated cells are
expressed as percentage of untreated samples. The results are mean7SD of three independent experiments. (b) CrPV IGR-Luc (upper panel), sgmRNA CþLuc (medium
panel) and RNA cap-Luc (lower panel) were generated by in vitro transcription using T7 RNA polymerase and then, in vitro translated using nuclease-treated rabbit
reticulocyte lysate (RRL), programmed with 200 ng of the different mRNAs. Luciferase activity values of Pat A-treated cells are expressed as percentage of untreated samples.
The results are mean 7 SD of three independent experiments. (c) Effect of potassium [Kþ] on in vitro translation of sgmRNA CþLuc and its inhibition by Pat A. In vitro
transcribed sgmRNA CþLuc (200 ng) was translated in RRL at different concentrations of [Kþ] (80, 100, 120, 140, 160 and 180 mM) and treated or not with 200 nM of Pat A.
Luciferase activity results are mean7SD of three independent experiments. The percentage values of Pat A-treated cells relative to their respective untreated cells are
indicated in the ﬁgure.
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agents selectively inhibit the initiation of protein synthesis by targeting
eIF4A, thus blocking the activity of the eIF4F complex. These inhibitors
can be useful to ascertain the participation of eIF4A in the translation
of some cellular and viral mRNAs. As reported in this work, Pat A
strongly blocks the synthesis of SINV nsPs when used at early times
post infection. This inhibition of viral translation is irreversible such
that treatment for only 1 h is sufﬁcient to block the synthesis of viral
proteins at late times, as well as the inhibition of cellular translation.
The arrest of late viral protein synthesis is most likely due to the
inhibition of viral RNA replication and transcription that is accom-
plished by nsPs. Therefore, we can conclude that SINV gmRNA requires
eIF4A for translation and the blockade of nsP synthesis abrogates the
production of sgmRNA. The possibility that Pat Amay affect other steps
different to initiation is not supported by the ﬁnding that translation
driven by the CrPV IRES is not only resistant, but is actually stimulated
by Pat A, indicating that the elongation or termination processes of
mRNA translation are not affected by this compound. The stimulation
of CrPV IRES translation by Pat A may be a consequence of the
inhibition of cellular protein synthesis and the concomitant release
from mRNA competition. However, it is formally possible that Pat A
affects other cellular functions, such as the redistribution of nuclear
proteins, and that these reactions may affect sgmRNA translation at
high concentrations of Pat A. The potential repercussions of these
alterations for protein synthesis remains to be investigated, but we
believe that the most important activity of Pat A on mRNA translation
is its selective interaction with eIF4A, leading to the disruption of the
eIF4F complex (Bordeleau et al., 2005; Low et al., 2005).
The results obtained with Pat A on the translation of SINV sgmRNA
reinforce the view that eIF4A and the eIF4F complex are dispensable
in infected cells (Castelló et al., 2006; Garcia-Moreno et al., 2013; Sanz
et al., 2009). Thus, at concentrations of 200 nM Pat A there is a
profound inhibition of cellular translation, while sgmRNA is only
slightly blocked. Curiously, as observed with other translation inhibi-
tors, protein synthesis directed by sgmRNA is negatively affected out
of the replication complex (Garcia-Moreno et al., 2013). Therefore, our
present results with Pat A are consistent with the concept that this
messenger exhibits a dual mechanism for its translation and conse-
quently the structure of sgmRNA does not confer independence for
several eIFs (Sanz et al., 2009). This has been also clearly established
for the requirement of eIF2. In this case, there is a stem-loop structure
downstream of the AUG initiation codon (DLP) that confers eIF2
independence, but only in infected cells (Garcia-Moreno et al., 2013,
2014; McInerney et al., 2005; Ventoso et al., 2006). However, this DLP
structure is not involved in providing independence for eIF4A (Garcia-
Moreno et al., 2013). The structural requirements necessary for eIF4A-
independent translation of sgmRNA remain to be investigated.
SINV infected cells undergo a drastic modiﬁcation during infection,
from a Pat A-sensitive status at early times to a more resistant status
during the late phase of the viral cycle. Our kinetic analyses indicate
that this change occurs at about 4 hpi. From this time onwards,
translation of sgmRNA becomes independent of several eIFs, including
the eIF4F complex. Future studies will be needed to determine the
precise modiﬁcations that take place in SINV-infected cells to alter the
mechanism of initiation of translation.
Methods
Cell lines and viruses
The cell lines used in this work were Baby hamster kidney
(BHK-21) cells and Aedes albopictus C6/36 cells, both obtained from
Fig. 7. Time-course of Pat A resistance of sgmRNA translation. (a) BHK cells were infected with SINV (MOI of 10 pfu/cell). At the indicated times post infection, cells were
treated with vehicle or Pat A for 1 h at a concentration of 200 nM while they were labeled with [35S]MetCys. Radiolabeled proteins were separated by SDS-PAGE, followed
by autoradiography. The results shown are representative of three independent experiments. (b) The percentage of cellular (actin) and viral C protein synthesis in cells
treated or not with Pat A (200 nM) were calculated from values obtained by densitometric scanning of the corresponding bands. The results are mean7SD of three
independent experiments. (c) Inhibition of Pat A on viral C protein is represented as the percentage of corresponding untreated samples. These results represent the
mean7SD of three independent experiments.
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ATCC. BHK-21 cells were grown at 37 1C, 5% CO2 in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 5% fetal calf
serum (FCS). C6/36 cells were cultured at 28 1C without CO2 in M3
medium supplemented with 10% FCS. SINV derived from the
pT7SVwt infective clone was used (Sanz and Carrasco, 2001). Viral
infections of BHK-21 cells were carried out in DMEM without
serum for 1 h at 37 1C, whereas infections of C6/36 cells were
performed at 28 1C. Subsequently, medium was removed and
infection was continued in DMEM with 5% FCS or M3 medium
with 10% FCS, respectively, at the temperatures indicated. Infec-
tions with SINV were carried out at a multiplicity of 10 pfu per cell.
Plasmids and recombinant DNA procedures
The plasmids employed in this work are listed and described in
Table S1. Plasmids were used as DNA templates for in vitro
transcription with T7 or Sp6 RNA polymerases. pT7 SVwt (Sanz
and Carrasco, 2001) was used as the parental plasmid for all of the
constructs. The luciferase gene was derived from the plasmid pKS-
Luc (Sanz et al., 2007).
Plasmid rep Bip-Luc was prepared with a product obtained after
two consecutive PCRs between HpaI and SphI sites in rep Cþ luc. In the
ﬁrst PCR, oligonucleotides 50 HpaI (5ʹ-GCTATGGCGTTAACCGGTCTG-3ʹ)
and 30 Nexo SV-Bip (5ʹ-GGCCGGCGTCGACCTGCTGACTATTTAGG-3ʹ)
were used plus rep C+luc as DNA template. The other PCR product
was obtained using 50 Nexo SV-Bip (5ʹ-CCTAAATAGTCAGCAGGTC-
GACGCCGGCC-3ʹ) and 30 Luc SphI (5ʹ-CCCGGGGCATGCGAGAATCT-
GACGCAG-3ʹ) oligonucleotides plus pBS-BIP-IRES-FFL-pA as DNA
template, kindly provided from Dr. M. Hentze (EMBL Heidelberg,
Germany). Oligonucleotides 50 HpaI and 30 Luc SphI with a mixture
of the above products as DNA template were employed in the
next PCR.
Antibodies
Rabbit polyclonal antibodies raised against SINV C protein and
rat polyclonal antibodies raised against bacterially produced nsP1
were produced in our laboratory. Rabbit polyclonal anti-nsP2 was
a kind gift from Dr. Richard W Hardy (Indiana University, USA).
Goat polyclonal anti-TIA-1 was purchased from Invitrogen and
Santa Cruz Biotechnology. Anti-rabbit and anti-rat immunoglobu-
lin G antibodies coupled to peroxidase were purchased from
Amersham. Speciﬁc antibodies conjugated to Alexa 488 or Alexa
555 (A-21202 and A-21432 respectively) were obtained from
Invitrogen.
Inhibitors
The following chemical inhibitors were used: pateamine A was
puriﬁed as previously described (Bordeleau et al., 2005), hippur-
istanol (Bordeleau et al., 2006), sodium arsenite (Riedel-de Haën)
and cycloheximide (Sigma).
In vitro RNA transcription and translation
Linearized plasmids were used as templates for in vitro RNA
transcription using T7 or SP6 RNA polymerases (New England
Biolabs), as previously described (Garcia-Moreno et al., 2013).
In vitro translation was carried out in nuclease-treated rabbit
reticulocyte lysate (RRL) (Promega). One hundred nanograms of
in vitro transcribed mRNAs were added to the translation mixture.
Protein synthesis was estimated by measuring luciferase activity.
RNA transfection
In vitro transcribed RNAs were transfected using Lipofectamine
2000 (Invitrogen) according to the supplier's recommendations.
Measurement of luciferase activity
Luciferase activity was determined as described by Sanz et al.
(2014).
Analysis of protein synthesis and western blotting
Protein synthesis was analyzed at the indicated times by
replacing growth media for 1 h with 0.2 ml of methionine/
cysteine-free DMEM supplemented with 1 μl of EasyTagTM
EXPRESS 35S Protein Labeling, [35S]MetCys (11 mCi ml1, Perkin
Elmer) per well of an L-24 plate. Labeling medium also included
inhibitors when the action of these compounds was assayed.
Radioactive proteins and samples for western blotting were
analyzed as described (Garcia-Moreno et al., 2013). Protein synth-
esis was quantiﬁed by densitometry using a GS-800 Calibrated
Densitometer (Bio-Rad).
Immunoﬂuorescence assays
Fixation, permeabilization and confocal microscopy were per-
formed as described (Madan et al., 2008) using a confocal laser
scanning and multiphoton microscope LSM 710 coupled to an
inverted microscope (Axio Observer, Zeiss). Primary antibodies
used were: rabbit polyclonal anti SINV nsP2, and goat polyclonal
anti-TIA-1 at a 1:500 dilution. Speciﬁc antibodies conjugated to
Alexa 488 and Alexa 555 were employed as secondary antibodies
at a 1:1000 dilution. DAPI (4ʹ-6-diamidino-2-phenylindole) was
used to stain the nuclei.
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ARTÍCULO 2:  
Translation of Sindbis subgenomic mRNA is independent of eIF2, eIF2A and 
eIF2D 
En células de mamífero, la traducción del sgRNA de SINV no parece verse afectada 
por la inactivación del eIF2. Varios estudios han sugerido que la función del eIF2, 
suministrar Met-tRNAiMet, podría ser reemplazada, cuando está inactivado, por los 
factores eIF2A o eIF2D (Ventoso, Sanz et al. 2006, Kim, Park et al. 2011). Para determinar 
si eIF2A y eIF2D son requeridos en la traducción de mRNAs virales, se utilizaron líneas 
humanas semihaploides knock out (KO) estables (HAP1) para los factores eIF2A, eIF2D 
o ambos (Horizon Discovery Group plc). Inicialmente se comprobó que la viabilidad, la 
morfología y el crecimiento de estas líneas KO eran semejante al de la línea parental, 
HAP1 wt. Después, estas cuatro líneas fueron infectadas con SINV y se analizó la 
inhibición de la traducción celular y de la producción de proteínas virales en la fase tardía 
de la infección sin apreciar diferencias significativas entre las líneas HAP1 mencionadas. 
Adicionalmente, se confirmó que la producción de proteína viral en estas líneas celulares 
tampoco se veía afectada por la fosforilación del eIF2α, mediada por arsenito sódico. 
De forma paralela, se estudió la síntesis de proteínas tras el silenciamiento mediado por 
RNAs pequeños de interferencia (siRNAs) para eIF2A o el eIF2D en células HAP1 wt, 
HAP1 eIF2A– y HAP1 eIF2D–. Estos resultados reafirmaron los obtenidos anteriormente 
y descartaron que los pequeños péptidos amino-terminales de eIF2A o eIF2D que aún 
pudieran producirse en las líneas KO intervengan en la traducción del sgRNA. De esta 
forma, se pudo concluir que eIF2, eIF2A y eIF2D no son necesarios para la traducción 
del sgRNA de SINV durante la fase tardía de la infección. 
Por otra parte, se estudió la posible implicación de eIF2A y eIF2D en la iniciación 
de la traducción en codones no-AUG. Se mutó el AUGi del sgRNA de SINV a otros 
codones (CUG para leucina y GCG para alanina) en replicones de SINV con luciferasa 
como gen reportero. Las variantes mutadas mostraron una menor eficiencia en la 
producción de luciferasa en comparación con el replicón wt con AUGi. Sin embargo, no 
se encontraron diferencias en la síntesis de proteínas de cada uno de estos replicones 
entre las líneas HAP1, lo que descarta que eIF2A o eIF2D sean necesarios para iniciar en 
codones no-AUG. 
Los virus animales han evolucionado desarrollando una gran variedad de 
elementos estructurales en sus mRNAs que maximizan su expresión bajo las condiciones 
de estrés generadas durante la infección. El sgRNA de SINV contiene varios motivos 
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estructurales que promueven su traducción durante la fase tardía de la infección. Uno 
de estos motivos es el hairpin denominado DSH, que se localiza a 27 nt downstream del 
AUGi del sgRNA de SINV (considerando A como la posición +1) (Frolov and Schlesinger 
1996, Carrasco, Sanz et al. 2018). El DSH participa en la señalización correcta del codón 
de iniciación de la traducción del sgRNA y, por tanto, la alteración de su estructura 
conduce a una traducción con leaky scanning que inicia en otros codones AUG situados 
downstream (Frolov and Schlesinger 1996, Sanz, Castello et al. 2009, Garcia-Moreno, 
Sanz et al. 2015). En este trabajo, se analizó el papel del DSH en la señalización de CUG 
como codón de iniciación en la traducción del sgRNA. Para ello se transfectaron las 
líneas HAP1 wt, HAP1 eIF2A– y HAP1 eIF2D– con replicones que portaban el DSH 
desestructurado y AUG o CUG como codones de inicio. Los experimentos en las líneas 
HAP1 determinaron que eIF2A y eIF2D no estaban implicados en el reconocimiento del 
codón de iniciación y tampoco afectan a la función del DSH. Estos resultados apoyan la 
propuesta de que el eIF2 podría no ser reemplazado por ninguna proteína celular 
durante la traducción del sgRNA de SINV, sino que este mRNA viral podría haber 
evolucionado una estructura especializada que lo hace independiente de eIF2.  
 
 
 
 
 
 
 
SANZ, M. A., GONZALEZ ALMELA, E. AND CARRASCO, L. 2017. Translation of 
Sindbis Subgenomic mRNA is Independent of eIF2, eIF2A and eIF2D. Sci Rep 7: 
43876. 
1Scientific RepoRts | 7:43876 | DOI: 10.1038/srep43876
www.nature.com/scientificreports
Translation of Sindbis Subgenomic 
mRNA is Independent of eIF2, 
eIF2A and eIF2D
Miguel Angel Sanz, Esther González Almela & Luis Carrasco
Translation of Sindbis virus subgenomic mRNA (sgmRNA) can occur after inactivation of eIF2 by 
phosphorylation in mammalian cells. Several studies have suggested that eIF2 can be replaced by 
eIF2A or eIF2D. HAP1 human cell lines knocked-out for eIF2A, eIF2D or both by CRISPR/Cas9 genome 
engineering were compared with wild-type (WT) cells to test the potential role of eIF2A and eIF2D in 
translation. Sindbis virus infection was comparable between the four cell lines. Moreover, synthesis 
of viral proteins during late stage infection was similar in all four cell lines despite the fact that eIF2α 
became phosphorylated. These findings demonstrate that eIF2A and eIF2D are not required for the 
translation of sgmRNA when eIF2α is phosphorylated. Moreover, silencing of eIF2A or eIF2D by 
transfection of the corresponding siRNAs in HAP1 WT, HAP1-eIF2A− and HAP1-eIF2D− cells had 
little effect on the synthesis of viral proteins late in infection. Modification of AUGi to other codons 
in sgmRNA failed to abrogate translation. Sindbis virus replicons containing these sgmRNA variants 
could still direct the synthesis of viral proteins. No significant differences were found between the cell 
lines assayed, suggesting that neither eIF2A nor eIF2D are involved in the translation of this sgmRNA 
bearing non-AUG codons.
Upon infection of susceptible cells, animal viruses express their genomes to synthesize a number of viral proteins 
involved in genome replication and in the modulation of many cellular functions. Viral proteins are produced 
by translation of mRNAs that have evolved several structural characteristics to compete with cellular mRNAs. 
Accordingly, translation of some viral mRNAs follows a variety of virus-dependent non-canonical mechanisms. 
Sindbis virus (SINV), an alphavirus, has two different mRNAs that are translated at different times during infec-
tion. SINV genomic RNA is of positive polarity and is immediately translated early during infection to produce 
non-structural proteins (nsP1–4) that participate in genome replication and transcription1,2. The recognition of 
an internal promoter in the negative strand RNA that is complementary to the genomic RNA is necessary to initi-
ate synthesis of subgenomic mRNA (sgmRNA), the most abundant viral mRNA during the late phase of infection 
that directs the synthesis of structural proteins when cellular translation is drastically inhibited. SINV sgmRNA 
(4,105 nt without the poly(A) tail) devotes the bulk of its sequence (3,738 nt) to encode the structural proteins 
C-E3-E2-6K-E1, initially synthesized as a polyprotein. The coding sequence is flanked by two untranslated regions 
(UTR). The 5′ -UTR (49 nt) represents the leader sequence and contains a cap structure at its 5′ end. This leader 
sequence confers eukaryotic initiation factor complex, eIF4F, independence and is implicated in the shut-off of 
host translation3,4. It has been suggested that 80S ribosomes could directly interact with the AUG initiation codon 
without scanning by the preinitiation complex5; however, it has been demonstrated that scanning of the leader 
sequence is obligatory for sgmRNA translation6. For this scanning to occur, recognition of the cap-structure 
by eIF4E is likely not necessary since cleavage of eIF4G by poliovirus 2Apro or human immunodeficiency virus 
protease does not impede sgmRNA translation in SINV-infected cells3,7. The 3′ -UTR (323 nt) can be divided into 
three different domains. One region of 19 nt near to the poly-(A) tail is involved in RNA replication8,9, while an 
A/U-rich domain of about 60 nt interacts with the host protein HuR, participating in mRNA stability10–12. The 
240-nt-region located between the end of the coding region and the A/U-rich domain contains three repeated 
sequences13 and is involved in the stimulation of translation in insect cells14. This structure at the 3′ -UTR there-
fore constitutes a translational enhancer that functions in a cell-specific manner. Besides the aforementioned 
structures present at the 5′ -and 3′ -UTR, a hairpin in the coding sequence can be found located 77–139 nt from 
the 5′ end15. This downstream hairpin (DLP) is not a true enhancer of protein synthesis, but instead is involved in 
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conferring eIF2-independent translation of sgmRNA in infected mammalian cells16–18. A second important func-
tion of the DLP is to signal the precise codon at which to start translation7. Thus, DLP disorganization does not 
diminish translation in PKR-deficient mouse embryonic fibroblasts, but its translation is obstructed when eIF2 
is phosphorylated17,18. It is therefore interesting to note that sgmRNA translation can take place without an intact 
eIF4F complex and after eIF2 inactivation by eIF2α phosphorylation in SINV-infected cells, despite the fact that 
this mRNA does not contain an IRES motif19 and is translated by a scanning mechanism6.
The possibility that eIF2 function is replaced by other cellular factors has been proposed5,17. One such possibil-
ity is that eIF2A substitutes for eIF2 in SINV-infected cells. eIF2A is a 65 kDa protein that was described several 
years ago, but its precise function in mammalian cells remains unclear and deletion of the yeast orthologue has 
no effect on cell viability, although sporulation is affected20. Early results demonstrated that eIF2A can interact 
with Met-tRNAiMet to bind it to the ribosome21; however, this binding was much less efficient than that observed 
using genuine eIF2 on artificial templates and eIF2A was unable to promote the binding of Met-tRNAiMet to 
globin mRNA22. More recent results from mammalian cells suggest that eIF2A is involved in the translation of 
some specialized cellular mRNAs that initiate translation with non-AUG codons23,24. The finding that yeast eIF2A 
is found in 40S and 80S ribosomes suggests its involvement in the initiation of at least some mRNAs25. Indeed, 
eIF2A represses the translation of several yeast mRNAs bearing IRES structures26,27. Accordingly, the functioning 
of eIF2A in yeast and mammalian cells may differ.
A second possibility is that eIF2D initiates sgmRNA translation in place of eIF25. eIF2D has two functional 
domains: PUA and SUI128. The PUA domain is an RNA-binding domain found in several enzyme families, such 
as those that modify tRNA. The SUI1 domain, which is also found in eIF1, is involved in the recognition of the 
translation initiation codon. eIF2D is an initiation factor that was erroneously named ligatin5, but further studies 
demonstrated that eIF2D and ligatin were two different proteins29. Initially, eIF2D was purified from rabbit retic-
ulocyte lysates as a 65 kDa protein that could displace deacylated tRNA and mRNA from recycled 40S ribosomal 
subunits, and was also able to interfere with the formation of the 48S initiation complex promoted by eIF25. A 
complex between Met-tRNAiMet and eIF2D is formed in a GTP-independent fashion. This complex can interact 
with the 40S ribosomal subunit to deliver the initiator to the P site29. Accordingly, eIF2D has been considered as 
a true initiation factor, though the exact function of this protein in mammalian cells remains enigmatic. Akin to 
eIF2A, the orthologue of eIF2D is dispensable in yeast20,29, but comparable studies have not been performed in 
mammalian cells. Our present results show that human cells with a knock-out for eIF2A or eIF2D are viable and 
synthesize proteins in a manner similar to wild-type cells. In addition, by investigating the potential involvement 
of these two proteins for the translation of SINV sgmRNA, we demonstrate that these factors are not required for 
sgmRNA translation, even when eIF2α is phosphorylated. These findings support the novel proposal that eIF2 is 
not replaced by a cellular protein during the translation of SINV sgmRNA, instead this viral mRNA has evolved 
a specialized structure that makes it independent for eIF2. The consequences for the virus life cycle are that 
significant amounts of structural proteins can be produced upon the translation of sgmRNA even under stress 
conditions that appear after viral infection.
Results
Characterization of cell lines and translation of cellular mRNAs. We first assessed the viability and 
cellular translation of WT and KO cell lines. No differences were found in these parameters between HAP1 paren-
tal (HAP1 WT) and the two KO cell lines, HAP1-eIF2A− and HAP1-eIF2D−, and all cell lines display the same 
fibroblast-like morphology and grew equally well (results not shown). We next examined the expression of eIF2A 
and eIF2D by immunocytochemistry using specific antibodies. Double staining of HAP1 WT cells with Topro-3 
revealed that eIF2A was clearly expressed in the cytoplasm and a proportion was also found in the nucleus, 
whereas eIF2D was mainly expressed in the cytoplasm (Fig. 1A). As anticipated, eIF2A was detected both in WT 
and HAP1-eIF2D− cells, but not in HAP1-eIF2A− cells (Fig. 1A). A similar result was found for eIF2D expression 
(Fig. 1A). Loss of eIF expression in the respective KO cell lines was verified by western blotting (Fig. 1B). This is 
the first time that KO cell lines for eIF2A or eIF2D have been obtained in mammalian cells.
We next examined the cellular response to sodium arsenite treatment, which induces endoplasmic reticulum 
stress response and phosphorylation of eIF2α , resulting in global translation inhibition30. As shown in Fig. 2, 
arsenite treatment of HAP1 WT cells induced the formation of stress granules containing TIA-1 protein, which 
redistributed from the nucleus to the cytoplasm. Analysis of eIF2A and eIF2D expression in WT cells following 
arsenite exposure revealed that eIF2D but not eIF2A clearly co-localized with TIA-1 in cytoplasmic stress gran-
ules (Fig. 2). Subsequently, the action of arsenite on cellular translation in WT and KO cell lines was measured 
by radioactive labeling of cellular proteins followed by their detection using SDS-PAGE and fluorography. No 
differences were found in protein synthesis between the three cell lines (Supplementary Figure 1). Accordingly, 
arsenite induced a similar concentration-dependent inhibition of cellular translation in all three cell lines, which 
was particularly profound at 50–100 μ M and almost complete at 200 μ M (Supplementary Figure 1A). This find-
ing suggests that eIF2A or eIF2D do not substitute, even partially, the action of eIF2 during the initiation of 
global mRNA translation. Furthermore, the total amount of eIF2α and the degree of eIF2α phosphorylation was 
comparable between the three cell lines and increased in parallel with the blockade of cellular protein synthesis 
(Supplementary Figure 1B). In summary, HAP1-eIF2A− and HAP1-eIF2D− cell lines are viable and protein syn-
thesis is blocked by eIF2α phosphorylation to an extent similar to that found in HAP1 WT cells.
Viral protein synthesis in HAP1 eIF2A and eIF2D KO cells. Previous studies testing the involvement 
of eIF2A on viral mRNA translation have used RNA interference approaches (siRNA) to reduce the amount 
of eIF2A in cultured cells17,31. Although instructive, this approach has two major weaknesses: often, residual 
amounts of eIF2A could partially maintain viral translation and siRNA treatment may have some side-effects 
on viral replication and/or translation steps. The use of KO cells overcomes these problems, constituting a more 
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robust approach to test the functionality of eIF2A or eIF2D in SINV-infected cells. Thus, WT and KO cell lines 
were infected with SINV and protein synthesis was analyzed by radioactive labeling at different periods post 
infection. No differences were found between the three cell lines in the amount or in the kinetics of viral proteins 
synthesized (Fig. 3A and B), supporting the view that neither eIF2A nor eIF2D are required for SINV sgmRNA 
translation. Additionally, the absence of these factors did not affect earlier steps of viral replication that are nec-
essary for sgmRNA translation.
It is well established that SINV replication stimulates PKR, leading to eIF2α phosphorylation7,16,17. We there-
fore analyzed the induction of eIF2α phosphorylation in the three cell lines during SINV infection. The kinetics 
and the degree of eIF2α phosphorylation were similar in the three cell lines upon infection with SINV (Fig. 3C). 
Phosphorylation of eIF2α increased at 3 hours post infection (hpi) and reached a maximum after 5–7 h. To further 
question whether eIF2A or eIF2D could replace eIF2 for the translation of SINV sgmRNA, cells were treated with 
arsenite, which induces almost 100% phosphorylation of eIF2 in SINV-infected cells (7). At 7 hpi, mock-infected 
or SINV-infected HAP1 cells were treated with 200 μ M arsenite and 15 min later protein synthesis was estimated 
by radioactive labeling over the next hour. Cellular translation was blocked by arsenite treatment, whereas almost 
no inhibition was detected in SINV-infected cells (Fig. 4A and B). Viral protein synthesis occurred at similar 
levels in all three cell lines and was equally resistant to arsenite. Although viral translation was not diminished by 
arsenite, polyprotein processing was affected leading to an accumulation of the glycoprotein precursor, which is 
in agreement with previous observations7. Consistent with our earlier results (Fig. 3), eIF2α was clearly phospho-
rylated in all three cell lines infected with SINV (Fig. 4C). eIF2α phosphorylation was maintained upon addition 
of arsenite, suggesting that virtually all eIF2α was phosphorylated under these conditions. As expected, eIF2A 
and eIF2D expression was absent in the respective HAP1 KO cell lines (Fig. 4D). Collectively, these results show 
that neither eIF2A nor eIF2D are necessary for SINV sgmRNA translation, even when eIF2α is phosphorylated.
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Figure 1. Characterization of the different HAP1 cell lines by immunocytochemistry and western blotting. 
(A) HAP1 WT, HAP1-eIF2A− and HAP1-eIF2D− cells were seeded on coverslips in wells of an L-4 plate, fixed 
and stained with anti-eIF2A or anti-eIF2D rabbit polyclonal antibodies. The presence and localization of eIF2A 
and eIF2D (green) were observed by confocal microscopy using secondary anti-rabbit antibodies conjugated to 
Alexa 488. Nuclei (blue) were stained with Topro-3. (B) The presence of eIF2A or eIF2D in HAP1 WT, HAP1-eIF2A− 
or HAP1-eIF2D− cells was also determined by western blotting with anti-eIF2A and anti-eIF2D antibodies.
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Translation of SINV sgmRNA in cells devoid of eIF2A and eIF2D. The possibility that eIF2A could be 
replaced by eIF2D and vice versa, although unlikely, in the single KO cell lines studied above was next evaluated. 
To do this, we used a double KO HAP1 cell line deficient for both eIF2A and eIF2D. Viability and morphology 
of this cell line was similar to that of wild-type HAP1 cells. As expected, HAP1 eIF2A−/2D− cells did not express 
eIF2A or eIF2D as revealed by immunocytochemistry and by western blotting using specific antibodies against 
these proteins (Fig. 5A and B). Next, translation of sgmRNA in these cells was assayed at different times after 
SINV infection by radioactive labeling and SDS PAGE. As shown in Fig. 5C and D, SINV infection of HAP1 
eIF2A−/2D− resulted in a rapid inhibition of cellular translation and the synthesis of late viral proteins directed 
by sgmRNA to levels comparable to those observed with HAP1 WT cells. These findings are conclusive and are 
consistent with the notion that neither eIF2A nor eIF2D participate in the initiation of sgmRNA translation. As 
a complementary test to determine whether eIF2A or eIF2D participate in SINV sgmRNA translation, we used 
a gene silencing approach to knock-down these proteins. As stated earlier, a potential pitfall of this approach is 
that residual amounts of initiation factor remain after silencing. Nevertheless, it serves to bolster the experiments 
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Figure 2. Induction of stress granules by sodium arsenite treatment in HAP1 cell lines. HAP1 WT, HAP1-
eIF2A− and HAP1-eIF2D− cells previously seeded on coverslips in wells of an L-4 plate were treated or not with 
200 μ M arsenite for 1 h and then fixed and permeabilized. Immunodetection was carried out using primary 
goat anti-TIA-1, rabbit anti-eIF2A or rabbit anti-eIF2D antibodies. An anti-goat antibody conjugated to Alexa 
555 was used to detect TIA-1 (red) and anti-rabbit antibodies conjugated to Alexa 448 were employed to detect 
eIF2A (green) or eIF2D (green). DAPI (4′-6-diamidino-2-phenylindole) was used to stain the nuclei (blue).
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using KO cell lines since siRNAs block translation of the corresponding mRNA and, in principle, no truncated 
initiation factors are synthesized. Cell lines were mock- or SINV-infected 42 h after transfection of the corre-
sponding HAP1 cell lines with siRNAs. Protein synthesis was measured by radioactive labeling at 6–7 hpi and 
analyzed by SDS PAGE (Fig. 6A and B). Once again, translation of SINV sgmRNA was clearly apparent under all 
the conditions tested. siRNAs depleting eIF2A or eIF2D in HAP1 WT cells failed to block SINV protein synthe-
sis. Furthermore, HAP1 eIF2A− cells transfected with siRNA for eIF2D also synthesized viral proteins at control 
levels. A similar situation was found when HAP1 eIF2D− cells were transfected with siRNA to deplete eIF2A. 
Therefore, the depletion of eIF2A or eIF2D in HAP1 WT or in the KO cell lines has no detrimental effects on 
sgmRNA translation. The amount of eIF2A or eIF2D present 48 h after siRNA transfection in the three cell lines 
was analyzed by western blotting. Densitometric analysis indicated that eIF2A was silenced by 83% in HAP1 WT 
and 99% in HAP1 eIF2D−, whereas eIF2D was silenced by 81% in HAP1 WT and 85% in HAP1 eIF2A− (Fig. 6C). 
These results clearly indicate that depletion of eIF2A or eIF2D does not abrogate the synthesis of viral proteins 
directed by sgmRNA and are consistent with the findings described using KO cell lines.
Protein synthesis directed by SINV sgmRNA lacking the initiator AUG codón. In eukaryotes, a 
number of proteins are synthesized starting at non-AUG codons32,33. Recent evidence has implicated eIF2A in 
P-eIF2α P-eIF2α
eIF2α-Total eIF2α-Total
HAP1 WT
0 3 5 7 hpi 0 3 5 7 hpi
HAP1 eIF2A -
P-eIF2α
eIF2α-Total
0 3 5 7
HAP1 eIF2D -
hpi
A
C
37
37
C
PE2
E1
Glyco- 
precursor
C
PE2
E1
Glyco- 
precursor
C
PE2
E1
Glyco- 
precursor
25
37
50
75
100 
150 
250 
200
0
100
 R
el
at
iv
e 
%
 o
f 
  C
 s
yn
th
es
is
HAP1 WT
HAP1 eIF2A -
HAP1 eIF2D -
3 hpi 7 hpi5 hpi
B
HAP1 WT
0 3 5 7 hpi 0 3 5 7 hpi
HAP1 eIF2A -
0 3 5 7
HAP1 eIF2D -
hpi
Figure 3. Effect of SINV infection on protein synthesis and eIF2α phosphorylation in HAP1 cell lines. 
Equal numbers of HAP1 WT, HAP1-eIF2A− and HAP1-eIF2D− cells were infected or not with 10 pfu/cell SINV 
and labeled with 35S-Met/Cys from 3 to 4, 5 to 6 or 7 to 8 hpi. (A) After labeling, cells were collected in loading 
buffer and analyzed by SDS-PAGE and autoradiography to detect protein synthesis. (B) Densitometric analysis 
of C production in WT and KO cells. The graph shows the percentage values in relation to the amount of C 
synthesized in HAP1 WT cells at different hpi. The results are displayed as mean ± SD of three representative 
experiments. (C) The amount of phospho-eIF2α and total eIF2α was analyzed in parallel by western blotting.
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the initiation of translation on non-AUG codons in mammalian cells23,24. Because SINV sgmRNA can still direct 
translation even when the initiator AUG codon has been changed to other codons7, we questioned whether this 
initiation was mediated by a mechanism involving eIF2A or eIF2D. To do this, we examined SINV replicons 
bearing sgmRNAs with altered AUGi codons (see scheme in Fig. 7A and B). Thus, AUGi was modified to CUG 
(encoding Leu) or GCG (encoding Ala), rendering rep C + luc (Met-Leu) or rep C + luc (Met-Ala), respectively. 
These replicons were obtained by in vitro transcription of the corresponding plasmids and were transfected into 
the three HAP1 cell lines. We initially tested the kinetics of luciferase production and found that its synthesis 
from each replicon was very similar in the three cell lines; however, luciferase production was 50–60% (Met-Leu) 
and 20–25% (Met-Ala) relative to control (wt) values (Fig. 7C). Remarkably, this inhibition was similar in the 
three cell lines. Thus, the absence of eIF2A or eIF2D did not affect sgmRNA translation with the replicons when 
the AUGi was changed to CUG or GCG. Previously, we found that the initiation of translation in SINV sgmRNA 
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Figure 4. Effect of SINV infection and sodium arsenite treatment on protein synthesis and eIF2α 
phosphorylation in HAP1 cell lines. Mock-infected or SINV- infected cells from each HAP1 line were treated 
or not with 200 μ M arsenite at 7 hpi during 1 h and 15 min and labeled with 35S-Met/Cys during the last hour 
of treatment. (A) Cells were collected in loading buffer and analyzed by SDS-PAGE and autoradiography 
to detect the protein synthesis. (B) Densitometric analysis of cellular and viral proteins synthesized in the 
absence or presence of arsenite in the different cell lines. The graph shows the percentage values obtained from 
untreated versus their counterpart cells treated with arsenite. The results are displayed as mean ± SD of three 
representative experiments. (C) The amount of phospho-eIF2α and total eIF2α was analyzed in parallel by 
western blotting. (D) As a control for the presence of eIF2A and eIF2D, the amount of these proteins was also 
analyzed by western blotting using a mixture of rabbit polyclonal anti-eIF2A and rabbit polyclonal anti-eIF2D 
as primary antibodies.
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variants that do not contain AUGi takes place at the mutated AUGi and at the following AUG that appears in the 
C coding sequence7. To assess the start site of C synthesis, the different forms of this protein were analyzed by 
western blotting. The second AUG of the open reading frame of C from these variants was also mutated to distin-
guish easily by electrophoretic separation the products derived from initiation at the alternative codons because 
the protein derived from the translation at the AUG (3° in the wt sequence) yields a product with 20 amino acids 
less as compared to genuine C. As shown in Fig. 8A and B, rep C + luc synthesized genuine C protein, whereas 
rep C + luc (Met-Ala) synthesized similar amounts of two C products of different mobility. These two different 
forms of C differ in about 20 aminoacids, according to the expected products derived from the initiation at the 
Figure 5. SINV protein synthesis of the double KO cell line HAP1 eIF2A−/2D−. (A) HAP1 WT, and HAP1 
(eIF2A−/eIF2D−) cells were seeded on coverslips in wells of an L-4 plate, fixed and stained with anti-eIF2A 
or anti-eIF2D rabbit polyclonal antibodies. The presence and localization of eIF2A and eIF2D (green) were 
observed by confocal microscopy using secondary anti-rabbit antibodies conjugated to Alexa 488. Nuclei (blue) 
were stained with Topro-3. (B) Western blotting analysis using a mixture of rabbit polyclonal anti-eIF2A and 
rabbit polyclonal anti-eIF2D as primary antibodies and anti-rabbit immunoglobulin G antibody coupled to 
peroxidase as secondary antibodies in lysates of HAP1 WT and HAP1 (eIF2A−/eIF2D−) cells. (C) Equal numbers 
of HAP1 WT and HAP1 (eIF2A−/eIF2D−) cells were infected or not with 10 pfu/cell of SINV and labeled with 
35S-Met/Cys from 3 to 4, 5 to 6 or 7 to 8 hpi. Then, cells were collected in loading buffer and analyzed by SDS-
PAGE and autoradiography to detect protein synthesis. (D) Densitometric analysis of C production in WT and 
double KO cells. The graph shows the percentage values in relation to the amount of C synthesized in HAP1 WT 
cells at different hpi. The results are displayed as mean ± SD of three representative experiments.
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Figure 6. Effect of silencing eIF2A or eIF2D on SINV sgmRNA translation. HAP1 WT, HAP1-eIF2A− and 
HAP1-eIF2D− cells were treated with a mixture of siRNAs against eIF2A, eIF2D or control siRNAs and at 
42 hpt cells were infected or not with SINV (10 pfu/cell). (A) Protein synthesis was analyzed from 6 to 7 hpi 
by radioactive labeling and SDS-PAGE. (B) Densitometric analysis of cellular and viral proteins synthesized 
in the siRNA-treated cells. The graphs show the percentage values obtained from cells treated with siRNAs 
against eIF2A or eIF2D versus their counterpart cells treated with control siRNAs. The results are displayed as 
mean ± SD of three representative experiments. (C) The degree of depletion of eIF2A or eIF2D was analyzed 
in parallel by western blotting using a mixture of rabbit polyclonal anti-eIF2A and rabbit polyclonal anti-
eIF2D as primary antibodies. As a loading control, the amount of eIF2α was also determined (upper panel). 
Densitometric analysis of the amount of eIF2A or eIF2D in the siRNA-treated cells. The graph shows the percentage 
values obtained from cells treated with siRNAs against eIF2A or eIF2D versus their counterpart cells treated with 
control siRNAs. The results are displayed as mean ± SD of three representative experiments (lower panel).
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alternative codon GCG (first AUG mutation) or third AUG. Moreover, rep C + luc (Met-Leu) rendered two C 
products, but the amount of genuine C, which presumably initiates at CUG, was more than 90% of the total. 
Again, no differences were observed regarding the different C products synthesized in WT and the different KO 
cell lines tested. These results indicate that neither eIF2A nor eIF2D are involved in the initiation of sgmRNA 
translation when CUG or GCG replaces AUGi. Previous observations from our laboratory have demonstrated 
that SINV replicons induce the phosphorylation of eIF2α in a way akin to SINV infection [15]. We therefore used 
western blotting to assess whether the replicons described above also induce eIF2α phosphorylation in the HAP1 
cell lines. Indeed, transfection of the SINV replicons induced the phosphorylation of eIF2α in a similar manner 
in the three cell lines (Fig. 8C).
The finding that rep C + luc (Met-Leu) used CUG in place of AUGi quite efficiently while the third AUG of 
sgmRNA was practically ignored was striking. Since one of the functions of the DLP is to signal the precise codon 
to start translation, we decided to analyze the functioning of the DLP in the sgmRNA variant encoding Leu in 
place of Met. We generated a new construct bearing CUG as the initiation codon, followed by an unstructured 
DLP: rep C + luc (Met-Leu-Δ DLP) (see Fig. 7A and B). The corresponding replicative RNA was transfected into 
HAP1 cells and C protein production was analyzed by western blotting. As controls, we used rep C + luc, which 
renders a genuine C protein, and an unstructured DLP in rep C + luc (Δ DLP), which leads to a loss of fidelity 
in the election of the AUGi. Thus, several C products are produced that initiate at different codons as a result of 
leaky scanning7,17. We found that rep C + luc (Met-Leu) almost entirely initiated at CUG, giving rise to a C pro-
tein of the same mobility as the control (Fig. 9). Notably, the presence of the unstructured DLP in the rep C + luc 
(Met-Leu-Δ DLP) construct abrogated the initiation at CUG and almost all of the C generated initiated at the 
third AUG codon (Fig. 9). Nonetheless, the recognition of CUG and the initiation at the third AUG codon when 
DLP was unstructured, were similar in all three HAP1 cell lines tested, further demonstrating that neither eIF2A 
nor eIF2D are involved in the recognition of the initiation codon in sgmRNA and in the functioning of the DLP.
Figure 7. Translation of sgmRNA WT or mutated at the initiation codon in HAP1 cell lines transfected 
with SINV replicons. (A) Schematic representation of the SINV genome and the replicon wt used to make the 
different variants tested. (B) Schematic representation of the secondary structure of SINV sgmRNA. The AUGs 
mutated in the variants Met-Leu or Met-Ala are highlighted as well as the third in-frame AUG (the first and the 
second AUGs were mutated to CUG or GCG, respectively). Modified DLP structure, Δ DLP is also illustrated. 
(C) HAP1 WT, HAP1-eIF2A− and HAP1-eIF2D− cells were transfected with in vitro synthesized replicons 
rep C + luc, rep C + luc (Met-Leu) or rep C + luc (Met-Ala), and cells were recovered to measure luciferase 
activity at different periods post transfection. Luciferase activity results are displayed as mean ± SD of three 
representative experiments performed in triplicate.
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Discussion
Several mRNAs from animal viruses are able to direct translation even after phosphorylation of eIF2α 34–36. 
In most cases, however, the precise mechanism by which the initiation event occurs when eIF2 is inactivated 
is unclear. An extreme case of initiation of mRNA translation in the absence of eIFs, including eIF2, is repre-
sented by mRNAs bearing an IRES in the intergenic region in Cricket paralysis virus (CrPV)37. In this setting, 
the IRES is a folded structure that mimics tRNA and can interact with the decoding A site of the ribosome38,39. 
The IRES is translocated to the P site by eEF2, leaving the A site free and the first codon ready to start translation. 
Other animal viruses including picornaviruses that contain an IRES element can initiate translation by a dual 
mechanism. Early during infection, intact eIF2 is necessary to initiate viral protein synthesis, whereas at late 
periods mRNA translation occurs even when eIF2 is phosphorylated40–42. In this case, picornavirus proteases 
confer eIF2 independence for IRES-driven translation41,43,44. However, the precise mechanism by which picorna-
viruses initiate translation without eIF2 remains to be elucidated. Hepatitis C virus provides another example of 
eIF2-independent translation driven by an IRES element35,45. In this context, several factors have been suggested 
to replace eIF2, including eIF5B, eIF2D or eIF2A5,29,31,46. A different example of eIF2-independent translation is 
provided by the capped sgmRNA from alphaviruses7,16,17. In this case, the hairpin located 24 nt downstream of 
the AUGi is required to initiate translation without active eIF2. The precise functioning of this hairpin during 
initiation remains enigmatic. Initially, a stable hairpin structure was noticed in the coding region of sgmRNA, 
that enhaced its translation15. It was speculated that this hairpin stalled ribosomes leaving the AUGi at the P site. 
However, this possibility seems unlikely because for this to occur the hairpin should be located at 14 nt down-
stream the initiation codon47. It was later observed that when eIF2α does not become phosphorylated, translation 
of the sgmRNA takes place without the integrity of this hairpin16,17. Another model for the function of DLP is that 
it interacts with the ribosomal P site in a manner similar to that described for CrPV6. The possibility that eIF2 is 
replaced by eIF2A has also been proposed based on gene silencing17. However, this possibility seems unlikely in 
view of our present findings since we demonstrate that sgmRNA is efficiently translated in HAP1 cells lacking 
eIF2A, even when eIF2α is phosphorylated. Moreover, our present observations on the effect of silencing eIF2A 
on sgmRNA translation clearly indicate that this factor is not necessary in the human cell line analyzed. Also, the 
suggestion that eIF2D (previously known as ligatin) participates in protein synthesis directed by SINV sgmRNA 
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Figure 8. Western blot analysis of SINV protein C and phosphorylation of eIF2α. (A) HAP1 WT, HAP1-
eIF2A− and HAP1-eIF2D− cells were transfected with in vitro synthesized replicons rep C + luc, rep C + luc 
(Met-Leu) or rep C + luc (Met-Ala). At 7 hpt, cells were collected in loading buffer and analyzed by western 
blotting with an anti-C antibody. The mobilities of the C products derived from the different replicons are 
indicated by arrows. (B) Densitometric analysis of the different C proteins synthesized from rep C + luc (Met-
Leu) or rep C + luc (Met-Ala). The graph shows the percentage values in relation to the amount of C synthesized 
by rep C + luc in each cell line. The results are displayed as mean ± SD of three representative experiments.  
(C) Analysis of eIF2α phosphorylation and total eIF2α by western blotting using specific antibodies as 
described in Materials and Methods.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7:43876 | DOI: 10.1038/srep43876
is not supported by our present results. It seems clear from our findings that cells lacking eIF2D and active eIF2 
are infected with SINV and synthesize viral late proteins at levels similar to those of controls. Therefore, whereas 
the precise mechanism of protein synthesis directed by sgmRNA in the absence of active eIF2 remains to be 
resolved, we are confident that eIF2A or eIF2D are dispensable for this process.
An additional function of the hairpin DLP is to signal the start codon of sgmRNA in such a manner that the 
change of AUGi to other codons engenders sgmRNA functional, albeit to a lower extent7. We show here that 
the substitution of CUG (leucine) for AUGi has a moderate effect on viral protein synthesis directed by this 
mRNA variant. Indeed, only 40–50% inhibition of C synthesis was observed. Since binding of the ternary com-
plex GTP-eIF2-Met-tRNAiMet is only promoted by AUG codons, the synthesis of C protein initiating at Leu will 
take place without eIF2. Interestingly, even in this case neither eIF2A nor eIF2D were required for this non-AUG 
initiation of translation since the level of the production of C protein was similar in the three cell lines transfected 
with the rep C + luc (Met-Leu). However, the disorganization of the DLP has profound effects with regards to 
the initiation codon used. In rep C + luc (Δ DLP), initiation was observed at the first AUGi and also at the second 
and third AUGs, indicating that the genuine DLP structure is important to signal the correct initiation codon. 
Notably, initiation at CUG in cells transfected with rep C + luc (Met-Leu-Δ DLP) was abrogated when the DLP 
was unstructured. In this case, a truncated C protein was synthesized that mainly starts at the third AUG, and a 
similar pattern was found in the three cell lines assayed. Therefore, we can conclude that the structure of the DLP 
hairpin is more important for initiation codon selection than the presence of eIF2A or eIF2D. In sharp contrast 
to previous reports, the possibility that now arises is that eIF2 is not substituted by any other factor to translate 
sgmRNA in SINV infected cells. It could even be possible that the DLP itself could carry out this function. We 
have previously proposed that the DLP directly interacts with the 40S ribosomal subunit or the 80S ribosome at 
either the A- or P-site, resembling in this regard the initiation event followed by the IGR IRES of CrPV6,37,38. The 
suggestion that Semliki Forest virus DLP can interact with a sequence present in 18S rRNA to signal the initiation 
start codon is interesting48; however, the speculation that eIF4A participates in the unwinding of DLP after this 
interaction is not supported by the evidence that selective inhibitors of eIF4A, such as hippuristanol or pateamine 
A, do not influence initiation of SINV sgmRNA18,49. Our current observations support the concept that eIF2 is 
not replaced by cellular proteins, instead the acquisition of the DLP structure during alphavirus evolution led to 
eIF2 independent translation. It is known that the presence of DLP structure allows the translation of sgmRNA 
when eIF2 is phosphorylated16–18. This is important for the virus biology because large amounts of structural 
proteins have to be synthesized under stress conditions. It is well established that alphavirus infection induces the 
phosphorylation of eIF2α upon infection of mammalian cells. Therefore, the virus has evolved the DLP within the 
coding region of sgmRNA to be translated under stress conditions that appear after infection. Curiously, the DLP 
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Figure 9. Involvement of the DLP hairpin in signaling the initiation codon. (A) HAP1 WT, HAP1-eIF2A− 
and HAP1-eIF2D− cells were transfected with in vitro synthesized replicons rep C + luc, rep C + luc (Δ DLP), 
rep C + luc (Met-Leu) or rep C + luc (Met-Leu-Δ DLP). The DLP structure and the mutations introduced to 
generate the variant Δ DLP are indicated in Fig. 7B. At 7 hpt, cells were collected in loading buffer and analyzed 
by western blotting with an anti-C antibody. The mobilities of the C products derived from the different 
replicons are indicated by arrows. (B) Densitometric analysis of the different C proteins synthesized by the 
replicons in relation to the canonical product of C synthesized by rep C + luc in each cell line. The results are 
displayed as mean ± SD of three representative experiments.
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structure also allows the initiation of the translation using alternative codons as GCG or CUG. This represents a 
unique example of a viral mRNA that is capped, is translated following the scanning mechanism and still does not 
utilize eIF2 during the initiation process6. Thus, the functional replacement of eIF2 and the ternary complex by a 
viral RNA structure may be a common mechanism employed by a variety of animal viruses including those that 
contain an IRES in their mRNAs. Further experiments aimed to elucidate this step during the initiation of SINV 
sgmRNA are needed. Nonetheless, the important conclusion of our present observations is that neither eIF2A nor 
eIF2D substitute for eIF2 and are not required to initiate translation of this viral mRNA.
Methods
Cell lines and viruses. Wild-type (WT) HAP1 human haploid cells and HAP1 cells knocked-out for 
eIF2A (cat# HZGHC002650c001), eIF2D (cat# HZGHC002652c005) or double knock-out for eIF2A and eIF2D 
(HZGHC005122c010) were purchased from Horizon Discovery Group plc. The eIF2A knock-out (KO) cell line 
(gi|977380191|ref|NM_032025.4|) has a 16 bp deletion in exon 4 resulting in a frameshift that generates a protein 
of 108 aa rather than 585 aa of the WT protein. The eIF2D KO cell line (gi|56699484|ref|NM_006893.2|) has a 
10 bp deletion in exon 3 resulting in a frameshift that generates a protein of 103 aa rather than 584 aa of the WT 
protein. The double KO line has the same 16 bp deletion in exon 4 of the single eIF2A KO cell line and a 22 bp 
deletion in exon 3 of eIF2D that generates a protein of 99 aa rather than 584 aa of the WT protein. Cells were 
cultured in IMDM (Invitrogen) supplemented with 10% fetal calf serum. SINV stock was obtained from a pT7 SV 
WT infective cDNA clone50. Titers of viruses were determined by plaque assay.
Plasmids and constructs. SINV replicons expressing C and luciferase were obtained by in vitro transcrip-
tion from plasmids derived from pT7 SV wt50. pT7 rep C + luc51 and pT7 rep C + luc Δ DLP18 have been described 
previously. pT7 rep C + luc (Met-Ala), pT7 rep C + luc (Met-Leu) and pT7 rep C + luc (Met-Leu-Δ DLP) were 
constructed for the present study. To generate pT7 rep C + luc (Met-Ala), the Hpa I/Aat II digestion fragment 
from pT7 rep C (Met-Ala)7 was cloned into the corresponding sites of pT7 rep C + luc. pT7 rep C + luc (Met-Leu) 
was designed as the variant Met-Ala, but in this case both the first and second ATGs of the 26S sequence were 
mutated to GTGs. pT7 rep C + luc (Met-Leu-Δ DLP) has an altered DLP sequence (Δ DLP) in addition to the 
GTG mutations.
In vitro RNA transcription and transfection. Plasmids digested with Xho I were used as templates for 
in vitro RNA transcription with T7 RNA polymerase (New England Biolabs) in reactions containing the m7G(5′ ) 
ppp(5′ )G cap analog (New England Biolabs). In vitro-synthesized RNAs were treated with DNase I and then 
transfected in cells using Lipofectamine 2000 reagent (Invitrogen).
Analysis of protein synthesis by radioactive labeling. Protein synthesis was measured by incubating 
cells in 0.2 ml DMEM without methionine and cysteine, supplemented with 1 μ l EasyTagTM EXPRESS 35S protein 
labeling mix, [35S]Met/Cys (11 mCi ml−1, 37.0 Tbq mmol−1; Perkin Elmer) per well of a 24-well plate for 60 min. 
Cells were collected in loading buffer (62.5 mM Tris-HCl pH 6.8, 2% SDS, 0.1 M dithiothreitol, 17% glycerol 
and 0.024% bromophenol blue) and autoradiographic analysis was performed following SDS-polyacrylamide gel 
electrophoresis.
Measurement of luciferase activity. Cells were lysed in a buffer containing 0.5% Triton X-100, 25 mM 
glycylglycine pH 7.8, 1 mM dithiothreitol and complete, EDTA-free, protease inhibitor cocktail (Roche). 
Luciferase activity was detected using the Luciferase Assay System (Promega) in a Monolight 2010 luminometer 
(Analytical Luminescence Laboratory).
Antibodies. Primary antibodies used in this work included a rabbit polyclonal antibody raised against puri-
fied SINV C protein generated in our laboratory. Rabbit polyclonal anti-TIA-1 (C-20): sc-1751 and rabbit pol-
yclonal anti-eIF2α antibodies were purchased from Santa Cruz Biotechnology. Rabbit polyclonal anti-eIF2D 
antibody was purchased from Proteintech, rabbit polyclonal anti-eIF2A antibody was purchased from Bethyl 
Laboratories Inc., and a rabbit polyclonal antibody raised against phospho-eIF2α (serine 51) was purchased from 
Cell Signaling Technology.
Immunocytochemistry and confocal microscopy. Fixation, permeabilization and confocal microscopy 
were performed as described52 using the LSM 710 confocal laser scanning and multiphoton microscope coupled 
to an inverted microscope (Axio Observer, Zeiss). Primary antibodies were detected by secondary antibodies 
coupled to Alexa 488 or Alexa 555. Nuclei were stained with Topro-3 or DAPI (4′-6-diamidino-2-phenylindole). 
All images were collected and analyzed using Zeiss ZEN 2010 software.
Western blotting. Cells were collected in sample buffer, boiled for 5 min and processed by SDS-PAGE. After 
electrophoresis, proteins were transferred to a nitrocellulose membrane. Specific rabbit polyclonal antibodies raised 
against phospho-eIF2α (Ser 51), total eIF2α , SINV Capsid, eIF2A and eIF2D were used at 1:1000 dilution in PBS 
with 3% BSA and 0.1% Tween 20, except when phospho-eIF2α was analyzed we instead used TTBS (Tris-buffered 
saline, 0.1% Tween 20). Anti-rabbit immunoglobulin G antibody coupled to peroxidase (Amersham) was used at a 
1:5000 dilution. Protein bands were visualized with the ECL detection system (Amersham).
siRNA transfection. For transient transfections, siRNAs targeting specifically eIF2A (L-014766-01-0005, 
Dharmacon), eIF2D (L-003680-01-0005, Dharmacon) or a control siRNA (D-001810-01-05, Dharmacon) 
were transfected with Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s instructions. At 
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42 hours post-transfection, cells were infected or not with SINV (multiplicity of infection, 10). Protein synthesis 
was analyzed from 6 to 7 hours post infection by radiactive labeling and SDS-PAGE and the degree of depletion 
of eIF2A and eIF2D was assessed by western-bloting.
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ARTÍCULO 3:  
A viral RNA motif involved in signaling the initiation of translation on non-AUG 
codons. 
La iniciación en codones no-AUG es una estrategia de traducción empleada tanto 
por mRNAs virales como celulares. El sgRNA de SINV constituye un excepcional sistema 
modelo para analizar esta traducción, ya que se trata de un mRNA capeado que inicia 
su traducción mediante scanning y sin la participación de ciertos factores de iniciación. 
Partiendo de los resultados del anterior artículo, en este trabajo se investigó el 
mecanismo de iniciación de la traducción del sgRNA con CUG en lugar de AUGi, así 
como los requerimientos estructurales del DSH para señalizar correctamente el codón 
de inicio. Investigaciones previas habían determinado que la traducción del sgRNA 
podía iniciar, aunque ineficientemente, en diferentes codones no-AUG. Por este motivo, 
se estudió (1) qué aminoácido se incorpora en la proteína C de SINV cuando la 
traducción inicia en un codón CUG o GUG, (2) los requerimientos de la estructura DSH 
situada en la secuencia codificante para señalizar correctamente la iniciación en CUG, y 
(3) la posible participación en esa iniciación de eIF2, eIF2A o eIF2D.  
Inicialmente se estudió la participación del eIF2 en la iniciación cuando el AUGi es 
reemplazado por CUG. Como era de esperar, eIF2 no participa en la iniciación sobre 
codones CUG. Se analizó la plasticidad del sgRNA de SINV para iniciar en codones no-
AUG mediante la transfección de una batería de replicones con CUG, CUC, GUG o AUU 
en lugar del AUGi en células BHK y C6/36. CUG, seguido de GUG, fueron los codones 
más eficientes en dirigir la iniciación, por lo que la investigación se enfocó en ellos. La 
siguiente cuestión de interés era averiguar cuál tRNA reconocía el codón CUG como 
codón de iniciación, puesto que trabajos anteriores han sugerido que CUG podría 
reconocerse tanto por el Met-tRNAi (Kearse and Wilusz 2017, Liang, Chen et al. 2017, 
Na, Barbhuiya et al. 2018) como por el Leu-tRNA (Starck, Jiang et al. 2012). Estos tRNAs 
incorporarían metionina o leucina, respectivamente. En este trabajo, se analizaron por 
espectrometría de masas (LC-MS/MS) los péptidos derivados de la proteína C producida 
por virus o replicones con el AUGi mutado a CUG o GUG para determinar el primer 
aminoácido incorporado. De este modo, se pudo detectar que para CUG tanto leucina 
como metionina fueron incorporados como primer aminoácido, mientras que para GUG 
fueron metionina o valina. Sin embargo, la proporción exacta entre los péptidos 
iniciados con metionina o con leucina o valina no pudo ser determinada con esta 
metodología. Posteriormente, se realizó una estimación cuantitativa de la proporción de 
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estos péptidos a través del análisis de la síntesis de proteínas dirigido por diferentes 
construcciones con mutaciones puntuales sobre los codones AUG.  
En este trabajo también se analizó la importancia de la secuencia leader y de la 
estructura y secuencia del DSH en la señalización del codón de iniciación. Se examinó 
la producción de la proteína C a partir de distintos replicones con variaciones tanto en 
estructura como en secuencia para el DSH, en paralelo con variantes que tenían AUG o 
CUG como codón de iniciación del sgRNA. Este estudio se realizó comparativamente 
en células de mamífero (BHK) y de mosquito (C6/36). Por otra parte, el papel de la 
estructura del DSH en la traducción del sgRNA fue examinado fuera del contexto 
replicativo. Para ello, se emplearon sgRNAs obtenidos in vitro que presentaban el DSH 
wt o el DSH desestabilizado, y AUG o CUG como codón de iniciación. Este ensayo se 
realizó con variantes del sgRNA de SINV obtenidas in vitro transfectadas tanto en células 
(BHK y C6/36) como en los sistemas de traducción in vitro (lisado de reticulocitos de 
conejo y extractos de Drosophila melanogaster). 
 Para conocer el proceso de iniciación con codones alternativos resulta 
fundamental determinar en qué sitio ribosómico entra el primer tRNA. Se utilizó 
bruceantina para bloquear la iniciación en el sitio P ribosómico y averiguar si el sgRNA 
de SINV inicia la traducción en el sitio A. Finalmente, se examinó la posible participación 
de eIF2A y eIF2D en la iniciación en CUG para el sgRNA de SINV. Células HAP1 wt y 
doble KO para los mencionados factores fueron infectadas por SINV (wt y variante CUG) 
y la síntesis de proteínas fue analizada mediante marcaje radioactivo. 
Nuestros resultados mostraron que tanto el Leu-tRNA como el Val-tRNA pueden 
participar en la iniciación de la traducción del sgRNA mediante un mecanismo 
dependiente del DSH e independiente de los factores eIF2, eIF2A y eIF2D. Además, se 
demostró que la estructura del DSH en el mRNA controla su habilidad de señalar la 
iniciación de la traducción en codones no-AUG.  
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A viral RNA motif involved in signaling the initiation
of translation on non-AUG codons
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ABSTRACT
Noncanonical translation, and particularly initiation on non-AUG codons, are frequently used by viral and cellular mRNAs
during virus infection and disease. The Sindbis virus (SINV) subgenomic mRNA (sgRNA) constitutes a unique model system
to analyze the translation of a capped viral mRNAwithout the participation of several initiation factors. Moreover, sgRNA
can initiate translation even when the AUG initiation codon is replaced by other codons. Using SINV replicons, we exam-
ined the efficacy of different codons in place of AUG to direct the synthesis of the SINV capsid protein. The substitution of
AUGbyCUGwas particularly efficient in promoting the incorporation of leucine ormethionine in similar percentages at the
amino terminus of the capsid protein. Additionally, valine could initiate translation when the AUG is replaced by GUG. The
ability of sgRNA to initiate translation on non-AUG codons was dependent on the integrity of a downstream stable hairpin
(DSH) structure located in the coding region. The structural requirements of this hairpin to signal the initiation site on the
sgRNAwere examined in detail. Of interest, a virus bearing CUG in place of AUG in the sgRNAwas able to infect cells and
synthesize significant amounts of capsid protein. This virus infects the human haploid cell line HAP1 and the double knock-
out variant that lacks eIF2A and eIF2D. Collectively, these findings indicate that leucine-tRNA or valine-tRNA can partici-
pate in the initiation of translation of sgRNA by amechanism dependent on the DSH. This mechanism does not involve the
action of eIF2, eIF2A, or eIF2D.
Keywords: initiation of translation; Sindbis virus translation; noncanonical translation; non-AUG codon; RNA motif
INTRODUCTION
Animal viruses have evolved a variety of elements in their
mRNAs tomaximize their translatability under stress condi-
tions generated after infection. Accordingly, some viruses
contain elements that promote the interaction of preinitia-
tion complexes or even ribosomes to internal structures
known as internal ribosome entry sites (IRESs) (Lee et al.
2017; Martinez-Salas et al. 2017). Viral mRNAs bearing
IRES elements can be translated under conditions that
could be antagonistic to the activity of cellular mRNAs.
Another interesting example is provided by the subge-
nomic mRNA (sgRNA) of Sindbis virus (SINV), which con-
tains motifs that promote its translatability during the late
phase of the virus life cycle (Carrasco et al. 2018). SINV be-
longs to the alphavirus genus and contains a single strand-
ed RNA of positive polarity as genome, which encodes two
open reading frames (ORFs). The first ORF is expressed
from the genomic mRNA (gRNA), which synthesizes the
nonstructural proteins (nsP1–4) involved in RNA replication
(Rupp et al. 2015). The second ORF is expressed from the
sgRNA and directs the synthesis of viral structural proteins,
initially translated as a polyprotein that is subsequently
cleaved to the mature products: capsid protein, glycopro-
teins E1, E2, and E3 and viroporin 6K and its truncated
product TF (Griffin 2013; Ramsey and Mukhopadhyay
2017). Synthesis of sgRNA requires the recognition of an
internal promoter located on the negative stranded RNA
that promotes transcription of multiple copies of this sub-
genomic messenger. This negative stranded RNA is com-
plementary to the genome and is produced by viral RNA
replication in close association with spherules protruding
from cytoplasmic vacuoles (Pietila et al. 2017a,b). Most
alphaviruses, exemplified by SINV, replicate in two quite
different hosts, insects and mammals and, accordingly, vi-
ral mRNA structures have adapted to these diverse host
species. One adaptation is an RNA motif found at the 3′
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untranslated region (3′-UTR), which contains three repeat-
ed sequences forming three stem–loop hairpins. This mo-
tif is involved in enhancing translation specifically in insect
cells, whereas the absence of this structure is not important
for sgRNA translation in mammalian cells (Garcia-Moreno
et al. 2016). This element thus confers translatability in a
cell-specific manner. A second RNA structure involved in
translation is found in the coding region of the sgRNA, in
the form of a hairpin located 27–84 nt downstream from
the AUG initiation codon (with A at the +1 position)
(Carrasco et al. 2018). This downstream stable hairpin
(DSH) provides eIF2-independence after the inactivation
of this factor by its phosphorylation at serine 51 (Ventoso
et al. 2006; Garcia-Moreno et al. 2013). This phosphoryla-
tion event is mediated by protein kinase R (PKR), which is
activated by viral dsRNA synthesis. eIF2 inactivation is ob-
served in mammalian, but not in insect cells, which lack
PKR (Ventoso 2012). Thus, the repeated stem–loop motif
at the 3′-UTR is necessary for alphavirus translation in in-
sect cells, whereas the DSH is required for efficient synthe-
sis of structural proteins in mammalian cells.
Another important function of the DSH is its participa-
tion in the correct signaling of the initiation codon of
sgRNA. Interestingly, alterations in the DSH structure re-
sult in leaky scanning, such that initiation of capsid (C) pro-
tein synthesis is observed at downstream AUG codons
(Frolov and Schlesinger 1996; Sanz et al. 2009). It was re-
cently demonstrated that the initiation of protein synthesis
directed by sgRNA occurs following the classical scanning
model (Garcia-Moreno et al. 2015); however, scanning can
occur in the absence of some crucial eIFs, such as eIF4G,
eIF4A, and eIF2 (Castello et al. 2006; Garcia-Moreno
et al. 2013; Gonzalez-Almela et al. 2015). The currentmod-
el for translation initiation on sgRNA is that preinitiation
complexes interact with the cap structure present at the
5′-end, perhaps promoted by eIF3D, and without the par-
ticipation of the eIF4F complex (Lee et al. 2016). After
binding, the preinitiation complex scans the leader se-
quence of sgRNA base-by-base until the initiation codon
is encountered. Subsequently, the correct functioning of
the DSH element is required to build up the 80S ribosome,
which will start the elongation phase (Carrasco et al. 2018).
We previously found that the AUG initiation codon could
be replaced by other codons, although protein synthesis
directed by these variant sgRNAs was reduced (Sanz
et al. 2009, 2017). Nevertheless, replacement of AUG by
CUG was particularly efficient and the synthesis of the
C protein by this sgRNA variant was ∼60% of that from
the control AUG. Thus, the precise mechanism of sgRNA
translation in the absence of the AUG initiation codon, as
well as the functioning of DSH in this process, remains un-
known. In the present study, we investigated the mecha-
nism of initiation on sgRNA containing CUG in place of
AUG, and also the structural requirements of DSH for its
proper functioning in signaling the initiation codon.
These events occur in cells more frequently than previous-
ly anticipated and have a profound impact on cell function-
ing, especially during stress conditions and disease, as
revealed recently using ribosome profiling (Kearse and
Wilusz 2017). For instance, a variety of aberrant peptides
are synthesized on non-AUG codons, that play a part in
the pathology of several neurodegenerative diseases
(Kumar et al. 2017; Tabet et al. 2018). Our current findings
are further insight into the mechanism of the initiation of
translation on non-AUG codons. We found that leucine
or methionine is incorporated at the amino terminus of
the SINV C protein directed by the CUG codon. Notably,
translation initiation on sgRNA bearing CUG does not re-
quire eIF2 and this factor is not replaced by eIF2A or
eIF2D. Overall, these observations add new insight into
the mechanism of initiation of this viral mRNA and high-
light the functioning of the DSH structural motif.
RESULTS
Replacement of the AUG initiation codon with other
codons in sgRNA: synthesis of capsid protein by SINV
replicons
We recently demonstrated that sgRNA is able to direct
protein synthesis in human cells transfected with SINV rep-
licons when the AUG initiation codon is replacedwith CUG
(Sanz et al. 2017). To gain further insight into the mecha-
nism of this phenomenon, we initially studied the partici-
pation of eIF2 in this process. We used two replicons
that produce sgRNA encoding the C protein upstream of
the luciferase gene: one containing AUG as the intiation
codon, rep C+ luc (AUG), and the other containing CUG
as the initiation codon, rep C+ luc (CUG) (see scheme
Fig. 1A). We first analyzed the synthesis of C and luciferase
in mammalian baby hamster kidney (BHK) cells transfected
with the two replicons. It is well established that replication
of SINV in BHK cells induces eIF2α phosphorylation (Sanz
et al. 2009; Garcia-Moreno et al. 2013). To ensure that eIF2
was phosphorylated at high levels, some cultures were
treated with thapsigargin (TG), which inactivates eIF2 by
inducing the phosphorylation of the α subunit. Thus, 3 h af-
ter transfection cells were treated with 2 or 5 μM TG for a
further 2 h. The synthesis of C and luciferase was examined
in cell extracts by western blotting and measurement of lu-
ciferase was also analyzed bymeasuring its activity. Results
showed robust levels of C and luciferase synthesis by the
two replicons, indicating that CUG can also initiate protein
synthesis directed by sgRNA in BHK cells (Fig. 1B–D).
eIF2α phosphorylation was induced by both SINV repli-
cons and was modestly increased by TG treatment
(Fig. 1B). Consistent with previous results (McInerney
et al. 2005; Ventoso et al. 2006; Sanz et al. 2009), the phos-
phorylation of eIF2α had no inhibitory effects on sgRNA
translation from rep C+ luc (AUG). Further, almost no
Sanz et al.
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inhibition of sgRNA translation occured with or without TG
treatment in cells transfected with rep C+ luc (CUG), indi-
cating that eIF2 does not participate in the initiation event
directed by the CUG codon. As a control of the inhibitory
action of TG, the translation of mRNAs bearing the EMCV
IRES or the Globin leader sequence was strongly blocked
by treatment with TG in BHK cells (Fig. 1E). We also as-
sessed the production of C protein in transfected BHK cells
by immunocytochemistry with an anti-C polyclonal rabbit
antibody. Abundant amounts of C were detected in cells
transfected with either rep C+ luc (CUG) or rep C+ luc
(AUG) (Supplemental Fig. 1), and levels did not noticeably
decrease after TG treatment. Of note, the replication of
the SINV replicons induced the release of TIA1 protein
from the nucleus to the cytoplasm, but no stress granules
were formed, contrary to what happens in untransfected
cells after TG treatment. Indeed, stress granules were not
apparent in transfected cells even with TG treatment.
The extent of translation initiation on non-AUG codons
in cellular mRNAs depends on the codon used (Kearse
and Wilusz 2017). After AUG, CUG is usually the most effi-
cient codon to promote initiation, followedbyGUGorAUU
(Kearse andWilusz 2017). We compared the efficacy of dif-
ferent codons to direct C protein synthesis using a battery
of SINV replicons bearing CUG, CUC, GUG, or AUU in
place of the initiator AUG codon in sgRNA. A second and
third AUG codon in the C sequence are located 7 and 19
codons, respectively, downstream from the first AUG
(Fig. 2A). All variants withmutations in the initiator AUG co-
don were also modified at the second AUG codon (to
A
B
C E
D
FIGURE 1. Analysis of C protein synthesis by SINV replicons bearing AUG or CUG as the initiation codon. (A) Schematic representation of rep
C+ luc (AUG) and rep C+ luc (CUG). (B) BHK cells were transfected with in vitro transcribed replicons. After 3 h, cells were treated or not with
thapsigargin (TG; 2 or 5 μM) or cyclohexamide (CHX; 50 μg/mL) for 2 h. Cells were collected in loading buffer and analyzed by western blotting
using anti-C, anti-luciferase and anti-P-eIF2α antibodies. Additionally, eIF2α was analyzed as a loading control. (C ) Densitometric analysis of
C and luciferase are shown in the graphs as the relative percentage of their corresponding untreated controls. The values from CHX treatments
were subtracted from all as a baseline. Error bars represent the standard error of the mean, n=3. (D) Luciferase activity is represented as the
percentage relative to the untreated controls. The readings from CHX treatments were subtracted from all as a baseline. Error bars represent
the standard error of the mean, n=3. (E) BHK cells were transfected with in vitro transcribed RNAs EMCV-luc or Cap.BGlo-luc. One hpt, cells
were treated or not with TG (1, 2, or 5 μM) or CHX (50 μg/mL) for 2 h. Then, luciferase activity was measured and is represented in the graph as
percentage relative to the untreated control. The readings from CHX treatments were subtracted from all as a baseline. Error bars represent
the standard error of the mean, n=3. Statistical significance in panels C–E was calculated compared to control using Student’s t-test unpaired
two-tails t-test, and is shown as: (∗) P<0.05
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CUG), to facilitate the electrophoretic separation of the C
proteins produced by leaky scanning. The synthesis of
C protein was evaluated by western blotting of cell extracts
after transfection of the replicons in BHK cells, and densi-
tometry of the corresponding band was performed to
give an estimation of the efficacy of the codons to initiate
translation. Results showed that AUG was the best codon
to initiate C synthesis on sgRNA, but substantial levels of
C were also produced from rep C+ luc (CUG) (Fig. 2B,C).
In this case, the anti-C antibody recognized two products:
one, named C1, migrated as authentic C and was pro-
duced with an efficiency of 64% as compared with the
A
B C
FIGURE 2. Translation initiation by SINV replicons using different non-AUG codons. (A) Representation of the secondary structure of the first 180
nt of sgRNA. The leader sequence is colored in blue. First, second and third AUGs in wt sequence of C are highlighted in red. (B) BHK or C6/36
cells were transfected with the different replicons produced by in vitro transcription. After 7 h, cells were collected in loading buffer and analyzed
by western blotting with an anti-C antibody. The mobilities of the C products from the different replicons are indicated as C1 (initiation in the first
AUG or in the same codonmutated to CUG, CUC, GUG, or AUU), and C3 (initiation in the third AUG codon relative to the wt sequence). α-tubulin
was analyzed as a loading control. (C ) Densitometric analysis of the different C proteins synthesized from the replicons. Graphs show the percent-
age values relative to the amount of C synthesized by rep C+ luc (AUG) in each cell line. The black bars correspond to translation initiation at AUG
and the gray bars at non-AUGs. The results are shown as mean±SD of three experiments. Statistical significance in panel C was calculated com-
pared to control using Student’s t-test, (∗) P<0.05, (∗∗) P<0.01, (∗∗∗) P<0.001.
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only one produced by rep C+ luc (AUG); the second prod-
uct, named C3, represented only 1% and migrated faster
(Fig. 2B,C). The product C1 derives from translation initia-
tion at the first CUG whereas C3 corresponds to initiation
at the first nonmutated AUG codon by leaky scanning,
which matches the third AUG in the wild-type (wt) se-
quence (Fig. 2A). The second most efficient codon after
CUG was GUG (46%), which encodes for valine, whereas
practically no C synthesis was found with CUC (leucine) or
AUU (isoleucine). Nevertheless, a small production of C3,
<6%, could be observed in all these variants (Fig. 2B).
These findings indicate that, following AUG, the tRNAleu
isoform containing the anti-codon corresponding to CUG
is presumably the best to initiate translation on sgRNA, fol-
lowed by GUG, whereas the tRNAleu (CUC) and the tRNAile
(AUU) isoforms are devoid of this activity.
Since SINV has two different natural hosts (mammals and
insects), it was of interest to analyze the replicons contain-
ing the different codons in insect cells. Accordingly,Aedes
albopictusC6/36 cells were transfected with the same rep-
licons and C synthesis was estimated as before. Curiously,
the activity of these codons was much lower in C6/36 cells
and only C produced by initiation onCUG could be detect-
ed with any certainty, yielding ∼30% of the control levels
(Fig. 2B,C). This observation suggests that the mechanism
followed by mammals and insects to select the start codon
has a different stringency. Indeed, no leaky scanning was
apparent in mosquito cells with the sgRNAs analyzed.
Leucine or methionine can be incorporated at the
amino terminus of C when AUG is replaced by CUG
It is thought that in the majority of cases, translation initia-
tion with CUG involves the misincorporation of methio-
nine, mediated by the ternary complex Met-tRNAi
Met-
eIF2-GTP, which should be capable of recognizing CUG
instead of AUG (Kearse and Wilusz 2017; Liang et al.
2017; Sellier et al. 2017; Na et al. 2018). Leucyl-tRNA has
also been shown to participate in the initiation event medi-
ated by CUG (Starck et al. 2012). To distinguish which ami-
noacyl tRNA is involved in the initiation directed by CUGor
GUG, the corresponding SINV replicons (and control AUG)
were transfected into BHK cells, cell extracts were separat-
ed by SDS-PAGE, and the band corresponding to C pro-
tein was excised and digested for mass spectrometry
(LC–MS/MS) analysis. For this purpose, the arginine resi-
due at the third position of theCprotein sequencewasmu-
tated to valine in order to obtain a tryptic peptide of an
adequate size (see scheme in Fig. 3A). Following transfec-
tion of rep C+ luc (AUG), a peptide of 11 amino acids was
detected that was consistent with the amino-terminal se-
quence of C, which has the initial methionine modified
by acetylation (Fig. 3B, upper panel). Notably, the cor-
responding peptide containing leucine at the amino termi-
nus was also identified in cells transfected with rep C+ luc
(CUG) (Fig. 3B, middle panel). In this case, a peptide start-
ing with methionine was also detected (Supplemental Fig.
2A). The precise proportion of each peptide bearing
leucine or methionine cannot be determined by this anal-
ysis, since it is qualitative and not quantitative. Similarly,
the corresponding peptides bearing valine (Fig. 3B, lower
panel) or methionine (Supplemental Fig. 2B) at the amino
terminus were found in cells transfected with rep C+ luc
(GUG). Therefore, we conclude that in addition to methio-
nine, leucyl-tRNA, or valyl-tRNA can recognize CUG or
GUG, respectively, during the initiation of C synthesis.
To obtain a quantitative estimation of the percentage of
incorporation of methionine or leucine at the amino termi-
nus, we constructed replicons in which all the AUG codons
present in the C protein, except for the first AUG, weremu-
tated to CUG (termed rep C [one AUG]), or in which no
AUGs were present in the entire C sequence (termed rep
C [no AUGs]). These two replicons differ from rep C+ luc
by the presence of a stop codon at the end of the C se-
quence and also the absence of the luciferase gene.
These modifications were designed to obtain only the
C protein, since the mutations introduced into the C se-
quence to suppress the ten AUGs may affect its proteolytic
activity when C plus luciferase are synthesized. BHK cells
transfected with these replicons were radioactively labeled
with translabel [35S] methionine/cysteine from 6–7 hpt. It
must also be remembered that the C sequence contains
no cysteine residues. Since only a proportion of cells are
transfected with these replicons, most of the radiolabeled
proteins are cellular. Thus, cells were treated or not with
200 μM sodium arsenite (Ars) during labeling to block cel-
lular protein synthesis (SINV sgRNA translation is resistant
to this inhibitor). Results from western blotting showed a
band corresponding to the size of authentic C protein
from both replicons (Fig. 3C), suggesting that translation
begins at the corresponding initiation codons, AUG or
CUG. We next inactivated the peroxidase activity of the
membrane and exposed it to X-ray film to detect the radio-
actively labeled C protein. Radioactive methionine was
clearly incorporated into C protein produced by rep C
(one AUG) and, albeit in a lower proportion, also in C de-
rived from rep C (no AUGs) (Fig. 3C), which agrees with
the data obtained by LC–MS/MS. We then calculated the
proportion of C obtained by immunoblotting versus radio-
active labeling in cells transfected with either replicon.
Densitometric analysis indicated that leucine was in-
corporated at the CUG codon in ∼65% of cases, whereas
methioninewas incorporated in 35%of the initiation events
(Fig. 3D).
Analysis of the role of sgRNA leader sequence
in signaling the initiation codon of translation
The leader sequence of mRNAs plays an important role in
signaling the correct initiation codon to start translation
Translation initiation on non-AUG codons
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and, in particular, the sequence context around the AUG is
critical in this respect (Kozak 1991; Kearse and Wilusz
2017). For optimal signaling of the AUG codon, positions
located at−6, −3 and +4 (with the A at position +1) should
contain a purine residue. Initially, we assayed the impor-
tance of the AUG in the luciferase gene expressed from
a SINV replicon. To this end, we made use of the replicon
rep Lluc-luc (AUG) (see scheme Fig. 4A; Sanz et al. 2010),
which has the last 38 nt of the leader sequence of sgRNA
(L26S) substituted for the last 42 nt of the leader sequence
of luciferase, followed by the complete sequence of this
gene. We also constructed a variant, rep Lluc-luc (CUG),
bearing CUG in place of AUG. The synthesis of luciferase
was then assayed by western blotting in BHK cells.
Results showed that the expression of luciferase was rather
inefficient as compared with luciferase produced by rep C
+ luc even when the initiation codon is AUG, <25%,
because it does not contain the genuine sgRNA leader se-
quence and the DSH structure (Fig. 4B,E). Replacement of
the AUG for CUG led to barely detectable levels of lucifer-
ase, indicating poor initiation (Fig. 4B,E). Two additional
SINV replicons were constructed bearing the luciferase
A
C
D
B
FIGURE 3. Leucine or methionine can be incorporated at the amino terminus when AUG is replaced by CUG. (A) Amino-terminal amino acid
sequences of wt C protein and corresponding mutants, marked in red. (B) BHK cells were transfected with in vitro synthesized replicons
rep C+ luc (AUG), rep C+ luc (CUG), or rep C+ luc (GUG), all containing the R to V mutation in C. After 8 h, cultures were collected and ex-
tracted proteins were separated by SDS-PAGE, visualized by Coomassie blue staining, and then protein bands from the different samples were
excised, trypsin-digested and analyzed by LC–MS/MS. The MS/MS spectra of amino-terminal peptides of C detected are displayed. (C ) BHK
cells were mock-transfected or transfected with in vitro synthesized replicons rep C (one AUG) or rep C (no AUGs). After 7 h, cells were treated
or not with sodium arsenite (Ars) for 15 min and then protein synthesis was detected with [35S] Met/Cys labeling for 45 min. Samples were
immunoblotted with anti-C antibodies (western blot). Then, peroxidase activity was inactivated by heating the membrane at 120°C for
15 min before exposure to an X-ray film to detect radioactive signals ([35S] Met/Cys.) (D) The proportion obtained by immunoblotting or ra-
dioactive labeling of C protein in cells transfected with both replicons was calculated and the radioactive signal was normalized to the amount
of C by immunoblotting; the graph shows the percentage incorporation of [35S] Met/Cys in C protein by rep C (no AUGs) relative to rep C (one
AUG). The results are shown as mean±SD of three experiments. Statistical significance in panel D was calculated compared to control using
Student’s t-test, (∗) P<0.05, (∗∗) P<0.01, (∗∗∗) P<0.001.
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FIGURE 4. The DSH structure, by itself, specifies the translation initiation site. (A) Schematic representation of the replicons: rep C+ luc, rep Lluc-
luc, rep Lluc C+ luc, and rep C+ luc pre. L26S is equivalent to the wt leader sequence of sgRNA, Lluc indicates that the leader sequence of lu-
ciferase is replacing the wt leader sequence and the indication pre refers to six nucleotides mutated in the leader sequence before the initiator
AUG/CUG codon. (B) BHK cells were transfected with rep C+ luc (AUG) as a control, rep Lluc-luc (AUG), or rep Lluc-luc (CUG). After 7 h, cells were
collected in loading buffer and extracted proteins were analyzed by western blotting with an anti-luciferase antibody. A protein that is recognized
nonspecifically by antibodies is also shown as a loading control (u.p.). (C ) BHK cells were transfectedwith rep C+ luc (AUG), rep C+ luc (CUG), rep
Lluc-C+ luc (AUG), or rep Lluc-C+ luc (CUG). After 7 h, cells were collected in loading buffer and extracted proteins were analyzed by western
blotting with an anti-C antibody. The mobilities of the C products are indicated as C1 (initiation in the first AUG or in the same codon mutated
to CUG) and C3 (initiation in the third AUG codon relative to the wt sequence). α-tubulin was analyzed as a loading control. (D) BHK cells were
transfected with rep C+ luc (AUG), rep C+ luc (CUG), rep C+ luc pre (AUG), or rep C+ luc pre (CUG). After 7 h, cells were collected in loading
buffer and extracted proteins were analyzed bywestern blottingwith an anti-C antibody. Themobilities of the C products are indicated as in panel
C. α-tubulin was analyzed as a loading control. (E) Densitometric analysis of luciferase or C proteins synthesized from the respective replicons. The
graphs show the percentage values in relation to the amount of luciferase or C synthesized by rep C+ luc (AUG). The black bars correspond to
translation initiation at AUG and gray at CUG. The results are displayed as mean±SD of three experiments. Statistical significance in panel E was
calculated compared to control using Student’s t-test, (∗) P<0.05, (∗∗) P<0.01, (∗∗∗) P<0.001.
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leader sequence followed by the sequence encoding
C plus luciferase: rep Lluc-C+ luc (AUG) and rep Lluc-C+
luc (CUG) (see scheme Fig. 4A). The first replicon contain-
ing the AUG initiation codon synthesized C protein to a
level similar (92%) to that of BHK cells transfected with con-
trol rep C+ luc (AUG). Interestingly, rep Lluc-C+ luc (CUG)
also synthesizedC protein, althoughwith a lower efficiency
than rep C+ luc (CUG): 45% versus 80%, with 100% as the
control rep C+ luc (AUG) (Fig. 4C,E). This result indicates
that CUG can still be partially recognized as an initiation
codon when the DSH structure is present in the C protein
sequence, but replacement of the genuine leader 26S se-
quence of sgRNA by the luciferase counterpart affects this
recognition.
Finally, we wished to analyze the sequence prior to the
initiation codon without altering the composition of pu-
rines and pyrimidines. Thus, the six nucleotides upstream
of the initiation codon were mutated from ACCACC to
GUUGUU, rendering the replicons rep C+ luc pre (AUG)
and rep C+ luc pre (CUG). Transfection of these SINV rep-
licons in BHK cells led to the production of C protein to lev-
els comparable with the corresponding rep C+ luc
counterparts (Fig. 4D,E). Therefore, the exact sequence
ACCACC upstream of the initiation codon is not crucial
to initiate at the correct position.
Involvement of the DSH structure in signaling the
initiation of sgRNA translation in transfected cells
and in cell-free systems
To evaluate the participation of the DSH structure in
sgRNA translation out of the replication context, we
compared C production in cells transfected with replicons
C+ luc or their respective sgRNAs made by in vitro tran-
scription. We tested sgRNAs containing wild-type DSH
(DSH-wt) or a destabilized DSH (DSH-destab), previously
designated as ΔDLP. (Ventoso et al. 2006; Garcia-
Moreno et al. 2013). No base-pairing occurs in the stem
of the variant DSH-destab and the hairpin structure fails
to form. Analysis of DSH function was performed both in
BHK and insect cells. Consistent with the results described
above, transfection of replicons bearing AUG or CUG as
sgRNA initiation codons gave rise to considerable C pro-
tein production in BHK cells (Fig. 5A, upper panel). In con-
trast, the initiation of translation on CUG in C6/36 cells was
very inefficient (Fig. 5A, lower panel). Destablization of the
DSH in rep C+ luc (AUG) led to leaky scanning in BHK
transfected cells, resulting in the synthesis of smaller forms
of C protein that initiate at downstream AUGs (Fig. 5A, up-
per panel), which agrees with previous results (Frolov and
Schlesinger 1996; Ventoso et al. 2006; Sanz et al. 2009).
This leaky scanning was not observed in rep C+ luc
(AUG) DSH-destab-transfected insect cells (Fig. 5A, lower
panel). Of note, the integrity of the DSH was crucial to ini-
tiate translation on CUG, since noC production initiating at
this codon was detected either in BHK or in mosquito cells
transfected with rep C+ luc (CUG) DSH-destab (Fig. 5A,D).
We next studied translation of sgRNA in the absence of
viral replication by transfection of sgRNAs produced by
in vitro transcription from their respective plasmids. As
shown in Figure 5B, sgRNA C+ luc (AUG) DSH-wt was ef-
ficiently translated both in BHK and insect cells, whereas
the variant sgRNA C+ luc (AUG) DSH-destab exhibited
leaky scanning only in BHK cells, as occurred with the rep-
licons. Also consistent with the findings using replicons,
transfection of the sgRNA C+ luc (CUG) DSH-wt synthe-
sized appreciable amounts of C protein only in BHK cells
(Fig. 5B). Strikingly, the sgRNA C+ luc (CUG) DSH-destab
was unable to initiate translation at the CUG codon, both in
BHK and insect cells (Fig. 5B,D).
Finally, to analyze the behavior of the RNA variants, they
were in vitro translated in rabbit reticulocyte lysates (RRL)
and in Drosophila melanogaster extracts (DME). Figure
5C shows that C synthesis was efficiently synthesized in
both extracts by sgRNA C+ luc (AUG) DSH-wt. Notably,
the sgRNA bearing CUG as the initiation codon was trans-
lated less efficiently than the AUG counterpart in both cell-
free systems. In addition, the sgRNA bearing the destabi-
lized DSHwas devoid of any activity to generate C proteins
using CUG as initiation codon (Fig. 5C,D). Collectively,
these findings reveal that CUG can initiate translation on
sgRNA outside the viral replication context. More impor-
tantly, the integrity of the DSH is necessary to initiate trans-
lation on CUG.
Structure-activity relationship of DSH in signaling
the initiation on CUG
We next sought to analyze in more detail the structural re-
quirements of DSH to participate in the initiation of C syn-
thesis using the CUG codon, in particular to know whether
the structure or the sequence, or both, were important for
DSH functioning. We thus designed a number of DSH var-
iants with modifications in the stem or the loop and ana-
lyzed in parallel DSH variants bearing AUG or CUG as
initiation codons in SINV replicons. The replicons were
transfected both into BHK andmosquito cells and the level
of C protein was estimated by western blotting as de-
scribed above.
The computer predictions of the structures, including
the DSH-wt and DSH-destab, and the free energy required
for their melting are shown in Figure 6. The first variant
tested had the entire DSH structure replaced by a new se-
quence (DSH-new), with a free energy similar to genuine
DSH. The replicon bearing DSH-new produces a C protein
nine amino acids shorter than authentic C protein and has
16 residues different. When compared with DSH-wt, the
production of C with DSH-new was 75% in BHK cells and
40% in C6/36 cells (Fig. 7A,C,E). Curiously, the replicon
bearing DSH-new and containing CUG in place of AUG
438 RNA, Vol. 25, No. 4
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FIGURE 5. Translation of sgRNA with wild-type or destabilized DSH and AUG or CUG initiation codons in different systems. (A) BHK (top) or
C6/36 (bottom) cells were transfected with the following rep C+ luc replicons: DSH-wt (AUG), DSH-wt (CUG), DSH-destab (AUG), or DSH-destab
(CUG). After 7 h, cells were collected in loading buffer and extracted proteins were analyzed by western blotting with an anti-C antibody. The
mobilities of the C products are indicated as C1 (initiation in the first AUG or in the same codon mutated to CUG) and C3 (initiation in the third
AUG codon relative to the wt sequence). α-tubulin was analyzed as a loading control. (B) BHK (top) or C6/36 (bottom) cells were transfected with
the different sgRNAs synthesized by in vitro transcription and, 3 h later, cells were collected and extracted proteins were analyzed by western
blotting as in panelA. (C ) The different sgRNAs were in vitro translated using rabbit reticulocyte lysates (RRL) orDrosophila melanogaster extracts
(DME). After 2 h, protein production was analyzed by western blotting with an anti-C antibody, as in A or B. (D) Densitometric analysis of the dif-
ferent C proteins synthesized in relation to the amount of C of their respective DSH-WT (AUG) controls. Black bars correspond to translation ini-
tiation at AUGand gray at CUG. The results are displayed asmean±SD of three representative experiments. Statistical significance in panelDwas
calculated compared to control using Student’s t-test; (∗) P<0.05, (∗∗) P<0.01, (∗∗∗) P<0.001.
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FIGURE 6. Secondary structure prediction of wild-type sgRNA and the variantsmutated in theDSH structure. The secondary structures of the first
180 nt of the different sgRNAs (except for DSH-new andDSH-HCV, whose secondary structures comprise only the first 156 or 189 nt, respectively)
were obtained using the Vienna RNA Website (http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi) and are colored by base-pairing
probability. The free energy of the thermodynamic assembly (ΔG) is shown in each case. The three first AUG codons in phase are marked. In
each case the mutated bases are indicated in red font next to the structure. The mutation A to C introduced to avoid a STOP codon in DSH-
HCV is highlighted in green. DSH-destab: mutations were made to destabilize the DSH. DSH-new: to replace the DSH with a new hairpin.
DSH-stem 16: to modify the sequence reinforcing DSH hairpin stability. DSH-out: to modify the sequence and the structure downstream from
DSH. DSH-re-stab: to reconstitute the structure previously destabilized in DSH-destab. DSH-HCV: to replace the DSH by the domain II of
HCV IRES. DSH-Loop 2 and DSH-Loop 6: to modify the sequence of DSH loop.
Sanz et al.
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failed to produce C protein in either of the cell lines. Thus,
DSH-new cannot replace the genuine DSH structure in sig-
naling the translation initiation site on CUG, even though
they both have a similar free energy. This finding demon-
strates that the function of the DSH is not to stall the initi-
ation complex, as previously speculated (Frolov and
Schlesinger 1996). The next variant tested has 16 modified
nucleotides in the sequence, but these changes do not al-
ter the structure of the stem (DSH-stem 16), although it
slightly increases its free energy andmodifies seven amino
acids in the sequence of C (Fig. 6). The production of C
with this variant was similar to the control in transfected
BHK cells, even when CUG was present (Fig. 7A,E). Of
note, there was a substantial inhibition in the synthesis of
C protein in insect cells (∼70%) with replicons bearing
AUG or CUG (Fig. 7C,E), likely because melting of this
DSH variant is hampered by insect ribosomes as was de-
scribed previously (Garcia-Moreno et al. 2015).
A
C
E
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FIGURE 7. Participation of stem and loop regions of DSH in the initiation of translation. (A,B) BHK cells were transfected with the in vitro tran-
scribed replicons indicated in the figure. After 7 h, cells were collected in loading buffer and extracted proteins were analyzed by western blotting
with an anti-C antibody. Themobilities of the C products are indicated as C1 (initiation in the first AUG or in the same codonmutated to CUG) and
C3 (initiation in the third AUG codon relative to the wt sequence). α-tubulin was analyzed as a loading control. (C,D) C6/36 cells were transfected
with the in vitro transcribed replicons indicated in the figure. After 16 h, cells were collected in loading buffer and extracted proteins were ana-
lyzed by western blotting with an anti-C antibody. The mobilities of the C products are indicated as C1 (initiation in the first AUG or in the same
codon mutated to CUG) and C3 (initiation in the third AUG codon relative to the wt sequence). α-tubulin was analyzed as a loading control.
(E) Densitometric analysis of the C protein synthesized from the respective replicons. The graphs show the percentage values in relation to
the amount of C synthesized by rep C+ luc (AUG) in each cell line. The black bars correspond to translation initiation at AUG and gray at
CUG. The results are displayed as mean±SD of three representative experiments. Statistical significance in panel E was calculated compared
to control using Student’s t-test, (∗) P<0.05, (∗∗) P<0.01, (∗∗∗) P<0.001.
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A sequence close to the DSH that has the ability to form
another shorter hairpin was also mutated (DSH-out). In this
variant, seven conservative mutations were introduced
maintaining the amino acid sequence. This alterationmod-
ifies the secondary structure of the RNA after the DSH se-
quence generating even shorter hairpins (Fig. 6). The
behavior of this variant was quite similar to that of the con-
trol with regard to the production of C and the signaling of
the initiation codon, even when CUG was present (Fig. 7A,
E). Moreover, in mosquito cells this variant was more effec-
tive than DSH-stem 16, perhaps due to the differences in
the free energy of both variants (Fig. 7C,E). Using DSH-
destab, we also designed a construct to restabilize the
stem by mutating the corresponding bases to hybridize
with the formerlymutated bases (DSH-re-stab). This variant
shows a similar structure to DSH-wt by computer predic-
tion, but exhibited a lower free energy and the mutations
modified the composition of C protein in six amino acids
(Fig. 6). Transfection of the replicon containing DSH-re-
stab (AUG) recovered its ability to produce C protein sim-
ilar to that of DSH-wt (AUG) in BHK cells (Fig. 7A,E).
However, the DSH-re-stab (CUG) variant only partially re-
covered its activity to use CUG as the initiation codon, as
the synthesis of authentic C was only 15% as compared
with 80% using DSH-wt (CUG). Moreover, we observed
high leaky scanning of the DSH-re-stab (CUG) variant since
part of the C protein synthesized started at the third AUG
codon, rendering a smaller product (C3). In C6/36 cells,
DSH-re-stab (CUG) partially recovered its functioning to
signal CUG as the initiation codon as compared with
DSH-destab (CUG) (15% versus 0%) (Fig. 7C,E). Thus,
restabilization of the DSH results in substantial synthesis
of C protein from the CUG initiation codon, suggesting
that the structure of the stem is important, but also that
the sequence plays a part in the DSH activity. A similar con-
clusion could be drawn with the DSH-stem 16, in which
substantial levels of C proteins were observed. However,
the free energy of the hairpin seems also to be important
for its correct functioning, since a more stable DSH is bet-
ter than that with lower stability. Nevertheless, if the DSH is
very stable, then insect ribosomes are hampered in their
ability to melt the structure. Regarding the DSH-out vari-
ant, practically no influence in the synthesis of C protein
was found, indicating that this sequence does not contrib-
ute to signal the start codon.
We recently reported that the DSH bears a resemblance
to the domain II of the IRES sequence of hepatitis C virus
(HCV) (Carrasco et al. 2018). Not only was the structural or-
ganization of DSH and HCV domain II similar, but the
sequences of the loop of DSH and the apical loop of
HCV domain II were almost the same: CUAGCCAUG in
HCV and CUGCCAUG in SINV DSH. This observation
prompted us to analyze whether there is functional conver-
gence between the two structures and to what extent the
DSH could be replaced by HCV domain II in SINV repli-
cons. Our attention was also directed to know whether
the IRES domain fromHCV could be involved in the signal-
ing of the start codon. It is well established that the mech-
anism of action of HCV domain II involves its interaction
with the E and P ribosomal sites to replace the initiator
Met-tRNAi
Met (Spahn et al. 2001; Lukavsky et al. 2003;
Locker et al. 2007). Notably, domain II can even displace
the ternary complex from preloaded ribosomes (Jaafar
et al. 2016). Moreover, as occurs with SINV, the AUG initi-
ation codon of HCV RNA can be replaced by other codons
to initiate translation (Reynolds et al. 1995). The replace-
ment of the DSH by domain II involves an increase in three
amino acids of C protein. Also, the inserted sequence con-
tains 25 different codons. To avoid a stop codon, a point
mutation was made without affecting the base-pairing in
the stem. The secondary structure of this DSH–HCV con-
struct is shown in Figure 6. Production of C from DSH–
HCV (AUG) in BHK cells reached 55% of control DSH-wt
(AUG) levels, and only a small production of C3 (3%) was
observed (Fig. 7B,E). A similar proportion was detected
in C6/36 cells, but no leaky scanning was detected (Fig.
7D,E). The initiation on CUG in DSH–HCV (CUG) was
very inefficient as compared with the control, with about
5% of initiation on CUG in BHK cells (Fig. 7B,E) and slightly
more (7%) in insect cells (Fig. 7D,E). In addition, leaky scan-
ning was evident in both cell lines (20% in BHK cells and
10% in C6/36 cells).
In the case of HCV, the sequence of the apical loop in
domain II is important for IRES function (Kalliampakou
et al. 2002). Thus, we next tested whether the sequence
of the DSH loop from SINV was important for the function-
ing of this structure. Accordingly, two additional variants
were made: one containing two point mutations in this
loop (DSH-Loop2), and the other with 6 nt modified
(DSH-Loop6) (Fig. 6). Both variants were tested with AUG
or CUG as the initiation codon of C protein. The replicons
DSH-Loop2 bearing AUG or CUG behaved similar to their
controls in both cell lines (Fig. 7B,D,E). In contrast, initia-
tion at CUG in DSH-Loop6 resulted in a very poor produc-
tion of C, representing only 10% as compared with the
control in BHK cells and even less (2%) in insect cells.
This finding is paramount in understanding the functioning
of DSH, since in this case the structure and the free energy
of DSH were not modified, but it was unable to signal CUG
as the initiation codon in both cell lines. Also, this finding is
consistent with the potential functional convergence be-
tween domain II of HCV and SINV DSH, since the exact se-
quence in the loop plays an important part in their activity.
Construction of a SINV variant bearing CUG in place
of AUG in sgRNA
We reasoned that since substantial levels of C protein are
producedwith the sgRNAvariant bearing CUG, it might be
possible to obtain a viable virus containing this initiation
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codon for further analyses under infection conditions.
Accordingly, the plasmid containing the genomic RNA
clone was mutated at the AUG to CUG in the sgRNA se-
quence. Also, the third arginine of C was mutated to a va-
line to facilitate proteomic analysis. The transcribed
genomic RNA (gRNA [CUG]) was transfected into BHK
cells and the virus was collected after four passages. We
initially confirmed the presence of CUG in this gRNA using
RT-PCR and sequence analysis of the corresponding band,
which indicated that the CUG was present in SINV-CUG.
Once it was assured that the CUG remained in the virus af-
ter these passages, BHK cells were infected with wt SINV
or the variant SINV-CUG. Cells were then radioactively la-
beled at different stages post-infection, and the proteins
synthesized were analyzed by SDS-PAGE followed by au-
toradiography. Figure 8A shows that the kinetics of viral
protein synthesis were similar between wt SINV and
SINV-CUG, albeit in the latter case the level of the struc-
tural proteins synthesized was lower than in the control.
Nevertheless, both viruses were able to interfere with cel-
lular translation.
It was of interest to test whether the initiation of Cprotein
was with leucine or with methionine in BHK cells infected
with SINV-CUG. Cells were thus infected and extracted
proteins were separatedby SDS-PAGE at 7 hpost-infection
(hpi). As before, the band corresponding to C protein was
excised from the gel and subjected to proteomic analysis.
Notably, a variety of amino-terminal peptides were ob-
tained, some of them starting with leucine, and others
withmethionine (Supplemental Table 1). This finding dem-
onstrates that the initiation of sgRNA (CUG) can occur with
leucine or methionine under the intracellular conditions
generated in SINV infected cells. The finding that other
peptides were also identified was striking. For instance,
threonine was incorporated before leucine, indicating
that the ACC codon located before CUG was recognized
by the initiation complex. This ACC codon is in a good ge-
nomic context since there are purines at−6,−3, and+4po-
sitions. Indeed, initiation of cellular mRNA translation with
threonine has been recently reported (Na et al. 2018).
Curiously, leaky scanningoccurred in some instances, since
phenylalanine, glycine or valinewere also found at the ami-
no terminus. Moreover, a peptide starting with asparagine
was detected, suggesting that initiation can also occur at
this AAU codon. Another possibility, however, is that these
peptides are generated after the removal of the initial
amino acids present at the amino terminus. In conclusion,
the initiation event on sgRNA exhibits great plasticity
for translation initiation on non-AUG codons in virus-
infected cells.
Action of bruceantin on the translation of sgRNA
The inhibitor bruceantin has been previously used to se-
lectively block the initiation of protein synthesis; specifi-
cally, it is thought that bruceantin at low concentrations
blocks the initiation at the P ribosomal site, whereas at
higher concentrations it can interfere with the elongation
steps (Liao et al. 1976; Starck et al. 2008; Gürel et al.
2009). To test the action of bruceantin on the initiation of
translation mediated by AUG or CUG, sgRNAwas translat-
ed in RRL. As control mRNAs, we used SINV gRNA-luc,
which is translated by a canonical mechanism (Carrasco
et al. 2018), and an mRNA bearing the intergenic region
(IGR) of Cricket paralysis virus (CrPV) followed by the lucif-
erase gene: IGR CrPV-luc mRNA (see scheme in Fig. 8B).
This latter messenger contains an IRES that initiates trans-
lation at the A site. We found that concentrations of bru-
ceantin >10 nM inhibited protein synthesis directed by
SINV gRNA-luc, whereas under the same conditions trans-
lation directed by IGR CrPV-luc mRNAwas stimulated (Fig.
8C). Of note, translation of sgRNA C+ luc (CUG) was also
stimulated by bruceantin under the same conditions,
whereas protein synthesis directed by sgRNA C+ luc
(AUG) was partially inhibited. These findings indicate that
sgRNA C+ luc (CUG) translation is not blocked by bru-
ceantin, but rather stimulated. In this regard, the behavior
of sgRNAC+ luc (CUG) may be similar to that of IGR CrPV-
luc mRNA, suggesting that it might start translation at the
A site.
We also wished to analyze the action of bruceantin on
viral protein synthesis in infected cells. Thus, BHK cells
were infected with wt SINV or SINV-CUG and 7 h later
the cultures were preincubated for 15 min with different
concentrations of bruceantin. Subsequently, the cell cul-
tures were radioactively labeled during 1 h in the presence
of the inhibitor and extracted proteins were separated by
SDS-PAGE. Results showed that in control BHK cells, bru-
ceantin blocked cellular translation by 80% at 100 nM and
>90% at higher concentrations (Fig. 8D,E). We noted that
the sensitivity of protein synthesis to bruceantin in intact
cells was lower than in cell-free systems, as higher concen-
trations were necessary to interfere with translation in in-
tact cells. In cells infected with wt SINV, the inhibition of
sgRNA translation was less affected than for cellular
mRNAs after bruceantin treatment. Accordingly, an inhibi-
tion of only 30% was observed at 100 nM bruceantin, al-
though higher concentrations (400 nM) resulted in a
profound blockade of translation (Fig. 8D,E). sgRNA trans-
lation was even less affected in SINV-CUG-infected cells
and 100 nM bruceantin inhibited viral protein synthesis
by only 22%. It is likely that high concentrations of this in-
hibitor interfere with the elongation steps, as previously
reported (Liao et al. 1976; Fresno et al. 1978). Therefore,
bruceantin selectively inhibits the initiation steps only at
low concentrations, such as those used in cell-free sys-
tems, whereas higher concentrations might block the
ribosomal A-site and, consequently, the elongation phase
of translation (Liao et al. 1976; Starck et al. 2008; Gürel
et al. 2009).
Translation initiation on non-AUG codons
www.rnajournal.org 443
Cold Spring Harbor Laboratory Press on April 4, 2019 - Published by rnajournal.cshlp.orgDownloaded from 
A D
B
C
E
FIGURE 8. Bruceantin differentially affects cellular and viral protein synthesis. (A) BHK cells were mock infected or infected with 10 plaque-form-
ing units/cell wt SINV or SINV (CUG). Then, the medium was changed to a labelingmedium with [35S] Met/Cys to detect the proteins synthesized
during the next hour at the indicated times post-infection. Proteins were separated by SDS-PAGE and fixed and labeled proteins were visualized
by autoradiography. Synthesized viral proteins C, PE2, E1 and E2 are indicated in the gel as well as cellular actin. (B) Schematic representation of
the in vitro transcribedmRNAs: SINV gRNA-luc, IGRCrPV-luc, sgRNAC+ luc (AUG), and sgRNAC+ luc (CUG). (C ) RRLwere pretreated or not with
the indicated concentrations of bruceantin for 20 min. Subsequently, 100 ng SINV gRNA-luc, IGR CrPV-luc, as controls, and sgRNAC+ luc (AUG)
and sgRNA C+ luc (CUG) mRNAs were added and incubated for 90 min at 30°C. Luciferase synthesis was estimated by measuring luciferase ac-
tivity. The values shown are percentages of the value of their respective nontreated counterparts and are the mean±SD of three independent
experiments. Statistical significance was calculated compared to each respective control using Student’s t-test, and is shown as (∗) P<0.05.
(D) BHK cells mock infected or infected with 10 plaque-forming units/cell wt SINV or SINV (CUG) were maintained in growth medium for 7
h. The medium was then changed to a labeling medium and cells were nontreated or treated with different amounts of bruceantin for 15 min
before addition of [35S] Met/Cys to detect the proteins synthesized during the next hour. Proteins were separated by SDS-PAGE and fixed
and labeled proteins were visualized by autoradiography. The viral proteins C, PE2, E1, and E2 are indicated in the gel and also the cellular actin.
(E) Densitometric analysis of protein synthesis. In mock-infected cells, the level of actin was used to determine the effect of bruceantin in treated
versus untreated cells. In cells infected with wt SINV or SINV (CUG), protein C was used to determine the inhibitory effect of the compound by
comparing the amounts present in treated cells versus their nontreated counterparts. The results are displayed as mean±SD of three represen-
tative experiments.
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Infection of wild-type and double knockout
(eIF2A−/eIF2D−) HAP1 cells by SINV
It is generally considered that translation initiation on non-
AUG codons can occur with the ternary complex of active
eIF2 incorporating a methionine, whereas when leucine is
at the amino terminus, this role is fulfilled by eIF2A, that
could deliver leucyl-tRNA to the ribo-
some, for a review see (Kearse and
Wilusz 2017).However, theexact func-
tioning of eIF2A remains a mystery,
since KO mice for eIF2A gene do not
show any alteration (Golovko et al.
2016). In some viral RNAs such as
HCV or SINV, the possibility that
eIF2A or eIF2D are involved in the ini-
tiation event onAUGcodons has been
suggested (Ventoso et al. 2006; Dmi-
triev et al. 2010; Skabkin et al. 2010).
However, using a human haploid cell
line (HAP1) with a double knockout
(KO) for eIF2A and eIF2D (eIF2A−/
eIF2D−), we recently demonstrated
that these factors were not required
to initiate translation on HCV or SINV
mRNAs (Sanz et al. 2017; Gonzalez-
Almela et al. 2018). Nevertheless, it
might still be possible that initiation
on CUG in sgRNA could be mediated
by eIF2A or eIF2D, as proposed for
other cellular mRNAs (Starck et al.
2012, 2016). To address this, we
analyzed SINV infection in wt HAP1
and HAP1-double KO cells. Results
showed that the kinetics and the level
of SINV protein synthesis were similar
between the two cell lines infected
with wt SINV or SINV-CUG (Supple-
mental Fig. 3A). Moreover, the shut-
off of host translation was also ex-
tremely potent in both cell lines. This
finding clearly indicates that eIF2A
and eIF2D are not necessary to initiate
translation on CUG in SINV-infected
cells.
As it was possible that active eIF2
may participate in this initiation event
when eIF2A and eIF2D are absent, as
in double KO cell line, we treated cells
with different concentrations of TG or
Ars to inhibit the activity of eIF2. Both
compounds potently blocked protein
synthesis in the two cell lines exam-
ined (Supplemental Fig. 3B). Western
blotting confirmed that TG and Ars in-
duced the phosphorylation of eIF2α (Supplemental Fig.
3C). Finally, the action of 5 μM TG or 200 μM Ars, was as-
sayed in both cell lines infected with wt SINV or SINV-CUG.
As shown in Figure 9, TG or Ars treatment exhibited a sim-
ilar action on protein synthesis in cells infected with these
viruses. Consistent with the observation that sgRNA trans-
lation is resistant to the inactivation of eIF2 in infected
A
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FIGURE 9. Infection of HAP1 wild-type (wt) and the double KO cell line HAP1 eIF2A−/eIF2D−
by wt SINV or SINV CUG. (A) HAP1wt and HAP1 double KO cells weremock infected or infect-
edwith 10 plaque-forming units/cell wt SINVor SINV (CUG) for 1 h. Then, the infectivemedium
was replaced by fresh growth medium. At 7 h post-transfection, cells were incubated in radio-
active labeling medium with [35S] Met/Cys and treated or not with thapsigargin (TG; 5 μM) or
sodium arsenite (Ars; 200 μM) for 1 h. Then, cells were collected in loading buffer and analyzed
by SDS-PAGE, fluorography and autoradiography. (B) In parallel, the state of phosphorylation
of eIF2 was analyzed by western blotting with anti-P-eIF2α and anti-eIF2α antibodies.
(C ) Densitometric analysis of C synthesis is shown in the graphs as relative to their correspond-
ing untreated samples. The results are displayed as mean±SD of three representative exper-
iments. The black bars correspond to translation initiation at AUG and gray at CUG.
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cells, there was very little inhibition of viral protein synthe-
sis in the human cell lines. Analysis of eIF2α phosphoryla-
tion in the infected cells, with or without TG or Ars
treatment, showed that SINV infection resulted in in-
creased phosphorylation of eIF2α, which was very clear af-
ter TG or Ars treatment, both in wt HAP1 and HAP1-
double KO cells (Fig. 9B). These observations demonstrate
that eIF2, eIF2A and eIF2D are not required to initiate
translation of sgRNA using CUG as the initiation codon.
DISCUSSION
All living organisms, including viruses, need to synthesize
the correct proteome in order to replicate and survive.
Accordingly, the adequate selection of the initiation co-
don is very important for the synthesis of authentic pro-
teins, since initiation at other sites would lead to aberrant
polypeptides (Drummond and Wilke 2009; Rozov et al.
2016). Whereas the vast majority of both cellular and viral
mRNAs initiate translation at AUG codons (Haimov et al.
2015; Kearse andWilusz 2017), some can initiate their pro-
tein synthesis on codons other than AUG, particularly up-
stream ORFs (Starck et al. 2016; Kearse and Wilusz
2017). On these occasions, initiation can take place at co-
dons such as CUG, GUG, AUU, among others (Peabody
1989; Van Damme et al. 2014). To what extent methionine
is also incorporated at these non-AUG codons or whether
the initiation of translation can take place with other amino
acids remains contentious (Starck et al. 2012; Liang et al.
2017; Sellier et al. 2017; Na et al. 2018). In this regard, it
has been shown that inmammalian cells leucine is incorpo-
rated as the first amino acid during translation of some
mRNAs that contain CUG instead of AUG (Starck et al.
2012). However, few studies have analyzed the initiation
with amino acids other than methionine in near-AUG co-
dons, perhaps because the initiation in near-AUGs codons
is little efficient (Liang et al. 2017). In this sense, the viral
system we used allows to obtain relatively high amounts
of protein C initiating in near-AUG codons, particularly
in CUG, which facilitates this type of study. It is thought
that in those cases where methionine incorporation is
directed by non-AUG codons, the ternary complex Met-
tRNAi
Met-eIF2-GTP is misincorporated at the amino termi-
nus at the ribosomal P site. In other instances, as occurs
when the initiator is leucyl-tRNAleu, it has been suggested
that the monomeric protein eIF2A replaces the trimeric
eIF2 (Starck et al. 2012, 2016). However, only partial inhibi-
tion of this initiation event was found after knockdown of
eIF2A. Thus, the exact mechanism by which initiation takes
place using non-AUG codons is still a matter of research. In
this sense, the use of KO cell lines similar to the one used in
the present work will be important to uncover the proteins
involved in this process.
The best understood mechanism of initiation at non-
AUG codons is on the second cistron of CrPV RNA. In this
case, initiation is mediated by an IRES present in the IGR
of CrPV in such a way that a pseudoknot structure in the re-
gion 3 of the IGR IRES interacts with the ribosomal A site
and is then translocated to the P site (Johnson et al. 2017;
Pisareva et al. 2018). The initiation codon used is GCU,
which directs the incorporation of alanine at the amino ter-
minus when the second cistron is translated. None of the
eIFs participate in this initiation event and alanyl-tRNA is
bound to the A ribosomal site mediated by translation
elongation factor 1A (eEF1A) (Jan and Sarnow 2002;
Fernandez et al. 2014). This aminoacyl-tRNA is then trans-
located to theP sitemediatedbyeEF2 in aGTP-dependent
process. We have previously advanced the idea that some
similarities exist between the mechanism of initiation di-
rected by IGR CrPV and the alphavirus sgRNA (Garcia-
Moreno et al. 2015; Sanz et al. 2017; Carrasco et al. 2018).
SINV provides a unique model to study the initiation of
translation on non-AUG codons and the mRNA require-
ments to accomplish this task. In principle, several possibil-
ities might account for translation initiation on non-AUG
codons. One is that methionine can be incorporated
even when CUG was present. Alternatively, it is possible
that leucine is the first amino acid at the amino terminus.
Our present findings demonstrate that both possibilities
can occur, although leucine is preferentially incorporated
at the amino terminus. Therefore, methionyl-tRNA or
leucyl-tRNA act as initiators on this CUG codon.
However, we do not yet know which isoform of Met-tRNA
participates in this process: the initiator, Met-tRNAi
Met, or
the isoform that participates during the elongation phase
Met-tRNAe
Met. Met-tRNAi
Met forms the ternary complex
with eIF2 and GTP, whereas Met-tRNAe
Met interacts with
eEF1A and GTP. Two models can thus be envisaged.
Either leucyl-tRNAormethionyl-tRNA forms a ternary com-
plex with eIF2, or they both interact with eEF1A. The fact
that eIF2 is very selective for the initiator Met-tRNAi
Met
and that this initiation factor forms ternary complexes
with other aminoacyl-tRNAs very inefficiently (Kolitz and
Lorsch 2010), does not support the participation of eIF2
in this process. Moreover, the demonstration that eIF2 be-
comes inactive after its phosphorylation in SINV-infected
cells is also consistentwith the idea that eIF2 is not involved
in this initiation event. The replacement of eIF2 by other
factors such as eIF2A or eIF2D can also be discarded,
because the synthesis of SINV capsid protein can occur
on double KO cell lines for these factors, even when AUG
has been replaced by CUG. Yet another mechanism could
involve the participation of a putative cellular factor that in-
teracts with some aminoacyl-tRNAs and is able to bind
them to ribosomes (Schleich et al. 2017; Hellen 2018).
For instance, the heterodimer DENR-MCT-1 can interact
with tRNA to recruit it to ribosomes during the reinitiation
of translation (Schleich et al. 2014; Lomakin et al. 2017;
Ahmed et al. 2018). There is still the possibility that low
amounts of unphosphorylated eIF2 may participate in
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sgRNA translation. Also, the presence of phosphatases in
the foci where sgRNA translation takes place could provide
small amounts of unphosphorylated eIF2. We believe that
these speculations are unlikely because eIF2 and ribo-
somes do not colocalize in SINV-infected cells (Sanz et al.
2009). Moreover, even low amounts of phosphorylated
eIF2 strongly decrease translation since GDP-GTP ex-
change is blocked (Donnelly et al. 2013). It could also be
possible that eEF1A or another cellular protein with the
ability to interact with aminoacyl-tRNA participates in this
initiation event. In the case of the ternary complex amino-
acyl-tRNA-eEF1A-GTP, it has to interact with the A site on
the 80S ribosomes, since elongation factors have to bind
to the GTPase center located at the major ribosomal sub-
unit. We have previously suggested that this A site should
be open if the P site is occupied by the DSH element
(Garcia-Moreno et al. 2015; Carrasco et al. 2018). Our pres-
ent findings are in good agreement with this idea since
bruceantin had no effect on sgRNA C+ luc (CUG) transla-
tion in RRL, and the blockade of viral translation by bru-
ceantin was poorer than that for cellular protein synthesis
in BHK cells infected with SINV-CUG. Interestingly, the
DSH element can directly interact with the 18S rRNA
(Toribio et al. 2016) and, in this manner, could promote
the formation of the 80S ribosome on the initiation codon,
as we have previously suggested (Fig. 10; Carrasco et al.
2018). In addition, DSH exhibits structural similarities to
the domain II of the HCV IRES (Carrasco et al. 2018), and
there are similarities between this domain and the CrPV
IRES (Pisareva et al. 2018). Hence, it is likely that both
DSH and the HCV domain II share functional properties.
Also, consistentwith thismodel is the finding that threonine
or valine, among others, can be found at the amino termi-
nus of C protein, indicating that other amino acids can also
participate in the initiation event depending on the codon
present at the A site.
The finding that CUG can replace the AUG initiation co-
don in SINV sgRNA and that this is dependent on the in-
tegrity of DSH opened the possibility to analyze the
structural requirements of DSH in this process. Our present
findings provide further insight into the structural require-
ments of DSH to participate in signaling the initiation co-
don. Overall, our observations lend support to the model
in which DSH interacts with the 40S subunit, promoting
the recruitment of the 60S to form the 80S ribosome
(Fig. 10; Carrasco et al. 2018). For this interaction, the
structure, but not the sequence of the stem region, seems
to be important. However, the loop sequence is crucial
because the mutation of the six nucleotides of this loop
decreases the initiation on CUG codons, particularly in in-
sect cells. Indeed, this DSH variant demonstrates that the
functioning of DSH is not to stall the preinitiation complex-
es at the correct codon. According to Kozak’s model, the
optimal position for a hairpin to stall ribosomes at the ini-
tiation codon is at 14 nt (Kozak 1990, 1991). However, po-
sitioning DSH from 24 to 15 nt downstream from the AUG
is highly detrimental for its activity (Frolov and Schlesinger
1996). DSH structure is very important for sgRNA transla-
tion (for review, see Carrasco et al. 2018). However, DSH
structure can be modified to some extent maintaining its
function, although it cannot be replaced by any hairpin,
even if it has a similar free energy (Garcia-Moreno et al.
2015). Our current results lead to the following conclusions
about the structure-activity relationship of DSH: (i) The
structure of the stem is crucial, but not its sequence, (ii)
the sequence of the loop plays an important part in the
function of DSH, and (iii) the DSH can be replaced to
some extent by domain II of the HCV IRES.
FIGURE 10. Schematic representation of the initiation events of SINV
sgRNA. Initially, the 40S ribosomal subunit together with eIF1, eIF1A,
and eIF3 interact with the cap structure at the 5′ end of sgRNA. Then,
scanning of the leader sequence takes place until the AUG initiation
codon is recognized. The DSH structure interacts with the 40S to
stop scanning and to promote the binding of the 60S ribosomal sub-
unit, after the dissociation of eIFs promoted by eIF5B. Once the 80S
ribosome is formed, the elongation phase proceeds.
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MATERIALS AND METHODS
Cell cultures and viruses
BHK-21 cells (ATCC: CCL-10) were cultured at 37°C in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10%
fetal calf serum (FCS) at 5% CO2. Wild-type HAP1 human haploid
cells and cells double knockout for eIF2A and eIF2D (cat#
HZGHC005122c010) were purchased from Horizon Discovery
Group plc. This line has a 16 bp deletion in exon 4 of the eIF2A
gene and a 22 bp deletion in exon 3 of eIF2D gene. HAP1 cells
were cultured in Iscove’s modified Dulbecco’s medium
(Invitrogen) supplemented with 10% FCS at 5% CO2. The Aedes
albopictus cell line C6/36 (ATCC: CRL-1660) was grown at 28°C
in M3 medium, containing 10% FCS and without CO2. All media
contained 100 μg/mL streptomycin and 100 IU/mL penicillin.
Viral stocks were derived from the infective cDNA clones wt
SINV, from pT7 SVwt (Sanz and Carrasco 2001), and the SINV
CUG-variant, from the same plasmid but with the AUG initiation
codon of C mutated to CUG. In vitro transcribed genomes were
transfected into BHK cells and viruses were amplified in the
same cell line.
Plasmids
Plasmids were used as DNA templates for in vitro RNA transcrip-
tion with T7 or SP6 RNA polymerases. pToto1101/Luc (SINV
gRNA-luc) was generously provided by Charles Rice (Rockefeller
University) (Bick et al. 2003). Plasmid T7 Rluc ΔEMCV IGR-Fluc
was used to obtain IGR CrPV luc mRNA (Wilson et al. 2000).
The pTM1-Luc vector was constructed as described previously
(Sanz et al. 2010). Cap.βGlobin-Luc transcripts were obtained by
in vitro transcription using pKS-GL-FL as a template, as described
previously (Castello et al. 2009)
pT7 SVwt (Sanz and Carrasco 2001) and pT7 rep C+ luc (Sanz
et al. 2007) were used as template plasmids to obtain variants
of infective clones or replicons, respectively. The plasmids to pro-
duce sgRNAs derived from their respective replicons, which were
modified to introduce the promotor sequence of T7 RNA poly-
merase directly upstream of the sgRNA sequences. To obtain
each variant, we used four oligonucleotides: Two included HpaI
or AatII restriction sites and two were designed specifically to in-
troduce the mutations with complementary sequences. We
carried out two PCR reactions using pT7SV wt or pT7 rep C+
luc as template DNA and the oligonucleotides 5′HpaI and the
3′-specific oligonucleotide or 5′-specific oligonucleotide and
3′AatII. We then performed a second PCR with a mixture of these
products as DNA template and the oligonucleotides with HpaI
and AatII sites. The products of the second PCR were digested
as appropriate and cloned into pT7 SV wt or pT7 rep C+ luc. To
introduce the CUG mutation into pT7 rep Lluc-luc (Sanz et al.
2010), we used the same protocol but used the oligonucleotide
3′SphI-luc in place of 3′AatII. To obtain the plasmids to produce
sgRNAs, we used the oligonucleotides 5′SacI - T7prom and
3′AatII with the respective pT7 rep C+ luc variant DNA templates.
The PCR products are digested with SacI and AatII and cloned
into pT7 rep C+ luc. The sequence of C with all in frameAUG trip-
lets mutated to CUG (or all but the first) was obtained by multiple
PCR reactions using specific oligonucleotides. The sequences in-
troduced into plasmids were then verified by sequencing. The list
of oligonucleotides used is shown in Supplemental Table 1.
Antibodies
The following primary antibodies were used: rabbit polyclonal
antibody against purified SINV C protein, generated in our labo-
ratory; rabbit polyclonal anti-firefly luciferase (ab 21176, Abcam);
goat polyclonal anti-TIA-1 (C-20) sc-1751 and rabbit polyclonal
anti-eIF2α antibodies (Santa Cruz Biotechnology); mouse mono-
clonal anti-α-tubulin (T5168, Sigma-Aldrich); rabbit polyclonal
anti-eIF2D antibody (Proteintech Group); rabbit polyclonal anti-
eIF2A (Bethyl Laboratories Inc.); and rabbit polyclonal antibody
anti-phospho-eIF2α (serine 51) (Cell Signaling Technology).
Anti-rabbit or anti-mouse IgG secondary antibodies coupled
to peroxidase (Amersham Biosciences) were used at a 1:5000
dilution.
In vitro transcription and transfection
Plasmids digested with XhoI were used as templates for in
vitro RNA transcription with T7 or Sp6 RNA polymerases (New
England Biolabs). With the exception of IGR CrPV luc, all in vitro
produced RNAs were capped by adding the m7G(5′)ppp(5′)G
cap analog to the transcription mixture. The transcription mix-
tures were treated with DNAse I and used directly for transfection.
BHK or C6/36 subconfluent cells grown in 24-well plates were
transfected (per well) with a mixture of 1 μg RNA and 2 μL
Lipofectamine 2000 in 200 μL Opti-MEM I medium (both from
Invitrogen). Experiments to analyze the translation of sgRNAs
were performed in Opti-MEM I medium. For those experiments
requiring a longer duration, the transfection medium was
changed after 2 h to DMEM with 10% FCS for BHK cells or M3
with 10% FCS for C6/36 cells.
Immunofluorescence and confocal microscopy
Fixation, permeabilization, and confocal microscopy were per-
formed as described previously (Madan et al. 2008) using an
LSM 710 confocal laser scanning and multiphoton microscope
coupled to an inverted microscope (Axio Observer). Primary anti-
bodies were detected by secondary antibodies coupled to Alexa
488 or Alexa 555. Nuclei were stained with DAPI (4′-6-diamidino-
2-phenylindole). All images were collected and analyzed using
Zeiss ZEN 2010 software.
In vitro translation
A nuclease-treated rabbit reticulocyte lysate system (RRL,
Promega) was used for in vitro translation. Reactions containing
100 ng of in vitro transcribed mRNAs were incubated for 90 min
at 30°C. An in vitro translation assay in Drosophila embryo ex-
tracts was also carried out, as previously described (Gebauer
et al. 1999). Reaction mixtures containing 1 μg of in vitro synthe-
sized RNA, 40% embryo extract (a kind gift from Dr. F. Gebauer,
Centre for Genomic Regulation, Barcelona, Spain), 0.1 mM
spermidine, 60 μM amino acids, 16.8 mM creatine phosphate,
80 ng/μL creatine kinase, 24 mM HEPES pH 7.4, 1.4 mM
Sanz et al.
448 RNA, Vol. 25, No. 4
Cold Spring Harbor Laboratory Press on April 4, 2019 - Published by rnajournal.cshlp.orgDownloaded from 
magnesium acetate, 100 mM potassium acetate and 100 ng/μL
calf liver tRNA were incubated in a final volume of 50 μL at 25°
C for 90 min. Protein synthesis was determined by measuring lu-
ciferase activity or by western blotting.
Luciferase activity measurement
BHK cells were lysed in a buffer containing 0.5% Triton X-100,
25 mM glycylglycine pH 7.8, 1 mM dithiothreitol and complete
EDTA-free protease inhibitor cocktail (Roche Molecular Systems
Inc.) at the concentration indicated by the supplier. Luciferase ac-
tivity for cells and RRL assays was determined using the Luciferase
Assay System (Promega) and a Sirius Luminometer (Titertek-
Berthold).
As a control, cycloheximide was added to block translation,
which allowed us to determine the luciferase synthesized in the
absence of compounds during the first hour of transfection.
Analysis of protein synthesis by radioactive
labeling
Protein synthesis was analyzed at the times indicated by replacing
growth media with 0.2 mL DMEM without methionine-cysteine
supplemented with 1 μL of EasyTag EXPRESS 35S Protein
Labeling mix, [35S]Met-Cys (11 mCi mL−1; PerkinElmer) per well
of an L-24 plate. Cells were then collected in sample buffer,
boiled for 5 min and analyzed by autoradiography on SDS-poly-
acrylamide gels. Protein synthesis was quantified by densitometry
using a GS-800 calibrated imaging densitometer (Bio-Rad).
Western blotting
Cells were collected in sample buffer, boiled for 5 min and pro-
cessed by SDS-PAGE. After electrophoresis, proteins were trans-
ferred to nitrocellulosemembranes. Protein bandswere visualized
with the ECL detection system (Amersham). Quantification was
made by densitometry, as above.
Mass spectrometry analysis of SINV capsid
amino terminus
BHK cells (1 × 106) were transfected with 5 μg of in vitro synthe-
sized replicons, rep C+ luc (AUG), rep C+ luc (CUG), or rep C+
luc (GUG), all containing the R3 to V mutation in C, and 10 μL
Lipofectamine 2000. After 8 h, cultures were collected and pro-
tein extracts were separated by SDS-PAGE and visualized by
coomassie blue staining. Protein bands migrating at the molecu-
lar weight of C from each replicon were excised. A sample of
cells infected with wt virus was used to determine C mobility.
The same protocol was followed for the analysis of cells infected
with SINV (CUG) at 10 plaque-forming units/cell and collected
after 7 h.
In-gel digestion
After drying, gel bands were destained in acetonitrile:water (1:1),
reduced and alkylated (disulfide bonds from cysteinyl residues
were reduced with 10 mM DTT for 1 h at 56°C, and thiol groups
were alkylatedwith 50mM iodoacetamide for 1 h at room temper-
ature in the dark), and then digested in situ with sequencing grade
trypsin (Promega) as described previously (Perez et al. 2012). The
gel pieces were dehydrated by removing all liquid using sufficient
acetonitrile, which was then removed and the gel pieces dried in
a speed vac. Gels were reswollen in 50 mM ammonium bicarbon-
ate pH 8.8with 12.5 ng/μL trypsin for 1 h in an ice-bath. The diges-
tion buffer was then removed and gels were covered again with
50 mM ammonium bicarbonate and incubated at 37°C for
12 h. Digestion was stopped by the addition of 1% trifluoroacetic
acid. Supernatants were dried down and then desalted onto
ZipTipC18 Pipette tips (Millipore) formass spectrometric analysis.
Reverse phase-liquid chromatography
RP-LC–MS/MS analysis
The desalted protein digest was dried, resuspended in 10 μL of
0.1% formic acid and analyzed by RP-LC–MS/MS in an Easy-nLC
II system coupled to an ion trap LTQ-Orbitrap-Velos-Pro hybrid
mass spectrometer (Thermo Scientific). The peptides were con-
centrated (on-line) by reverse phase chromatography using a
0.1 mm×20 mm C18 RP precolumn (Thermo Scientific), and
then separated using a 0.075 mm×250 mm C18 RP column
(Thermo Scientific) operating at 0.3 μL/min. Peptides were eluted
using a 100-min dual gradient from 5% to 25% solvent B in 68min
followed by gradient from 25% to 40% solvent B over 90 min
(Solvent A: 0.1% formic acid in water, solvent B: 0.1% formic
acid, 80% acetonitrile in water). ESI ionization was done using a
stainless steel nano-bore emitter, ID 30 μm, interface (Proxeon
Biosystems). The Orbitrap resolution was set at 30.000. Peptides
were detected in survey scans from400 to 1600 amu (1 μscan), fol-
lowed by fifteen data-dependent MS/MS scans (Top 15), using an
isolation width of 2 u (in mass-to-charge ratio units), normalized
collision energy of 35%, and dynamic exclusion applied during
30 sec periods. Peptide identification from raw data was carried
out using PEAKS Studio 8.5 software (Bioinformatics Solutions
Inc.) (Han et al. 2004, 2011; Zhang et al. 2012). Database search-
ing was performed against Local Data Base (SINV capsid se-
quence). The following constraints were used for the searches:
tryptic cleavage after Arg and Lys, up to two missed cleavage
sites, and tolerances of 20 ppm for precursor ions and 0.6 Da
for MS/MS fragment ions, and the searches were performed al-
lowing optional Met oxidation, amino-terminal acetylation and
Cys carbamidomethylation. False discovery rates (FDRs) for pep-
tide spectrum matches were limited to 0.01.
Secondary structure prediction
RNA optimal secondary structures were predicted using the
RNAfoldwebServer: http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi.
Statistical analysis
Data analysis was performed using Excel (Microsoft). Data are
shown as mean with standard error. Statistical validation was
done using unpaired two tails Student’s t-test with unequal vari-
ances. Statistical significance is shown as ∗ P<0.05, ∗∗ P<0.01,
∗∗∗ P<0.001.
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ARTÍCULO 4:  
System-wide profiling of RNA-Binding Proteins uncovers key regulators of virus 
infection 
Otro de los objetivos de esta tesis es determinar las proteínas que interaccionan 
con los mRNAs virales y celulares y que, por tanto, puedan estar implicadas en su ciclo 
replicativo, incluyendo la traducción. La identificación de estas proteínas es esencial 
para conocer en detalle el mecanismo de síntesis de proteínas virales y el proceso de 
inhibición de la expresión de mRNAs celulares. Los trabajos anteriores se enfocan en el 
estudio analítico de proteínas celulares específicas que previamente han sido sugeridas 
como factores potencialmente implicados en la traducción viral. Siguiendo otra 
aproximación, esta parte del proyecto de tesis pretende abordar el estudio exploratorio 
del total de proteínas, virales y celulares, que interaccionan con todos los mRNAs 
presentes en la célula durante la infección de SINV. Para llevar a cabo el aislamiento y 
clasificación de estas proteínas, se realizó una colaboración con el laboratorio del Dr. 
Alfredo Castelló (Universidad de Oxford), experto en la identificación de las proteínas 
que interaccionan con los mRNAs y autor el método de captura del interactoma (RNA-
interactome capture, RIC) (Castello, Fischer et al. 2012). Esta colaboración comenzó con 
un periodo de tres meses de estancia en el laboratorio del Dr. Castelló durante el año 
2015, y posteriormente siguió desarrollándose a distancia. En esta colaboración, se 
desarrolló y se empleó por primera vez la técnica de comparative RNA-interactome 
capture (cRIC) en células infectadas con SINV. Esta metodología permite analizar la 
respuesta del conjunto de proteínas de unión a RNA (RNA-binding proteins, RBPs) a 
cambios en las condiciones del ambiente celular, como los que ocurren durante la 
infección viral. Con esto, se pudo determinar la interacción diferencial de las RBPs con 
los RNAs tras la infección por SINV.  
Durante mi estancia en Oxford realicé la captura del interactoma de células 
HEK293 infectadas con SINV, aplicando conjuntamente la técnica SILAC (Stable Isotpe 
Labeling with Amino acids in Cell culture ). Esta última técnica está basada en detectar, 
mediante espectrometría de masas, cambios en la abundancia de proteínas entre 
distintas muestras que han sido marcadas con isotopos no radioactivos. Las células se 
cultivaron en medios que contenían aminoácidos marcados con diferentes isótopos 
estables para que fueran incorporados en las proteínas de nueva síntesis. Estas células 
se infectaron con SINV y se irradiaron con luz ultravioleta para unir covalentemente las 
proteínas al RNA. Posteriormente, las muestras obtenidas fueron procesadas 
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paralelamente por análisis transcriptómico y proteómico convencional. Después, se 
realizaron los análisis de proteómica cuantitativa, secuenciación del RNA y estadística.  
En este trabajo se ha detectado un gran número de RBPs (247) cuya actividad de 
unión al RNA se ve alterada por la infección por SINV. Muchas de ellas carecen de 
dominios de unión al RNA clásicos. Asimismo, se ha determinado que estas alteraciones 
en su actividad están relacionadas con la degradación de RNAs celulares y el cambio en 
el patrón de distribución de numerosas proteínas celulares, que pueden encontrarse 
concentradas en lugares próximos a los centros de replicación viral. También se ha 
estudiado, mediante técnicas de silenciamiento génico, empleo de inhibidores y 
sobreexpresión de factores, el papel de algunas de estas RBPs en promover u 
obstaculizar la infección, obteniendo resultados muy interesantes para algunas RBPs, 
como la exonucleasa XRN1 o GEMIN5. La primera resultó ser vital para la progresión de 
la infección de SINV, ya que la línea KO para XRN1 resulta refractaria a la infección, 
mientras que GEMIN5 inhibe la traducción viral. 
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SUMMARY
The compendium of RNA-binding proteins (RBPs)
has been greatly expanded by the development
of RNA-interactome capture (RIC). However, it re-
mained unknown if the complement of RBPs
changes in response to environmental perturbations
and whether these rearrangements are important. To
answer these questions, we developed ‘‘compara-
tive RIC’’ and applied it to cells challenged with an
RNA virus called sindbis (SINV). Over 200 RBPs
display differential interaction with RNA upon SINV
infection. These alterations are mainly driven by the
loss of cellular mRNAs and the emergence of viral
RNA. RBPs stimulated by the infection redistribute
to viral replication factories and regulate the capacity
of the virus to infect. For example, ablation of XRN1
causes cells to be refractory to SINV, while GEMIN5
moonlights as a regulator of SINV gene expression.
In summary, RNA availability controls RBP localiza-
tion and function in SINV-infected cells.
INTRODUCTION
RNA-binding proteins (RBPs) assemble with RNA forming ribo-
nucleoproteins (RNPs) that dictate RNA fate (Glisovic et al.,
2008). Historically, most of the known RBPs were characterized
by the presence of well-established RNA-binding domains
(RBDs), which include the RNA recognition motif, K-homology
domain, and others (Lunde et al., 2007). However, stepwise iden-
tiﬁcation of unconventional RBPs evoked the existence of a
broader universe of protein-RNA interactions than previously
anticipated (Castello et al., 2015). Recently, a system-wide
approach termed RNA-interactome capture (RIC) has greatly
expanded the compendium of RBPs (RBPome) (Hentze et al.,
2018). RIC employs UV crosslinking, oligo(dT) capture under
denaturing conditions, and quantitative proteomics to identify
the complement of proteins interacting with polyadenylated
(poly(A)) RNA in living cells (Baltz et al., 2012; Castello et al.,
2012). RIC uncovered hundreds of unconventional RBPs,
several of which are now known to play crucial roles in cell
biology (Hentze et al., 2018). Recent work has suggested that
cells can adapt to physiological cues through discrete alterations
in the RBPome (Perez-Perri et al., 2018; Sysoev et al., 2016).
However, it remains unknown to what extent the RBPome can
be remodeled, how RBP responses are triggered, and what
are the biological consequences of this plasticity. For example,
RIC reported changes in the composition of the RBPome during
fruit ﬂy embryo development that could be explained by match-
ing alterations in protein abundance (Sysoev et al., 2016).
However, several RBPs did not follow this trend, displaying pro-
tein-level independent changes in RNA binding and raising the
question of whether physiological perturbations can induce
such responsive behavior more widely. To address this possibil-
ity, we developed a ‘‘comparative RIC’’ (cRIC) approach to pro-
ﬁle with high accuracy RBP dynamics in cells infected with
sindbis virus (SINV) (Figures 1A and 1B).
Viruses have been fundamental for the discovery and charac-
terization of important steps of cellular RNA metabolism such as
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Figure 1. Application of RIC to HEK293 Cells Infected with SINV
(A) Schematic representation of cRIC.
(B) Schematic representation of SINV and chimeric SINV-mCherry genomes.
(C) Analysis of the proteins synthesized in uninfected and SINV-infected HEK293 cells by [35S]-Met/Cys incorporation for 1 h followed by autoradiography.
(D) Analysis of total and phosphorylated eIF2a by western blotting.
(legend continued on next page)
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RNA splicing, nuclear export, and translation initiation. This is
due to their ability to hijack key cellular pathways by interfering
with the activity of master regulatory proteins (Akusjarvi, 2008;
Carrasco et al., 2018; Castello´ et al., 2011; Garcia-Moreno
et al., 2018; Lloyd, 2015). Furthermore, specialized RBPs are
at the frontline of cellular antiviral defenses, detecting path-
ogen-associated molecular patterns (PAMPs) such as double-
stranded RNA (dsRNA) or RNAs with 50 triphosphate ends
(Barbalat et al., 2011; Vladimer et al., 2014). Hence, virus infected
cells represent an optimal scenario to assess the RBPome
rearrangements.
Our data show that the complement of active cellular RBPs
strongly changes in response to SINV infection, mainly due to
deep variations in RNA availability. Importantly, ‘‘altered’’ RBPs
are critical, as their perturbation affects viral ﬁtness or/and the
ability of the cell to counteract the infection. We envision that
these RBPs represent novel targets for host-based antiviral
therapies.
RESULTS AND DISCUSSION
Applying RIC to Cells Infected with SINV
To study the dynamics of cellular RBPs in response to physiolog-
ical cues, we challenged cells with a cytoplasmic RNA virus and
applied RIC. We chose SINV and HEK293 cells as viral and
cellular models, respectively. SINV is a highly tractable virus
that is transmitted from mosquito to vertebrates, causing high
fever, arthralgia, malaise, and rash in humans. SINV replicates
in the cytoplasm of the infected cell and produces three viral
RNAs (Figures 1B and S1A): genomic RNA (gRNA), subgenomic
RNA (sgRNA), and negative-stranded RNA. gRNA is packaged
into the viral capsid and is translated toproduce the nonstructural
proteins (NSPs) that form the replication complex. The sgRNA is
synthesized froman internal promoter andencodes the structural
proteins (SPs), which are required to generate the viral particles.
The negative strand serves as a template for replication. Both
gRNA and sgRNA have cap and poly(A) tail.
HEK293 cells are an excellent cellular model to study SINV, as
its infection exhibits all the expected molecular signatures,
including (1) active viral replication (Figures 1C, S1B, and S1C),
(2) host protein synthesis shutoff while viral proteins are
massively produced (Figures 1C and S1B), (3) phosphorylation
of the eukaryotic initiation factor 2 subunit alpha (EIF2a) (Fig-
ure 1D), and (4) formation of cytoplasmic foci enriched in viral
RNA and proteins, commonly known as viral replication factories
(Figures S1C and S1D). SINV infection causes a strong induction
of the antiviral program, including b-interferon (b-IFN), which
reﬂects the existence of active antiviral sensors and effectors
(Figure S1E). Importantly, SINV achieves infection in a high
proportion of cells (85%) with relatively low number of viral par-
ticles (MOI) (Figure S1F), reducing cell-to-cell variability and bio-
logical noise.
Pilot RIC experiments in uninfected and SINV-infected cells
revealed the isolation of a protein pool matching that previously
observed for human RBPs (Castello et al., 2012), which strongly
differed from the total proteome (Figure 1E). No proteins were
detected in nonirradiated samples, demonstrating the UV de-
pendency of RIC. Infection did not induce major alterations in
the protein pattern observed by silver staining, which corre-
spond to the most abundant housekeeping RBPs (Figure 1E).
However, other less predominant bands displayed substantial
differences, calling for in-depth proteomic analysis. Oligo(dT)
capture led to the isolation of both host and SINV RNAs in in-
fected cells (Figure 1F), which is expected as gRNA and sgRNA
are polyadenylated.
SINV Infection Alters the Activity of Hundreds of RBPs
To allow accurate quantiﬁcation of RBPs associated with poly(A)
RNA under different physiological conditions, we developed a
cRIC approach by combining the original protocol (Castello
et al., 2013) with stable isotope labeling by amino acids in cell
culture (SILAC) (Figure 1A). In brief, cells were grown in presence
of light, medium, or heavy amino acids with incorporation
efﬁciency >98%. Labeled cells were infected with SINV and irra-
diated with UV light at 4 and 18 h post-infection (hpi), using un-
infected cells as a control (Figure 1A). These times correlate
with key states in the SINV biological cycle; i.e., at 4 hpi, viral
gene expression coexists with host protein synthesis, while the
proteins synthesized at 18 hpi are almost exclusively viral (Fig-
ure 1C). SILAC labels were permutated among uninfected,
4 hpi, and 18 hpi in the three biological replicates to correct for
possible isotope-dependent effects. After lysis, aliquots were
stored for parallel transcriptomic and whole-proteome analyses.
We combined equal amounts of the lysates from the three con-
ditions prior to the oligo(dT) capture, and eluates were analyzed
by quantitative proteomics (Figure 1A). Protein intensity ratios
between condition pairs were computed, and the signiﬁcance
of each protein intensity change was estimated using a moder-
ated t test (Figures 2A–2D, S2A, and S2B). We used a semiquan-
titative method for the cases in which an intensity value was
missing (‘‘zero’’) in one of the two conditions leading to ‘‘inﬁnite’’
or zero ratios (Sysoev et al., 2016).
We identiﬁed a total of 794 proteins, 91% of which were
already annotated by the Gene Ontology term ‘‘RNA-binding’’
or/and previously reported to be RBPs in eukaryotic cells by
RIC (Hentze et al., 2018). Hence, the protein composition of
our dataset largely resembles that of previously established
RBPomes. Only 17 proteins displayed differential interaction
with RNA at 4 hpi (Figures 2A, 2B, and S2A; Table S1). Fifteen
of these were detected exclusively by the semiquantitative
method due to the lack of intensity value in one condition, reﬂect-
ing possible ‘‘on-off’’ and ‘‘off-on’’ states (Table S1). By contrast,
236 RBPs displayed altered RNA-binding activities at 18 hpi (Fig-
ures 2C, 2D, and S2B; Table S1). A total of 247 RBPs displayed
(E) Silver staining analysis of the ‘‘inputs’’ (i.e., total proteome, left) and eluates (i.e., RBPome, right) of a representative RIC experiment in SINV-infected cells.
(F) qRT-PCR analysis of the eluates of a representative RIC experiment using speciﬁc primers against SINV RNAs, actb and gapdh (for normalization) mRNAs.
Error bars represent SE.
hpi, hours post-infection; MW, molecular weight.
See also Figure S1.
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differential binding in infected cells (4 and 18 hpi) and are referred
to here as ‘‘altered RBPs.’’ Interestingly, 181 of these lack clas-
sical RBDs, highlighting the importance of unconventional RBPs
in virus infection.
To validate these results, we applied RIC to cells infected with
SINV but, in this case, the eluates were analyzed bywestern blot-
ting. We selected nine altered RBPs falling into three statistical
categories; i.e., four with 1% false discovery rate (FDR), four
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Figure 2. Analysis of the RNA-Bound Proteome in SINV-Infected HEK293 Cells by cRIC
(A) Scatterplot showing the intensity ratio between 4 hpi and uninfected conditions of each protein (dots) in the eluates of two biological replicates of cRIC.
(B) Volcano plot showing the log2 fold change and the signiﬁcance (p value) of each protein between 4 hpi and uninfected conditions using data from three
biological replicates.
(C) As in (A) but for 18 hpi.
(D) As in (B) but for 18 hpi.
(E) Western blotting analysis with speciﬁc antibodies of the eluates of a representative RIC experiment in SINV-infected HEK293 cells.
(F) Molecular function (top) and cellular component (bottom) Gene Ontology (GO) term enrichment analysis of the stimulated (salmon) against inhibited (blue)
RBPs (18 hpi).
(G) Representative scatterplot comparing the raw intensity of each protein in the eluates of two cRIC replicates at 18 hpi.
FDR, false discovery rate; n.s., non-signiﬁcant.
See also Figure S2 and Table S1.
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with 10% FDR, and one with nonsigniﬁcant changes. We
included a positive control (the viral RBP SINV capsid [C]), two
‘‘non-altered’’ RBPs (MOV10 and EPRS), and a negative control
(b-actin [ACTB]). Strikingly, the RNA-binding behavior of each
protein fully matched the proteomic outcome, including those
classiﬁed with 10% FDR (Figure 2E). Changes in RNA binding
increased progressively throughout the infection. The proteomic
data assigned a nonsigniﬁcant downregulation to HNRNPR
(Table S1); however, the reduced activity of this protein was
apparent by western blotting (Figure 2E), suggesting that our da-
taset may contain false negatives. Nonetheless, the excellent
agreement between the proteomic and western blotting data
supports the high quality of our results.
Determination of the RBP Networks Altered by SINV
Infection
Among the 247 altered RBPs, 133 presented reduced and 114
increased association with RNA, and they are here referred to
as ‘‘inhibited’’ and ‘‘stimulated’’ RBPs, respectively. Most of
the inhibited RBPs were linked to nuclear processes such as
RNA processing and export (Figures 2F and S2C). While cyto-
plasmic viruses are known to hamper nuclear RNA metabolism,
the mechanisms by which this occurs remain poorly understood
(Castello´ et al., 2011; Gorchakov et al., 2005; Lloyd, 2015).
Whether the inhibition of nuclear RBPs contributes to this phe-
nomenon should be further investigated. Conversely, a large
proportion of the stimulated RBPs are cytoplasmic and are
linked to protein synthesis, 50 to 30 RNA degradation, RNA trans-
port, protein metabolism, and antiviral response (Figures 2F
and S2D).
Interestingly, several RBPs involved in translation were stimu-
lated at 18 hpi despite the shutoff of host protein synthesis (Fig-
ure 1C), including 9 eukaryotic initiation factors, 3 elongation
factors, and 12 ribosomal proteins. This enhancement is likely
due to the high translational activity of SINV RNAs (Figure 1C)
(Frolov and Schlesinger, 1996). The core components of the
cap-binding complex EIF4A1 and EIF4E were not stimulated
by the infection despite the activation of their protein partner,
EIF4G1 (Table S1). In agreement, EIF4A1 and EIF4E do not
participate in SINV sgRNA translation (Carrasco et al., 2018).
A recent report showed that EIF3D is a cap-binding protein
that controls the translation of speciﬁc mRNA pools (Lee et al.,
2016). EIF3D is stimulated by SINV, and thus its potential contri-
bution to SINV RNA translation deserves further consideration.
Importantly, 88 altered RBPs associate with ribosomes in mouse
cells (Table S2) (Simsek et al., 2017). The existence of ‘‘special-
ized ribosomes’’ has been proposed; however, experimental ev-
idence is sparse (Au and Jan, 2014). Our results indicate that the
composition of ribosomes and the scope of proteins associated
with them may strongly differ between infected and uninfected
cells, possibly resulting in differential translational properties.
cRIC uncovered 16 altered RNA helicases (Table S2), 13 of
which were inhibited upon infection. RNA helicases are funda-
mental at virtually every stage of RNA metabolism (Chen and
Shyu, 2014), and their inhibition is expected to have important
consequences in RNA metabolism. Only 3 helicases were stim-
ulated by SINV (DDX1, DHX57, and DHX29) (Figure 2E; Table
S2). DHX29 enhances 48S complex formation on SINV sgRNA
in reconstituted in vitro systems (Skabkin et al., 2010), and its
stimulation supports its regulatory role in infected cells.
Notably, a deﬁned subset of antiviral RBPs is stimulated upon
SINV infection, including IFI16, IFIT5, TRIM25, TRIM56, and
ZC3HAV1 (ZAP) (Table S1). IFI16 was previously described to
bind dsDNA in cells infected with DNA viruses (Ni et al., 2016).
Our data reveal that IFI16 also binds RNA, and it is activated early
after SINV infection (4 hpi). This agrees with the recently
described ability of IFI16 to restrict RNA virus infection (Thomp-
son et al., 2014). These ﬁndings highlight the capacity of cRIC to
identify antiviral factors responding virus infection.
Interestingly, cRIC also identiﬁed viral RBPs associated with
poly(A) RNA, including the known viral RBPs (i.e., RNA helicase
NSP2, the RNA polymerase NSP4, and capsid) and, unexpect-
edly, also NSP3 and E2 (Figures 2G and S2E). NSP3 was only
quantiﬁed in two replicates (Figure S2E), and thus its interaction
with RNA requires experimental conﬁrmation. The identiﬁcation
of E2 in cRIC eluates was unexpected. In the viral particle of
the related VEEV, E2 interacts with the capsid protein nearby
cavities that communicate with the inner part of the virion where
the gRNA density resides (Zhang et al., 2011), potentially
enabling transitory or stochastic interactions with viral RNA.
RBP Responses to SINV Are Not Caused by Changes in
Protein Abundance
Changes detected by cRIC can be a consequence of matching
alterations in protein abundance (Sysoev et al., 2016). To assess
this possibility globally, we analyzed the total proteome by quan-
titative proteomics (cRIC inputs; Figure 1A). Importantly, SINV
infection did not cause noticeable changes in host RBP levels,
including 129 RBPs with altered RNA-binding activity (Figures
3A–3C and S3A–S3C; Table S3). In agreement, silver and Coo-
massie staining did not show noticeable protein ﬂuctuations
except for the viral capsid (Figure 1E and 3D). The lack of
changes in protein levels, even for altered RBPs, was conﬁrmed
by western blotting (Figure 3E; Table S3). It is not wholly unex-
pected that RBPs are unaffected in spite of the shutoff of cellular
protein synthesis. Analogous to siRNA experiments, detectable
decreases in protein abundance may require hours or even
days after translational suppression, especially for relatively sta-
ble proteins.
The Transcriptome Undergoes Pervasive Changes in
SINV-Infected Cells
Mechanistically, the activity of host RBPs can also be dictated by
changes in the availability of their target RNAs. To test this pos-
sibility, we analyzed by RNA sequencing (RNA-seq) the total
RNA isolated from cRIC input samples (Figure 1A). 4 h of SINV
infection had a relatively minor impact on the host transcriptome
(Figure 3F). By contrast, deep changes were observed at 18 hpi,
with 12,372 differentially expressed RNAs (p < 0.1; Figures 3G
and S3E–S3G). Only 1,448 RNAs were upregulated, and these
were enriched in the Gene Ontology (GO) term ‘‘antiviral
response.’’ By contrast, 10,924 RNAs were downregulated,
including many housekeeping genes (Table S4).
To validate these results by an orthogonal approach, we
used qRT-PCR focusing on 20 mRNAs randomly chosen
across the whole variation range. Importantly, data obtained
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Figure 3. Proteomic and Transcriptomic Analyses of Whole SINV-Infected Cell Lysates
(A) Scatterplot comparing the intensity ratio between 4 hpi and uninfected conditions of each protein (dots) in the inputs (total proteome) of two biological
replicates of cRIC. Black dots represent proteins signiﬁcantly enriched in either 4 hpi or uninfected conditions in Figure 2A.
(B) As in (A) but for 18 hpi.
(C) Scatterplot comparing the intensity of each protein in the inputs of two cRIC replicates at 18 hpi.
(D) Representative Coomassie blue staining of cells infected with SINV.
(E) Western blotting analysis of lysates of cells infected with SINV (see Table S3 for quantiﬁcation).
(F) MA plot comparing the read coverage and the log2 fold change between 4 hpi and uninfected cells of each gene detected in the RNA sequencing (RNA-seq)
experiment. Red dots represent RNAs enriched with p < 0.1.
(G) As in (F) but for 18 hpi.
(H) Correlation of the RNA-seq and RT-qPCR data by plotting the log2 fold change for randomly selected transcripts by the twomethods. Error bars represent SE
of three independent experiments.
See also Figure S3 and Tables S3 and S4.
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C
A
B
D
Figure 4. Host RBP Localization in SINV-Infected Cells
(A) RNA-seq read coverage of the positive and negative RNA strand of SINV. Note that the y axes in both plots have different scales.
(B) Localization analysis of SINV RNA and capsid protein in infected HeLa cells at 18 hpi by combined in situ hybridization and immunoﬂuorescence.
(legend continued on next page)
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with both techniques strongly correlated (R2 = 0.82) (Figure 3H),
conﬁrming the RNA-seq results. The decreased availability of
cellular RNA could explain why 133 RBPs display reduced
association with poly(A) RNA in infected cells (Table S1).
In addition, inhibited RBPs could exchange poly(A) mRNA
for non-poly(A) RNAs, which are not captured by the
oligo(dT) beads.
Stimulated RBPs Are Relocated to the Viral Replication
Factories
SINV produces two overlapping mRNAs, gRNA and sgRNA (Fig-
ures 1B and S1A), and, consequently, the read coverage was
substantially higher in the last third of the gRNA, where both tran-
scripts overlap (Figure 4A). Both sgRNA and gRNA have poly(A)
and thus should contribute to the cRIC results (Figures 4A and
S4A). Conversely, the negative strand has low abundance and
lacks a poly(A) tail. Importantly, SINV RNAs become the most
abundant RNA species, after rRNA, at 18 hpi (Figures 3G and
S3G). The emergence of such abundant RNA substrates likely in-
duces cellular RBPs to exchange the ‘‘declining’’ cellular mRNAs
for ‘‘emerging’’ viral RNAs, driving the remodeling of the
RBPome. Alternatively, ‘‘dormant’’ RBPs could be ‘‘awakened’’
by the recognition of signatures within the viral RNA, analogous
to known antiviral RBPs (Vladimer et al., 2014). We thus hypoth-
esized that RBPs displaying enhanced binding should co-
localize with viral RNA.
SINV RNA and capsid accumulate in cytoplasmic foci that
correspond to the viral factories (Figures S1D, 4B, and S4A).
To test whether stimulated RBPs relocate to these foci, we
generated 26 tetracycline-inducible cell lines expressing host
RBPs fused to EGFP. These included 16 lines expressing stimu-
lated RBPs and 8 expressing inhibited RBPs. The non-altered
RBP, MOV10, and unfused EGFP were used as controls. Strik-
ingly, 9 out of the 16 stimulated RBPs (56%) accumulated at viral
factories demarcated by SINV C (Figures 4C, 4D, and S4B). Five
additional stimulated RBPs (29%) showed diffuse localization in
cytoplasm but were also present at the capsid-containing
foci (Figure S4B). In situ hybridization analysis conﬁrmed that
SINV RNA co-localized with a representative stimulated RBP,
GEMIN5, supporting the potential interplay between stimulated
RBPs and viral RNA (Figure S4C). Among the stimulated RBPs,
only NGDN, HNRNPA1 and themitochondrial translation elonga-
tion factor TUFM (3 out of 16; 17%) were absent in the viral fac-
tories, which suggests that their function is restricted to host
RNAs. HNRNPA1 was shown to bind SINV RNA (LaPointe
et al., 2018; Lin et al., 2009), while in our analysis, it strictly dis-
plays nuclear localization (Figure S4B). We cannot rule out that
a small pool of HNRNPA1 is present in the viral factories at unde-
tectable levels or, alternatively, that the EGFP tag is affecting
HNRNPA1 localization.
In contrast to stimulated RBPs, only one (out of 8; 12.5%) in-
hibited RBP was enriched in the viral factories (Figures 4D and
S4B). This protein, called UPF1, is a helicase involved in the
nonsense-mediated decay pathway and is known to inhibit
infection of alphaviruses (Balistreri et al., 2014). Conversely, 5
out of 8 (62.5%) virus-inhibited RBPs are nuclear and remained
nuclear after infection (Figures 4C, 4D, and S4B). These results
indicate that, with exceptions, inhibited RBPs do not redistribute
to the viral factories.
The Exonuclease XRN1 Is Essential for SINV Infection
The loss of cellular mRNAs is likely contributing to the remod-
eling of the RBPome by diminishing substrate availability. How-
ever, it is unclear how this phenomenon is triggered and
whether it beneﬁts or hampers viral infection. Changes in
RNA levels can globally be a consequence of reduced tran-
scription and/or increased RNA degradation. To explore which
of these pathways contribute the most to RNA loss in SINV-in-
fected cells, we compared the fold change of each mRNA in
our dataset to the rate of synthesis, processing, and degrada-
tion of each individual transcript (Mukherjee et al., 2017). Tran-
scription could explain most of the differences at 4 hpi,
whereas RNA degradation accounted for more than 50% of
the explained variance at 18 hpi (Figures 5A and S5A). We
reasoned that this phenomenon can be a combined effect of
the activation of the 50 to 30 RNA degradation machinery, as
the exonuclease XRN1 and its interactor, PATL1, are stimulated
at 18 hpi (Table S1), and a reduced transcriptional activity
(Gorchakov et al., 2005).
XRN1 is broadly considered as an antiviral factor that erases
viral RNA (Molleston and Cherry, 2017). RNA pseudoknots pre-
sent in several viral RNAs are able to stall XRN1, leading to the
production of sgRNAs (Chapman et al., 2014; Pijlman et al.,
2008). In dengue virus (DENV), XRN1-derived sgRNAs can
beneﬁt infection by interfering with the antiviral response (Mano-
karan et al., 2015).
In SINV-infected cells, XRN1 and MOV10 foci (corresponding
to P-bodies) are juxtaposed to the viral replication factories, sug-
gesting that the exonuclease could attack viral RNA (Figures 4C,
S4C, and 5B). To our surprise, XRN1 knockout (KO) cells were
refractory to SINV infection, while partial KO led to an intermedi-
ate phenotype (Figure 5C). These results suggest that XRN1 ac-
tivity is instead essential for SINV infection. XRN1 KO cells did
not exhibit any defect in cell morphology, proliferation rate, or
viability, and they supported efﬁciently the replication of HIV-1
(Figures 5D and S5C–S5F). These results indicate that XRN1
KO lines are not metabolically deﬁcient or subjected to a heavy
stress incompatible with virus infection.
To determine if XRN1 activity involves the generation of
RNA degradation products, we analyzed our RNA-seq data.
However, we did not found any increase in read coverage
compatible with XRN1-derived degradation products, suggest-
ing that XRN1 role in SINV infection differs from that described
for DENV.
(C) Localization by immunoﬂuorescence of the EGFP-fused RBPs and SINV C. Green and red ﬂuorescence intensity proﬁles in a representative 5-mm section
(white line) are plotted in (B) and (C).
(D) Summary of the observed localization of the 26 proteins tested in (C) and Figure S4B.
Scale bars represent 10 mm. AFU, arbitrary ﬂuorescence units.
See also Figure S4.
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RBPome Responses Are Biologically Important
To determine to a broader extent whether RBP responses are
functionally important, we sought to study the impact of altered
RBPs on virus infection. The ligase RTCB, together with DDX1,
FAM98A, and other RBPs, forms the tRNA ligase complex
(TRLC) (Popow et al., 2011). RTCB and DDX1 were stimulated
by SINV (Table S1), and these and FAM98A accumulated in
the viral factories (Figures 4C and S4B). TRLC mediates the un-
usual ligation of 30-phosphate or 20,30-cyclic phosphate to a
50-hydroxyl and these molecule ends are generated by a limited
repertoire of cellular endonucleases, which include the endo-
plasmic reticulum resident protein IRE1a (Popow et al., 2011).
SINV has been proposed to cause unfolded protein response
(Rathore et al., 2013), which is compatible with the activation
of IRE1a and TRLC in infected cells (Jurkin et al., 2014). Notably,
inhibition of IRE1awith 4m8C strongly reduced viral ﬁtness in low,
A
B
C
D
Figure 5. The Exonuclease XRN1 in Cells Infected with SINV
(A) Contribution of transcription, processing, and degradation to the transcriptomic changes induced by SINV. We compared our RNA-seq data to available data
estimating these parameters (Mukherjee et al., 2017). ANOVA was used to predict the contribution of each RNA biological process to the variance in RNA levels.
(B) Immunolocalization of XRN1 and SINV C. Green and red ﬂuorescence proﬁles for regions of interest (ROI) are displayed.
(C) Top: mCherry ﬂuorescence in XRN1 KO and control cells infected with SINV-mCherry measured every 15 min in a plate reader with atmospheric control
(5% CO2 and 37C). RFU, relative ﬂuorescence units. Western blot of XRN1 and SINV C (bottom).
(D) Infection ﬁtness of HIV-1Nef-mCherry and HIV-1Gag-mCherry pseudotyped viruses in XRN1 KO cells. mCherry expression was measured as in (C).
mCherry ﬂuorescence is represented as mean ± SD of three independent infections in each of the three biological replicates (n = 9). ***p < 0.001; **p < 0.01;
*p < 0.05.
See also Figure S5.
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non-cytotoxic concentrations (Figures 6A and S6A), suggesting
that IRE1a and TRLC are positively contributing to SINV
infection.
PPIA (also cyclophilin A) has also been classiﬁed as an RBP by
RIC studies (Hentze et al., 2018). It switches proline conforma-
tion-modulating protein activity, which plays a crucial role in hep-
atitis C virus infection (Rupp and Bartenschlager, 2014). PPIA is
also important for the infection of other viruses, such as HIV-1
(Li et al., 2007). PPIA RNA-binding activity is stimulated by
SINV infection and is recruited to the viral factories (Figures 2E
and S4B). Interestingly, SINV-mCherry infection is delayed by
PPIA loss of function (KO and inhibition; Figures 6B, S6A, and
S6B). Overexpression had no effect in SINV-mCherry ﬁtness
(Figure 6B, bottom).
The heat shock chaperone HSP90AB1 is stimulated by SINV
(Table S1). HSP90AB1 has been classiﬁed as an RBP by RIC
(Hentze et al., 2018), and its RBD has been located in a discrete
region at its C-terminal domain (Figure S6C) (Castello et al.,
2016). Chaperones from the HSP90 family are important in the
remodeling of RNPs and are linked to virus infection (Geller
et al., 2012; Iwasaki et al., 2010). Notably, SINV-mCherry infec-
tion was signiﬁcantly delayed in HSP90AB1 KO cells, even
though four homologs of this protein exist (Figures 6C and
S6B). Moreover, the pro-viral activity of HSP90AB1 was
conﬁrmed by treatment with speciﬁc inhibitors (Figures 6C and
S6A). Again, overexpression had no effect in SINV-mCherry
ﬁtness (Figure 6C). The implication of PPIA and HSP90 in the
biological cycle of a variety of unrelated viruses highlights these
proteins as master regulators of infection (Garcia-Moreno
et al., 2018).
PA2G4 RNA-binding activity was also enhanced by SINV
(Table S1). It associates with ribosomes (Table S2) (Simsek
et al., 2017) and regulates the cap-independent translation
of foot-and-mouth disease virus (FMDV) RNA (Monie et al.,
2007). Treatment with its speciﬁc inhibitor WS6 hampered
SINV-mCherry ﬁtness (Figures 6D and S6A), suggesting that
this protein promotes SINV infection. Overexpression did not
cause any effect, as with previous examples (Figure 6D).
The possibility that PA2G4 contributes to the non-canonical,
cap-dependent translation of SINV RNAs should be further
investigated.
SRPK1 is a kinase that phosphorylates the RS repeats pre-
sent in SR proteins, which are involved in alternative splicing
regulation, RNA export, and stability (Howard and Sanford,
2015). SINV infection stimulates SRPK1 RNA-binding activity
(Table S1) and causes its relocation to viral replication factories
(Figure 4C). Inhibition of SRPK1 hampers SINV and HIV-1
infection (Fukuhara et al., 2006), and we show here that
overexpression of SRPK1 enhances SINV ﬁtness (Figure 6E).
This suggests that SRPK1 positively contributes to SINV
infection. Future work should determine if SRPK1 kinase
activity is involved in infection, and if so, which proteins it
phosphorylates.
We tested the effects of overexpression of nine additional
stimulated or inhibited RBPs fused to EGFP (Figures S6D and
S6E). Phenotypes in viral ﬁtness ranged from nonexistent
(ALDOA, XRCC6, RPS10, MOV10, NGDN, and CSTF2) to mild
(RPS27, NONO, and DKC1). The lack of phenotypic effects in
overexpression experiments does not rule out that the protein
actually participates in SINV infection (see above). Nevertheless,
RBPs whose overexpression affects infection ﬁtness have po-
tential as regulatory proteins.
The family of tripartite-motif-containing (TRIM) proteins
comprises more than 75 members endowed with E3 ubiquitin
ligase activity, and few of them have been classiﬁed as RBPs
by RIC (Hentze et al., 2018). Notably, SINV infection enhanced
TRIM25 and TRIM56 interaction with RNA (Table S1), corre-
lating with their redistribution to viral replication factories (Fig-
ure 4C). TRIM25 was proposed to interact with DENV RNA
(Manokaran et al., 2015); however, this analysis employed
native immunoprecipitation (IP) that cannot distinguish be-
tween direct and indirect protein-RNA interactions. To test if
TRIM25 interacts directly with SINV RNA, we immunoprecipi-
tated under stringent conditions TRIM25-EGFP from SINV-
infected cells irradiated with UV light. Co-precipitated RNA
was analyzed by RT-PCR using speciﬁc primers against
SINV RNA. A band with the expected size was detected in
TRIM25-EGFP IPs, but not in the negative controls (Figure 7A),
conﬁrming that TRIM25 interacts with SINV RNA directly.
TRIM25 interaction with RNA enhances its E3 ubiquitin ligase
activity (Choudhury et al., 2017). TRIM25-EGFP overexpres-
sion inhibited SINV-mCherry infection (Figure 7B), which
agrees with its ability to activate the key antiviral factors
RIG-I and ZC3HAV1 through ubiquitination (Gack et al.,
2007; Li et al., 2017). It is known that TRIM56 binds double-
stranded DNA. However, it enhances the antiviral response
in cells infected with both DNA and RNA viruses (Seo et al.,
2018; Tsuchida et al., 2010). cRIC thus complements these
results, revealing that TRIM56 interacts directly with RNA
(Table S1). As with TRIM25, overexpression of TRIM56-
EGFP reduced SINV ﬁtness (Figure 7B), conﬁrming its capac-
ity to restrict the infection of the RNA virus, SINV.
Importantly, 160 out of the 247 altered RBPs lack previous
connections to virus infection (Garcia-Moreno et al., 2018).
Hence, our dataset likely contains numerous pro- and antiviral
RBPs yet to be uncovered.
GEMIN5 Binds to the 50 UTR of SINV RNAs and Regulates
Viral Protein Expression
GEMIN5 is a member of the survival motor neuron (SMN) com-
plex, which mediates the assembly of the small nuclear RNPs
(snRNPs) (Gubitz et al., 2002). It is strongly stimulated by SINV
infection and redistributed to the viral factories co-localizing
with SINV RNA (Figures 2E, 4C, and S4C). To our surprise,
none of the known molecular partners of GEMIN5 (i.e., GEMIN
and SMN proteins) were stimulated by SINV (Table S1), implying
a GEMIN5-speciﬁc response that agrees with the existence of a
free pool of GEMIN5 (Battle et al., 2007). In SINV-infected cells,
overexpression of GEMIN5-EGFP caused a moderate but signif-
icant delay of mCherry production and strongly inhibited capsid
synthesis (Figure 7B). These results align well with the described
role of GEMIN5 in translational control (Francisco-Velilla et al.,
2018; Pin˜eiro et al., 2015).
Protein-protein interaction analysis of GEMIN5-EGFP re-
vealed that, in our experimental settings, it interacts with the
ribosome, especially with the 60S subunit (Figure 7C, pink
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Figure 6. Impact of Stimulated RBPs in SINV Infection
(A) Expression of mCherry in HEK293 cells infected with SINV-mCherry and treated or not with the IRE1a inhibitor 4m8C. Red ﬂuorescence was measured as in
Figure 5C.
(B) As in (A) but with PPIA KO cells (top), the PPIA inhibitor cyclosporine A (CysA) (middle), and cells overexpressing PPIA-EGFP (bottom). KO and overexpression
of PPIA and SINV C accumulation (18 hpi) were assessed by western blotting.
(C) mCherry ﬂuorescence in HSP90AB1 KO cells (top), cells treated with ganetespib or geldamycin (middle panels), or cells overexpressing HSP90AB1-EGFP
(bottom) and infected with SINV-mCherry. KO and overexpression of HSP90AB1 and SINV C accumulation (18 hpi) were assessed by western blotting.
(D) As in (A) but using the PA2G4 inhibitor WS6 (top) and cells overexpressing PA2G4-eGFP (midde). Right: western blots against SINV C at 18 hpi.
(E) As in (A) but with cells overexpressing SRPK1 (top). Overexpression of SRPK1 was assessed by western blotting. Bottom: western blots of SINV C in these
cells at 18 hpi.
mCherry ﬂuorescence is shown as the mean ± SD of three independent infections in each of the three biological replicates (n = 9). ***p < 0.001; **p < 0.01;
*p < 0.05. SINV-mChe, SINV-mCherry; n.s., non-signiﬁcant.
See also Figure S6.
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dots, left; Figures S7C and S7D; Table S5). This interaction is
sustained in SINV-infected cells (Figure 7C, pink dots, middle
and right). These results are in agreement with previous studies
showing that GEMIN5 impacts protein synthesis at the transla-
tion elongation step through its direct interaction with the 60S ri-
bosomal subunit and, in particular, with RPL3 and RPL4, which
are also enriched in our IPs (Table S5) (Francisco-Velilla et al.,
2016). We noticed that GEMIN5 is by far the most enriched
protein in our IPs and that its Intensity Based Absolute Quantiﬁ-
cation (iBAQ) score is signiﬁcantly higher than that of EGFP, sug-
gesting that GEMIN5-EGFP interacts with the endogenous
GEMIN5, likely forming oligomers, as previously described (Xu
et al., 2016). Moreover, our data showed that GEMIN5 interacts
with various viral proteins, chieﬂy with NSP1, NSP2, NSP3 and
SINV C (Figure 7C, middle). The implications of these interac-
tions in the modulation of GEMIN5 function deserve future
considerations.
GEMIN5 is cleaved by the L protease of FMDV, and resulting
C-terminal moiety enhances internal ribosome entry site (IRES)-
driven translation (Pin˜eiro et al., 2013). However, GEMIN5 is not
cleaved in SINV-infected cells (Figure 3E), and SINV RNAs lack
an IRES and are capped (Carrasco et al., 2018). To test
whether GEMIN5 binds SINV RNA, we performed an IP and
RT-PCR analysis as outlined above. A PCR product was ampli-
ﬁed in GEMIN5-EGFP eluates (Figure 7A), which agrees with
the striking co-localization of SINV RNA and GEMIN5 (Fig-
ure S4C). To get insights into how GEMIN5 recognizes SINV
RNAs, we employed single-nucleotide-resolution crosslinking
and immunoprecipitation followed by sequencing (iCLIP) (Ko¨nig
et al., 2010). Interestingly, the footprints with highest coverage
mapped to the 50 ends of the gRNA and sgRNA (Figures 7D and
S7E–S7G). These reads often presented an additional guano-
sine at the 50 end (Figure S7H), likely reﬂecting binding to the
cap structure. These results support previous data showing
that GEMIN5 is captured in cap-Sepharose beads (Bradrick
and Gromeier, 2009). Additional peaks overlap with the down-
stream loop (DLP), which is a hairpin structure that stimulates
the translation of the sgRNA (Frolov and Schlesinger, 1996).
Interaction with the cap, 50 UTR, and DLP of viral RNAs aligns
well with the proposed role as translational regulator and the
observed inhibition of capsid expression. Our data support
the model in which GEMIN5 recognizes the 50 end of the
gRNA and sgRNA and prevents their translation by interfering
with ribosomal function.
Outlook
We show here that SINV infection induces changes in the active
RBPome that affects both well-established and unconventional
RBPs. Mechanistically, the RBPome rearrangement can be ex-
plained by the loss of cellular RNA and the emergence of the
highly abundant viral RNA. Supporting this conclusion, we
observed that most of the RBPs with enhanced activity
accumulate in the viral factories together with the viral RNA.
However, this RNA-driven remodeling of the RBPome is
not incompatible with complementary ‘‘ﬁne-tuning’’ regulatory
mechanisms affecting RBPs on an individual basis. For example,
it is known that virus infection triggers signaling pathways
involving kinases (Figure 1D), E3 ubiquitin ligases, prolyl cis/trans
isomerases, and chaperones (Carrasco et al., 2018; Gack et al.,
2007; Li et al., 2017). Here, we show that these protein families
are represented among the stimulated RBPs, including SRPK1,
TRIM25, TRIM56, PPIA, and HSP90AB1. Hence, it is plausible
that post-translational control also contributes to RBP regulation
in SINV-infected cells. Moreover, interactions with viral proteins
can regulate RBP function (Fros et al., 2012). We show that
GEMIN5 interacts with several viral proteins, suggesting that
this regulatory mechanism may apply to altered RBPs more
broadly (Figure 7C).
Importantly, changes in the RBPome are biologically impor-
tant, as perturbation of the altered RBPs strongly affects
SINV infection. Therefore, every protein reported here to
respond to SINV infection has potential as anti- or pro-viral fac-
tor, highlighting cellular RBPs as promising targets for antiviral
therapies.
Some of the outstanding questions derived from this work
include whether the distinct composition of ribosomes in in-
fected cells affects their translational properties, why the lack
of the exonuclease XRN1 makes the cells refractory to SINV,
what triggers the degradation of host RNA, and why the
transcripts induced by the antiviral response are resistant to
degradation. Moreover, GEMIN5 emerges as a highly respon-
sive RBP that impairs SINV infection. The exact mechanisms
underpinning GEMIN5 effects in translation require further
investigation.
Figure 7. Effects of RBPs with Antiviral Potential in SINV Infection
(A) UV crosslinking and immunoprecipitation of TRIM25-EGFP, GEMIN5-EGFP, XRCC6-EGFP, or unfused EGFP in cells infected or not with SINV for 18 h. The
presence of SINV RNA in eluates and inputs was detected by RT-PCR using speciﬁc primers against SINV RNAs.
(B) Relative mCherry ﬂuorescence produced in cells overexpressing TRIM25-EGFP (top left), TRIM56-eGFP (top middle), GEMIN5-eGFP (top right), and infected
with SINV-mCherry (measured as in Figure 5C). mCherry expression is represented as the mean ± SD of three independent infections in each of the three
biological replicates (n = 9). Overexpression was assessed by western blotting. Bottom: western blots of SINV C at 18 hpi, indicating below the average inhibition
of C relative to control cells. ***p < 0.001; **p < 0.01.
(C) Volcano plots comparing the intensity of proteins in GEMIN5-EGFP versus unfused EGFP IPs in uninfected (left) and infected cells (middle); every dot rep-
resents a protein. Dark green dots are proteins enriched with p < 0.01, blue dots are those enriched with p < 0.1, and gray dots represent nonenriched proteins.
Pink dots represent ribosomal proteins. Right: a volcano plot comparing the intensity of proteins in GEMIN5 IPs in infected versus uninfected cells.
(D) iCLIP analysis of GEMIN5-binding sites on SINV RNA. Top: coverage pileup of 50 ﬁrst base of unique molecules mapping to the SINV genome, shown as 20-nt
sliding mean of ﬁve replicates after GFP background subtraction. Each position is given relative to total SINV count (RPM). Middle: key features of SINV
annotation. Bottom: the top track shows iCLIP coverage but as a heatmap representation. The middle heatmap shows GEMIN5 binding sites along SINV divided
into ﬁve groups according to strength of binding. The bottom heatmap shows the number of replicates supporting each binding site when binding sites are called
independently for each replicate.
See also Figure S7 and Table S5.
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Finally, cRIC has been applied here to cells infected with SINV.
However, it can now be extended to other viruses or physiolog-
ical cues to improve our understanding of RBP regulation and its
biological importance.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
We used here human embryo kidney 293 cells (HEK293, ECACC #85120602), HeLa (ATCC cat. no. CCL-2) and baby hamster kidney
cells (BHK-21, clone 13, ECACC #85011433); HEK293 Flp-In TREx are commercially available (Thermo Fisher Scientiﬁc, #R78007),
while HeLa Flp-In TREx are a generous gift from Dr. Matthias Gromeier (Duke University Medical Center, Durham, NC, USA). All cells
were cultured in DMEM with 10% FBS and 1x penicillin/streptomycin (Sigma Aldrich, #P4458) at 37C with 5% CO2. The media of
Flp-In TREx (Tet-on) cells was supplemented with 15 mg/ml Blasticidin S and 100 mg/ml Zeocin. To generate RBP-eGFP-expressing
cell lines, cells were transfected with pOG44 and the corresponding pcDNA5-FTR-TO plasmid (Table S6) using X-tremeGENE 9 DNA
transfection reagent following manufacturer’s recommendations (Sigma-Aldrich, #6365787001). For the selection of inducible cell
lines, Zeocin was replaced by 150 mg/ml Hygromycin B as indicated in the manufacturer’s manual (Thermo Fisher Scientiﬁc). Protein
induction was achieved by supplementation of the medium with 1 mg/ml doxycycline. To generate KO cells, we transfected HEK293
using TRANSIT-CRISPR (Sigma-Aldrich) with SygRNAs assembled with Cas9 (Sigma-Aldrich, #CAS9PROT-50UG) and tracrRNA
(Sigma-Aldrich, #TRACRRNA05N-5NMOL), followed by cell serial dilution and selection of KO cell clones. Alternatively, we gener-
ated px459 derived plasmids including sequences targeting the genes of interest (pX459 was a gift from Feng Zhang; Addgene
plasmid #62988). These plasmids were transiently transfected into HEK293 cells using X-tremeGENE 9. Cells expressing the
construct were selected with 1 mg/ml puromycine for 96 h, followed by cell serial dilution to obtain individual clones. To generate
TRIM25 KO cells, HEK293 were transfected with 200 ng GeneArt CRISPR nucleasemRNA (Thermo Fisher Scientiﬁc, #A29378) along
with 50 ng of two distinct, in vitro transcribed sgRNAs targeting sequences in exon 1 of the TRIM25 gene. Single cells were seeded,
grown and checked for KO by western blotting.
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Cell culture in SILAC media
Cells were grown in SILAC DMEM media (Thermo Scientiﬁc, #10107883) containing 10% dialysed FBS (Silantes GmbH,
#281000900) and isotopic labeled arginine and lysine (Silantes GmbH amino acids: L-Arginine 13C,15N labeled #201604102; L-Argi-
nine 13C labeled #201204102; L-Lysine 13C,15N labeled #211604102; 4.4.5.5.-D4-L-Lysine #211104113). Prior to experiments, we
conﬁrmed bymass spectrometry that the incorporation of isotopic labeled amino acids was superior to 98% using whole cell lysates.
Viruses
We used the SINV clone pT7-SVwt (Sanz and Carrasco, 2001) to generate the SINV suspension. The plasmid pT7-SVmCherry was
generated by inserting mCherry after the duplicated subgenomic promoter in pT7-SVwt. To obtain SINV and SINV-mCherry viruses,
pT7-SVwt and pT7-SVmCherry plasmids were ﬁrst linearized with XhoI and used as a template for in vitro RNA transcription with
HiScribe T7 ARCA mRNA kit (New England Biolabs, #E2065S). Transcribed genomic RNA was transfected into BHK-21 using Lip-
ofectamine 2000 reagent (Invitrogen, #11668027). Viruses were collected from the supernatant 24 h later and cleared by centrifuga-
tion at 2000 rpm for 3 min followed by ﬁltration with 0.45mm PVDF syringe ﬁlter units (Merck, #SLHV033RS). Cleared supernatants
were titrated by plaque assay using BHK-21 cells.
Pseudotyped HIV-1Nef-mCherry and HIV-1Gag-mCherry were produced as follows. For HIV-1Nef-mCherry, a sequence encoding the end
of env followed by a linker, mCherry, T2A self-cleaving peptide and the beginning of Nef protein was synthesized using the GeneArt
Gene synthesis service (Thermo Fisher Scientiﬁc), and cloned between the BamHI and XhoI restriction sites of pNL4-3.Luc.R-E-
plasmid (NIBSC – Centre for AIDS Reagents, #2128), which is defective for Vpr and Env. For HIV-1Gag-mCherry, a PSPXI restriction
site ﬂanked by ﬂexible linker was introduced into gag of the pNL4-3 plasmid (NIBSC – Centre for AIDS Reagents, #2006) by over-
lapping PCR (primers in Table S6) as in (M€uller et al., 2004). mCherry sequence was ampliﬁed by PCR ﬂanked by PspXI restriction
sites and cloned into pNL4-3 using the newly generated PspXI site. Finally, the fragment between SpeI and BamHI was replaced by
that of pNL4-3.Luc.R-E-. Pseudotyped viral particles were produced by co-transfecting HEK293T cells (kindly provided by Prof. Jan
Rehwinkel, University of Oxford, UK) with pNL4-3.R-E-Nef-mCherry or pNL4-3.R-E-Gag-mCherry plus pHEF-VSVG (NIH AIDS Reagent
Program, #4693), which encodes for the glycoprotein of vesicular stomatitis virus (VSV).
METHOD DETAILS
RNA interactome capture
Comparative RNA interactome capture (cRIC) was performed based on the previously described protocol (Castello et al., 2012; Cas-
tello et al., 2013) with the following alterations: HEK293 cells, previously grown in media with isotopic labeled amino acids, were
seeded in three sets of 3x15 cm dishes at 80% conﬂuence, each set with a different SILAC label. One set of dishes remained unin-
fected and two sets were infected with SINV at a multiplicity of infection (MOI) of 10. One of these infected cell sets was incubated for
4 h and the other for 18 h. To correct for isotope-dependent effects, we permutated the SILAC labels between the three conditions in
the three biological replicates. After incubation, cells were irradiated with 150 mJ/cm2 of UV light at 254 nm, and lysed with 3 mL of
lysis buffer (20mMTris-HCl pH 7.5, 500mMLiCl, 0.5%LiDSwt/vol, 1mMEDTA, 0.1% IGEPAL (NP-40) and 5mMDTT). Lysateswere
homogenized by passing the lysate at high speed through a 5 mL syringe with a 27G needle, repeating this process until the lysate
was fully homogeneous. 400 ml of lysate were taken for total proteome and transcriptome analysis (Figure 3; Tables S3 and S4). Pro-
tein content was measured using a kit compatible with ionic detergents (Thermo Fisher, Pierce 660nm Protein Assay Kit #22662 with
IDC reagent #22663) and equal amounts of each of the three lysates weremixed. The ﬁnal volumewas adjusted to 9mL and 1.5mL of
pre-equilibrated oligo(dT)25 magnetic beads (New England Biolabs, #S1419S) were added and incubated for 1 h at 4
C with gentle
rotation. Beads were collected in the magnet and the lysate was transferred to a new tube and stored at 4C. Beads were washed
once with 10 mL of lysis buffer, incubating for 5 min at 4C with gentle rotation, followed by two washes with 10 mL of buffer 1
(20 mM Tris-HCl pH 7.5, 500 mM LiCl, 0.1% LiDS wt/vol, 1 mM EDTA, 0.1% IGEPAL and 5 mM DTT) for 5 min at 4C with gentle
rotation and two washes with buffer 2 (20 mM Tris-HCl pH 7.5, 500 mM LiCl, 1 mM EDTA, 0.01% IGEPAL and 5 mM DTT). Beads
were then washed twice with 10 mL of buffer 3 (20 mM Tris-HCl pH 7.5, 200 mM LiCl, 1 mM EDTA and 5 mM DTT) at room temper-
ature. Beads were resuspended in 900 ml of elution buffer and incubated for 3 min at 55C with agitation. Eluates were stored
at 80C and beads were recycled as indicated in the manufacturer’s manual, and re-used for two additional capture rounds. For
RIC experiments followed by western blot analysis, we used the small scale RIC settings described in (Castello et al., 2013).
Conventional protein analyses
Samples were resolved on SDS-PAGE and analyzed by i) western blotting using speciﬁc antibodies, the Li-Cor Odyssey system for
visualization and the Image Studio Lite software (Li-Cor) for quantiﬁcation, ii) Coomassie blue staining with the InstantBlue Protein
Stain reagent (Expedeon, #ISB1L) or iii) silver staining using SilverQuest kit (Invitrogen, #LC6070). Data shown in the manuscript
are representative gels from at least three independent replicates. Details on antibodies can be found in the key resource table.
Radioactive labeling of newly synthesized proteins was performed by replacing the growth media for 1 h with DMEM lacking methi-
onine and cysteine and supplemented with Easytag EXPRESS35S Protein Labeling Mix [35S]Met-Cys (Perkin Elmer,
#NEG772002MC). Samples were then analyzed by SDS-polyacrylamide gels (15%) followed by autoradiography.
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Reverse-transcription and quantitative PCR
Total RNAwas isolated using TRIzol (Invitrogen, #15596026). Reverse transcription was performed using Superscript III reverse tran-
scriptase (Invitrogen, #18080044) with random hexamers priming (Invitrogen, #N8080127), following manufacturer’s instructions.
RT-qPCR analysis was performed with 2x qPCR SyGreen Mix Lo-ROX (PCRBiosystems, #PB20.11-01) and gene speciﬁc primers
(Table S6) in a BioRad CFX96 Real-Time system, and analyzed with REST software (Pfafﬂ, 2001).
Plasmids and recombinant DNA procedures
Plasmids for generation of inducible cell lines were created by conventional cloning methods. Inserts were generally ampliﬁed from
HEK293 cDNA or template plasmids using speciﬁc primers (Table S6). Inserts were cloned into the pcDNA5/FRT/TO with eGFP pre-
ceded or followed by a ﬂexible linker encoding for GGSGGSGG (glycine and serine repeats) to facilitate the folding of the RBP of
interest independently from the eGFP. For CRISPR/Cas9 expression plasmids, annealed oligos were inserted into the BbsI site
of px459.
mCherry-based viral ﬁtness assay
5x104 cells were seeded on each well of a 96-well microplate with ﬂat mClear bottom (Greiner Bio-One, #655986) in DMEM lacking
phenol-red and supplemented with 5% FBS and 1 mM sodium pyruvate. Cells (control, knock-out and Tet-on) were infected with
SINV-mCherry at 0.1 MOI in complete DMEM (lacking phenol-red) with 2.5% FBS. Cells were incubated at 37C and 5% CO2 in a
CLARIOstar ﬂuorescence plate reader (BMG Labtech) for 24 h; eGFP and/or mCherry signal was monitored by measuring ﬂuores-
cence (eGFP: excitation 470 nm, emission 515 nm; mCherry: excitation 570 nm, emission 620 nm) every 15 min. To monitor the shut
off of protein synthesis with this method (Figure S1B), Tet-on HEK293 eGFP-control cells were induced with 1 mg/ml doxycycline for
4 h and then infected as indicated above. In experiments with HIV-1 mCherry replicons, 5x104 cells were seeded on each well of
a 96-well plate in clear DMEM supplemented with 2.5% FBS and 1 mM sodium pyruvate, and infected with pseudotyped
HIV-1Nef-mCherry or HIV-1Gag-mCherry. mCherry signal wasmonitored for 72 h in a ﬂuorescence plate reader as indicated above. In over-
expression experiments, Tet-on HEK293 cells expressing RBP-eGFP fusion proteins were either induced with 1 mg/ml doxycycline
for 16 h or mock-induced and then infected with SINV-mCherry. In inhibitor assays, HEK293 cells were infected with SINV-mCherry
as above and inhibitors or vehicle (DMSO) were added at 1 hpi at the concentrations indicated in the ﬁgures. Statistical signiﬁcance of
the difference in mCherry expression at 18 and 24 hpi was determined by t test (n = 9).
Drugs and cell viability assay
The following chemical inhibitors were used in this work: cyclosporin A (Insight Biotechnology Ltd, #sc-3503), Ganetespib (Cam-
bridge Bioscience Ltd, #19432), Geldanamycin (Cambridge Bioscience Ltd, #SM55-2), 4m8C (Merck Chemicals, #412512) and
WS6 (Cambridge Bioscience Ltd, #17672). To test cell viability at the concentrations used, 5x104 HEK293 cells were seeded on
each well of a 96-well microplate with ﬂat, transparent bottom and incubated with DMEM (no phenol red) supplemented with 5%
FBS and 1 mM sodium pyruvate. 24 h later cells were treated with the compounds and incubated for another 24 h at 37C and
5%CO2. Cell viability was estimated by adding CellTiter 96 Aqueous One Solution (Promega, #G3580) andmeasuring 490 nm absor-
bance following themanufacturer’s recommendations. To evaluate cell viability and proliferation in knockout cells, 2.5x104 cells were
seeded per well of a 96-well plate and incubated in DMEM (no phenol red, 5% FBS, 1mM sodium pyruvate) at 37C and 5%CO2. Cell
viability was measured at the indicated times using CellTiter 96 Aqueous One Solution as described above. In parallel, the number of
cells was counted using the Countess II FL Automated Cell Counter (Thermo Fisher Scientiﬁc).
Protein-protein interactions analysis
4.2x106 HEK293 Tet-on cells expressing eGFP or GEMIN5-eGFP proteins were seeded on a 10 cm dish and incubated with DMEM
supplemented with 10% FBS and 1 mg/ml doxycycline. After 24 h, cells were infected with 10 MOI of SINV in DMEM lacking FBS and
incubated for 1 h, followed by media exchange (DMEM with 1% FBS). Cells were harvested at 18 hpi and lysed in 1 mL of Triton-X-
lysis buffer (10 mM Tris HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 5 mM MgCl2, 5 mM DTT and 0.1 mM AEBSF serine protease
inhibitor). For immunoprecipitation (IP), 40 ml GFP-Trap_A beads slurry (ChromoTek GmbH, #gta-20) were equilibrated in Triton-X-
lysis buffer and then added to 500 ml of whole-cell lysate. Mixture was diluted with 4.5 mL of Triton-X-lysis buffer, and mixed with
gentle rotation for 16 h at 4C. GFP-Trap beads were washed once with Triton-X-lysis buffer, collecting the beads by gentle centri-
fugation after eachwash (1000 g for 5min at 4C). In the secondwash, the Triton-X-lysis buffer was supplemented with 1 ml/ml RNase
A (Sigma Aldrich, #4642) and beads were incubated for 5 min at 37Cwith gentle rotation. Beads were washed three additional times
with Triton-X-lysis buffer. Proteins were released from the GFP-Trap beads via pH elution by resuspension in 50 ml 0.2 M glycine pH
2.5 for 30 s followed by collection of the beads through a quick spin. The supernatant was transferred to a new tube and neutralised
with 5 ml of 1 M Tris base pH 10.4.
RBP-RNA interaction analysis: CLIP/RT-PCR
6.5x105 cells were seeded on each well of a 6-well plate and incubated in DMEMwithout phenol red and supplemented with 5% FBS
and 1 mg/ml doxycycline. After 24 h, cells were either mock-infected or infectedwith SINV at aMOI of 10. At 18 hpi, culture media was
removed and cells were irradiated with 150 mJ/cm2 of UV light at 254 nm. Cells were lysed in 400 ml of lysis buffer (100 mM KCl,
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5 mM MgCl2, 10 mM Tris pH 7.5, 1% IGEPAL, 1 mM DTT, 100 U/ml Ribolock RNase inhibitor [ThermoFisher Scientiﬁc, #EO0381],
0.1 mM AEBSF, 200 mM ribonucleoside vanydil complex). Lysates were diluted with 5x high-salt buffer (1.25 M NaCl,
100 mM Tris pH 7.5, 0.1% SDS) and H2O to reach 500 ml of 1x high-salt buffer. Lysates were then cleared by centrifugation
(5000 rpm for 3 min at 4C). Supernatants were transferred to a new tube and snap frozen in dry ice. An aliquot (50 ml) was taken
as ‘input’. Lysates were pre-cleared with 15 ml of pre-equilibrated control agarose beads (Pierce Control Agarose resin, Thermo
Fisher Scientiﬁc, #26150) by incubation under gentle rotation for 30 min at 4C followed by centrifugation at 1000 g for 2 min at
4C. Supernatants were transferred to a new tube. 15 ml GFP-Trap_A bead slurry were equilibrated with 1x dilution buffer
(500 mM NaCl, 1 mM MgCl2, 0.05% SDS, 0.05% IGEPAL, 50 mM Tris pH 7.5, 100 U/ml Ribolock RNase inhibitor, 0.1 mM AEBSF),
incubated with 1 mg/ml E. coli tRNA for 15min and, after two washes with dilution buffer, they were added to the lysates. Themixture
was incubated for 2 h at 4C with gentle rotation and beads were recovered by centrifugation at 1000 g for 2 min at 4C. Beads were
washed twice with 100 ml of ice-cold high-salt buffer (500 mM NaCl, 20 mM Tris pH 7.5, 1 mM MgCl2, 0.05% IGEPAL, 0.1% SDS,
100 U/ml Ribolock RNase inhibitor, 0.1 mM AEBSF), three times with 100 ml ice-cold low-salt wash buffer (150 mM NaCl,
20 mM Tris pH 7.5, 1 mMMgCl2, 0.01% IGEPAL, 50 U/ml Ribolock RNase inhibitor) and resuspended in 50 ml of proteinase K buffer
(100 mM NaCl, 10 mM Tris pH 7.5, 1 mM EDTA, 0.5% SDS). Protein digestion was carried out by incubation with 200 mg/ml of pro-
teinase K (Invitrogen, #AM2546) for 30min at 37Cwith agitation (1100 rpm) and then raising temperature to 50C for 1 h. After centri-
fugation at 1000 g and 4C for 2min, the supernatant containing the RNAwas transferred to a low binding tube. RNAwas then puriﬁed
using RNeasy mini kit (QIAGEN, #74104) in parallel to the total RNA present in inputs. cDNA library was prepared with Superscript III
reverse transcriptase and oligo(dT)20 primer (Thermo Fisher Scientiﬁc, #18418020) following the manufacturer’s recommendations.
Finally, the presence of SINV sequences in cDNA libraries was detected by PCR using Phusion polymerase (New England Biolabs,
#M0530S) and SINV C speciﬁc primers (Table S6).
Analysis of GEMIN5 binding sites by iCLIP
In order to identify GEMIN5 binding sites on SINV RNA at a high resolution, we employed iCLIP-seq (Ko¨nig et al., 2010). 10x106
HEK293 Tet-on GEMIN5-eGFP cells were seeded in 5 sets of 3x15 cm dishes and induced for 24 h with doxycycline. Each cell
set was then infected with 10 MOI of SINV. Similar procedure was carried out for 1 set 3x15 cm dishes of control HEK293 Tet-on
eGFP cells with 8 h doxycycline induction. At 18 hpi, cells were washed with PBS 1x and UV irradiated with 150 mJ/cm2 at
254 nm. Cells were then lysed with 1 mL of lysis buffer (NaCl 100 mM, MgCl2 5 mM, Tris pH 7.5 10 mM, IGEPAL 0.5%, SDS
0.1%, Na deoxycholate 0.5%, DTT 1 mM, 0.1 mM AEBSF) and the three plates of each condition set were pooled (3 mL of ﬁnal vol-
ume). Lysates were then passed through a 27G needle three times and sonicated with three cycles of 10 s, with 15 s pause between
pulses, using a Digenonde bioruptor at level M at 4C. The homogenate was centrifuged 17900 g at 4C for 10 min, and topped up to
3 mL with lysis buffer. To obtain RNA fragments of suitable length and to degrade DNA, 3 mL (replicates 1-2, control) or 1 mL (rep-
licates 3-5) of thawed lysate was incubatedwith 20 URNase I (Life Technologies, #AM2295) and 4 U Turbo DNase (Life Technologies,
#AM2238) per ml of lysate for 3 min at 37C, with 1100 rpm agitation. Subsequently, lysates were placed on ice and supplemented
with 440 U RiboLock RNase Inhibitor. 40 mL of control agarose bead slurry per ml of lysate was pre-equilibrated in lysis buffer and
resuspended in 50 ml of lysis buffer. Beads were added to the lysate and incubated for 30 min at 4C with gentle rotation. The super-
natants were then collected by centrifugation for 2 min at 4C and 2500 g, and then incubated with 40 mL of pre-equilibrated
GFP_trap_A beads per ml of lysate for 2 h at 4C with gentle rotation. Next, the beads were collected by centrifugation (2 min,
4C, 2500 g) and washed twice with 1 mL of high salt buffer (NaCl 500 mM, Tris HCl pH 7.5 20 mM, MgCl2 1 mM, IGEPAL 0.05%,
SDS 0.1%, 0.1 mM AEBSF, 1 mM DTT), twice with 1 mL of medium salt buffer (NaCl 250 mM, Tris HCl pH 7.5 20 mM, MgCl2
1 mM, IGEPAL 0.05%, 0.1 mM AEBSF, 1 mM DTT), and twice with 1 mL of PNK wash buffer (20 mM Tris-HCl pH 7.4,
10 mM MgCl2, 0.2% Tween-20) (replicates 1-2, GFP control) or low salt buffer (NaCl 150 mM, Tris HCl pH 7.5 20 mM, MgCl2
1 mM, IGEPAL 0.01%, 0.1 mM AEBSF, 1 mM DTT) (replicates 3-5). Beads were resuspended in 20 mL PNK mix [15 mL H2O, 4 mL
5x PNK buffer pH6.5 (350 mM Tris-HCl pH 6.5, 50 mMMgCl2, 25 mM DTT), 5 U of PNK enzyme (NEB, #M0201S), 20 U of Ribolock]
and incubated for 20 min, at 37C at 1100 rpm. Beads were then washed once with low salt buffer, once with high salt buffer, and
twice with low salt or PNK wash buffer. Beads were then resuspended in 20 mL ligation mix [ligation buffer (50 mM Tris-HCl,
10 mMMgCl2, 10 mM DTT), 10 U of RNA ligase (NEB, M0204S), 20 U of Ribolock, 1.5 mM pre-adenylated linker L3 (TriLink Biotech-
nologies, # T1-BGV01A), 4 mL PEG400 (Sigma-Aldrich, #202398-250G)] and incubated O/N at 16C shaking at 1100 rpm. Subse-
quently, beads were washed with 500 mL of cold low salt or PNK wash buffer and three times with 1 mL of high salt buffer. Beads
were transferred to a low binding tube during the third wash. The beads were further washed twice with 1 mL ice-cold low salt or
PNK wash buffer and resuspended in 20 mL low salt or PNK wash buffer, 1x NuPAGE loading buffer (Invitrogen, #NP0007) and
100 mM DTT and denatured at 70C (1200 rpm, 10 min). The supernatant was collected by centrifugation (1 min at 4C and
2500 g), loaded on a 4%–12% Bis-Tris NuPage gel (Invitrogen, #NP0321) and run 90 min at 150 V in 1x MOPS running buffer (Life
Technologies, #NP0001). Protein-RNA complexes were transferred to a membrane of nitrocellulose (30 V for 1 h). Region matching
190-280 kDa was then cut out, transferred to a fresh microfuge tube, topped up with 200 mL of proteinase K mix (80 mM Tris-Cl pH
7.4; 40 mMNaCl; 8 mM EDTA and 800 mg of proteinase K), and incubated for 20 min at 37C and 1100 rpm. Subsequently, 200 mL of
PKurea buffer (100 mM Tris-Cl pH 7.4; 50 mMNaCl; 10 mM EDTA; 7 M urea) was added and the sample then incubated for 20 min at
37C at 1100 rpm. RNA was then phenol/chloroform extracted as in (Huppertz et al., 2014; Ko¨nig et al., 2010). Pellets were
resuspended in 5 mL of nuclease free H2O and stored at 20C. Reverse transcription was carried out using Superscript III
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(Life Technologies, #18080-044) and unique Rclip primers as in (Huppertz et al., 2014; Ko¨nig et al., 2010). The reaction was then
transferred to a low DNA binding tube and precipitated with ethanol as in (Ko¨nig et al., 2010). The pellets were resuspended in
12 mL of 1x TBE-urea loading buffer, heated for 3 min at 80C and separated on a 6% TBE-urea precast gel (Life Technologies,
#EC6865BOX) for 40 min at 180 V. For replicates 1-2 and the control, the region of the gel corresponding to 85-200 nucleotides
was cut off the gel and placed in a 0.5 mL microtube pierced with a needle inside a 1.5 mL microtube. Samples were spun at
16000 g for 1 min, and the ﬂow-through topped up with 400 ml of diffusion buffer (0.5 M ammonium acetate, 10 mM magnesium ac-
etate, 1mMEDTA, 0.1%SDS) and incubated at 50C for 30min. For replicates 3-5, two regions of the gel containing cDNA fragments
of 120-200 nucleotides and 85-120 nucleotides were cut off from the gel and crushed into small pieces using a pestle in 400 mL TE
buffer. The sampleswere then incubated for 1 h at 37Cand 1100 rpm, placed on dry ice for 2min, and incubated again for 1 h at 37C
and 1100 rpm. In all cases, the disrupted gel was then ﬁltered by spinning through a Costar SpinX column (Sigma, #CLS8160-96EA)
by centrifugation at 16000 g. The cDNA was then extracted using phenol/chloroform as in (Ko¨nig et al., 2010). Pellets were resus-
pended in 8 mL ligation mix [1x CircLigase Buffer II; 2.5 mM MnCl2; 30 U of CircLigase II (Epicenter, #CL9025K)] and incubated for
1 h at 60C. We next added 30 mL of oligo annealing mix [25 mL H2O; 4 mL NEBuffer 4 (NEB, #B7004S); 0.3 mM cut_oligo (Sigma-Al-
drich)] and the sample was heated for 1 min at 95C followed by a temperature decrease of 1C every 40 s until reaching 25C. The
samples were then digested with 2 mL of BamHI (Thermo Fisher, #FD0054) and incubated for 30min at 37C. After incubation at 80C
for 5 min, cDNA was ethanol precipitated (Ko¨nig et al., 2010). Pellets were resuspended in 20 mL H2O and mixed with 1 mL of 10 mM
primer mix P5/P3 Solexa and 20 mL Accuprime Supermix 1 (Life Technologies, #12342-010). The libraries were then ampliﬁed for 18
cycles (replicate 1), 23 cycles (replicate 2), 25 cycles (replicates 3-5) or 30 cycles (control GFP) and the products were then analyzed
on a 6%TBE precast gel (Life Technologies, #EC6265BOX) in TBE buffer for 60min at 140 V. The gel was stained with 1x TBE plus 1x
SybrGold for 20 min (Life Technologies, #S11494) and bands of appropriate size cut out under blue light trans-illuminator. The gel
slices were dissolved with a pestle in 100 mL diffusion buffer (0.5 M ammonium acetate; 10 mM magnesium acetate; 1 mM
EDTA pH 8.0; 0.1% SDS), incubated for 30 min at 50C at 1100 rpm and ﬁltered in a Costar SpinX column as above. The library
was puriﬁed using QIAquick Gel Extraction Kit (QIAGEN, #28704) and quantiﬁed on a Bioanalyser using a DNA high-sensitivity
chip. Libraries were pooled for sequencing and processed using single-end sequencing mode with a NextSeq 500/550 High Output
v2 kit (75 cycles, Illumina, #FC-404-2005).
Immunoﬂuorescence and RNA FISH assays
High Precision Coverslips (Marienfeld, #0107052) were washed once in 1 M HCl for 30 min on a rocking machine, twice in double
distilled water for 10 min and once in ethanol 70% for 10 min. 150,000 cells were seeded on the dried coverslips and incubated
in DMEM with 10% FBS. In the case of the Tet-on cells, protein induction was performed with 1 mg/ml doxycycline. 16 h later cells
were either mock-infected or infected for 1 h at 37C with 10 MOI of SINV in DMEMwithout FBS, followed by the replacement of the
mediumwith DMEM supplemented with 1% FBS. At the corresponding times post-infection, cells were rinsed once in PBS and ﬁxed
in 4%methanol-free formaldehyde for 10 min. After three 5 min washes in PBS, cells were permeabilised for 5 min with 1x PBS sup-
plemented with 0.1% Triton X-100 (PBST). Next, cells were rinsed twice in PBST and once in PBST supplemented with 2%BSA, and
blocked for 1 h with PBST supplemented with 2%BSA. Cells were later incubated for 1 h with primary antibodies (a-SINV C at 1:200
dilution or a-XRN1 at 1:50 dilution) in PBST + 2% BSA. Cells were subsequently rinsed in PBST + 2% BSA and washed three times
with PBST + 2% BSA for 10 min. Cells were then incubated for 1 h in darkness with the secondary antibodies (a-rabbit Alexa488,
a-rabbit Alexa594 or/and a-mouse Alexa488; Thermo Fisher Scientiﬁc, #A-21206, #A-21207, #A-21202 respectively) and/or GFP-
Booster_Atto488 (ChromoTek GmbH, #gba488-100) at 1:500 dilution in PBST supplemented with 2% BSA. Cells were washed
once with PBST supplemented with 2% BSA and three additional times with PBST supplemented with 2% BSA for 10 min. Cells
were incubated with 2 mg/ml of DAPI in PBS for 5 min. Finally, cells were washed twice in PBST, once in PBS for 5 min, once in
milliQ H2O and mounted on glass slides using Vectashield Antifade mounting medium (Vector Laboratories, #H-1000).
For combined immunoﬂuorescence and RNA FISH, cells were seeded in coverslips and ﬁxed and permeabilised as described
above. Then, cells were rinsed three times in PBST and incubated for 1 h with primary antibody (a-SINV C at 1:200 dilution) in
PBST + 0.5 U/ml RiboLock RNase inhibitor. Next, cells were washed once in PBST and three additional times with PBST for
10 min. Cells were then incubated with secondary antibody (a-rabbit Alexa488 at 1:500 dilution) in PBST supplemented with
0.5 U/ml RiboLock RNase inhibitor for 1 h in darkness. Cells were washed once with PBST, and two additional times with PBST
for 10 min, once in PBS for 10 min and ﬁxed again in 4% methanol-free formaldehyde for 10 min. Cells were washed twice in
PBS for 5 min, once in 1x PBS / 1x SSC for 5 min, once with 2x SSC for 5 min and twice with pre-hybridization buffer (2x SSC
and 10% deionized formamide in DEPC water) at 37C for 10 min. Next, cells were incubated with RNA probes [2 pmol/ml oligo(dT)25
or oligo(dA)25 coupled to Alexa 594 (Life technologies Ltd), or 125 nM SINV RNAs-speciﬁc Stellaris probes (LGC Biosearch Technol-
ogies)] in hybridization buffer (2x SSC, 10% deionized formamide and 10% dextran sulfate in DEPC water) for 16 h at 37C in a wet
chamber. In the case of Tet-on cells expressing GEMIN5-eGFP or MOV10-YFP proteins, GFP-Booster_Atto488 (1:500 dilution) was
included at this step. Cells were subsequently washed twice with pre-hybridization buffer for 10 min at 37C and incubated for 5 min
at 37Cwith 2 mg/ml DAPI in pre-hybridization buffer. Finally, cells were washed twice with 2x SSC for 5 min, twice with 1x PBS, once
for 5 min with 1x PBS and once in milliQ H2O. The coverslip was mounted immediately after on glass slides using Vectashield.
In both cases, images were acquired on an API DeltaVision Elite wideﬁeld ﬂuorescence microscope using a 100X oil UPlanSApo
objective (1.4 NA) and deconvolved with SoftWoRx v6.5.2 (GE Healthcare). Fluorescence intensity proﬁles were obtained using the
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script ‘‘Multichannel Plot Proﬁle’’ in the BAR collection for ImageJ (https://imagej.net/BAR). In Figures 4 and S4, RBPswere classiﬁed
as ‘enriched’ when accumulating in viral factories co-localizing with SINV C; ‘absent’ when undetectable in viral factories; and
‘diffused’ RBPs when distributed across the cytoplasm and thus present but not enriched in viral factories.
Determining the percentage of infected cells
9x105 HEK293 cells were seeded on washed coverslips and incubated in DMEM minus phenol red + 5% FBS + 1 mM sodium py-
ruvate for 24 h. Cells were infected with different MOI of SINV-mCherry in complete DMEM (lacking phenol-red) with 2.5% FBS. At
18 hpi, cells were ﬁxed and processed for immunoﬂuorescence as indicated above using a-SINV C antibody and DAPI. Images were
acquired on an API DeltaVision Elite wideﬁeld ﬂuorescence microscope using a 60X oil PlanApo objective (1.42 NA). The percentage
of infected cells was calculated by counting C-expressing cells and the total number of DAPI-stained cells using the ‘‘Cell Counter’’
plugin in ImageJ. To deﬁne the MOI of SINV used in cRIC experiments and ﬁtness assays, different concentration of viruses were
tested. We selected 10 MOI for cRIC experiments because it is the minimal dose promoting high percentage of infected cells in a
reproducible manner. We selected 0.1 MOI for ﬁtness experiments as it allows optimal measurement of the mCherry ﬂuorescence
in the CLARIOstar plate reader.
Mass spectrometry
cRIC inputs (whole cell lysates) and eluates were processed following the ﬁlter aided sample preparation (FASP) as in (Castello et al.,
2013). GEMIN5-eGFP and eGFP IPs were processed with a single-pot solid-phase-enhanced sample preparation (SP3) protocol us-
ing 70% acetonitrile for protein binding (Sielaff et al., 2017). All samples were acidiﬁed with 5% formic acid prior to mass spectro-
metric analysis.
Peptides from the cRIC inputs, and GEMIN5-eGFP and eGFP IPs were analyzed on an Ultimate 3000 ultra-HPLC system (Thermo
Fisher Scientiﬁc) and electrosprayed directly into a QExactive mass spectrometer (Thermo Fisher Scientiﬁc). They were initially trap-
ped on a C18 PepMap100 pre-column (300 mm inner diameter x 5 mm, 100A˚, Thermo Fisher Scientiﬁc) in solvent A (0.1% [vol/vol]
formic acid in water). The peptides were then separated on an in-house packed analytical column (75 mm inner diameter x 50cm
packed with ReproSil-Pur 120 C18-AQ, 1.9 mm, 120 A˚, Dr. Maisch GmbH) using a linear 15%–35% [vol/vol] acetonitrile gradient
(2 h for whole cell lysates and 1 h for protein-protein interaction samples) and a ﬂow rate of 200 nl/min. Full-scan mass spectra
were acquired in the Orbitrap (scan range 350-1500 m/z, resolution 70000, AGC target 3 3 106, maximum injection time 50 ms) in
a data-dependent mode. After the mass spectrum scans, the 20 (for whole cell lysates) or 10 (GEMIN5 IPs) most intense peaks
were selected for higher-energy collisional dissociation fragmentation at 30% of normalized collision energy. Higher-energy colli-
sional dissociation fragmentation spectra were also acquired in the Orbitrap (resolution 17500, AGC target 53 104, maximum injec-
tion time 120 ms) with ﬁrst ﬁxed mass at 180 m/z.
For cRIC eluates, liquid chromatography (LC) was performed using an EASY-nano-LC 1000 system (Thermo Fisher Scientiﬁc) in
which peptides were initially trapped on a 75 mm internal diameter guard column packed with Reprosil-Gold 120 C18, 3 mm, 120 A˚
pores (Dr. Maisch GmbH, #r13.9g) in solvent A using a constant pressure of 500 bar. Peptides were then separated on a 45C heated
EASY-Spray column (50 cm x 75 mm ID, PepMap RSLC C18, 2 mm, Thermo Fisher Scientiﬁc #164540) using a 3 h linear 8%–30%
[vol/vol] acetonitrile gradient and constant 200 nl/min ﬂow rate. Peptides were introduced via an EASY-Spray nano-electrospray
ion source into an Orbitrap Elite mass spectrometer (Thermo Fisher Scientiﬁc). Spectra were acquired with resolution 30000, m/z
range 350-1500, AGC target 1x106, maximum injection time 250 ms. The 20 most abundant peaks were fragmented using CID
(AGC target 5x103, maximum injection time 100 ms, normalized collision energy 35%) in a data dependent decision tree method.
Peptide identiﬁcation and quantitation of all proteomics experiments was then performed using MaxQuant (v1.5.0.35) (Cox and
Mann, 2008). Data were searched against the Human Uniprot database (version, January 2016) alongside a custom database
including all the known SINV polypeptides and a list of common contaminants provided by the software. eGFP protein sequence
was included in the analysis of GEMIN5-eGFP and eGFP IPs (Uniprot ID C5MKY7). The search parameters for the Andromeda search
engine were: full tryptic speciﬁcity, allowing two missed cleavage sites, ﬁxed modiﬁcation was set to carbamidomethyl (C) and the
variable modiﬁcation to acetylation (protein N terminus), oxidation (M). Match between runs was applied. All other settings were set
to default, leading to a 1% FDR for protein identiﬁcation. Raw and processed proteomic data have been deposited to the
ProteomeXchange Consortium (Deutsch et al., 2017) via the PRIDE partner repository with the dataset identiﬁer PXD009789.
RNA sequencing
RNA from the ‘inputs’ (whole cell lysate) of cRIC experiments was extracted using TRIzol. Strand-speciﬁc RNA-seq was performed
with 100 ng of total RNA. Libraries were prepared using NEBNext Ultra Directional RNA library Prep Kit for Illumina (New England
Biolabs, #E7420S) according to manufacturer instructions. In brief, RNA was fragmented for 15 min at 94C and then reverse tran-
scribed. cDNA and double-stranded cDNA was puriﬁed with AMPure XP beads (Beckman Coulter, #A63881). After end repair,
NEBNext Adaptors for Illumina (New England Biolabs, #E7335S) were ligated onto the cDNA according to the kit manual. Libraries
were ampliﬁed by 15 cycles of PCR. We used the following combination of barcodes for sample multiplexing: S1_Mock ATCACG,
S1_SV4h CGATGT, S1_SV18h TTAGGC, S2_Mock ACAGTG, S2_SV4h CAGATC, S2_SV18h ACTTGA, S3_Mock GATCAG,
S3_SV4h TAGCTT and S3_SV18h GGCTAC. Libraries with an average length of 320 nt were pooled and sequenced with an Illumina
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NextSeq instrument, using 78 nt paired-end sequencing mode with a NextSeq 500/550 High Output v2 kit (150 cycles, Illumina #FC-
404-2002). Raw and processed RNA-seq are available at GEO: GSE125182.
QUANTIFICATION AND STATISTICAL ANALYSES
Proteomic quantitative analysis
To compare the cRIC inputs and eluates under different conditions, peptide intensity ratios between two samples were computed
and summarized. The log2-intensity ratio of each protein was tested to be different from zero in the three biological replicates using
moderated t test, which is implemented in the R/Bioconductor package limma (Smyth, 2004). p values were corrected for multiple
testing by controlling the false discovery rate with themethod of Benjamini-Hochberg. For proteins for which the protein intensity was
‘zero’ in one of the two conditions, we applied a semiquantitative approach that assumes that proteins without quantitative informa-
tion are below the detection limit (Sysoev et al., 2016). The approach compiles the number of replicates in each condition in which a
given protein has an intensity value. When comparing 2 conditions and three biological replicates, this leads to a matrix with 16
different groups (detected 0, 1, 2 or 3 times in condition 1 versus detected 0, 1, 2 or 3 times in condition 2). A protein is classiﬁed
as ‘altered RBP’ by the semiquantitative method if an intensity value is assigned to it in 3 or 2 of the replicates in one of the two con-
ditions, while only 1 or 0 intensity values are detected in the other condition.
The fraction of RNA-bound RBPs was determined by computing the ratio between the protein intensity of each individual RBP in
the cRIC eluates and that in the whole cell lysate (Figure S3D). Hence, this calculation reﬂects amount of protein crosslinked to RNA
(cRIC eluates) divided by the total amount of protein (cRIC inputs).
Results were visualized using the R package ggplot2 (Wickham, 2009). To assess the scope of previously known RBPs within
the RBPome of uninfected and SINV-infected HEK293 cells, proteins identiﬁed by cRIC here were compared to those
compressing the superset of human RBPs reported in (Hentze et al., 2018). GO annotations were obtained from the R package
mRNAinteractomeHeLa (http://www.hentze.embl.de/public/RBDmap/) (Castello et al., 2012) (Key Resources Table), and gene set
enrichment analysis was performed by applying Fisher’s exact test to categories of GO annotations with at least three annotated
proteins.
We compared the repertoire of RBPs with differential RNA-binding activity at 18 hpi (Table S1) with the mouse ribo-interactome
(Table S2) (Simsek et al., 2017). Speciﬁcally, we considered proteins in the Table S3 of (Simsek et al., 2017) with negative predictive
values (NPV)R 0.99 in puromycin and RNase samples as ‘ribosome-associated proteins’, as described in that study. To ﬁnd mouse
orthologs for RBPs responding to SINV infection, we used the R package biomaRt to identify ENSEMBL peptide IDs for our RBPome
dataset and hom.Hs.inp.db (Carlson and Pages, 2015) to provide mapping between human and mouse proteins using these IDs
(Key Resources Table). If a mouse ortholog of an altered RBP identiﬁed at 18 hpi was found in the ‘ribo-interactome’
(Simsek et al., 2017) or if the gene symbols between human and mouse matched directly, the human RBP was considered as ‘ribo-
some-associated’. Results of this analysis are provided in Table S2.
For GEMIN5 protein-protein interaction analysis, protein quantiﬁcation was performed by label free quantiﬁcation usingMaxQuant.
Ratios were compiled and normalized to eGFP protein intensity in each sample, which is expected to be the same across samples.
Signiﬁcance of the fold changes was estimated by t test using the software Perseus (Tyanova et al., 2016). We performed three main
comparisonswith the data from the IPs: i) GEMIN5-eGFP versus eGFP both in uninfected cells; ii) GEMIN5-eGFP versus eGFP both in
SINV-infected cells; and iii) GEMIN5-eGFP in uninfected cells versus GEMIN5-eGFP in SINV-infected cells (Figure 7C, left, middle
and right, respectively). Resulting data are summarized in Table S5. Raw and processed proteomic data from GEMIN5-eGFP IPs
have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identiﬁer PXD009789.
The R package ggplot2 was utilized to visualize GEMIN5-eGFP proteomics data in volcano plots (Figures 7C). Only proteins that
were identiﬁed as high-conﬁdence interactors of GEMIN5-eGFP (i.e., p value < 0.01 and positive log2 fold change) in the left panel of
Figure 7C were displayed in the comparison between infected and uninfected cells in the right panel. Proteins with names starting
with ‘RPS’ or ‘RPL’, were classiﬁed as ‘ribosomal’ and displayed in the volcano plots as pink dots.
STRING (Szklarczyk et al., 2017) was used to display the connectivity between altered RBPs in SINV-infected cells (Figures S2C
and S2D) and between the proteins comprising the GEMIN5 interactome (Figure S7D). Protein networks were generated using the
following parameters: display – conﬁdence; Interaction sources – experiments and databases; interaction score – high-conﬁdence
(0.700). Disconnected nodes were hidden from display and nodes colored based on functional enrichment within the network as
determined by STRING. GEMIN5 protein interactome (Figure S7D) was deﬁned as proteins enriched in GEMIN5-eGFP IPs over
eGFP IPs with p value < 0.01. STRING-based GO enrichment for GEMIN5 protein interactome is provided in Table S5.
RNA sequencing data analysis
Wecombined the human genome (version hg38) with SINV sequence as our reference genome. RNA-seq readswere thenmapped to
this reference genome using STAR (Dobin et al., 2013). Reads mapping to each transcript were counted with featureCounts in Sub-
read software package (Liao et al., 2013). Only uniquely mapped reads are considered for counting. SINV infection is known to shut
off transcription globally (Gorchakov et al., 2005), which may bias (underestimate) differential expression results if normalization is
carried out assuming that overall RNA abundance remains unchanged. Therefore, we decided to normalize reach counts in each
condition to the corresponding rRNA expression by dividing a factor proportional to the total rRNA read counts in 3 conditions
Molecular Cell 74, 1–16.e1–e11, April 4, 2019 e9
Please cite this article in press as: Garcia-Moreno et al., System-wide Proﬁling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection,
Molecular Cell (2019), https://doi.org/10.1016/j.molcel.2019.01.017
(0.899, 1 and 0.473 for Mock, 4 hpi and 18 hpi respectively). We conﬁrmed by RT-qPCR that rRNA does not change in abundance in
course of infection. The R package DESeq2 (Love et al., 2014) was used for differential gene expression analysis based on rRNA
normalized read counts. As DESeq2 requires the reads counts to be un-normalized and in the form of integer values, rRNA normal-
ized read counts were rounded to the closest integer to make the ‘‘DESeqDataSet’’ to start the differential analysis. We estimated the
size factor of each sample separately in DESeq2, instead of pooling all the samples prior to estimating this parameter.
Differential RNA expression between infected (4 and 18 hpi) and uninfected cells was visualized in MA plots (Figures 3F and 3G)
using DESeq2. To visualize the overall effect of experimental covariates and potential batch effects, a principal component plot of the
samples was generated using the plotPCA function in DESeq2, based on the principal component analysis (PCA) of the variance sta-
bilized expression of the top 500 genes with the highest expression variance among samples. As shown in Figure S3F, the variance
explained by the ﬁrst and second PC (on X and Y-axes) combined accounts for a high percentage (96%) of the total variance, and
samples within the same condition clustered better between them than with the other two conditions. It is interesting to note that the
ﬁrst PC along accounts for 94%of the total variance, and it distinctly separates 18 hpi to the other samples (i.e., uninfected and 4 hpi),
indicating that the cellular transcriptome is dramatically altered at 18 hpi.
Genes related to GO terms ‘Response to virus’ (GO:0009615) and ‘Defense response to virus’ (GO:0051607) were extracted from
‘‘hsapiens_gene_ensembl’’ dataset (GRCh37) from Bioconductor package biomaRt (Durinck et al., 2009) and plotted as a heatmap
using the R package pheatmap (Kolde, 2015) (Figure S1E). This package was also used to make a heatmap for differentially ex-
pressed cellular RNAs, including those transcripts passing the following thresholds: i) log2 fold change > 3 or < 3 and ii) adjusted
p value < 0.01 (Figure S3E).
Reads mapping to positive and negative strands of viral RNAs were separated using SAMtools view utility (Li et al., 2009). In Illu-
mina reverse paired end sequencing, paired reads came from opposite strands. Therefore, readswith the second pair mapping to the
positive strand, or with the ﬁrst pair mapping to the negative strand, were both counted as mapping to the positive strand and vice
versa. The total read counts mapping to each strand were compiled and counted using SAMtools merge and SAMtools depth,
respectively.
Analysis of RNA synthesis, processing, and degradation
We used analysis of variance (ANOVA) to evaluate in what extent the changes in transcript levels are explained by the rate of RNA
synthesis, processing and degradation. Themeasurement of the rate of these RNA processes for each individual RNAwere obtained
from (Mukherjee et al., 2017). We built a multiple linear regression using the rate of the above-mentioned RNA processes as ‘predic-
tors’ or ‘factors’, and the transcriptome changes in SINV infected cells as the ‘response variable’.
Ti=A0i+A1iDi+A2iPi+A3iSi+Ei
i indicates all the individual RNAmolecules; Ti is the expression change for themolecule between the two conditions compared; A0i is
the regression intercept; Di, Pi and Si are the rate of degradation, processing and synthesis, respectively; Ei is the ‘error term’ in the
multiple linear regression.
After ﬁtting the model, the total variance explained, or R-squared, is deﬁned as the sum of squares (SS) contributed to the total SS
by different factors, i.e., the three predictor variables and the error term, as indicated in the equation below:
SStotal=SSDegration+SSProcessing+SSSynthesis+SSerror
Therefore, the contribution of the three predictors to the alterations in the transcriptome can be measured by their proportion of SS.
The partial SS for each predictor is obtained using the ‘‘sequential sum of squares’’ method implemented in ANOVA function in R
(Key Resources Table). These data (mock compare to 4 hpi and mock compare to 18 hpi) are shown in Figure 5A. A more detailed
description of ANOVA can be found in NIST/SEMATECH e-Handbook of Statistical Methods (https://www.itl.nist.gov/div898/
handbook/eda/section3/eda355.htm).
iCLIP-seq data processing
To identify GEMIN5 binding sites on SINV RNAs, reads in the fastq ﬁles from sequencing were demultiplexed to separate the samples
according to the sample barcodes. Molecular and sample barcodes as well as trailing adaptor sequences were trimmed off. Molec-
ular barcode information was stored in the read name. Reads were then mapped to a combined human (GRCh38) and SINV genome
(pT7-SVwt) sequence using STAR. Uniquely aligned readswere then extracted using SAMtools. Binding sites were determined as the
50-most base of each uniquely mapped read. PCR duplicates were identiﬁed as reads with the samemapping position andmolecular
barcode and each unique fragment counted just once. The 50-most base in sequenced reads corresponds to the base directly 30 of
the crosslinked base. The number of unique fragment counts per position gives a measure of GEMIN5 interaction strength with that
position along the RNA.
Due to the sheer abundance of SINV RNA at 18 hpi, some background signal could be observed in GFP control. To account for this
background, GFP signal was subtracted from GEMIN5 signal after correction to total SINV reads. Signal along SINV was then visu-
alized individually per replicate (Figure S7) and as an average of all ﬁve replicates (Figure 7) as a coverage track and heatmap.
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Because the binding sites are narrow (sharp) and hence difﬁcult to see when plotting the full SINV region, the plot shows an average
over a sliding window of 20 nt. Note that the negative signal from y axis (higher signal in GFP) is cut off to better highlight GEMIN5
enriched regions.
Signiﬁcantly crosslinked sites were determined using iCount peaks (Key Resources Table). iCount peaks was run to generate a
background distribution by randomly distributing the crosslinked sites a hundred times along the SINV genome and compare the
actual observed distribution to this background to generate a false discovery rate. Since regions corresponding to genomic, subge-
nomic and 30 end region have different overall abundance, they were indicated as individual gene segments in the calculation to ac-
count for potentially higher background. Sites meeting FDR cutoff of 0.01 within 5 nt of each other were then merged using iCount
clusters to form binding sites. Binding sites were then given a ‘strength score’ calculated as counts within the binding site divided by
its width, and visualized in a heatmap in ﬁve bins to differently highlight the strengths of binding at different sites (Figures 7 and S7).
This process was done for the GEMIN5 replicates separately as well as for the library size normalized average of the ﬁve replicates.
Figure 7D additionally shows a heatmap that indicates how many replicates support a genomic position as binding site when deter-
mined individually per replicate. ggplot2 was used to facilitate plotting the heatmaps.
To look at base composition around the start of the SINV sgRNA, the 50-most base of unique fragments was extracted from aligned
reads taking softclipping into account. Count per base relative to total count in the sgRNA region is show in Figure S7H to indicate
relative binding site frequency and whether the sequenced base matches the genome.
Raw and processed iCLIP-seq data are available at GEO: GSE125182.
DATA AND SOFTWARE AVAILABILITY
The accession number for themass spectrometry data reported in this paper is ProteomeXchange: PXD009789. The accession num-
ber for the RNA-seq and iCLIP data reported in this paper is GEO: GSE125182.
Molecular Cell 74, 1–16.e1–e11, April 4, 2019 e11
Please cite this article in press as: Garcia-Moreno et al., System-wide Proﬁling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection,
Molecular Cell (2019), https://doi.org/10.1016/j.molcel.2019.01.017
Materiales y Métodos y Resultados 
107 
ARTÍCULO 5:  
The initiation factors eIF2, eIF2A, eIF2D, eIF4A, and eIF4G are not involved in 
translation driven by Hepatitis C virus IRES in human cells 
Uno de los objetivos principales de esta tesis es examinar la implicación de 
diferentes eIFs en la traducción viral. Una de las estrategias de los virus para evitar el 
requerimiento de diferentes eIFs es la presencia de elementos IRES en sus RNAs. Este 
es el caso de HCV, cuyo único mRNA posee un elemento IRES en su extremo 5’. Se han 
hecho muchos esfuerzos para averiguar el mecanismo preciso de iniciación de la 
traducción del mRNA de HCV. En este trabajo, se examina la participación de varios eIFs 
en este proceso. Para ello, se realizó un análisis comparativo con distintos mRNAs que 
expresan luciferasa como gen reportero bajo el control de diferentes IRES y secuencias 
leader con requerimientos conocidos de eIFs. Este estudio se llevó a cabo en las líneas 
celulares humanas Huh-7, derivada de células de hepatocarcinoma, y HAP1 wt y KO para 
eIF2A, eIF2D o doble KO para ambos (Horizon Discovery Group plc). Para analizar la 
participación de los diferentes eIFs, se emplearon: inhibidores conocidos para eIF2 y 
eIF4A, agentes que inducen el secuestro de eIF4G en SGs, y las líneas KO mencionadas. 
Nuestros resultados mostraron que ninguno de los inhibidores logró bloquear la síntesis 
de proteínas dirigida por el IRES de HCV. Por otra parte, también se estudió mediante 
inmunohistoquímica el efecto de varios compuestos en la salida de proteínas del núcleo 
al citoplasma y la formación de SGs, donde quedarían secuestrados factores que, en 
consecuencia, no podrían participar en la traducción del mRNA de HCV.  
Finalmente, como varios estudios han sugerido que el eIF2 podría ser 
reemplazado por los factores eIF2A o eIF2D en condiciones de estrés (Terenin, Dmitriev 
et al. 2008, Dmitriev, Terenin et al. 2010, Skabkin, Skabkina et al. 2010, Kim, Park et al. 
2011), se analizó la síntesis de proteínas dirigida por el IRES de HCV mediante la 
expresión del gen reportero luciferasa. Este ensayo se realizó en líneas celulares 
humanas KO para eIF2A, eIF2D o ambos factores en condiciones donde eIF2α estaba 
fosforilado. Nuestros resultados indicaron que ninguna de estas dos proteínas es 
requerida para la traducción del mRNA de HCV incluso cuando eIF2 está inactivo.  
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The Initiation Factors eIF2, eIF2A,
eIF2D, eIF4A, and eIF4G Are Not
Involved in Translation Driven by
Hepatitis C Virus IRES in Human
Cells
Esther González-Almela, Hugh Williams, Miguel A. Sanz and Luis Carrasco*
Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain
Animal viruses have evolved a variety of strategies to ensure the efficient translation
of their mRNAs. One such strategy is the use of internal ribosome entry site (IRES)
elements, which circumvent the requirement for some eukaryotic initiation factors (eIFs).
Much effort has been directed to unravel the precise mechanism of translation initiation
by hepatitis C virus (HCV) mRNA. In the present study, we examined the involvement
of several eIFs in HCV IRES-driven translation in human cells in a comparative analysis
with mRNAs bearing the encephalomyocarditis virus or the Cricket paralysis virus IRES
element. Consistent with previous findings, several inhibitors of eIF2 activity, including
sodium arsenite, thapsigargin, tunicamycin, and salubrinal, had no inhibitory effect on
the translation of an mRNA bearing the HCV IRES, and all induced the phosphorylation
of eIF2α. In addition, hippuristanol and pateamine A, two known inhibitors of eIF4A,
failed to block HCV IRES-directed translation. To test the release of nuclear proteins to
the cytoplasm and to analyze the formation of stress granules, the location of the nuclear
protein TIA1 was tested by immunocytochemistry. Both arsenite and pateamine A could
efficiently induce the formation of stress granules containing TIA1 and eIF4G, whereas
eIF3 and eIF2 failed to localize to these cytoplasmic bodies. The finding of eIF4A and
eIF4G in stress granules suggests that they do not participate in mRNA translation.
Human HAP1 cells depleted for eIF2A, eIF2D, or both factors, were able to synthesize
luciferase from an mRNA bearing the HCV IRES even when eIF2α was phosphorylated.
Overall, these results demonstrate that neither eIF2A nor eIF2D does not participate in
the translation directed by HCV IRES. We conclude that eIF2, eIF4A, eIF2A, and eIF2D
do not participate in the initiation of translation of HCV mRNA.
Keywords: regulation of protein synthesis, initiation factor of translation, inhibitors of eIF2, regulation of viral
translation, eIF2 phosphorylation
INTRODUCTION
Hepatitis C virus (HCV) is responsible for the vast majority of chronic viral hepatitis and induces
hepatocarcinoma in humans (Hajarizadeh et al., 2013; Khullar and Firpi, 2015). HCV belongs to the
Flaviviridae family and contains a 9.6 kb single-stranded RNA of positive polarity as its genome.
Its genomic RNA is the only known viral mRNA and bears a single open reading frame (ORF)
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encoding for a large polyprotein, which after proteolytic
processing renders the mature viral proteins that participate in
genome replication and in the assembly of new virus particles
(Paul et al., 2014). Translation of HCV mRNA is promoted and
regulated by an internal ribosome entry site (IRES) element that
mediates the internal initiation of translation by supporting the
interaction of components that participate in protein synthesis
(Hellen and Pestova, 1999; Khawaja et al., 2015). Results from
in vitro experiments initially suggested that the first step in
the initiation of this viral mRNA involved the recruitment
of initiation factors eIF3, eIF2, eIF5, GTP, initiator tRNAiMet
and a 40S ribosomal subunit by HCV IRES, yielding a 43S
preinitiation complex (Pestova et al., 1998; Otto and Puglisi,
2004). Precise attachment of this complex at the initiation AUG
codon forms a 48S complex in a process that does not involve
eIF4F or the scanning of the 5′-UTR. The HCV mRNA has
the ability to interact directly with the 40S ribosomal subunit,
recruiting then eIF3 and the ternary complex. In this process, two
modules of the IRES region, domains II and III, are necessary
for the interaction with the small ribosomal subunit and eIF3
(Lukavsky, 2009; Khawaja et al., 2015; Yamamoto et al., 2015).
Also, interaction of the HCV mRNA with preinitiation complexes
bearing eIFs can take place, in a process that displaces eIF2,
but requires eIF1A and eIF3 (Jaafar et al., 2016). Subsequently,
the 60S ribosomal subunit interacts with this complex in a
process mediated by eIF5B, which induces the release of eIF3
and leads to the formation of the 80S initiation complex, ready
to start the elongation process. This mechanism of internal
initiation is in sharp contrast to the canonical initiation of cellular
capped mRNAs. In this latter instance, the initiation of protein
synthesis begins with the recognition of the cap structure by
the eIF4F complex, which contains eIF4E, the cap recognition
protein, eIF4G, a scaffolding protein, and eIF4A, which exhibits
helicase activity in an ATP-dependent manner (Topisirovic
et al., 2011). Once eIF4F is bound to the cap structure at the
5′ end of cellular mRNAs, the small 40S ribosomal subunit
bearing eIF3 and the ternary complex eIF2-Met-tRNAiMet-GTP
interact with the mRNA. In addition, other factors such as
eIF1, eIF1A, and eIF5 bind to the small ribosomal subunit
forming the 48S complex. Then, this complex scans the 5′-
UTR until the initiator AUG codon is encountered (Sonenberg
and Hinnebusch, 2009; Hinnebusch et al., 2016). Joining of
the 60S ribosomal subunit is promoted by eIF5B concomitant
with the release of the eIFs in a GTP-dependent manner. Aside
from the requirement of only a few eIFs for the translation
of HCV mRNA, a number of IRES trans-acting factors, which
modulate HCV mRNA translation have been reported. These
factors include NSAP1, La protein, hnRNP L and D, Gemin5,
LSm1-7, IMP-1 and PCBP2; although their exact mechanism
of action in the translation of this viral mRNA remains largely
unknown (Niepmann, 2013).
The participation of eIF2 in the initiation of HCV mRNA
translation is controversial. In principle, two different
mechanisms can be followed: translation of HCV mRNA
takes place with eIF2 when this factor is active under normal
conditions; yet, IRES-driven translation occurs after inactivation
of this factor by phosphorylation under stress conditions. Initial
studies using reconstituted translation systems indicated that
eIF2 was necessary for the translation of this viral mRNA in vitro
(Pestova et al., 1998; Hellen and Pestova, 1999). Moreover,
analyses using mRNAs bearing HCV IRES in cell free systems
revealed the presence of eIF2 in the initiation complexes (Otto
and Puglisi, 2004). However, the interaction of this viral IRES
with preinitiation complexes displaces eIF2 from them (Jaafar
et al., 2016). That said, a novel class of inhibitors of the formation
of the ternary complex had no effect on HCV IRES-driven
translation, whereas these compounds potently interfered with
canonical protein synthesis (Robert et al., 2006). In addition,
stress conditions that promote the phosphorylation of eIF2α
and block cellular protein synthesis did not compromise HCV
mRNA translation (Terenin et al., 2008; Kim et al., 2011; Dabo
and Meurs, 2012; Jaafar et al., 2016). In light of this, several
candidates have been put forward to replace eIF2 for protein
synthesis promoted by HCV IRES under stress conditions. For
example, eIF5B can substitute for eIF2 in vitro in the delivery
of Met-tRNAiMet to small ribosomal subunits directed by HCV
mRNA (Terenin et al., 2008). Under these conditions, the
initiation of protein synthesis by HCV mRNA only requires two
initiation factors: eIF3 and eIF5B. Another proposal suggested
that eIF2D can substitute for eIF2 when this factor is inactivated
(Dmitriev et al., 2010; Skabkin et al., 2010). However, the
possibility that eIF5B or eIF2D participate in the initiation of
HCV mRNA in intact cells under stress conditions was not
analyzed, and only in vitro observations were reported. The
involvement of eIF2A for the translation of HCV mRNA in
place of eIF2 in intact cells and in cell free systems, has also
been proposed (Kim et al., 2011). Accordingly, Huh-7 cells
depleted for eIF2A cannot translate luciferase driven by the HCV
IRES in a bicistronic mRNA when eIF2α is phosphorylated.
In contrast to these findings, recent results have shown that
depletion of eIF2A or eIF2D or both factors in Huh-7 cells have
no effect for the translation of HCV mRNA (Jaafar et al., 2016).
Under stress conditions, only eIF1A, eIF5B, and eIF3 should be
necessary to direct the synthesis of proteins by this viral mRNA.
It has been speculated that under conditions in which eIF2 is
non-functional, the initiator Met-tRNAiMet can bind directly
to the ribosome following a mechanism that does not require
the ternary complex, but is directed by HCV IRES (Jaafar et al.,
2016).
Although eIF2A and eIF2D can form a complex with
Met-tRNAiMet and deliver it to 40S or 80S ribosomes, their
involvement in translation remains obscure. Indeed, early results
demonstrated that eIF2A can interact with Met-tRNAiMet and
deliver it to the ribosome (Merrick and Anderson, 1975).
However, this binding was much less efficient than that observed
using genuine eIF2 on artificial templates and eIF2A was unable
to promote the binding of Met-tRNAiMet to globin mRNA
(Adams et al., 1975). Moreover, a complex between Met-
tRNAiMet and eIF2D is formed in a GTP-independent fashion,
which can interact with the 40S ribosomal subunit to deliver
the initiator to the P site of the ribosome (Dmitriev et al.,
2010). eIF2D could displace deacylated tRNA and mRNA from
recycled 40S ribosomal subunits, and was also able to interfere
with the formation of the 48S initiation complex promoted
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by eIF2 (Skabkin et al., 2010). Both eIF2A and eIF2D are
65 kDa proteins. Deletion of the yeast ortholog of eIF2A or
eIF2D has no effect on cell viability (Zoll et al., 2002; Dmitriev
et al., 2010). Consistent with these observations, human cells
depleted for the genes encoding these two initiation factors
are also viable and global protein synthesis is unaffected (Sanz
et al., 2017). Results from mammalian cells have suggested
that eIF2A is involved in the translation of specialized cellular
mRNAs that initiate translation with non-AUG codons (Liang
et al., 2014; Starck et al., 2016). Elegant studies have recently
implicated eIF2A in cancer progression because it is involved in
the initiation of translation of upstream ORFs (Sendoel et al.,
2017). However, mice deleted for the eIF2A gene are completely
normal, supporting the concept that eIF2A is not necessary for
the translation of both normal and specialized cellular mRNAs
(Golovko et al., 2016).
Here, we examined the involvement of several eIFs in HCV
IRES-driven translation in human cells. Our findings indicate
that knock out human cells for eIF2A, eIF2D, or both, are not
only viable, but also synthesize proteins in a manner similar
to that of wild-type cells. In addition, by investigating the
potential involvement of these two proteins for the translation
of HCV mRNA, we demonstrate that these factors are not
required for translation of this viral mRNA, even when eIF2α is
phosphorylated.
MATERIALS AND METHODS
Cell Lines
Huh-7 cells are a well differentiated hepatocyte-derived cellular
carcinoma cell line established by Nakabayashi et al. (1982).
Cells were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM, Thermo Fisher Scientific, Waltham, MA, United States)
supplemented with non-essential amino acids, 4 µM glutamine,
10% fetal calf serum, 50 U mL−1 penicillin and 50 U mL−1
streptomycin.
Wild-type (WT) HAP1 human near-haploid cells and
knock-out HAP1 cells for eIF2A (cat# HZGHC002650c001),
eIF2D (cat# HZGHC002652c005) or double knock-cells
(cat# HZGHC005122c010) were purchased from Horizon
Discovery Group plc (Cambridge, United Kingdom). The
eIF2A knockout (KO) cell line (gi|977380191|ref|NM_032025.4|)
has a 16 bp deletion in exon 4 resulting in a frameshift
that generates a protein of 108 amino acids in place of the
original protein of 585 amino acids. The eIF2D KO cell line
(gi|56699484|ref|NM_006893.2|) has a 10 bp deletion in exon 3
resulting in a frameshift that generates a protein of 103 amino
acids in place of the original protein of 584 amino acids. The
double KO line has the same 16 bp deletion in exon 4 of the single
eIF2A KO cell line and a 22 bp deletion in exon 3 of eIF2D that
generates a protein of 99 amino acids in place of the 584 amino
acid protein. Cells were cultured in Iscove’s Modified Dulbecco’s
Medium (IMDM, Invitrogen, Carlsbad, CA, United States)
supplemented with 10% fetal calf serum.
All cell lines were maintained at 37◦C with 95% humidity and
5% CO2.
Plasmids and Reporter Constructs
The pT7HCV33core-Luc vector was kindly donated by
Dr. Takashi Shimoike (National Institute of Infectious Diseases,
Musashimurayama, Tokyo). It contains nucleotides 1–374 of the
HCV genome followed by the firefly luciferase gene and finally
the 3′ UTR of HCV. The construct is transcribed from a T7
polymerase promoter that precedes these sequences (Shimoike
et al., 2009). The gene segments from HCV comprise the
5′ UTR containing the IRES, followed by the first 33 nucleotides
of the HCV Core protein encoding a sequence that has previously
been shown to be crucial for the proper function of the IRES
(Reynolds et al., 1995). HCV-Luc RNA was in vitro transcribed
from pT7HCV33core-Luc.
The pTM1-Luc vector was derived from pTM1 (Moss et al.,
1990), and was constructed as described (Sanz et al., 2010).
It contains a modified form of the encephalomyocarditis virus
(EMCV) IRES along with the firefly luciferase gene. EMCV-Luc
RNA was in vitro transcribed from pTM1-Luc.
The pT7-RLuc-1EMCV-IGR-FLuc vector has been previously
described (Redondo et al., 2011). It contains the T7 promoter
followed by the Renilla luciferase gene and a deactivated form
of the EMCV IRES; it also contains the intergenic region of
cricket paralysis virus (CrPV) followed by the firefly luciferase
gene. CrPV-Luc RNA was in vitro transcribed from pT7-RLuc-
1EMCV-IGR-FLuc.
The β-globin construct contains the leader sequence from
the human β-globin gene followed by the firefly luciferase
gene. A Cap.βGlobin-Luc transcript was obtained by in vitro
transcription using pKS-GL-FL as a template, as described
by Castello et al. (2009). This plasmid was kindly provided
by Dr. Matthias Hentze and Dr. Francesca Moretti (EMBL,
Heidelberg, Germany).
The pFKi389LucNS3-3_dg_JFH vector, which was kindly
donated by Dr. Ralph Bartenschlager (Department of Molecular
Virology, University of Heidelberg, Heidelberg, Germany), was
used to obtain rep HCV-Luc RNA by in vitro transcription.
This plasmid contains the T7 promoter sequence fused to
nucleotides 1–389 of the JFH-1 consensus sequence, followed
by the firefly luciferase gene, the EMCV IRES, the NS3-to-NS5B
coding sequence, the 3′ NTR of JFH-1, the hepatitis delta virus
genomic ribozyme (dg), and the T7 terminator sequence (Schaller
et al., 2007). All plasmids contain the ampicillin resistance gene
for selection purposes.
In Vitro Transcription
Plasmids were linearized with the appropriate restriction
enzymes (pT7HCV33core-Luc: BamHI, pT7-RLuc-1EMCV-
IGR-FLuc: BamHI, pTM1-Luc: XhoI, pKS-GL-FL: HindIII;
pFKi389LucNS3-3_dg_JFH: MluI). All restriction enzymes
were purchased from New England Biolabs (Ipswich, MA,
United States). Linearized plasmids were used as templates for
in vitro RNA transcription using T7 or T3 RNA polymerases
(New England Biolabs, Ipswich, MA, United States), the
m7G(5′)ppp(5′)G cap analog (New England Biolabs) was used
for Cap.βGlobin-Luc transcription. Mixtures were incubated
for 2 h at 37◦C. In vitro-synthesized RNAs were treated with
recombinant DNase I (RNase-free) (Takara Bio USA Inc., Terra
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Bella, CA, United States) for 30 min at 37◦C. All transcripts
were transfected using Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA, United States) following the manufacturer
recommendations.
Inhibitors
Pateamine A [purified as described (Bordeleau et al., 2005)] and
hippuristanol (Bordeleau et al., 2006b) were kindly provided
by J. Pelletier (McGill University, Montreal, QC, Canada).
Sodium arsenite was obtained from Riedel-de Haën (Hanover,
Germany), and thapsigargin, tunicamycin, salubrinal, and
cycloheximide were purchased from Sigma–Aldrich (St. Louis,
MO, United States). Inhibitors are described in Table 1.
Luciferase Activity Assay
Cells were lysed in a buffer containing 0.5% Triton X-100,
25 mM glycylglycine pH 7.8, 1 mM dithiothreitol and complete
EDTA-free protease inhibitor cocktail (Roche Molecular Systems
Inc., Pleasanton, CA, United States) at the concentration
indicated by the supplier. Luciferase activity was determined
using the Luciferase Assay System (Promega, Madison, WI,
United States) and a Sirius Luminometer (Titertek-Berthold,
Pforzheim, Germany).
As a control, cycloheximide (CHX) was added to block
translation, in order to determine the luciferase synthesized in the
absence of compounds during the 1st hour of transfection.
Antibodies
Goat polyclonal anti-TIA-1 (C-20) (catalog number sc-17519),
rabbit polyclonal anti-eIF2α (catalog number sc-11386),
mouse monoclonal anti-eIF2α (catalog number sc-133132),
goat polyclonal anti-eIF3 (catalog number sc-16376), mouse
monoclonal anti-eIF4A (catalog number sc-14211), goat
polyclonal anti-eIF1 (catalog number sc-390122) antibodies
were purchased from Santa Cruz Biotechnology (Dallas, TX,
United States). Rabbit monoclonal anti-eIF1A antibody (catalog
number ab172623) was purchased from Abcam (Cambridge,
United Kingdom). Rabbit polyclonal anti-eIF2D antibody
(catalog number 12840-1-AP) was purchased from Proteintech
Group, Inc. (Rosemont, IL, United States). Rabbit polyclonal
anti-eIF2A antibody (catalog number A301-949A-M) was
purchased from Bethyl Laboratories Inc. (Montgomery, TX,
TABLE 1 | eIF2 inhibitors utilized in this study and the mechanisms by which they
increase eIF2α phosphorylation.
Inhibitor Mechanism of action
Sodium arsenite Induces phosphorylation of elF2α by activating
heme-regulated inhibitor kinase, a member of the
elF2α-specific kinase subfamily.
Thapsigargin Triggers the release of calcium to the cytoplasm from
the endoplasmic reticulum, activating PERK which in
turn phosphorylates elF2.
Tunicamycin Inhibits protein glycosylation and leads to endoplasmic
stress.
Salubrinal Inhibits the PP1/GADD34 complex which is known to
dephosphorylate elF2α.
United States). Rabbit polyclonal anti-phospho-eIF2α (serine
51) antibody (catalog number 9721) was purchased from Cell
Signaling Technology Inc. (Danvers, MA, United States). Rabbit
polyclonal antibody anti-eIF4GI has been obtained as previously
described (Aldabe and Carrasco, 1995).
Anti-rabbit immunoglobulin G antibody coupled to
peroxidase was purchased from Amersham (catalog number
NA934V) (GE Healthcare, Chicago, IL, United States). Specific
antibodies conjugated to Alexa 488 or Alexa 555 (A-21202 and
A-21432, respectively) were obtained from Invitrogen (Carlsbad,
CA, United States).
Immunocytochemistry and Confocal
Microscopy
Fixation, permeabilization and confocal microscopy were
performed as described by Madan et al. (2008) using the LSM
710 confocal laser scanning and multiphoton microscope
coupled to an inverted microscope (Axio Observer, Zeiss,
Oberkochen, Germany). Bound primary antibodies were
detected by secondary antibodies coupled to Alexa 488 or Alexa
555 (Molecular Probes Inc., Eugene, OR, United States). Nuclei
were stained with DAPI (4′-6-diamidino-2-phenylindole). All
images were collected and analyzed using Zeiss ZEN 2010
software.
Western Blotting
Cells were collected in sample buffer, boiled for 5 min
and processed by SDS-PAGE. After electrophoresis, proteins
were transferred to nitrocellulose membranes. Specific rabbit
polyclonal antibodies raised against phospho-eIF2α (Ser 51), total
eIF2α, eIF2A, and eIF2D were used at 1:1000 dilution in TBS
with 3% bovine serum albumin and 0.1% Tween 20. Anti-rabbit
immunoglobulin G antibody coupled to peroxidase (Amersham
GE Healthcare, Chicago, IL, United States) was used as secondary
antibody at a 1:5000 dilution. Protein bands were visualized with
the ECL detection system (Amersham, GE Healthcare).
Statistical Analysis
Data analysis was performed using Excel (Microsoft, Redmond,
WA, United States) and GraphPad Prism 6 (GraphPad Software
Inc., La Jolla, CA, United States) softwares. Data are shown
as mean with standard error. Statistical validation was done
using two-way analysis of variance (ANOVA) followed by a
Bonferroni post hoc test or one-way ANOVA with Tukey’s post
hoc test. Statistical significance is shown as: ∗p< 0.05, ∗∗p< 0.01,
∗∗∗p< 0.001.
RESULTS
HCV IRES-Driven Translation Is
Refractory to Inhibitors That Induce the
Phosphorylation of eIF2α in Human
Hepatic Cells
We sought to investigate the behavior of HCV IRES regarding
its dependence on several eIFs under appropriate physiological
Frontiers in Microbiology | www.frontiersin.org 4 February 2018 | Volume 9 | Article 207
fmicb-09-00207 February 13, 2018 Time: 11:47 # 5
González-Almela et al. Translation of Hepatitis C Virus RNA
conditions. To accomplish this, we used the Huh-7 human
hepatoma cell line. We first tested a monocistronic mRNA
encoding for luciferase, bearing the HCV IRES at the 5′ end and
containing the 3′-UTR of this RNA (HCV-Luc). The presence
of the 3′-UTR is important because it is involved in modulating
translation of HCV mRNA (Ito et al., 1998; Bai et al., 2013;
Shwetha et al., 2015). To reproduce conditions similar to those
found during HCV infection, we also tested a replicon of HCV
(rep HCV-Luc), which contains the firefly luciferase gene, the
EMCV IRES, the NS3-to-NS5B coding sequence, the 3′ NTR
of JFH-1 and the hepatitis delta virus genomic ribozyme (dg)
(Schaller et al., 2007). As controls, we employed an mRNA
bearing the CrPV intergenic region (IGR) (CrPV-Luc), which
does not require eIFs to initiate protein synthesis (Jan and
Sarnow, 2002; Fernandez et al., 2014). We also employed the
IRES of EMCV (EMCV-Luc), which uses eIF2 and eIF4A for
translation (Welnowska et al., 2011), and a capped mRNA
containing the globin 5′-leader sequence (Cap.βGlo-Luc), which
follows the canonical mechanism for its translation. All these
mRNAs encode luciferase as a reporter gene (Supplementary
Figure 1).
Initially, we explored the action of different concentrations
of several compounds that induce the phosphorylation of
eIF2α. Accordingly, Huh-7 cells were first transfected with
HCV-Luc and EMCV-Luc mRNAs for 1 h and the following
compunds were added to the culture medium for a further
2 h: sodium arsenite (ARS), thapsigargin (TG), tunicamycin
(TM), and salubrinal (SAL). The first three compounds
activate kinases that induce eIF2α phosphorylation, whereas
SAL inhibits eIF2α dephosphorylation (Boyce et al., 2005;
Sanz et al., 2009; Vaughn et al., 2014; Garcia-Moreno et al.,
2015). As a control, cycloheximide (CHX) was added to
block translation, in order to determine the luciferase
synthesized in the absence of compounds during the 1st
hour of transfection. The four compounds tested blocked
luciferase synthesis directed by EMCV IRES in a concentration-
dependent manner, albeit to different extents and with different
inhibitory concentrations (Figure 1A). By contrast, the same
compounds exerted a stimulatory effect on HCV-Luc mRNA
translation. Among the compounds, ARS and TG were the
most potent inhibitors/stimulators. Accordingly, 100 µM
ARS almost entirely inhibited EMCV-Luc translation and
stimulated HCV-Luc translation by ∼250%. A similar result
was obtained with 2 µM TG. TM also stimulated luciferase
production from HCV-Luc ∼200% at 10 µg mL−1, but the same
concentration inhibited EMCV-Luc translation by only 30%.
Higher concentrations of this compound further decreased the
translation of EMCV-Luc, whereas the translation of HCV-Luc
was partially inhibited. Perhaps this inhibition is due to the
toxicity of TM at these high concentrations. A moderate
inhibition of luciferase activity from EMCV-Luc was observed
with SAL up to 200 µM (∼40%), and activity was completely
inhibited at 400 µM. Conversely, the activity of HCV-Luc was
stimulated ∼150–175% or remained unaltered in relation to the
control.
To assess whether the compounds induced the
phosphorylation of eIF2α, we performed western blotting
on cell extracts using specific antibodies. A robust increase
in eIF2α phosphorylation in Huh-7 cells was found with
the four agents assayed, with the most potent being ARS
(Figure 1B). We next tested the activity of the two most
potent inhibitors, ARS and TG, on four different mRNAs:
HCV-Luc, EMCV-Luc, CrPV-Luc, and Cap.βGlo-Luc. Two
concentrations of the inhibitors were added 1 h after transfection
of the different mRNAs, and CHX was also added as a
control as before. We found that protein synthesis directed
by both EMCV-Luc and Cap.βGlo-Luc was effectively blocked
by both compounds (Figure 1C). Notably, HCV-Luc was
stimulated by ARS and TG ∼150%. A comparable response
was also found with CrPV-Luc mRNA, albeit with a stronger
stimulation, overall indicating a similar behavior of both
mRNAs in the presence of these inhibitors as regards to their
dependence on eIF2. This stimulation of HCV and CrPV
IRESs is probably due to the inhibition of global cellular
translation by these compounds, thus reducing cellular mRNA
competition.
The translation driven by rep HCV-Luc mRNA in the
presence of ARS was also tested. To do this, Huh-7 cells
were transfected with rep HCV-Luc mRNA for 1 h, and
subsequently different concentrations of ARS were added to
the culture medium for a further 2 h. The luciferase synthesis
directed by rep HCV-Luc was stimulated ∼158% by treatment
with 50 µM ARS (Figure 1D), which is in good agreement
with the results obtained with HCV-Luc, suggesting that HCV
does not require eIF2 for its translation under replication
conditions. Curiously, ARS concentrations above 200 µM were
inhibitory for rep HCV translation. This result suggests that
some differences exist between the translation of the HCV-Luc
mRNA and the rep HCV, which bears most of the viral coding
sequences.
Requirement of eIF4A for IRES-Driven
Translation
Two natural compounds of marine origin, hippuristanol (Hipp)
and pateamine A (Pat A), have been characterized as potent
blockers of eIF4A activity (Bordeleau et al., 2006a; Low et al.,
2007). eIF4A is the helicase subunit of the eIF4F complex,
which additionally contains eIF4E and eIF4G (Topisirovic
et al., 2011). Both inhibitors have been shown to exhibit a
dual inhibitory effect on some viral mRNAs (Garcia-Moreno
et al., 2013; Gonzalez-Almela et al., 2015). To analyze the
action of Hipp and Pat A on luciferase synthesis driven
by the HCV, EMCV and CrPV IRES elements, different
concentrations of these compounds were added 1 h after
transfection for a further 2 h. Consistent with previous works
(Garcia-Moreno et al., 2013; Gonzalez-Almela et al., 2015),
both Hipp and Pat A potently blocked EMCV IRES-dependent
luciferase synthesis in human hepatic cells. By contrast, both
compounds had no detrimental effect on translation driven
by HCV or CrPV IRESs in these cells, and in fact strongly
stimulated translation (Figure 2). These results are consistent
with the concept that eIF4F does not participate in protein
synthesis directed by HCV IRES (Hellen, 2009; Niepmann,
2013).
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FIGURE 1 | Translation from the HCV IRES in Huh-7 cells is resistant to the action of eIF2 inhibitors. (A) Translation from the IRES of HCV or EMCV as measured by
luciferase activity in response to eIF2 inhibitor treatment in Huh-7 cells. Cells were transfected with in vitro synthesized HCV-Luc or EMCV-Luc mRNAs for 1 h and
then incubated with either cycloheximide CHX (5 µg mL−1) or ARS, TG, SAL, or TM for a further 2 h. Percentage change is relative to that in the non-treated control
(inhibitor concentration = 0). The readings from CHX treatments were subtracted from all as a baseline. Error bars represent the standard error of the mean, n = 3.
(B) Inhibitor treatment induces eIF2 phosphorylation in Huh-7 cells. Cells were transfected with in vitro synthesized HCV-Luc RNA as above and then treated or not
(Continued)
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FIGURE 1 | Continued
with ARS (100 µM), TG (5 µM), TM (40 µg mL−1), or SAL (200 µM) for 2 h. Proteins were resolved by SDS-PAGE and blots were probed with antibodies against
phospho-eIF2α and total eIF2α. Shown is a representative blot from three independent experiments. The phosphorylation of eIF2α induction rate was evaluated by
normalizing the raw value of P-eIF2α to that of total eIF2α as shown in the bar graph. (C) Huh-7 cells were transfected with different in vitro transcribed reporter
RNAs: HCV-Luc, EMCV-Luc, CrPV-Luc or Cap.βGlobin-Luc. After 1 h of transfection, cells were treated or not with ARS or TG, or with CHX, after which luciferase
activity was measured. Bars represent the relative luciferase activity with non-treated control (inhibitor concentration = 0) set as 100%. The readings from CHX
treatments were subtracted from all as a baseline. Error bars represent the standard error of the mean, n = 3. (A,C) Statistical significance of the differences between
treated samples compared to control was calculated with two-way ANOVA and a Bonferroni post hoc test, and is shown as: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
(D) Huh-7 cells were transfected with in vitro synthesized rep HCV-Luc mRNA. After 1 h of transfection, cells were treated with different concentrations of ARS or
CHX (5 µg mL−1) for 2 h, after which luciferase activity was measured. Bars represent the relative luciferase activity with non-treated control (inhibitor
concentration = 0) set as 100%. The readings from CHX treatments were subtracted as a baseline. Error bars represent the standard error of the mean, n = 3.
Statistical significance of the differences between treated samples compared to control was calculated with one-way ANOVA and a Tukey’s post hoc test, and is
shown as: ∗p < 0.05, ∗∗∗p < 0.001.
FIGURE 2 | Translation from the HCV IRES in Huh-7 cells is resistant to the action of eIF4A inhibitors. Huh-7 cells were transfected with reporter RNAs (HCV-Luc,
EMCV-Luc, or CrPV-Luc) for 1 h and then treated with either Hipp (0.2 and 0.4 µM) or Pat A (0.2 and 0.4 µM) for 2 h, after which luciferase activity was measured.
Bars represent the relative luciferase activity with non-treated control (inhibitor concentration = 0) set as 100%. The readings from CHX treatments were subtracted
from all as a baseline. Error bars represent the standard error of the mean, n = 3. Statistical significance of the differences between treated samples compared to
control was calculated with two-way ANOVA and a Bonferroni post hoc test, and is shown as: ∗∗p < 0.01, ∗∗∗p < 0.001.
Cellular Localization of eIFs Treated with
Sodium Arsenite or Pateamine A
It is well established that ARS and Pat A induce the formation
of cytoplasmic stress granules (SGs). The molecular mechanism
of this induction is different for each compound: ARS induces
eIF2α phosphorylation, whereas SG formation by Pat A occurs
via a mechanism independent of this process (Dang et al., 2006;
Linero et al., 2011). A number of components of the translation
machinery, including preinitiation complexes containing 40S
ribosomal subunits, are present in SGs (Kedersha and Anderson,
2009; Anderson et al., 2015; Penas et al., 2016). It was of note that
HCV-Luc mRNA was efficiently translated even in the presumed
presence of SGs (Figures 1, 2). Curiously, HCV infection of
Huh-7 cells leads to a dynamic oscillation in the formation of SGs
(Ruggieri et al., 2012; Valadao et al., 2016).
To survey the action of ARS and Pat A on SG formation and
to examine the localization of different eIFs, Huh-7 cells were
transfected with HCV-Luc, incubated with ARS and Pat A for
2 h, and then processed for immunocytochemistry. We initially
examined the localization of eIF4G together with TIA-1, eIF3 or
eIF4A. As illustrated in Figure 3A, eIF4G (stained green) was
mostly located in the cytoplasm in Huh-7 control cells, whereas
TIA-1 (stained red) was predominantly nuclear. Transfection
with HCV-Luc RNA led to the appearance of a few SGs in
Huh-7 cells containing both eIF4G and TIA-1. Treatment of
transfected cells with ARS or Pat A greatly increased the number
and size of SGs containing TIA-1 and eIF4G (Figure 3A). eIF3
(stained red) commonly showed a granular and cytoplasmic
location. Furthermore, transfection with HCV-Luc RNA led
to the formation of some granules with concentrated eIF4G,
presumably SGs, without co-localization of eIF3. However, ARS
treatment robustly modified eIF3 distribution, which showed
a more compacted perinuclear location without co-localization
of eIF4G. This effect was not seen after Pat A treatment
(Figures 3A,B). Moreover, whereas eIF4A (stained red) displayed
a cytoplasmic location with a homogeneous dispersion in control
cells, it was clearly present in small SGs coincident with eIF4G
(stained green) in HCV-Luc transfected cells, which were larger
after treatment with ARS or Pat A (Figure 3A). The finding that
eIF4G is present in SGs suggests that it is not participating in
the translation of HCV-Luc mRNA. This is also in agreement
with the lack of inhibition when eIF4A is blocked by Hipp or
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FIGURE 3 | Analysis of stress granule formation in Huh-7 cells transfected with in vitro synthesized HCV-Luc RNA and treated with sodium arsenite or pateamine A.
Cells were seeded on microscope cover slips, transfected with HCV-Luc mRNA for 1 h and then treated with either ARS (200 µM) or Pat A (0.4 µM) for 2 h. Control
cells underwent the transfection procedure without RNA. After treatments, cells were permeabilized for immunocytochemistry. (A) Shows staining with primary rabbit
anti-eIF4G antibody (green) together with primary goat anti-TIA-1, goat anti-eIF3 or mouse anti-eIF4A antibodies (red). (B) Shows staining with primary rabbit
anti-eIF2 antibody (green) together with primary goat anti-TIA-1 or goat anti-eIF3 antibodies (red). Anti-goat antibodies conjugated to Alexa 555 were used to detect
TIA-1 or eIF3 (red), anti-mouse antibody conjugated to Alexa 555 was used to detect eIF4A (red), anti-rabbit antibodies conjugated to Alexa 448 were employed to
detect eIF4G or eIF2 (green). DAPI was used to stain the nuclei (blue). Scale bar, 20 µm.
Pat A, suggesting that the eIF4F complex is not involved in
HCV mRNA translation. We also considered it of interest to
analyze other factors of the translation machinery (Figure 3B).
eIF2 (stained green) had a dispersed cytoplasmic localization in
control and transfected cells with or without ARS treatment,
whereas in transfected cells treated with Pat A eIF2 appeared in
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FIGURE 4 | Thapsigargin, tunicamycin or salubrinal treatment induces stress granule formation in transfected Huh-7 cells. (A) Cells were seeded on microscope
cover slips and transfected with different reporter RNAs: HCV-Luc, EMCV-Luc, CrPV-Luc or Cap.βGlobin-Luc. After 1 h of transfection, cells were incubated in
DMEM medium for 2 h. (B) Cells were seeded on microscope cover slips and transfected with HCV-Luc. After 1 h of transfection, cells were treated with various
eIF2 inhibitors (TG, TM, or SAL) for 2 h. In both cases, after treatments cells were permeabilized for immunocytochemistry using primary goat anti-TIA-1 and rabbit
anti-eIF4G antibodies. An anti-goat antibody conjugated to Alexa 555 was used to detect TIA-1 (red) and an anti-rabbit antibody conjugated to Alexa 448 was
employed to detect eIF4G (green). DAPI was used to stain the nuclei (blue). Scale bar, 20 µm.
SGs coincident with TIA-1 (stained red) (Figure 3B). Curiously,
Pat A not only blocked the action of eIF4A, but also induced
the sequestration of eIF2 into SG granules. Finally, as shown in
Supplementary Figure 2, no change in the localization pattern
of eIF1A was found after RNA transfection with or without
treatment with ARS or Pat A. Therefore, eIF1A is not sequestered
into SGs. This is consistent with the idea that eIF1A may
participate in the translation of HCV mRNA (Jaafar et al.,
2016). In conclusion, eIF4G and eIF4A, which are located in
SG, are not involved in HCV mRNA translation, whereas eIF3
and eIF1A, which are present in the cytosol, could be engage
in the initiation of this translation. In the case of eIF2, it
is located in SG after phosphorylation by Pat A, consistent
with the concept that it does not participate in HCV IRES
translation.
We next addressed whether transfection with other RNAs
could also induce the formation of SGs. We transfected Huh-7
cells with HCV-Luc (as a control), EMCV-Luc, CrPV-Luc
or Cap.βGlobin-Luc RNAs for 1 h followed by incubation
in DMEM for 2 h before immunocytochemistry analysis.
Interestingly, the transfection with these RNAs also induced
the formation of a few small granules (Figure 4A). This
represent an interesting aspect to take into consideration,
since not only HCV-Luc RNA but also transfection with
other RNAs may induce this response. Of interest, treatment
with TG, TM or SAL also increased the formation of large
quantities of SGs in cells transfected with HCV-Luc mRNA
as shown by staining for eIF4G (green) and TIA-1 (red)
(Figure 4B).
Translation of mRNA Bearing HCV IRES
in Knock-out Human Cells Depleted for
eIF2A, eIF2D, or Both Factors
Several studies have suggested that eIF2 can be replaced
with other cellular proteins under stress conditions (Terenin
et al., 2008; Dmitriev et al., 2010; Skabkin et al., 2010; Kim
et al., 2011). Accordingly, the possibility that eIF2A or eIF2D
participate in the initiation of translation of HCV mRNA when
eIF2α is phosphorylated has been put forward. To test this
idea, we made use of human cells knocked out for eIF2A
(HAP1-eIF2A−), or eIF2D (HAP1-eIF2D−) or both (HAP1-
eIF2A−/2D−). We have recently shown that these cells are viable,
exhibit a normal morphology and have a similar synthesis of
global proteins to that of parental control cells (Sanz et al.,
2017).
First, we analyzed the activity of the different inhibitors
that induce the phosphorylation of eIF2α in WT HAP1 cells
transfected with different mRNAs. We followed a protocol
similar to that used for Huh-7 cells and each compound
was assayed at different concentrations. Consistent with the
results for hepatoma cells, the compounds differentially affected
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FIGURE 5 | Translation from the HCV IRES in HAP1 WT cells is resistant to the action of eIF2 inhibitors. (A) Translation from the IRES of HCV or EMCV as measured
by luciferase activity in response to eIF2 inhibitor treatment in HAP1 WT cells. Cells were transfected with HCV-Luc or EMCV-Luc mRNAs for 1 h and then incubated
with either CHX (5 µg mL−1) or ARS, TG, TM, or SAL for a further 2 h. Percentage change is relative to non-treated control (inhibitor concentration = 0). The
readings from CHX treatments were subtracted from all as a baseline. Error bars represent the standard error of the mean, n = 3. Statistical significance of the
differences between treated samples compared to control was calculated with two-way ANOVA and a Bonferroni post hoc test, and is shown as: ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001. (B) Inhibitor treatment induces eIF2α phosphorylation in HAP1 WT cells. Cells were transfected for 1 h and then treated or not with either
ARS (200 µM), TG (5 µM), TM (40 µg mL−1) or SAL (50 µM) for 2 h. Proteins were resolved using SDS-PAGE and then samples were probed with antibodies for
phospho-eIF2α and total eIF2α. Shown is a representative blot from three independent experiments. The phosphorylation of eIF2α induction rate was evaluated by
normalizing the raw value of P-eIF2α to that of total eIF2α as shown in the bar graph.
the translation directed by EMCV or HCV IRESs: whereas
translation driven by EMCV IRES was inhibited, HCV IRES-
dependent translation was stimulated by these compounds
(Figure 5A). As stated earlier, this stimulation can be due to
phosphorylation of eIF2α (Figure 5B), which blocks cellular
translation, and also to the sequestration of many cellular
mRNAs in SGs, impeding the competition for components of the
translational machinery.
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FIGURE 6 | Characterization of the different HAP1 cell lines by immunocytochemistry and western blotting. (A) HAP1 WT, HAP1-eIF2A−, HAP1-eIF2D−, and
HAP1-eIF2A−/eIF2D− cells were seeded on microscope coverslips, fixed and stained with primary rabbit polyclonal anti-eIF2A or anti-eIF2D antibodies and a mouse
monoclonal anti-eIF2α antibody. An anti-mouse antibody conjugated to Alexa 555 was used to detect eIF2α (red) and an anti-rabbit antibody conjugated to Alexa
488 was employed to detect eIF2A and eIF2D (green). DAPI was used to stain the nuclei (blue). Scale bar, 20 µm. (B) The presence of eIF2A or eIF2D in HAP1 WT,
HAP1-eIF2A−, HAP1-eIF2D−, and HAP1-eIF2A−/eIF2D− cells was also determined by western blotting with rabbit polyclonal anti-eIF2A and anti-eIF2D antibodies.
eIF2α was used as loading control for the four cell lines. Proteins were resolved by SDS-PAGE and samples were probed with antibodies to show the presence of
these factors in the HAP1 cells lines. Shown is a representative blot from three independent experiments.
To study the participation of eIF2A and eIF2D in the
translation of the mRNA reporter bearing HCV IRES, we
employed the KO cell lines indicated above. We first validated
the cell lines by immunohistochemistry and western blotting. The
subcellular localization of eIF2A and eIF2D in HAP1 WT, single
KO and double KO variants is shown in Figure 6. The expression
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FIGURE 7 | Resistance of HCV IRES translation to the eIF2 inhibitor sodium arsenite is independent of eIF2A and eIF2D. HAP1 cell lines WT, HAP1-eIF2A−,
HAP1-eIF2D−, and HAP1-eIF2A−/eIF2D− were transfected with reporter RNAs (HCV-Luc, EMCV-Luc, CrPV-Luc or Cap.βGlobin-Luc) for 1 h and treated with ARS
(200 µM) for 2 h. Bars represent the relative luciferase activity with non-treated control (inhibitor concentration = 0) set as 100%. The readings from CHX treatments
were subtracted from all as a baseline. Error bars represent the standard error of the mean, n = 3. Statistical significance of the differences between ARS treated
samples compared to control was calculated with two-way ANOVA and a Bonferroni post hoc test, and is shown as: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
of eIF2A and eIF2D was examined by immunocytochemistry
using specific antibodies. Double staining of HAP1 WT cells
revealed that eIF2A was clearly expressed in the cytoplasm and
a proportion was also found in the nucleus, whereas eIF2D
was mainly cytoplasmic. As expected, eIF2A was not detected
in HAP1-eIF2A− cells or HAP1 eIF2A−/eIF2D− (Figure 6A).
Similarly, eIF2D was not found in HAP1-eIF2D− cells or
HAP1 eIF2A−/eIF2D− (Figure 6A). Loss of eIF2A or eIF2D
in the respective KO cell lines was verified by western blotting
(Figure 6B).
The four cell lines, HAP1 WT, HAP1-eIF2A−, HAP1-eIF2D−,
and HAP1-eIF2A−/2D− were transfected with different mRNAs
encoding luciferase and treated or not with ARS to induce
eIF2α phosphorylation. Interestingly, the translation of the
different mRNAs was similar in all four cell lines analyzed, both
in the absence or presence of ARS (Figure 7). As expected,
luciferase synthesis from both control mRNAs, EMCV-Luc and
Cap.βGlo-Luc was strongly inhibited by ARS in all four cell lines.
By contrast, luciferase translation from CrPV-Luc mRNA was
stimulated by ARS treatment. Thus, HCV-Luc mRNA directed
the synthesis of luciferase in all four cell lines, even when ARS
was present and eIF2α was phosphorylated. This finding clearly
demonstrates that neither eIF2A nor eIF2D are involved in HCV-
Luc translation. Moreover, these two factors do not replace the
activity of eIF2 in IRES-driven translation when it is inactivated.
In the statistical analysis using two-way ANOVA, we have seen
that there is no statistical interaction between any of the four
HAP1 lines. That means that the effect of ARS is the same
in the four cell lines, although there are differences between
the levels of translation between them. The ARS increases in
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the same way the expression of Luc in the four lines tested
despite the absence of eIF2A and/or eIF2D. Therefore the level
of translation of HCV-Luc does not seem to depend on the
presence of these factors. In turn, we also see that there is a
significant difference between control cells and treated with ARS,
as indicated in Figure 7, therefore ARS effectively stimulates
the translation of HCV-Luc in the four HAP1 lines in a similar
degree. These findings are consistent with a recent report showing
that depleting Huh-7 cells of eIF2A, eIF2D or both with siRNAs
has no effect on luciferase synthesis promoted by HCV IRES
(Jaafar et al., 2016).
DISCUSSION
Animal viruses employ a variety of mechanisms to translate their
mRNAs (Firth and Brierley, 2012). The precise mechanisms of
viral mRNA translation remain the subject of intense research.
Some animal viruses utilize RNA components known as IRES
elements to direct the translation machinery to an internal
position at the 5′-UTR of the viral messenger (Hellen, 2009;
Plank and Kieft, 2012). However, the mechanism of IRES-driven
translation also can differ between the various animal viruses
that use this strategy. In the case of HCV, the exact mode
by which its mRNA initiates protein synthesis as regards to
participating eIFs is controversial. One school of thought is
that under normal cellular conditions, HCV mRNA initiates
translation using the ternary Met-tRNAiMet-eIF2-GTP complex,
whereas eIF2 is dispensable under stress conditions (Jaafar et al.,
2016). Yet, the possibility exists that eIF2 never participates in the
initiation of HCV mRNA in infected cells. Indeed, the interaction
of HCV IRES with the preinitiation complexes displaces eIF2
(Jaafar et al., 2016), and it is conceivable that the IRES element
itself is sufficient to initiate translation without eIF2, even when
this factor is active. Studies in vitro and experiments in culture
cells indicate that eIF2A can replace eIF2 in HCV IRES-directed
translation (Kim et al., 2011). Moreover, other studies point to
eIF2D as the responsible factor to initiate translation in place of
eIF2 (Dmitriev et al., 2010; Skabkin et al., 2010), based mainly
on in vitro observations. Our present findings in human cells
clearly demonstrate that neither eIF2A nor eIF2D are involved
in protein synthesis directed by HCV IRES, and are in accord
with a recent result demonstrating that knockdown of eIF2A or
eIF2D in hepatoma cells has little effect on HCV IRES-driven
translation (Jaafar et al., 2016). Therefore, the results obtained
using siRNAs by Jaafar et al. and our present findings with KO cell
lines are complementary and both demonstrate that those factors
do not participate in HCV translation. In addition, the possibility
that eIF2A can be replaced by eIF2D, or vice versa, is not
supported by the finding that in the double KO cell line HCV-Luc
mRNA is efficiently translated even under stress conditions in the
presence of ARS. Moreover, elegant studies directed to uncover
the cellular genes necessary for HCV replication and growth
failed to detect eIF2A or eIF2D (Marceau et al., 2016). Although
that study only examined cellular genes dispensable for human
HAP1 cells, it must be stressed that, as we have demonstrated,
neither eIF2A nor eIF2D are necessary for the viability of this
cell line (Sanz et al., 2017). Therefore, we can conclude that these
genes do not participate in the translation of this viral mRNA, and
they do not replace eIF2 even after the induction of cellular stress.
The use of KO cell lines will be helpful in future studies to unravel
the mode of initiation and the factors required to translate viral
mRNAs. Indeed, we believe that in vitro experiments that suggest
the requirement for some eIFs to translate a given mRNA should
be followed by in vivo experiments in culture cells and in this
respect KO cells will be useful tools. Remarkably, all eIFs could be
dispensable in in vitro translation of HCV at high concentrations
of magnesium ions (Lancaster et al., 2006). Thus, the modulation
of in vitro conditions strongly affects the requirements for eIFs in
the initiation of protein synthesis by HCV IRES.
There is more consensus about the lack of any involvement
of the three factors that form part of the eIF4F complex for
the initiation of protein synthesis directed by HCV mRNA
(Niepmann, 2013). Since this viral messenger does not have a
5′ cap structure, it seems logical that eIF4E is not involved in its
translation. Also, since there is no scanning mechanism during
the initiation event, eIF4A (the helicase enzyme involved in
scanning) does not participate in this process. There are currently
two compounds (Hipp and Pat A) from marine origin that are
selective inhibitors of eIF4A (Bordeleau et al., 2006a; Low et al.,
2007). Both are very useful to test the involvement of this factor in
the translation of any given mRNA. We show here that these two
agents do not affect luciferase synthesis driven by HCV IRES in
monocistronic mRNAs containing the HCV 3′-UTR in human
hepatic cells. Our results are in good agreement with previous
observations showing that these compounds do not block HCV
IRES-dependent translation in dicistronic mRNAs (Bordeleau
et al., 2006a; Low et al., 2007). This fact, together with the finding
that eIF4G are localized in SGs after ARS treatment, is consistent
with the idea that the eIF4F complex does not participate in the
initiation of translation of HCV mRNA.
Possibly the most important issue to be clarified in the
initiation of protein synthesis driven by HCV IRES is to
determine whether eIF2 is employed or not under normal
conditions. In vitro observations have demonstrated that the
HCV IRES can directly interact with native 40S ribosomal
subunits devoid of eIFs that, afterward, can recruit eIF3 and
the ternary complex containing eIF2 (Ji et al., 2004; Otto and
Puglisi, 2004). The interaction of the HCV IRES with 40S
or 80S ribosomes leads to the remodeling of its structure, in
such a way that domain II is bound to the tRNA exit site,
whereas domain III positions with the initiation codon at the
head of the small ribosomal subunit (Boehringer et al., 2005).
Fluorescently labeled 40S ribosomal subunits in the ribosomal
protein RPS25 irreversibly bind to HCV IRES, leading to
conformational rearrangements of domain II that are stabilized
by yet undefined cellular proteins (Fuchs et al., 2015). It is,
however, unclear if under physiological conditions in intact
cells HCV mRNA interacts with native 40S or more probably
with preinitiation complexes that would contain several eIFs,
including eIF3 and eIF1A (Jaafar et al., 2016). IRES binding to
preinitiation complexes in intact cells can displace eIF2 by the
interaction of domain II with the 40S subunit (Locker et al., 2007).
In fact, the binding sites of domain II and the ternary complex
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overlap in such a way that the interaction of both on the 40S
would clash (Jaafar et al., 2016). It is feasible that domain
II of HCV IRES functionally replaces the ternary complex,
without the necessity for other cellular factors such as eIF2A or
eIF2D even under normal cellular conditions. Indeed, domain
II adopts an L-shaped structure and interacts with the 40S
subunit in the head region of the E site, allowing the apical
loop of domain II to reach deeply into the mRNA cleft near
the coding RNA in the ribosomal P site (Spahn et al., 2001;
Lukavsky et al., 2003). Therefore, the IRES may be able to
replace the ternary complex and after the formation of the 80S
ribosome, the P site could be occupied, leaving the A site free
that could be positioned with the AUG initiation codon ready
to start translation. This model is akin to that described for
the functioning of CrPV IRES, with the exception that eIF3 is
involved in HCV translation (Jan and Sarnow, 2002; Fernandez
et al., 2014).
The exact functioning of eIF2A or eIF2D during cellular
mRNA translation remains to be elucidated. The recent
generation of an eIF2A knockout mouse clearly demonstrates
that this factor is not required during embryogenesis, nor
involved in the translation of tissue-specific mRNAs (Golovko
et al., 2016). The recent finding that eIF2A participates in
tumorigenesis makes the study of this factor particularly relevant
(Sendoel et al., 2017). Nonetheless, eIF2A is likely required
for additional functions besides its involvement in cancer
progression. The use of the human KO cell lines employed in
this work could help to improve our understanding of eIF2A and
eIF2D in translation. As observed recently (Sanz et al., 2017),
and in the present study, these two factors are not necessary for
global translation of cellular mRNAs and for luciferase synthesis
directed by HCV, EMCV, or CrPV IRESs. Future studies directed
to analyze the behavior of specialized cellular mRNAs in these
KO cell lines will help to ascertain the precise roles of eIF2A and
eIF2D.
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DISCUSIÓN 
1. FACTORES Y REQUERIMIENTOS ESTRUCTURALES IMPLICADOS EN LA 
TRADUCCIÓN DE LOS mRNAS DE SINV 
Los virus emplean la maquinaria de traducción celular para sintetizar sus propias 
proteínas compitiendo con los mRNAs celulares (Bushell and Sarnow, 2002). En el caso 
del virus SINV, a tiempos tempranos de la infección, una pequeña cantidad de proteínas 
virales es suficiente para realizar la replicación de su genoma, por lo que la traducción 
viral puede coexistir con la traducción celular. Sin embargo, a tiempos tardíos, la síntesis 
de gran cantidad de proteínas estructurales virales requiere el uso exclusivo de la 
maquinaria de traducción de la célula. Los mRNAs de SINV (gRNA y sgRNA), al igual 
que los mRNAs celulares, presentan una estructura cap en su extremo 5’-UTR, y una cola 
poli(A) en el 3’-UTR. A pesar de estas semejanzas con los mRNAs celulares, resulta 
interesante que el sgRNA de SINV no sólo puede traducirse mediante el mecanismo 
canónico sino, también, de forma no canónica e independiente de varios eIFs cuando 
se encuentra en un contexto replicativo, en la fase tardía de la infección (Sanz et al., 
2009). Trabajos anteriores han descrito que, en un contexto replicativo, la traducción del 
sgRNA de SINV no necesita eIF4G intacto, PABP o eIF2 activo (Ventoso et al., 2006, 
Castello et al., 2016, Castello et al., 2009). Esta adaptabilidad le ha permitido traducirse 
en ambientes celulares con diferente disponibilidad de eIFs y desarrollar su ciclo 
biológico entre invertebrados y vertebrados. Sin embargo, aún se desconoce el 
mecanismo exacto de iniciación de la traducción del sgRNA de SINV y, por tanto, qué 
factores celulares podrían participar en ella. En el caso de SINV, se han identificado 
varios elementos estructurales en los mRNAs virales que maximizan su traducción en 
diferentes tipos de células hospedadoras, lo que demuestra la gran plasticidad funcional 
que este virus ha desarrollado durante su evolución para adaptarse a diferentes especies  
(Ventoso, 2012, Ventoso et al., 2006, Garcia-Moreno et al., 2016).  
Durante la fase tardía de la infección, SINV induce una profunda supresión de la 
síntesis de proteínas en células de mamífero, lo cual facilita que la maquinaria celular se 
dedique prioritariamente a la traducción del sgRNA (Griffin, 2007). Esta inhibición de la 
traducción celular no se observa en la misma medida en células de mosquito (Garcia-
Moreno et al., 2013, Sanz et al., 2015). La coincidencia entre el shut-off de la síntesis de 
proteínas celulares con la prevalencia de la traducción viral demuestra que la traducción 
celular y viral emplean diferentes mecanismos. Dentro del ciclo de infección de SINV, 
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encontramos también diferencias entre la traducción del gRNA y del sgRNA. El gRNA 
se traduce inmediatamente tras la entrada en la célula empleando varios eIFs canónicos 
(Castello et al., 2006). Durante la fase tardía, la síntesis de proteínas no estructurales 
dirigida por el gRNA disminuye en favor de una muy eficiente traducción del sgRNA 
(Strauss and Strauss, 1994). Estas diferencias se ven reflejadas también en un distinto 
requerimiento de factores de traducción. 
En este trabajo se ha continuado con el estudio desarrollado durante los últimos 
años en nuestro laboratorio sobre las peculiaridades de la traducción de los mRNAs 
virales, especialmente de los mRNAs de SINV, así como el análisis del requerimiento de 
diferentes eIFs para la iniciación de su traducción. En este sentido, la participación de la 
helicasa eIF4A en la traducción de los mRNAs de SINV fue estudiada mediante el 
inhibidor selectivo Pat A (Gonzalez-Almela et al., 2015). Esta molécula interacciona de 
manera específica con el eIF4A resultando en la desorganización del eIF4F, e 
impidiendo la iniciación por el mecanismo canónico de traducción (Bordeleau et al., 
2006). Nuestros resultados concuerdan con trabajos anteriormente publicados 
(Bordeleau et al., 2005, Low et al., 2005), y muestran que el tratamiento con Pat A inhibe 
la síntesis de proteínas celulares. Además, se ha observado que, tras una hora de 
tratamiento con esta molécula, la traducción no se recupera, por lo que la inhibición 
mediada por Pat A es irreversible.  
A tiempos tempranos de la infección, la Pat A bloquea la síntesis de las nsPs de 
SINV. Sin embargo, durante la fase tardía de la infección, la traducción del sgRNA de 
SINV no se ve inhibida por la acción de este inhibidor. Curiosamente, fuera del contexto 
de replicación viral, la síntesis de proteínas virales dirigida por el sgRNA sí se encuentra 
afectada negativamente por el efecto de este inhibidor. No obstante, no parece que la 
Pat A influya en otros pasos de la traducción como la elongación o la terminación, 
puesto que la traducción dirigida por el IRES de la región intergénica (IGR) del virus de 
la parálisis del grillo (CrPV) no sólo es resistente, sino que se ve estimulada por el 
tratamiento con Pat A. Estos resultados coinciden con los obtenidos en el estudio de 
otro inhibidor selectivo del eIF4A, el hippuristanol (Garcia-Moreno et al., 2013) y con los 
conseguidos mediante la técnica cRIC donde se muestra que la actividad de unión al 
RNA de eIF4A no se ve alterada por la infección por SINV (Garcia-Moreno et al., 2019). 
Estas observaciones refuerzan la hipótesis de que el sgRNA presenta un 
comportamiento dual respecto al requerimiento de eIF4A dependiendo de si se 
encuentra en un contexto replicativo o no. Empleando Pat A, se ha observado que este 
cambio drástico ocurre en torno a las 4 hpi. Desde este momento en adelante, la 
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traducción del sgRNA pasa a ser independiente de varios eIFs, incluyendo el complejo 
eIF4F. Dado que, fuera del contexto de replicación viral, el sgRNA no puede traducirse 
sin eIF4A, eIF4G o eIF2, pero, en condiciones de replicación, su traducción es 
independiente de estos factores (Castello et al., 2006, Garcia-Moreno et al., 2013, Sanz 
et al., 2009, Gonzalez-Almela et al., 2015), la estructura de este RNA no debe de ser el 
único determinante de su modo de traducción. Resulta interesante que la 
independencia del eIF2 también se ve condicionada a un contexto replicativo. En este 
caso, la estructura del sgRNA, en concreto del DSH, es esencial para la independencia 
del eIF2 en células de vertebrado (Garcia-Moreno et al., 2015, Garcia-Moreno et al., 
2013, McInerney et al., 2005, Ventoso et al., 2006, Carrasco et al., 2018, Sanz et al., 2017, 
Sanz et al., 2019). Sin embargo, el DSH no confiere independencia del eIF4A (Garcia-
Moreno et al., 2013), por lo que los requerimientos estructurales que pudieran intervenir 
en este aspecto aún no han sido descubiertos.  
Muchos virus animales son capaces de traducir sus mRNAs tras la fosforilación de 
eIF2α (Clemens, 2005, Roberts et al., 2009, Dabo and Meurs, 2012). El mecanismo que 
permite la iniciación de la traducción cuando eIF2 está inactivo aún se desconoce. En el 
caso del sgRNA de SINV, el elemento DSH es requerido para iniciar la traducción 
cuando eIF2 no está disponible, aunque no se ha descrito aún el modo en el que esta 
estructura interviene en la iniciación (Sanz et al., 2009, McInerney et al., 2005, Ventoso et 
al., 2006). El sgRNA representa el primer ejemplo descrito de un mRNA viral capeado 
cuyo mecanismo de iniciación requiere de scanning y, pese a ello, no utiliza el eIF2 
(Garcia-Moreno et al., 2015). Inicialmente, se describió que esta estructura hairpin de la 
región codificante del sgRNA podría actuar parando el avance del ribosoma y 
posicionando el AUGi en el sitio P ribosómico (Frolov and Schlesinger, 1996). Sin 
embargo, esto no parece muy probable, ya que el DSH debería encontrarse a 14 nt 
downstream del codón de iniciación (Kozak, 1990). Más adelante, se observó que 
cuando eIF2α no se encontraba fosforilado, la traducción del sgRNA era independiente 
de la integridad del DSH (McInerney et al., 2005, Ventoso et al., 2006). Otra posibilidad 
es que el DSH actúe de forma parecida al IRES de la región IGR de CrPV. La estructura 
pseudoknot presente en la región 3’ de este IRES asemeja a un tRNA e interacciona con 
el sitio A ribosómico (Fernandez et al., 2014, Muhs et al., 2015, Johnson et al., 2017, 
Murray et al., 2016). Tras esto, el IRES se posiciona en el sitio P mediante la acción del 
eEF2, dejando el sitio A libre para que el codón iniciador comience la traducción. De 
forma semejante al IRES de CrPV, el DSH de SINV podría interaccionar con el sitio P del 
ribosoma (Garcia-Moreno et al., 2015). Por otro lado, estudios basados en silenciamiento 
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génico apuntan a que el eIF2 podría ser reemplazado por otro factor celular, como el 
eIF2A (Ventoso et al., 2006) o el eIF2D, anteriormente identificado como ligatina 
(Skabkin et al., 2010). Sin embargo, esta posibilidad parece poco probable considerando 
que nuestros resultados muestran que el sgRNA se traduce eficientemente en células 
HAP1 que carecen de eIF2A, eIF2D, o ambos, incluso cuando el eIF2α está fosforilado. 
Por tanto, aunque el mecanismo preciso por el que el sgRNA de SINV es capaz de dirigir 
la síntesis de proteínas en ausencia de eIF2 activo aún se desconoce, hemos demostrado 
que el eIF2A y el eIF2D no son necesarios para este proceso.  
El DSH también interviene en la señalización del codón de iniciación correcto en 
el sgRNA. Esta estructura es capaz de señalizar el codón iniciador incluso cuando se 
cambia el AUGi por otros codones, aunque en estos casos, la traducción resulta menos 
eficiente (Sanz et al., 2009). Nuestros experimentos muestran que la sustitución de AUGi 
por CUG (leucina) tiene un efecto moderado, manteniendo un 50-60% de la síntesis de 
C respecto a la forma wt. Destaca el hecho de que el DSH también permite la iniciación 
en otros codones alternativos como GCG o GUG. Resulta de interés que el codón CUC, 
aunque también codifique para leucina, fue muy ineficaz en traducción, por lo que el 
tipo de aminoácido codificado no parece ser relevante, aunque sí lo es la composición 
de nt del codón. Nuestros resultados apuntan a que eIF2, eIF2A y eIF2D no son 
necesarios para la iniciación en codones no-AUG. Como hemos observado, el nivel de 
producción de proteína C es similar entre las líneas HAP1 KO para eIF2A o eIF2D y la 
línea HAP1 wt cuando son transfectadas con rep C+luc (CUG). En cambio, la 
desestabilización del DSH tiene un gran efecto en la iniciación en codones no-AUG para 
el sgRNA. Como ocurre para rep C+luc DSH-destab (AUG), la desestabilización de la 
estructura del DSH promueve que la iniciación de la traducción no sólo ocurra en el 
primer AUGi, sino también en el segundo y el tercer AUG que se encuentran en un marco 
de lectura correcto. Esto demuestra que el mantenimiento de la estructura genuina del 
DSH es importante para señalizar el codón de iniciación. Los resultados obtenidos con 
rep C+luc DSH-destab (CUG) señalan que la iniciación en CUG se ve anulada cuando el 
DSH está desestructurado. En este caso la poca proteína C sintetizada corresponde a 
una variante truncada que inicia en el tercer AUG. Este patrón fue similar entre las líneas 
HAP1, sin encontrarse diferencias significativas en ausencia de eIF2A o eIF2D. Por tanto, 
se puede concluir que la estructura del DSH es muy importante para la selección del 
codón de iniciación correcto y que eIF2A y eIF2D no participan en la iniciación. En 
contraste con trabajos anteriores, nuestros descubrimientos apuntan a que eIF2 no es 
sustituido por otro factor celular en la traducción del sgRNA de SINV en células 
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infectadas. Más bien, estos datos sugieren la posibilidad de que el DSH por sí mismo 
sea el responsable de asegurar la traducción en independencia del eIF2. Como hemos 
propuesto anteriormente, el DSH podría interaccionar directamente con la subunidad 
ribosómica 40S o con el ribosoma 80S en el sitio P, de forma parecida a como lo hace el 
IRES de la IGR de CrPV (Garcia-Moreno et al., 2015, Hellen, 2009, Fernandez et al., 2014). 
Por otra parte, parece ser que el DSH de SINV se une al 18S rRNA para comenzar la 
traducción en el codón iniciador correcto, como se ha sugerido también para el DSH 
del virus del Bosque Semliki (Toribio et al., 2016), aunque no parece que la helicasa 
eIF4A esté implicada en este proceso fuera de los ensayos in vitro. En esta línea, varios 
trabajos muestran una clara evidencia de que inhibidores específicos del eIF4A no 
afectan a la iniciación del sgRNA de SINV (Gonzalez-Almela et al., 2015, Garcia-Moreno 
et al., 2013). Estas observaciones apoyan la idea de que la adquisición de la estructura 
DSH durante la evolución de los alfavirus permitió la independencia del eIF2 para su 
traducción en vertebrados (McInerney et al., 2005, Ventoso et al., 2006, Garcia-Moreno 
et al., 2013, Ventoso, 2012) facilitando así la síntesis de una gran cantidad de proteínas 
estructurales en las condiciones de estrés celular provocadas por la infección. 
Para todos los organismos vivos, incluyendo los virus, la selección del codón 
correcto de iniciación es muy importante para evitar la formación de polipéptidos 
aberrantes durante la síntesis de proteínas (Drummond and Wilke, 2009, Rozov et al., 
2016). Mientras que la mayoría de los mRNAs celulares y virales inician la traducción en 
codones AUG (Haimov et al., 2015, Kearse and Wilusz, 2017), algunos mRNAs pueden 
iniciar la síntesis de proteínas en codones alternativos, particularmente en ORFs situadas 
upstream de la secuencia codificante (uORFs) (Starck et al., 2016, Kearse and Wilusz, 
2017). En estos casos, la iniciación puede comenzar en codones CUG, GUG o AUU, entre 
otros (Peabody, 1989, Van Damme et al., 2014). Existe mucha controversia en la literatura 
sobre si para codones de iniciación no-AUG se incorpora el propio aminoácido que 
codifican o metionina (Starck et al., 2012, Liang et al., 2017, Sellier et al., 2017, Na et al., 
2018). Se ha demostrado que, en células de mamífero, la leucina puede incorporarse 
como el primer aminoácido durante la traducción de ciertos mRNAs que presentan CUG 
en lugar de AUG como codón iniciador (Starck et al., 2012). Sin embargo, pocos trabajos 
han conseguido analizar la iniciación con aminoácidos distintos a metionina en codones 
no-AUG (Liang et al., 2017). Esto podría deberse a que la iniciación en estos codones es 
poco eficiente, lo que dificulta la obtención de polipéptidos suficientes para su estudio. 
En este sentido, el sistema viral empleado en nuestros trabajos permite obtener 
cantidades relativamente altas de proteína C y de sus variantes que inician en codones 
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similares a AUG, facilitando su análisis. Por ello, SINV es un modelo excepcional para 
estudiar la iniciación de la traducción en codones no-AUG. La hipótesis más extendida 
es que la metionina es incorporada en el sitio P ribosómico de forma errónea para 
codones no-AUG por el complejo ternario Met-tRNAiMet-eIF2-GTP (Peabody, 1989, Liang 
et al., 2017, Sellier et al., 2017). Otros trabajos han sugerido que cuando la iniciación 
ocurre con el Leu-tRNA, la proteína eIF2A reemplaza al eIF2 (Starck et al., 2012, Starck 
et al., 2016). Sin embargo, la depleción de eIF2A en células supone sólo una inhibición 
parcial de este evento de iniciación. Por tanto, el mecanismo exacto por el que la 
iniciación ocurre en codones no-AUG aún requiere más investigación. En este sentido, 
el uso de líneas celulares KO similares a las empleadas en nuestros trabajos será de gran 
utilidad para descubrir las proteínas implicadas en este proceso.  
Uno de los mecanismos mejor estudiados de iniciación en codones no-AUG es el 
que se da en el segundo cistrón del RNA del virus CrPV. En este caso, el codón de 
iniciación empleado es GCU, que dirige la incorporación de alanina en el extremo 
amino-terminal de la proteína cuando el segundo cistrón es traducido. Ningún eIF 
participa en este evento de iniciación, y la unión del Ala-tRNA al sitio A ribosómico está 
mediada por el factor de elongación de la traducción eEF1A (Jan and Sarnow, 2002, 
Fernandez et al., 2014). Este aminoacil-tRNA es entonces translocado al sitio P por 
acción del eEF2 en un proceso dependiente de GTP (Murray et al., 2016). Como se ha 
señalado anteriormente, se ha avanzado en la idea de que existen algunas similitudes 
entre el mecanismo de iniciación dirigido por el IRES de CrPV y el del DSH de alfavirus 
(Garcia-Moreno et al., 2015, Sanz et al., 2017, Carrasco et al., 2018). En principio, varias 
posibilidades podrían valorarse para la iniciación de la traducción en codones no-AUG. 
Una de ellas es que se incorpore metionina cuando CUG, u otro codón no-AUG, esté 
presente. Alternativamente, es posible que se incorpore como primer aminoácido en el 
extremo amino-terminal el que se encuentra codificado por el codón no-AUG; en el caso 
de CUG, leucina. Nuestros resultados demuestran que ambas posibilidades pueden 
ocurrir, aunque para CUG, la leucina es preferencialmente incorporada en el extremo 
amino-terminal. Por tanto, el Met-tRNA y el Leu-tRNA pueden actuar como iniciadores 
para este codón CUG. No obstante, aún se desconoce qué isoforma del Met-tRNA 
participa en este proceso: el iniciador (Met-tRNAiMet) o la isoforma que interviene en la 
fase de elongación de la traducción (Met-tRNAeMet). Met-tRNAiMet forma el complejo 
ternario con eIF2 y GTP, mientras que Met-tRNAeMet interacciona con eEF1A y GTP. Los 
dos modelos son concebibles. Como se ha señalado anteriormente, el factor eIF2 es 
muy selectivo a la hora de formar el complejo ternario con el Met-tRNAiMet, pese a que 
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es capaz también de formarlo con otros aminoacil-tRNAs, aunque de forma muy 
ineficiente (Kolitz and Lorsch, 2010). No obstante, a pesar de que, tanto el Leu-tRNA 
como el Met-tRNA son capaces de formar un complejo ternario con eIF2, la inactivación 
del eIF2 tras su fosforilación en células infectadas por SINV impediría su participación en 
la traducción. El reemplazo del eIF2 por otros factores como el eIF2A o el eIF2D también 
puede descartarse, ya que la síntesis de la proteína C de SINV puede ocurrir en células 
KO para estos factores, incluso cuando AUGi ha sido reemplazado por CUG. Aunque no 
podemos descartar que exista otro mecanismo que implique la participación de otro 
factor celular putativo capaz de interaccionar con algunos aminoacil-tRNAs y unirlos a 
los ribosomas (Schleich et al., 2017, Hellen, 2018). Por ejemplo, el heterodímero DENR-
MCT1 puede interaccionar con el tRNA para acoplarlo al ribosoma durante la 
reiniciación de la traducción (Schleich et al., 2014, Lomakin et al., 2003, Ahmed et al., 
2018). Por otra parte, existe la posibilidad de que pequeñas cantidades de eIF2 no 
fosforilado participen en la traducción del sgRNA, si hay fosfatasas en los foci donde 
ocurre la traducción del sgRNA. Sin embargo, creemos que estas hipótesis resultan 
poco probables porque eIF2 no colocaliza con los ribosomas en células infectadas por 
SINV (Sanz et al., 2009). Además, incluso pequeñas cantidades de eIF2 fosforilado son 
capaces de inhibir potentemente la traducción, ya que la fosforilación de su subunidad 
α bloquea el intercambio de GDP a GTP, impidiendo la reactivación de eIF2 (Donnelly 
et al., 2013).  
Tanto el Leu-tRNA como el Met-tRNA interactúan con eEF1A, por lo que es 
también posible que el eEF1A, u otra proteína celular con la habilidad de interaccionar 
con los aminoacil-tRNAs, participe en este evento de iniciación. Resulta interesante que 
la actividad de unión al RNA de eEF1A se ve estimulada en células infectadas por SINV 
(Garcia-Moreno et al., 2019). En el caso de que se formen estos complejos ternarios 
aminoacil-tRNA-eEF1A-GTP, el aminoacil-tRNA debería unirse al sitio A en el ribosoma 
80S, ya que los factores de elongación se acoplan al centro GTPasa localizado en la 
subunidad mayor ribosómica. Anteriormente, se ha sugerido que este sitio A debería 
estar en conformación abierta si el sitio P está ocupado por el elemento DSH (Garcia-
Moreno et al., 2015, Carrasco et al., 2018). Nuestros resultados con bruceantina 
concuerdan con esta idea, ya que este inhibidor, que bloquea la iniciación en el sitio P 
ribosómico, no tiene efecto en la traducción del sgRNA C+luc (CUG) en RRL, y produce 
un bloqueo menor de la traducción viral respecto de la traducción celular en células BHK 
infectadas por SINV. Resulta de interés que el elemento DSH es capaz de interaccionar 
directamente con el 18S rRNA (Toribio et al., 2016), y de esta forma podría promover la 
Discusión 
132 
formación del ribosoma 80S posicionando correctamente el codón de iniciación 
(Carrasco et al., 2018). Además, el DSH exhibe similitudes estructurales con el dominio II 
del IRES de HCV (Carrasco et al., 2018). A su vez, este último es similar al IRES de CrPV 
(Pisareva et al., 2018). El parecido entre el DSH y el dominio II del IRES de HCV no es 
simplemente estructural, las secuencias del loop del DSH y del loop apical del dominio II 
presentan una alta semejanza: CUAGCCAUG en HCV y CUGCCAUG en SINV. Por tanto, 
es probable que exista también similitud en la función entre el DSH y el dominio II de 
HCV. El mecanismo de acción del dominio II implica su interacción con los sitios 
ribosómicos E y P para reemplazar el Met-tRNAiMet (Spahn et al., 2001, Lukavsky et al., 
2003, Locker et al., 2007). Incluso, se ha descrito que el dominio II podría ser capaz de 
desplazar el complejo ternario previamente cargado en el ribosoma (Jaafar et al., 2016). 
El hecho de que treonina o valina, entre otros, puedan ser encontrados en el extremo 
amino-terminal de la proteína C indicaría que otros aminoacil-tRNAs pueden participar 
en el evento de iniciación dependiendo del codón que se encuentre en el sitio A del 
ribosoma. Esto sería consistente con el modelo propuesto del funcionamiento del DSH. 
El descubrimiento de que CUG puede reemplazar al AUGi en el sgRNA de SINV y 
que su traducción es dependiente de la integridad del DSH genera gran interés en 
analizar los requerimientos estructurales de este hairpin para participar en la 
señalización del codón de iniciación. Nuestras observaciones apoyan el modelo en el 
que el DSH interacciona con la subunidad ribosómica 40S y promueve el reclutamiento 
de la subunidad 60S para el ensamblaje del ribosoma 80S (Carrasco et al., 2018). Para 
que se dé esta interacción, la estructura, pero no la secuencia, de la región stem parece 
ser importante. Sin embargo, la secuencia del loop es crucial. Como muestran nuestros 
resultados, la mutación en los seis nucleótidos de este loop afecta negativamente a la 
iniciación en CUG, particularmente en células de insecto (Sanz et al., 2019). De hecho, 
esta variante del DSH demuestra que la función del hairpin no es detener el complejo 
de preiniciación en el codón correcto. Según el modelo de Kozak, la posición óptima 
para que un hairpin pare al ribosoma en el codón de iniciación es a 14 nt de este (Kozak, 
1991, Kozak, 1990). Sin embargo, el cambio en la posición del DSH de 24 a 15 nt 
downstream del AUGi es altamente perjudicial para su actividad (Frolov and Schlesinger, 
1996). Como hemos señalado anteriormente, la estructura del DSH es muy importante 
para la traducción del sgRNA en células de mamífero (Carrasco et al., 2018). Aunque, 
esta estructura puede sufrir algunas modificaciones muy leves y seguir manteniendo su 
función. Cabe destacar que el DSH no puede ser completamente reemplazado por otro 
hairpin nuevo, aunque presente una energía libre similar (Garcia-Moreno et al., 2015).  
Discusión 
133 
Estos descubrimientos sobre la relación entre estructura y función del DSH 
conducen a las siguientes conclusiones: la estructura del stem es importante pero no su 
secuencia; la secuencia del loop tiene un papel crucial en la función del DSH; y el DSH 
puede ser reemplazado en cierta medida por el dominio II del IRES de HCV sugiriendo 
una convergencia funcional entre ambas estructuras. A pesar de que los resultados 
expuestos permiten comprender mejor el funcionamiento del DSH de SINV, será 
necesario continuar la investigación para conocer mejor su actividad durante la 
iniciación de la traducción. 
 
2. RESPUESTA DEL RBPOMA A LA INFECCIÓN POR SINV 
Tras el estudio analítico de proteínas celulares específicas, previamente sugeridas 
como potenciales factores implicados en la traducción viral, se realizó un estudio 
exploratorio para determinar qué proteínas celulares interaccionan con los mRNAs 
virales de SINV. Como se ha podido observar, la infección por SINV induce profundos 
cambios fisiológicos en las células. Estos cambios alteran la dinámica del conjunto de 
las proteínas de unión a RNA (RBPs) celulares, el RBPoma. La detección de todas las 
proteínas de unión al RNA cuya actividad cambia durante el ciclo viral de SINV es 
esencial para determinar potenciales factores celulares que se unan a los mRNAs virales 
e intervengan en su traducción. Para identificar estas proteínas, se realizó un estudio 
exploratorio de las RBPs celulares y sus dinámicas durante la infección por SINV en las 
células de origen humano HEK293. Estas células son un buen modelo para estudiar las 
proteínas y factores implicados en el ciclo de SINV, ya que en ellas se puede observar la 
replicación viral, el shut-off de la síntesis de proteínas celulares, la alta producción de 
proteínas virales, la fosforilación de eIF2α, la formación de factorías de replicación, y la 
respuesta antiviral celular.  
La infección por SINV induce cambios en el RBPoma activo. Se detectaron 247 
RBPs que mostraban alteraciones en su actividad de unión al RNA bajo condiciones de 
infección; 133 de ellas veían su actividad de unión al RNA reducida, mientras que para 
las otras 114 era estimulada. Resulta muy interesante, que 181 del total de estas RBPs 
carecen de los dominios de unión al RNA clásicos. Este hecho parece resaltar la 
importancia del papel de RBPs no convencionales en el desarrollo de la infección viral. 
El reajuste del RBPoma durante la infección por SINV puede derivar de la pérdida masiva 
de RNA celular y la aparición de grandes cantidades de RNA viral. La inhibición de la 
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transcripción parece ser la principal responsable de la disminución de los RNAs celulares 
a las 4 hpi, mientras que, a las 18 hpi, la degradación del RNA representa más del 50% 
del cambio descrito. Pensamos que este fenómeno puede deberse a un efecto 
combinado de la reducción en la actividad transcripcional y la activación de la 
maquinaria de degradación 5’-3’ del RNA, como es el caso de la exonucleasa XRN1, 
cuya actividad se encuentra estimulada a las 18 hpi (Mukherjee et al., 2017, Gorchakov 
et al., 2005). XRN1 está ampliamente considerada como un factor antiviral que degrada 
el RNA viral (Molleston and Cherry, 2017). Aunque en algunos casos, como en los 
flavivirus, XRN1 es esencial para la formación de los sfRNAs, que interfieren con la 
respuesta antiviral de la célula (Chapman et al., 2014, Pijlman et al., 2008, Manokaran et 
al., 2015). Nuestros resultados muestran la yuxtaposición de XRN1 con las factorías de 
replicación viral, sugiriendo que esta exonucleasa podría atacar al RNA viral. Pero 
sorprendentemente, las células KO para XRN1 son refractarias a la infección por SINV, y 
las KO parciales muestran un fenotipo intermedio. Estos datos sugieren que XRN1 es 
esencial para el desarrollo de la infección por SINV. 
La remodelación del RBPoma dirigida por los cambios en la abundancia de los 
RNAs es compatible con el afinado mecanismo regulatorio que modula la actividad de 
las RBPs de forma individual. Por ejemplo, se conoce que la infección viral dispara una 
serie de vías de señalización que implican la activación de varias quinasas, E3 ubiquitin 
ligasas, isomerasas y chaperonas (Carrasco et al., 2018, Gack et al., 2007, Li et al., 2017). 
En nuestro estudio, se muestra que estas familias de proteínas están representadas 
entre las RBPs cuya actividad resultó estimulada en la infección, incluyendo SRPK1, 
TRIM25, TRIM56, PPIA y HSP90AB1. Por tanto, es plausible que el control post-
traduccional también contribuya a la regulación de las RBPs en células infectadas por 
SINV. A su vez, hemos observado que la mayoría de las RBPs cuya actividad de unión al 
RNA se ve estimulada por la infección se acumulan en las factorías de replicación junto 
al RNA viral. Por otro lado, la interacción con proteínas virales podría regular la función 
de las RBPs (Fros et al., 2012). Uno de los casos más interesantes es el de GEMIN5. 
Nuestros datos muestran que GEMIN5 interactúa con varias proteínas virales, como 
nsP1, nsP2, nsP3 y C. Esta RBP está fuertemente estimulada por la infección con SINV y 
colocaliza con los RNAs de este virus en las factorías de replicación. Además, su 
sobreexpresión causa un moderado, pero significativo, retraso en la producción de 
proteínas virales. Estas observaciones coinciden con la descripción de GEMIN5 como 
un regulador de la traducción (Francisco-Velilla et al., 2018, Pineiro et al., 2013). Además, 
la interacción de GEMIN5 con la estructura cap, la 5’-UTR, y el DSH del sgRNA de SINV 
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apoyan el modelo en el que GEMIN5 reconoce el extremo 5’ del gRNA y del sgRNA, y 
previene su traducción, interfiriendo con la función del ribosoma. Las implicaciones de 
las interacciones con elementos virales en la modulación de la función de GEMIN5 
deberán estudiarse en futuras investigaciones.  
Otro factor cuya actividad de unión al RNA se ve estimulada durante la infección 
por SINV es el eIF3, en concreto su subunidad eIF3D, que es capaz de unirse al cap (Lee 
et al., 2016) y podría sustituir al eIF4E. Lo mismo ocurre con la actividad de la helicasa 
DHX29, lo cual podría apuntar a su posible papel en la traducción de SINV sustituyendo 
al eIF4A (Skabkin et al., 2010).  
Los cambios en el RBPoma son biológicamente importantes, ya que la 
perturbación de las RBPs afecta enormemente a la infección por SINV. Por tanto, las 
proteínas que, como se ha reportado, responden a la infección por SINV tienen una 
potencial función anti- o pro-viral, posicionando a las RBPs celulares como 
prometedoras dianas para terapias antivirales. 
Algunas de las cuestiones más relevantes que se derivan de este trabajo son (1) si 
la composición de los ribosomas en células infectadas altera sus propiedades de 
traducción, (2) por qué la ausencia de la exonucleasa XRN1 convierte a la célula en 
refractaria para SINV, (3) qué dispara la degradación del RNA celular, y (4) por qué la 
transcripción inducida por la respuesta antiviral es resistente a la degradación.  
 
3. REQUERIMIENTO DE FACTORES DE INICIACIÓN PARA LA TRADUCCIÓN 
DEL IRES DE HCV 
En este trabajo doctoral también se han analizado los requerimientos de eIFs para 
la traducción de un mRNA viral que, en este caso, utiliza el elemento IRES en su 
iniciación. Este estudio se ha llevado a cabo para comparar este mecanismo de iniciación 
con el estudiado anteriormente en el sgRNA de SINV.  
Los virus animales emplean una gran variedad de mecanismos para traducir sus 
mRNAs en condiciones de estrés, evitando la respuesta antiviral de las células (Firth and 
Brierley, 2012). HCV utiliza una estructura del RNA, conocida como elemento IRES, para 
dirigir la maquinaria de traducción a una posición interna en el 5’-UTR del mRNA viral 
(Hellen, 2009, Plank and Kieft, 2012). Numerosas investigaciones continúan analizando 
el mecanismo de la traducción dirigida por el IRES de HCV y su requerimiento de eIFs. 
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Algunos autores consideran que, en condiciones normales, el mRNA de HCV inicia su 
traducción usando el complejo ternario Met-tRNAiMet-eIF2-GTP, aunque eIF2 sea 
dispensable en condiciones de estrés (Jaafar et al., 2016). No obstante, existe la 
posibilidad de que eIF2 nunca participe en la iniciación del mRNA de HCV en células 
infectadas. De hecho, la interacción del IRES de HCV con los complejos de preiniciación 
parece desplazar el eIF2 fuera de estos complejos (Jaafar et al., 2016). Por lo tanto, es 
concebible que el elemento IRES sea suficiente para iniciar la traducción sin eIF2, incluso 
cuando este factor esté activo. Por otro lado, ensayos in vitro y experimentos en cultivos 
celulares apuntan a que el eIF2A puede reemplazar al eIF2 en la traducción dirigida por 
el IRES de HCV (Kim et al., 2011). Otros estudios in vitro señalan al eIF2D como sustituto 
del eIF2 en la traducción de HCV (Dmitriev et al., 2010, Skabkin et al., 2010). Nuestros 
resultados en células humanas demuestran que ni eIF2A ni eIF2D están implicados en la 
síntesis de proteínas dirigida por el IRES de HCV, y se corresponden con el estudio 
llevado a cabo por Jaafar et al. en células de hepatocarcinoma, donde el knockdown de 
eIF2A o eIF2D tiene muy poco efecto en la traducción dirigida por IRES de HCV (Jaafar 
et al., 2016). Los datos obtenidos con siRNAs aportan información complementaria a la 
generada a partir de las líneas HAP1 KO, y ambos coinciden en que estos factores no 
participan en la traducción del HCV. Además, la posibilidad de que eIF2A pueda estar 
reemplazado por eIF2D, o viceversa, fue descartada mediante ensayos realizados con la 
línea HAP1 doble KO. En esta línea celular, el mRNA HCV-Luc se traduce eficientemente 
en las condiciones de estrés producidas por el tratamiento con arsenito sódico. Por otra 
parte, estudios enfocados en identificar los genes necesarios para la replicación de HCV 
pero dispensables para el crecimiento celular no han señalado a eIF2A ni a eIF2D como 
candidatos (Marceau et al., 2016). Tanto eIF2A como eIF2D son genes dispensables para 
la viabilidad celular, según hemos demostrado (Sanz et al., 2017). Así pues, podemos 
concluir que estos genes no participan en la traducción del mRNA de HCV, y no 
reemplazan al eIF2, ni tan siquiera en condiciones de estrés celular.  
El uso de líneas celulares KO será de gran utilidad en estudios futuros para 
descubrir el modo de iniciación y los factores requeridos para la traducción de los 
mRNAs virales. Curiosamente, a altas concentraciones de magnesio, la traducción in 
vitro del mRNA de HCV no requiere de ningún eIF (Lancaster et al., 2006). Por tanto, la 
modulación de las condiciones in vitro afecta enormemente a los requerimientos de eIFs 
en la iniciación de la síntesis de proteínas dirigida por el IRES de HCV. Por ello, 
consideramos que sería de gran relevancia científica que los experimentos in vitro que 
sugieren el requerimiento de ciertos eIFs para la traducción de un determinado mRNA 
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se pudieran contrastar con ensayos in vivo en cultivos celulares y, en este aspecto, las 
líneas KO serían herramientas de gran utilidad. 
Existe un mayor consenso científico acerca de la independencia del complejo 
eIF4F, y sus tres factores, eIF4E, eIF4G y eIF4A, para la traducción del mRNA de HCV 
(Niepmann, 2013). Debido a que este mRNA viral no presenta una estructura cap en su 
extremo 5’, resulta lógico que el eIF4E no esté implicado en su traducción. Además, 
como durante la iniciación no ocurre el mecanismo de scanning, tampoco resultaría 
necesaria la helicasa el eIF4A. En nuestro trabajo mostramos que el tratamiento con 
inhibidores selectivos de eIF4A no afecta a la síntesis de luciferasa dirigida por el IRES 
de HCV presente en un mRNA monocistrónico, que contiene la región 3’-UTR de HCV, 
transfectado en células humanas de origen hepático. Por lo tanto, nuestros resultados 
con hipp y Pat A demuestran que el eIF4A no participa en el proceso de iniciación. Esto 
está en concordancia con las observaciones previas que mostraban que estos 
inhibidores no bloquean la traducción dirigida por el IRES de HCV en mRNAs 
dicistrónicos (Bordeleau et al., 2006, Low et al., 2007). Estas observaciones, junto con el 
descubrimiento de que eIF4G se encuentra localizado en los SGs tras el tratamiento con 
arsenito sódico, son consistentes con la idea de que el complejo eIF4F no participa en 
la traducción del mRNA de HCV. 
Posiblemente, el aspecto más importante para ser clarificado en la iniciación de la 
síntesis de proteínas dirigida por el IRES de HCV es determinar si el eIF2 está implicado 
en condiciones en las que no haya estrés celular. Experimentos in vitro han demostrado 
que el IRES de HCV puede interaccionar directamente con la subunidad 40S ribosómica 
sin eIFs, y que después, puede reclutar al eIF3 y al complejo ternario con eIF2 (Ji et al., 
2004, Otto and Puglisi, 2004). La interacción del IRES de HCV con la subunidad 40S o el 
ribosoma 80S lleva a la remodelación de su estructura. De esta forma, el dominio II 
queda unido al sitio de salida del tRNA, mientras que el dominio III se posiciona con el 
codón de iniciación en la cabeza de la subunidad pequeña ribosómica (Boehringer et 
al., 2005). Se ha observado que subunidades ribosómicas 40S marcadas con 
fluorescencia en su proteína RPS25 se unen de manera irreversible al IRES de HCV, 
provocando reajustes conformacionales del dominio II, que se encuentra estabilizado 
por proteínas celulares aún por identificar (Fuchs et al., 2015). Sin embargo, se 
desconoce si, en condiciones fisiológicas sin estrés, el mRNA de HCV interactuaría con 
la subunidad 40S, o más probablemente con los complejos de preiniciación que podrían 
contener ya varios eIFs, como eIF3 y eIF1A (Jaafar et al., 2016). La unión del IRES a los 
complejos de preiniciación en células sin condiciones de estrés puede desplazar el eIF2 
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mediante la interacción del dominio II con la subunidad 40S (Locker et al., 2007). De 
hecho, los sitios de unión al dominio II y al complejo ternario solapan de tal forma que 
la interacción de los dos sobre la subunidad 40S interferiría entre sí (Jaafar et al., 2016). 
Es posible que el dominio II del IRES de HCV reemplace funcionalmente al complejo 
ternario sin la necesidad de otros factores celulares como el eIF2A o el eIF2D, incluso 
en condiciones fisiológicas sin estrés. De hecho, el dominio II adopta una estructura en 
forma de “L” e interacciona con la subunidad 40S en la región de la cabeza del sitio E, 
permitiendo que el loop apical del dominio II pueda penetrar profundamente en la 
hendidura del mRNA cerca de la región codificante en el sitio P del ribosoma (Spahn et 
al., 2001, Lukavsky et al., 2003). Por tanto, el IRES podría ser capaz de reemplazar el 
complejo ternario y, tras la formación del ribosoma 80S, el sitio P estaría ocupado, 
dejando el sitio A libre para que se posicione el AUGi y comenzar la traducción. Este 
modelo es parecido al descrito para el funcionamiento del IRES de CrPV, con la 
excepción de que eIF3 sí está implicado en la traducción de HCV (Jan and Sarnow, 2002, 
Fernandez et al., 2014).  
La función exacta del eIF2A o del eIF2D durante la traducción de los mRNAs 
celulares permanece desconocida. La generación de un ratón KO para eIF2 claramente 
demuestra que este factor no es requerido durante la embriogénesis, ni tampoco está 
implicado en la traducción de mRNAs específicos de tejido (Golovko et al., 2016). El 
reciente descubrimiento de que el eIF2A participa en la tumorogénesis hace que el 
estudio de este factor sea especialmente relevante (Sendoel et al., 2017). Sin embargo, 
eIF2A es probablemente requerido para otras funciones adicionales en la célula aparte 
de su implicación en la progresión del cáncer. El uso de líneas celulares humanas KO 
como las empleadas en nuestros trabajos, puede ayudar a mejorar nuestro 
entendimiento del eIF2A y del eIF2D en la traducción. Como se ha observado 
recientemente (Sanz et al., 2017, Gonzalez-Almela et al., 2018), estos dos factores no son 
necesarios para la traducción global de mRNAs celulares ni para la síntesis de luciferasa 
dirigida por los IRES de HCV, EMCV o CrPV. Futuros estudios dirigidos a analizar el 
comportamiento de mRNAs celulares especializados en estas líneas KO ayudarán a 
averiguar la función de eIF2A y eIF2D en células de mamífero.  
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CONCLUSIONS 
 
1. Pateamine A strongly blocks the synthesis of SINV nsPs at early times post infection 
in an irreversible manner and therefore, SINV gRNA requires the eukaryotic initiation 
factor eIF4A for translation. 
2. SINV sgRNA is resistant to pateamine A inhibition at late times of infection but it is 
sensitive to pateamine A in transfected cells or in cell-free systems, indicating that 
this viral mRNA exhibits a dual mechanism for translation. Consequently, the structure 
of sgRNA is not the only element involved in the independence from several eIFs. 
3. The eukaryotic factors eIF2A and eIF2D are not required for SINV gRNA and sgRNA 
translation when eIF2α is phosphorylated. They are not necessary either for global 
translation of cellular mRNAs or for luciferase synthesis directed by EMCV or CrPV 
IRESs. 
4. SINV sgRNA can initiate translation in non-AUG codons, such as CUG, in a mechanism 
dependent on the downstream stable hairpin (DSH) element but independent of 
eIF2, eIF2A or eIF2D. 
5. The structure, but not the sequence, of the stem region of the SINV DSH, and the 
sequence of its loop play important roles in the function of this hairpin. DSH can be 
replaced to some extent by domain II of the HCV IRES. 
6. SINV infection induces changes in the active RBPome: 247 RNA binding proteins 
(RBPs) display differential interaction with RNA, and 181 of these lack classical RNA 
binding domains. These alterations are mainly driven by the loss of cellular mRNAs 
and the emergence of viral RNA. 
7. The RNA binding activity of the RBPs eIF3D, DHX29, PPIA, SRPK1, XRN1, TRIM25, 
TRIM56, GEMIN5 is stimulated upon SINV infection. These RBPs are located in close 
proximity to SINV replication factories. SINV fitness seems to benefit from the activity 
of IRE1α, tRNA-ligase complex (TRLC), HSP90AB1, PA2G4 and SRPK1, but TRIM25, 
TRIM56 and GEMIN5 hamper the infection. Interestingly, XRN1 is essential for SINV 
infection. 
8. The initiation factors eIF2, eIF2A, eIF2D, eIF4A, and eIF4G are not involved in 
translation driven by HCV IRES in human cells. 
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Abstract: Sindbis virus (SINV) contains an RNA genome of positive polarity with two open
reading frames (ORFs). The first ORF is translated from the genomic RNA (gRNA), rendering the
viral non-structural proteins, whereas the second ORF is translated from a subgenomic mRNA
(sgRNA), which directs the synthesis of viral structural proteins. SINV infection strongly inhibits
host cell translation through a variety of different mechanisms, including the phosphorylation of the
eukaryotic initiation factor eIF2α and the redistribution of cellular proteins from the nucleus to the
cytoplasm. A number of motifs have been identified in SINV sgRNA, including a hairpin downstream
of the AUG initiation codon, which is involved in the translatability of the viral sgRNA when eIF2
is inactivated. Moreover, a 3′-UTR motif containing three stem-loop structures is involved in the
enhancement of translation in insect cells, but not in mammalian cells. Accordingly, SINV sgRNA
has evolved several structures to efficiently compete for the cellular translational machinery.
Mechanistically, sgRNA translation involves scanning of the 5′-UTR following a non-canonical
mode and without the requirement for several initiation factors. Indeed, sgRNA-directed polypeptide
synthesis occurs even after eIF4G cleavage or inactivation of eIF4A by selective inhibitors. Remarkably,
eIF2α phosphorylation does not hamper sgRNA translation during the late phase of SINV infection.
SINV sgRNA thus constitutes a unique model of a capped viral mRNA that is efficiently translated
in the absence of several canonical initiation factors. The present review will mainly focus in the
non-canonical mechanism of translation of SINV sgRNA.
Keywords: regulation of translation; alphaviruses; initiation factors; RNA structure; IRES
1. Introduction
Sindbis virus (SINV) belongs to the alphavirus genus in the Togaviridae family and contains
a positive-strand RNA genome [1]. The alphavirus genus comprises ~30 virus species that are
transmitted by arthropods, typically mosquitoes, to a range of vertebrate hosts [2]. Exceptions to
this rule are the aquatic viruses salmonid alphavirus and Southern elephant seal virus, which are not
transmitted by mosquitoes. In addition, Eilat virus can replicate only in insects [3]. Alphaviruses
and their genetic variants have a very broad geographical distribution, indicating an ancient origin
and evolution [4,5]. Alphaviruses can be subdivided into two groups according to their geographical
origin—Old World viruses and New World viruses. Examples of Old World alphaviruses include
Semliki Forest Virus (SFV), Chikungunya virus (CHIKV), Ross River virus (RRV) and O’nyong’nyong
virus (ONNV), whereas New World alphaviruses are represented by SINV, Venezuelan, Western
and Eastern equine encephalitis viruses (VEEV, WEEV and EEEV) [2]. In mammals, alphaviruses
typically cause an acute infection, leading to a variety of symptoms and illnesses that are dependent
on the virus and host [1], including encephalitis, polyarthritis, myalgia, athritis and rash. By contrast,
insects survive the acute phase of infection and become persistently infected for life without apparent
Viruses 2018, 10, 70; doi:10.3390/v10020070 www.mdpi.com/journal/viruses
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pathological consequences [6,7]. Although, some mosquito cells infected with SINV can die in culture
in a cell clone specific manner [6]. SINV and SFV have been widely used in the laboratory as model
systems to study protein synthesis, transcription and replication at the molecular level, and to understand
viral pathogenesis and the interaction of these viruses with their hosts. In this regard, fundamental
aspects of translation regulation in virus-infected cells have been uncovered using SINV and SFV.
Moreover, the mechanisms of protein synthesis directed by SINV mRNAs are helping to shed light
on the structure-function relationship of viral mRNAs. From a practical viewpoint, SINV has been
employed in fields as diverse as cancer therapy and has aided in the understanding of the adaptive
antiviral response [8,9]. In the current review, we will summarize what is known about the mechanisms
of translation of SINV mRNAs, with a focus on the initiation events of non-canonical translation of
subgenomic mRNA (sgRNA).
2. Overview of the Sindbis Virus Life Cycle
The SINV virion is approximately 70 nm in diameter and has a single-strand 11.7 kb RNA
genome contained within an icosahedral-structured nucleocapsid made up of 240 copies of capsid
protein [10,11]. This is enveloped by a host-derived lipid bilayer membrane into which are embedded
viral-encoded glycoproteins E1 and E2. SINV replication occurs in the cytoplasm of infected cells
and begins by the recognition of receptors at the cell surface. These receptors include the laminin
receptor in mammalian cells, the C-type lectins DC-SIGN and L-SIGN in dendritic cells and the metal
ion transporter NRAMP (Natural Resistance-Associated Macrophage Protein), expressed both in
mammalian and insect hosts [12–14]. After entry, virus particles can follow different pathways to
reach the cytoplasm, the most relevant of which is the endocytosis mediated by clathrin. Following
endocytosis, virions are delivered into acidic endosomes from which, after fusion of the virus and
endosome membranes, the positive-sense RNA genome is delivered into the cytoplasm [15–17]. Virions
can also enter cells by directly penetrating the plasma membrane [18]. Efficient infection requires that
the genome maintains interactions with the capsid protein after genome delivery to the cytoplasm [19].
The arrival of the SINV genome RNA to the cytoplasm can specifically activate the protein kinase
general control nonderepressible-2 (GCN2), triggering an early antiviral response [20]. The SINV
genome contains two open reading frames (ORFs) that are expressed from two different mRNAs
that are translated at different times during the infection process—-the genomic RNA (gRNA) and
the sgRNA (Figure 1). The gRNA comprises the proximal two-thirds of the genome at the 5′ end,
and serves as mRNA for the synthesis of non-structural proteins (nsPs), whereas the more distal
one-third sgRNA encodes for structural proteins (Figure 1). The gRNA is translated promptly after
virus entry and genome delivery, whereas the sgRNA is translated at late phases of infection [21].
Both gRNA and sgRNA are capped at their 5′ ends and contain a poly(A) tail at the 3′ end. Interestingly,
a portion of gRNAs do not contain a cap structure at their 5′ end [22]. The first event in SINV replication
is the translation of the imput gRNA to produce nsP1–4, which participate in genome replication and
transcription [11]. These nsPs are synthesized from a single AUG initiation codon initially producing
two precursor polyproteins (P123 and P1234), which are then post-translationally processed through
proteolytic cleavage by nsP2 [23–26] (Figure 1). After initiation at the first AUG initiation codon
in gRNA, the majority of ribosomes (90–95%) translate this template until a stop codon (UGA) is
encountered, producing the first of the two precursor polyproteins, P123 [27]. In a small proportion
of cases, however, there is read-through of this stop codon, which can be suppressed by several
aminoacyl-tRNAs, generating the second precursor polyprotein, P1234. The precise function of the
individual nsPs has been the subject of intensive research [24–26,28]. nsP1 is a palmitoylated protein
that comprises an abundant component of the replicative complex and can interact with membranes.
It functions in the initiation and elongation of the minus-strand RNA synthesis via its interaction
with nsP4 [29,30]. The N-terminal moiety of nsP1 exhibits methyltransferase and guanylyltransferase
activities, which are involved in capping the viral positive-strand RNAs [31–33]. Its association with
cellular membranes is promoted by an amphipatic helix located in the middle region of nsP1 [33],
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which serves to anchor viral replicative complexes to membranes [34]. In addition, nsP1 can exhibit its
activity either as a mature protein or in the form of the precursors P123 or P1234. nsP2 also contains
several domains—an amino-terminal RNA helicase domain, a central protease region that catalyzes all
cleavage reactions between the non-structural proteins, and an inactive RNA methyltransferase-like
moiety [35,36]. nsP2 also functions in the obstruction of host cellular macromolecular synthesis,
such as transcription and translation, and can accordingly antagonize cellular antiviral responses
triggered by alphavirus infection [37,38]. Indeed, a fraction of nsP2 localizes to the nucleus and blocks
cellular RNA export to the cytoplasm [38,39]. Moreover, nsP2 induces degradation of Rpb1, a catalytic
subunit of the RNA polymerase II polymerization complex, mediated by its ubiquitination [40].
nsP3 is also organized into three domains—an amino-terminal macro or X domain [41], a central
alphavirus-specific region, and a carboxyl region with a hypervariable sequence containing several
phosphorylation sites [42]. nsP3 residues located after the macro domain participate in the positioning
of the P23 cleavage site [43]. nsP3 interferes with the formation of host cellular stress granules (SGs),
which are involved in innate antiviral mechanisms, through the interaction of its carboxy-terminal
domain with Ras-GTPase activating protein (GAP)-binding protein (G3BP) [44,45]. Finally, nsP4 is
an RNA-dependent RNA polymerase involved in the synthesis of the different viral RNAs—namely,
gRNA, sgRNA and minus-strand RNA complementary to the genome [46,47]. Preferential synthesis of
the negative strand of viral RNA is accomplished by P123 + nsP4 complex, whereas nsP1 + P23 + nsP4
complex synthesize both positive and negative sense strands [48,49]. Fully mature nsPs are produced
after the final cleavage event of P23, which switches the RNA template for synthesis of positive sense
genomic and subgenomic RNAs.
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Figure 1. Schematic representation of the synthesis of SINV non-structural and structural proteins.
SINV has two different mRNAs that are translated at different times during infection. SINV genomic
RNA (gRNA) codes both for non-structural proteins (nsPs) and structural proteins. The first two
thirds of the SINV genome is translated to nsP1–nsP4, which are required for transcription and
replication of SINV RNA; the remaining one-third of the genome codes for the viral structural proteins.
This ubgenomic mRNA (sgRNA) is transcribed from an internal prom ter in the minus strand RNA
derived from the replication of the gRNA, and is t anslated to a polyprotein that will be processed to C
(capsid)-E3-E2-6K-E1. ORF: open reading frame.
Overall, SINV gRNA participates in three different functions: (1) As an mRNA to direct the
synthesis of early viral nsPs; (2) as a template for the synthesis of the negative-strand RNA; and (3) by
interacting with the capsid protein, it helps forming nucleocapsids during the assembly process to
produce w virus particles. Fur hermore, the negative-strand RNA serves as template to synthesize
the two different viral mRNAs by the viral replicative machinery [49,50]. In SFV, genomi and negative-
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strand synthesis takes place within structures referred to as spherules, which are bulb-shaped
invaginations of the membrane of virus–modified endosomes known as type I cytopathic vacuoles
(CPV-1), which are induced after infection [34,51]. These spherules contain the replicative complexes
and their size depends on the length of the replicated RNA [52,53]. Thus, the synthesis of viral
RNAs in cytoplasmic RNA viruses takes place in close association with the cellular membranes [54,55].
The synthesis of cleavage intermediates of the alphavirus replicase can lead to membrane invaginations
in the absence of viral replication. Thus, the formation of membranous spherules can occur in the
absence of viral RNA synthesis [56]. Therefore, partially cleaved replicase proteins can participate
in the assembly of replication complexes, membrane deformation, and in different stages of viral
RNA synthesis. Analysis of the proteome of these replicative complexes has led to the identification
of a number of cellular proteins that can up- or down-regulate their activity on RNA synthesis [57].
A number of host cellular factors can interact with nsPs, as has been shown for nsP2 and nsP3, and can
modulate SINV RNA replication [58]. The recognition of an internal promoter in the negative strand
RNA that is complementary to the gmRNA is necessary to initiate synthesis of sgRNA. This sgRNA is
the most abundant SINV mRNA during the late phase of infection and directs the synthesis of five
structural proteins initially as a polyprotein, C-E3-E2-6K-E1. Translation of this sgRNA is coincident
with the dramatic inhibition of cellular mRNA translation.
The first protein to be synthesized during sgRNA translation is the capsid (C) protein, which is
autocatalytically cleaved off the nascent chain upon translation of the polyprotein on the polysomes [11]
(Figure 2). The C protein then binds to gRNA to form nucleocapsids in the cytoplasm. The amino-
terminus of the E3 glycoprotein contains the signal peptide, which interacts with membranes of the
endoplasmic reticulum (ER), and the polyprotein is translocated to the lumen. Here, it is cleaved
by host cellular proteases, including furin and signalase, to render E3, E2, 6K and E1 proteins [59].
Some years ago, a heptanucleotide slip site (UUUUUUA) was discovered within the gene encoding
6K that, in about 10% of cases, results in the ribosome shifting to the −1 reading frame, rendering
a novel transframe form (TF) of 6K and the E1 protein is not translated on these ocassions [60,61].
E2 and E1 interact with one and other to form dimers that migrate to the plasma membrane, leaving
their carboxy-termini at the cytoplasmic face of the membrane. Nucleocapsids containing one copy
of the genome interact with the cytoplasmic tails of viral glycoproteins to promote the budding of
new virus particles [62]. At only 55 amino acids in size, the SINV 6K protein belongs to the viroporin
family of proteins and is palmitoylated, helping it to target membranes [63–67]. The 6K protein
is also involved in the transport of viral glycoproteins through the vesicular system to the plasma
membrane [68,69]. As occurs with most viroporins, virus budding is promoted by 6K, but it is largely
excluded from virions and is only detected in low amounts in mature virus particles [66,70]. By contrast,
the transframe protein is apparently preferentially incorporated into released virions [71].
Viruses 2018, 10, 70 5 of 28
Viruses 2018, 10, x FOR PEER REVIEW  5 of 27 
 
 
Figure 2. Schematic representation of SINV sgRNA translation to render structural proteins C 
(capsid)-E3-E2-6K-E1. The sgRNA coding sequence is flanked by two untranslated regions (UTRs): 
5′-UTR, which contains a cap structure at its 5′ end, and 3′-UTR, which ends in a poly-(A) tail. The 
structural proteins are initially synthesized as a polyprotein. Ribosomes scan the capped sgRNA up 
to the first AUG and translation begins. First, C is synthesized and released from the polyprotein by 
autoproteolysis. The new N-terminus of the nascent polyprotein chain has a signal peptide for 
translocation to the endoplasmic reticulum (ER). Translation of the sgRNA continues, associated with 
the ER membranes, giving rise to the synthesis of the three glycoproteins E3, E2 and E1 and the 
viroporin 6K. The pE2 glycoprotein is synthesized across the ER membrane, where a carbohydrate 
attachment site may be responsible for the retention of the signal sequence in E2. The translocation of 
the glycoproteins across the ER membrane is regulated by various signal sequences. The 
glycoproteins and 6K are processed and cleaved by cellular proteases of the host vesicular system. 
Once the pE2–E1 heterodimer complex reaches the trans-Golgi, pE2 is cleaved by furin to form E3 
and E2. The cleavage of pE2 is required to generate infectious particles. 
Figure 2. Schematic representation of SINV sgRNA translation to render structural proteins C
(capsid)-E3-E2-6K-E1. The sgRNA coding sequence is flanked by two untranslated regions (UTRs):
5′-UTR, which contains a cap structure at its 5′ end, and 3′-UTR, which ends in a poly-(A) tail.
The structural proteins are initially synthesized as a polyprotein. Ribosomes scan the capped sgRNA
up to the first AUG and translation begins. First, C is synthesized and released from the polyprotein
by autoproteolysis. The new N-terminus of the nascent polyprotein chain has a signal peptide for
translocation to the endoplasmic reticulum (ER). Translation of the sgRNA continues, associated with
the ER membranes, giving rise to the synthesis of the three glycoproteins E3, E2 and E1 and the
viroporin 6K. The pE2 glycoprotein is synthesized across the ER membrane, where a carbohydrate
attachment site may be responsible for the retention of the signal sequence in E2. The translocation of
the glycoproteins across the ER membrane is regulated by various signal sequences. The glycoproteins
and 6K are processed and cleaved by cellular proteases of the host vesicular system. Once the pE2–E1
heterodimer complex reaches the trans-Golgi, pE2 is cleaved by furin to form E3 and E2. The cleavage
of pE2 is required to generate infectious particles.
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3. Inhibition of Host Translation by SINV Infection
Most cytolytic animal viruses induce a profound suppression of cellular protein synthesis in
infected cells, particularly during the late phase of infection [72]. This inhibition would thus clearly
interfere with the innate immune system and hence with the antiviral response [73]. This is the
case for SINV, which blocks cellular translation in order to get the protein synthesizing machinery
preferentially dedicated to translate the sgRNA, usually in a short time after infection (in BHK cells
it occurs approximately 3 h after virus entry) but this process is dependent on cell line. A strong
inhibition of host protein synthesis is found in vertebrate cells, but curiously, it is not observed when
SINV infects mosquitos [74,75]. Therefore, it is likely that cellular and viral mRNAs are translated by
different mechanisms. Although it is believed that gRNA is translated by a mechanism similar to that
used for host mRNAs, we are still largely ignorant of the precise eukaryotic initiation factors (eIFs)
necessary to initiate translation of SINV gRNA. In principle, both cellular and gRNA translation is
down regulated at late phases of infection, when sgRNA directs the synthesis of structural proteins
very efficiently [11]. The vast majority of cellular mRNAs contain a blocked cap structure at their 5′ end
and are translated by the canonical cap-dependent scanning mechanism. This involves recognition of
the cap by the heterotrimeric factor eIF4F, followed by the interaction of the preinitiation 43S complex
with the mRNA [76]. The eIF4F complex is composed of the cap-binding factor eIF4E, the helicase and
ATPase enzyme eIF4A, and the scaffolding protein eIF4G [77]. Unwinding of the secondary structure
present in the mRNA leader sequence is accomplished by the preinitiation complex together with
eIF4AI or eIF4AII, which are functionally interchangeable isoforms with 90% similarity [78]. After RNA
unwinding, the 40S ribosomal subunit containing several eIFs linearly scans the leader sequence until
an AUG codon is encountered in a good context [79]. Initiation of translation can also occur by other
mechanisms independent of cap recognition, such as internal initiation. In this case, initiation takes
place at an internal sequence located at the 5′ untranslated region (5′-UTR) of the mRNA, known as the
internal ribosome entry site (IRES) [80,81]. Yet another mechanism of translation has been observed
with SINV sgRNA, which contains a cap structure and is translated by a scanning mechanism of its
rather short leader sequence without the participation of crucial eIFs such as eIF2 or eIF4A [82].
3.1. Mechanisms of Inhibition of Cellular Protein Synthesis by SINV Infection
Distinct mechanisms have been suggested to account for the abrogation of cellular protein
synthesis by alphaviruses: (1) The phosphorylation of the α-subunit of eIF2; (2) Competition of
viral mRNAs for the host translational machinery; and (3) Modifications of the cytoplasmic ionic
environment. eIF2 plays a central role in mRNA translation and binds Met-tRNAiMet and GTP to form
a ternary complex that interacts with the AUG initiation codon and delivers the initiator Met-tRNAiMet
to the P site of the 40S ribosomal subunit. This event triggers GTP hydrolysis and eIF2-GDP is released
to the cytoplasm to be recycled to eIF2-GTP by eIF2B. Phosphorylation of the α-subunit of eIF2 at serine
51 renders this factor inactive because it forms a stable complex with eIF2B and no recycling between
GDP and GTP takes place [83,84]. Since the amount of eIF2B is about 10–20-fold less than eIF2, even a
low percentage of eIF2α phosphorylation is sufficient to block the initiation of translation. eIF2 plays
an important role in sensing metabolic status and cellular stress and, consequently, its activity is highly
regulated by four known protein kinases that respond to distinct stress stimuli—protein kinase R
(PKR) is activated by double-stranded RNA (dsRNA), PKR-like ER kinase (PERK) senses unfolded
proteins in the ER, and GCN2 and heme-regulated inhibitor (HRI) are activated by nutrient starvation
and heme deficiency, respectively [85].
SINV infection induces the phosphorylation of eIF2α in mammalian cells, which leads to an
inhibition of host mRNA translation [86–89]. This is due to the activation of PKR by the synthesis of
viral dsRNA in the cytoplasm [90]. Nevertheless, SINV infection of cells deficient in PKR, such as
PKR−/− murine embryonic fibroblasts (MEFs), also produce this blockade despite the fact that no
increased eIF2α phosphorylation is observed [87,90]. Moreover, SFV infection can reduce the levels
of phosphorylated eIF4E, the cap binding protein of the eIF4F complex; however, the significance of
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this finding is not clear [91]. It is possible that the lack of functionality of the eIF4F complex during
infection leads to eIF4E inactivation.
The possibility that the translational efficiency and the quantity of sgRNA play a role in the
inhibition of host protein synthesis has also been proposed [92]. Under this scenario, sgRNA would
compete with cellular mRNAs for the translational machinery, which is logical since sgRNA is
abundantly transcribed at late phases of infection and it is also efficiently engaged in translation [11].
However, SINV replicons encoding only for nsPs and lacking the coding sequences for sgRNA still
induce a profound inhibition of cellular protein synthesis comparable to that observed in cells infected
with wild-type virus [93,94]. Thus, in the absence of the synthesis of structural proteins directed by
sgRNA, there remains a drastic suppression of host translation, pointing to the idea that competition is
not necessary for this process. It is possible that the presence of abundant SINV mRNA sequences can
interfere with host macromolecular synthesis, without participating directly in translation (see below).
This type of competition may reflect the interaction with some cellular proteins by specific sequences
of SINV mRNA, even in the absence of sgRNA translation. The imbalance of ionic concentrations in
the cytoplasm of infected cells has been also implicated in the shut-off of host translation by several
viruses, including SINV [95,96]. Indeed, at late stages of SINV or SFV infection, the ionic content
of the cytoplasm is dramatically altered and plasma membrane permeability is increased [97,98].
This modification of the membrane is carried out by the 6K protein, which forms ion channels [66]. Yet,
replicons that encode only for the capsid protein or for any structural protein fail to modify membrane
permeability but still arrest cellular mRNA translation [88,94]. Overall, these observations suggest that
SINV employs additional mechanisms to obstruct cellular protein synthesis.
3.2. Involvement of nsP2 in Host Translation Shut-Off
Because alphavirus replicons encoding solely nsPs obstruct cellular translation to a degree similar
to that observed with wild-type virus, it was speculated that the synthesis of one of the nsPs was
responsible for this inhibition [93]. Indeed, analysis of a number of alphavirus nsP variants pointed to
nsP2 as being chiefly responsible for the inhibition of cellular macromolecular synthesis upon viral
infection [37,90,99]. Accordingly, SINV with a single nsP2 point mutation at proline 726 presented
defects in host translational shut-off [100]. Overall, these observations are consistent with the concept
that nsPs are necessary to trigger the shut-off of host protein synthesis. However, mutations in the
5′-UTR sequence of SINV sgRNA leading to higher than wild-type levels of nsP2 were found to prevent
the inhibition of host protein synthesis [92]. To reconcile these conflicting findings, we examined
the inhibition of cellular mRNA translation mediated by individual nsPs and also by nsP1–4 [75].
We found that individual expression of nsP1, nsP2 and nsP3, or nsP1–4 had little effect on cellular
protein synthesis. Of note, when nsP1–4 is expressed, not only are mature nsPs synthesized, but also
their precursors, which is more akin to the situation observed in SINV-infected cells. As a control for
these experiments, we expressed poliovirus (PV) 2Apro, which induces a profound arrest of cellular
mRNA translation upon cleavage of eIF4G [101]. This result is in clear contrast to that found with SINV
nsPs. Thus, the sole expression of nsPs is not sufficient to block cellular protein synthesis, and instead
the strong replication of viral RNAs in the cytoplasm may be responsible for triggering this inhibition.
In support of this concept, cellular shut-off does not occur in presence of inhibitors that reduce viral
RNA replication [75]. Thus, treatment of SINV-infected baby hamster kidney (BHK) cells with two
nucleoside analogs, 6-aza-uridine or ribavirin, prevents the inhibition of cellular protein synthesis
even though sgRNA translation is still apparent. This prevention is not due to the inhibition of eIF2α
phosphorylation, as it is also observed in PKR−/− MEFs, which do not phosphorylate eIF2α after
SINV infection.
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3.3. Redistribution of Cellular Proteins between the Nucleus and Cytoplasm. A Proposal for the Mechanism of
Cellular Translation Shut-Off
Several animal viruses provoke the relocalization of nuclear proteins to the cytoplasm as part of
the cellular response to viral infection, leading to the formation of SGs [73,102]. Because a number
of components that participate in protein synthesis are recruited to SGs, some viruses have evolved
mechanisms to disrupt the formation of these inclusion bodies. Accordingly, SINV blocks SG
formation by the interaction and complex formation of nsP3 with Ras-GTPase-activating protein
SH3 domain-binding protein-1 (G3BP) [44,45]. Many of the nuclear proteins that are relocated to the
cytoplasm after SINV or SFV infection are RNA-binding proteins (RBPs) and could directly interact
with viral mRNAs, as has been found for T-cell restricted intracellular antigen-1 (TIA-1), heterogeneous
nuclear ribonucleoprotein (hnRNP) A1, hnRNP K, hnRNP I, hnRNP M, polypyrimidine tract binding
protein (PTB) or the ELAV RNA-binding protein HuR [75,86,103–106]. Indeed, HuR strongly interacts
with the 3′-UTR of SINV and SFV mRNAs and participates in the regulation of their translation,
transcription and replication [107]. Interestingly, sequences located at the 3′-UTR of SINV mRNAs are
high-affinity binding sites for HuR, functioning with a “sponge”-like activity [108]. This sequestration
of HuR on the cytoplasmic sgRNA has profound consequences for several cellular functions on host
mRNAs, such as mRNA splicing, stability and decay.
As mentioned earlier, one plausible hypothesis to explain the shut-off of host translation is that
viral RNA replication leads to high levels of viral sequences in the cytoplasm, that in turn induce the
redistribution of nuclear proteins and the subsequent inhibition of protein synthesis. We found that
the exit of nuclear proteins, including TIA-1 and PTB, is clearly detected in SINV-infected cells, but not
upon the individual expression of nsPs or when viral RNA replication is reduced [75]. Moreover,
the infection of BHK cells with the nsP2 P726G point mutation SINV variant, which exhibits defects
in the shut-off of host protein synthesis, revealed that both viral RNA replication and the release
of nuclear proteins to the cytoplasm are greatly inhibited. Thus, robust viral RNA replication must
occur for the inhibition of cellular protein synthesis to proceed. Although this inhibition can take
place via redundant mechanisms, such as redistribution of nuclear proteins, modification of eIFs,
ionic imbalance or mRNA competition, it is probable that one of the most important factors to explain
this event is the re-localization of nuclear proteins. In this regard, it is important to consider that
a single viral protein that profoundly inhibits cellular translation, PV 2Apro, substantially modifies
the shuttling of proteins between nucleus and cytoplasm. This viral protease not only cleaves eIF4G,
but also several nuclear pore proteins (nuPs), disrupting the trafficking of proteins between nucleus
and cytoplasm [109–113]. Based on this evidence, we propose that SINV replication leads to high
levels of viral mRNAs in the cytoplasm that in turn modify the location of cellular proteins, triggering
the blockade of host protein synthesis [75,92,108]. This can be accomplished either by the release
of proteins that interact with cellular mRNAs or by sequestering components necessary for cellular
translation on viral mRNAs due to their “sponge”-like activity [108]. Future characterization of the
precise proteins that interact with viral and cellular mRNAs at late stages of infection in SINV infected
cells should shed more light on this inhibition.
4. Structure of SINV sgRNA
A number of elements have been identified in sgRNA that make it particularly efficient for
translation during infection (Figure 3). The SINV sgRNA is 4105 nucleotides (nt) in length without
the poly(A) tail, and devotes the bulk of its sequence (3738 nt) to encode the structural polyprotein
C-E3-E2-6K-E1. The coding sequence is flanked by two UTRs [114]. The 5′-UTR (49 nt) represents the
leader sequence and contains a cap structure at its 5′ end. The 3′-UTR (323 nt) is organized in three
different domains. In addition to the aforementioned 5′-and 3′-UTR, a hairpin (stem-loop) structure is
present in the coding sequence at 77–139 nt from the 5′ end, which also participates in the translation
of SINV sgRNA in infected cells.
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Figure 3. Some structural features of SINV mRNAs. (A) Secondary structure of the 5′-UTR and 3′-UTR
regions of SINV gRNA and sgRNA. The 5′-UTR + 96 nt ORF of sgRNA include the downstream stable
hairpin (DSH) from 77 to 139 nt. 5′-UTR gRNA has a free energy of the thermodynamic ensemble
is −7.77 kcal/mol. 5′-UTR + 96 nt ORF sgRNA has a free energy of the thermodynamic ensemble
is −60.31 kcal/mol. 3′-UTR has a free energy of the thermodynamic ensemble is −90.54 kcal/mol.
These structures were obtained by The Vienna RNA Website. Nucleic Acids Res. 2008 (website tool: http://
rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi) and are colored by base-pairing probability.
AUG start codons are shown surrounded by black boxes. Black arrows indicate the 5′ end of each
RNA secondary structure. The three stem-loops at the 3′-UTR structure are highlighted within circles;
(B) secondary structure of HCV Domain II and SINV DSH where similarity of the loops is marked in
red; (C) schematic representation of SINV gRNA, sgRNA and the constructions encoding luciferase:
(replicon) rep C+Luc and sgRNA C+Luc; (D) schematic representation of SINV construct containing
the leader sequence of sgRNA replaced by an IRES element followed by the luciferase gene and the
sgRNA synthesized from it. IRES: internal ribosome entry site.
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4.1. The 5′-UTR of SINV sgRNA
Although the 5′-UTR leader sequence is rather short, it contains several motifs that are significantly
implicated in different replicative functions, including transcription, translational shut-off, and viral
pathogenesis (Figure 3A). The leader sequence contains a type 0 cap structure (N7mGppp) at its
5′-end, promoting RNA stability [114]. This leader sequence confers eIF4F complex-independence
and is implicated in the inhibition of host translation [92,115]. Sequences in the negative-strand RNA
complementary to the first 1–10 nt of the leader sequence are involved in promoter recognition and in
the efficient transcription of sgRNA [114]. A SINV variant bearing a deletion of nucleotides 11–20 was
found to be deficient for sgRNA transcription and failed to efficiently shut-off host cell translation,
although it synthesized high levels of nsP2 [92]. By contrast, a revertant virus bearing a duplication of
the promoter sequences was found to produce wild-type levels of sgRNA, and efficiently inhibited
host translation. Accordingly, it has been postulated that this 11–20 nt region is necessary to interact
with a cellular factor, which enhances viral translation and competes with cellular mRNAs [92].
The mechanism of the initiation of sgRNA translation and the selection of the AUG initiation
codon have been studied in depth. Accordingly, sgRNA is translated via a scanning mechanism as the
presence of a hairpin structure before the initiation codon hampers protein synthesis directed by this
mRNA [82]. For this scanning process to occur, recognition of the cap structure by eIF4E is likely not
necessary because cleavage of eIF4G by PV 2Apro or human immunodeficiency virus (HIV) protease
does not impede sgRNA translation in SINV-infected cells [88,115]. Moreover, this scanning on sgRNA
takes place by a unique mechanism because it does not require some crucial initiation factors such as
eIF2 and eIF4A [82].
4.2. The Hairpin Structure in the Coding Region of sgRNA
Early studies identified sequences in the coding region of the SINV capsid protein that enhanced
the translation of sgRNAs [116,117]. Prediction of a stem-loop structure in these sequences indicated
the presence of a hairpin located 27 nt downstream of the AUG initiation codon, at position +1,
the first adenosine of AUG. This downstream hairpin structure, previously termed the downstream
loop (DLP) by us [87], is not a true enhancer of protein synthesis, but instead is involved in
conferring eIF2-independent translation of sgRNA in infected mammalian cells [86,87]. A second
important function of this DLP, better known as the downstream stable hairpin (DSH), is to signal
the precise codon at which translation begins [88,117]. Thus, whereas disorganization of the DSH
does not diminish translation in PKR-deficient MEFs, translation is obstructed when eIF2α is
phosphorylated [86,87]. The DSH has been proposed to be responsible for adaptation to certain
vertebrate hosts since no orthologue of the PKR gene has been found in insect cells [118]. A hypothesis
has been put forward that the acquisition of the DSH structure has allowed the colonization of
vertebrate hosts and the consequent geographic expansion of some alphaviruses worldwide [107].
An intriguing observation is that SINV sgRNA translation can occur even when the AUG codon is
replaced by other codons [88]. For instance, the substitution of AUG by CUG, which encodes leucine,
is particularly efficient as shown by the abundant amounts of structural proteins synthesized by this
variant [119]. However, this phenomenon is not observed after disorganization of the DSH and a SINV
variant sgRNA bearing CUG instead of AUG is practically unable to participate in translation if the
DSH is disorganized [119]. Moreover, a loss of fidelity of sgRNA bearing genuine AUG is observed
when the DSH is disorganized, leading to leaky scanning; in this scenario, the AUG initiation codon
is not recognized in many initiation events and ribosomes pass through to select other downstream
alternative AUGs [88,117]. The DSH therefore plays an important role in the selection of the start
codon on sgRNA.
Much effort has been made to better understand the functioning of the DSH during the process of
sgRNA translation. Based on the Kozak model, it was speculated that this hairpin stalled ribosomes
leaving the AUGi at the P site [117], thereby serving to mechanically stop the preinitiation complex
in such a way that initiation at the AUG could be facilitated. This hypothesis, however, is unlikely
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because it is known that for a hairpin to facilitate initiation, it must be located 14 nt downstream
of the AUG [79]. Placement of the DSH motif 9 nt closer to the AUG, which is an optimal position
according to Kozak’s model at 15 nt from the AUG, strongly reduces translation. Moreover, we found
that replacement of the DSH with a hairpin with a similar free energy does not confer translatability to
sgRNA when eIF2 is phosphorylated [82]. In contrast to this “mechanical” model, we have proposed
a “functional” action of DSH. Thus, its precise function would involve its active interaction with
ribosomes, probably at the P site, in such a way to signal the correct codon and replace the activity of
eIF2 [82]. It is also of interest to note that SFV sgRNA contains sequences that could interact with the
18S rRNA [120]. In conclusion, it is possible that the binding of DSH to ribosomes not only relieves the
necessity for eIF2, but also signals the correct codon to initiate translation.
4.3. The 3′-UTR of SINV sgRNA
The SINV 3′-UTR is rather long (323 nt) and can be divided into three distinct regions (Figure 3A).
A conserved 19 nt sequence can be found close to the poly(A) tail that, together with at least 11 nt of
this tail, forms part of the promoter to synthesize minus-strand RNA [121,122]. An AU-rich sequence
of about 60 nt is found before this conserved region, which interacts with the host protein HuR
and is involved in mRNA stabilization during alphavirus infection [104,107,108]. Finally, there are
three repeated stem-loop structures that are present not only in alphaviruses, but also in other
arthropod-borne viruses (e.g., arboviruses) [122–124]. These elements, as well as the AU-rich domain,
may contribute to the repression of deadenylation of viral mRNAs [125]. Deletion of most of the
3′-UTR whilst retaining the 19 nt conserved sequence decreases the efficiency of SINV replication in
mosquito cells relative to chicken cells [126]. Moreover, mutagenesis of this region has different effects
on viral replication in mice and in cultured murine cells [127], which are not only species-dependent,
but are also dependent on the tissue analyzed. The alphavirus 3′-UTR thus has an important role in
viral replication and adaptation to new hosts in mosquitos and mammalian cells. Indeed, adaptation
to mosquitoes, rather than mammalian hosts, is a major evolutionary force on the CHIKV 3′-UTR.
Deletions in the repeated stem-loop sequences result in the poor replication of the Asian lineages
in mosquito vectors [128]. Overall, these findings indicate that this motif and the 3′-UTR play a
significant part in the adaptation and evolution of CHIKV. We recently examined the role of the
repeated stem-loop structure at the 3′-UTR of SINV mRNAs during the virus life cycle in mammalian
and insect cells [129]. Notably, mutation of the three stem-loops had little effect on the translation of
gRNA and sgRNA in mammalian cells; however, protein synthesis directed by these two mRNAs
lacking this motif was profoundly suppressed in mosquito cells. Interestingly, the addition of the SINV
repeated sequence elements to the short 3′-UTR of sleeping disease virus (SDV), an alphavirus that
does not have an insect vector [130–133], potently increased its replication and translation in insect
cells [129]. To our knowledge, this motif constitutes the first example of an element from an animal
virus that confers translatability to mRNAs in a cell-specific manner and, accordingly, it could be
described as a translation enhancer “cell-specific” element. These observations explain, at a molecular
level, the acquisition of the repeated regions along alphavirus evolution. Indeed, it is thought that an
alphavirus ancestor initially infected marine organisms and did not have an invertebrate vector [2].
Subsequently, the marine alphavirus ancestor adapted along evolution to infect invertebrate hosts by
acquiring these repeated sequences at the 3′-UTR.
Another intriguing aspect of the three repeated stem-loops at the 3′-UTR is that any one of them
could theoretically interact by base-pairing with a stem-loop close to the cap structure at the 5′-end
(Figure 3A). It could be speculated that this base pairing is involved in sgRNA circularization to
facilitate translation. However, mutations of the loop at the 5′-UTR or disorganization of the stem-loop
have little effect on protein synthesis directed by sgRNA [129]. Thus, this interaction is perhaps
important for virus replication at the organismal level.
The 3′-UTR can also participate in the regulation of viral replication by its interaction
with microRNAs (miRNAs), which regulate cellular protein synthesis through inhibition and/or
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degradation of mRNAs. The expression of miRNAs is cell specific and is regulated at the transcriptional
level; therefore, the miRNAs present in a given tissue can also modulate viral replication [134–136].
One interesting example of this regulation of alphavirus replication is provided by the infection of
hematopoietic cells by EEEV. The hematopoietic-specific miRNA, miR-142-3p, binds to specific sites
at the 3′-UTR of the EEEV genome, blocking translation [137,138]. This inhibition in murine myeloid
cells minimizes induction of type I interferon and other innate immune effectors, allowing EEEV to
replicate almost undetected by host defense responses, which exacerbates disease in animal models.
Removal of the miR-142-3p binding sites from viral gRNA rescues viral translation and replication
in myeloid cells, resulting in enhanced systemic type I interferon production, prodromal signs of
disease, and attenuation of the virus [137]. The potential role that endogenous miRNAs can play
in the regulation of SINV replication is, however, not well understood. Indeed, human cell lines
lacking a functional Dicer enzyme, and therefore unable to produce miRNAs or siRNAs, showed no
enhancement in the replication of a variety of viruses including SINV [139], whereas deletion of the
miRNA processing enzyme Drosha in mammalian cells led to higher viral replication [140]. Since the
miRNA machinery naturally exerts an antiviral response in mammalian cells [141], the SINV-induced
translocation of Drosha into the cytoplasm may represent a broad antiviral response.
5. Mechanism of SINV sgRNA Translation
Perhaps the most relevant aspect of sgRNA translation is that it can take place in the absence
of several eIFs. The misleading concept that sgRNA translation can occur with “reduced levels” of
eIFs suggested that this mRNA is translated using the eIFs necessary to translate cellular mRNAs,
albeit at lower concentrations. In contrast to this notion, overwhelming evidence has shown that
SINV sgRNA can be translated in the absence of active eIF4F, after efficient cleavage of eIF4G, or in
presence of compounds that powerfully block the activity of eIF4A or eIF2. We recently showed in
human cells that eIF2A and eIF2D do not participate in the initiation of protein synthesis directed
by sgRNA [119]. Accordingly, SINV sgRNA has evolved novel sequences and structures for efficient
translation during infection. It is fascinating that the evolution of these structures accommodates two
different hosts—insects and vertebrates [129]; the final outcome being the generation of a viral mRNA
that has eliminated the requirements for several eIFs.
A very interesting aspect of sgRNA translation is that it is tightly coupled to its transcription in
infected cells [94]. Thus, transfection of sgRNA into cells at late stages of infection does not result
in its translation, since only the sgRNA synthesized during viral transcription is recognized by the
translational machinery. It is still not well understood why the transfected sgRNA, which contains all
the elements for efficient translation, is excluded from the protein-synthesizing machinery. Ostensibly,
only the newly-manufactured sgRNA at the viral replicative foci is engaged with ribosomes to direct
protein synthesis.
5.1. Protein Synthesis Directed by sgRNA without an Intact eIF4F Complex
Early work with cultured cells doubly infected with PV and SFV indicated that the synthesis of
structural proteins from alphaviruses was resistant, at least in part, to PV infection [54,142]. To examine
this in more detail, we constructed SINV strains bearing the PV 2Apro or the HIV PR gene under a
second internal promotor. Infection of mammalian cells with these recombinant SINV strains led
to the expression of PV 2Apro or HIV PR and the consequent cleavage of eIF4G [115]. Under these
conditions, no intact eIF4G was detected, but abundant synthesis of SINV structural proteins took
place. Moreover, HIV PR not only cleaves eIF4G, but also poly (A)-binding protein (PABP) [143],
suggesting that initiation on sgRNA does not require eIF4G or PABP. Overall, these results establish
that an intact eIF4F complex is not necessary to initiate sgRNA translation, which begs the question
of why this messenger contains a cap structure at its 5′ end but does not work as an IRES. A likely
possibility is that other proteins or factors replace the recognition of the cap by eIF4E in the eIF4F
complex. Indeed, this factor could be eIF3D, since it has been shown that it can participate in cap
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recognition on some specialized mRNAs without the requirement for eIF4E [144]. Moreover, eIF3 is
necessary for initiation in vitro on sgRNA in reconstituted systems [145].
Aside from the non-requirement of eIF4G, potent inhibition of eIF4A by selective inhibitors
does not affect protein synthesis directed by sgRNA, reinforcing the concept that the eIF4F complex
is not involved in the synthesis of SINV late proteins. In this regard, a number of new translation
inhibitors have been discovered through high-throughput screening methods [146]. One such molecule
is pateamine A (Pat A), a natural marine compound synthesized by the sponge Mycale sp. [147,148]
(Figure 4). Pat A targets eIF4A and enhances its helicase and ATPase activities in vitro, leading to the
disruption of its interaction with eIF4G and promoting the formation of a stable complex between
eIF4A and eIF4B [149,150]. Thus, translation of capped mRNAs that require eIF4F is blocked. However,
hepatitis C virus (HCV) mRNA is not inhibited by Pat A, although other mRNAs bearing picornavirus
IRES elements are blocked by this compound [149,150]. Additionally, Pat A induces the formation of
SGs by a pathway independent of eIF2α phosphorylation [151]. Protein synthesis directed by sgRNA
is resistant to Pat A inhibition, whereas gRNA translation is blocked [152]. Interestingly, the resistance
of sgRNA to Pat A is observed only in SINV-infected cells, and not when this mRNA is translated out
of the virus replicative context. To our knowledge, this represents the first example of a capped mRNA
that is resistant to Pat A.
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A seco d potent and selective inhibitor of eIF4A is hippuristanol (hipp) [149,153] (Figure 4),
a marine atural pr duct isolated from the gorgonian coral Isis hippuris [146]. Hipp binds to the
C-terminal domain of eIF4A, acting as an allosteric inhibitor of RNA interaction. This compound
blocks translation of cellular mRNAs but not HCV IRES-driven translation. Notably, protein synthesis
directed by sgRNA is not inhibited by hipp in SV-infected cells [74]; however, eIF4A is required to
translate this mRNA in transfected cells or in cell-free systems. Perhaps, the modifications of the
cytoplasm in the infected cells may create an environment that modifies the requirements for eIFs in
the translation of sgRNA.
5.2. Translation without eIF2
As mentioned earlier, SINV infection induces the phosphorylation of eIF2α leading to its
inactivation via activation of PKR by dsRNA. Several inhibitors such as sodium arsenite, dithiotreitol
or thapsigargin can further increase this phosphorylation in SINV-infected cells, from about 80% in
untreated cells to virtually 100% eIF2α phosphorylation in treated cells [88]. This finding demonstrated
that sgRNA translation did not occur at reduced levels of active eIF2, but rather took place when
practically all eIF2 was inactivated. As discussed previously, the hairpin located between 27 and
89 nt downstream from the AUG initiation codon is crucial to translate this mRNA when eIF2α is
inactivated [74,86,87,89]. It could be speculated that although the majority of eIF2α is phosphorylated
in SINV-infected cells, a small portion of active eIF2 remains in close proximity to the translation
machinery at sgRNAs. We evaluated this possibility by generating specific variant SINV sgRNAs
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containing two in-frame AUG start codons [82] (Figure 5). Curiously, initiation on this artificial sgRNA
took place at both AUGs, but each of them was preferentially selected depending on the activity of eIF2.
Thus, after eIF2α phosphorylation, translation on one AUG was reduced, while the initiation codon
closest to DSH was resistant to this inhibition. This result shows that on a single mRNA, one AUG
requires active eIF2 whereas the second one, which is at a short distance to the first AUG, initiates
translation in an eIF2-independent manner.
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(Upper panel) In the model of the scanning mechanism followed by WT SINV sgRNA to initiate
translation, the 40S ribosomal subunit attaches initially at the 5′ cap structure. Then, the 5′ UTR is
scanned base-by-base in a 5′–3′ direction until the initiation codon (AUG) is recognized. (Lower panel)
Model for translation initiation on SINV sgRNA bearing two alternative start codons (AUG). Under no
stress conditio s (left part), the preinitiation complex containing the 40S ribosomal subunit interacts
with the cap structure and ca s the leader sequence of sgRNA until the first AUG is encountered.
Then, the 80S initiation complex can be formed and elongation ensues. Another preinitiation complexes
can start scanning from the cap structure and, in some cases, skip the first AUG start codon and reach
the second AUG (genuine AUG), initiating the synthesis of authentic C protein from this start codon.
When eIF2 is phosphorylated (right part), the lack of functional eIF2 prevents the initiation in the
first AUG, nevertheless the genuine AUG, which is in proximity with DSH, manages to initiate the
translation independently of the eIF2.
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We have previously proposed that the function of eIF2 in SINV-infected cells can be replaced
by other cellular factors, such as eIF2A [87]. eIF2A was described several years ago, but its precise
activity in mammalian cells remains unclear and deletion of the yeast orthologue has no effect on cell
viability [154]. Early results demonstrated that eIF2A can interact with Met-tRNAiMet to bind it to
the ribosome [155]; however, this binding was much less efficient than that observed using genuine
eIF2 on artificial templates. Moreover, eIF2A was unable to promote the binding of Met-tRNAiMet
to globin mRNA [156]. Recent findings suggest that eIF2A is involved in the translation of some
specialized cellular mRNAs that initiate translation with non-AUG codons [157,158]. Of interest,
eIF2A has been implicated in cancer progression because it is involved in the initiation of translation
of unconventional upstream ORFs [159]. Surprisingly, the development of mice with deletion for the
eIF2A gene is completely normal, indicating that eIF2A is not required for the translation of both normal
and specialized cellular mRNAs [160]. Another possibility is that eIF2D initiates sgRNA translation in
place of eIF2 [145]. eIF2D was initially purified from rabbit reticulocyte lysates as an activity that could
displace deacylated tRNA and mRNA from recycled 40S ribosomal subunits. In addition, eIF2D could
interfere with the formation of the 48S initiation complex promoted by eIF2 [145]. A complex between
Met-tRNAiMet and eIF2D is formed in a GTP-independent fashion, and can interact with the 40S
ribosomal subunit to deliver the initiator to the ribosomal P site [161]. However, as with eIF2A,
the precise function of eIF2D in mammalian cells remains enigmatic.
To test the potential role of eIF2A and eIF2D in translation, we used human wild-type haploid
HAP1 cell lines or equivalent cells knocked-out for eIF2A, eIF2D or both by CRISPR/Cas9 genome
engineering. Cellular morphology, global protein synthesis and SINV infection was comparable
between all four cell lines [119]. Moreover, synthesis of viral proteins at late stages of infection also
was similar despite the fact that eIF2α became phosphorylated [119]. These findings show that eIF2A
and eIF2D are not required for the translation of sgRNA when eIF2α is phosphorylated. Moreover,
silencing of eIF2A or eIF2D by transfection of the corresponding siRNAs in HAP1 WT, HAP1-eIF2A−
and HAP1-eIF2D− cells had little effect on the synthesis of viral proteins late in infection. Elegant
studies employing CRISPR/Cas9 technology in HAP cells has provided an extensive analysis of the
human proteins that are involved in the replication of HCV, and are dispensable for cell viability [162].
Curiously, some of these proteins are not required for SINV replication. These results provide an
interesting approach to develop antiviral compounds against human viruses.
Our observations support the novel proposal that eIF2 is not replaced by a cellular protein during
the translation of SINV sgRNA. Instead, this viral mRNA has evolved a specialized structure that
confers independence for eIF2. In this regard, it is possible that the DSH functions in a way similar
to that of domain II of HCV IRES, because there are also great similarities between these elements,
including the sequence present at the loop (Figure 3B). Thus, domain II from HCV IRES can directly
interact with preinitiation complexes and 80S ribosomes and displace the bound eIF2, substituting
the requirement for this factor [163,164]. It can be hypothesized that some viral mRNAs can acquire
elements to maximize the translation process under infection conditions. The consequences for the
virus life cycle are that significant amounts of structural proteins can be produced upon the translation
of sgRNA even under stress conditions that appear after viral infection.
5.3. Mechanism of sgRNA Translation. Comparison with Cellular mRNAs
Work carried out in the past few years has provided a more detailed picture on the mechanism
by which sgRNA initiates translation. To compare this initiation mechanism with the canonical
cap-dependent scanning mechanism that takes place on cellular mRNAs, we will briefly summarize
the molecular events that initiate translation on cellular mRNAs. Cap recognition involves the
interaction of eIF4E with the methylated structure m7GpppN located at the 5′ end of eukaryotic
cellular mRNAs [77]. Binding of eIF3 to the eIF4G middle domain promotes the interaction of
the preinitiation complex 43S at the 5′ end of mRNAs [165]. Thus, there is an interaction of the
ribosomal subunit 40S, containing several eIFs such as eIF1, eIF1A, eIF3, and eIF2 in the form of
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ternary complex [166,167]. It has been proposed that the 40S ribosomal subunit bound to these eIFs
is in an “open” conformation, that is, competent for scanning, which involves linear base-by-base
inspection of the 5′-UTR [79,166,168,169]. This scanning takes place until an AUG initiation codon is
found in a suitable sequence context [79,170]. The secondary structure of the 5′-UTR is melted during
the scanning process, in part by the helicase activity of eIF4A, although stable hairpins cannot be
melted by small ribosomal subunits and eIF4A [78]. After positioning of the preinitiation complex at
the AUG initiation codon, base-pairing takes place with the anticodon present in the initiator tRNA
Met-tRNAiMet. Subsequently, the eIF5 carboxy moiety promotes the dissociation of eIF1, together with
inorganic phosphate derived from the GTP hydrolysis of the ternary complex [171,172]. In addition,
the eIF1A carboxy terminus moves closer to the eIF5 amino terminus [173]. This movement is coupled
to eIF1 exit, which leaves the P site free and allows tighter binding of the initiator tRNA at this site.
Concomitant with this rearrangement, eIF5B-GTP can now interact with the 40S subunit. In this manner,
eIF5 together with eIF2-GDP are released from the small ribosomal subunit, which is now in the “closed”
conformation and is committed to continue mRNA translation [172,173]. This interaction of eIF5B-GTP
stimulates the joining of the 60S subunit to form an 80S initiation complex. The initiation phase ends
with the Met-tRNAiMet accommodated in the P site of the 80S, leaving free the A site. The interaction
of the ternary complex aminoacyl-tRNA-eEF1-GTP to this site starts the elongation phase.
In common with cellular mRNAs, the initiation of SINV sgRNA translation also takes place
following the scanning mechanism [74,82]. The first event in this initiation could be the interaction of
eIF3, by means of its subunit eIF3D, to the cap structure at the 5′-end, without the participation of eIF4E
and the entire eIF4F complex [115,144,152]. After the interaction of eIF3 with the cap structure, the 40S
ribosomal subunit can bind to the mRNA. Although exactly which eIFs bind to this 40S ribosomal
subunit remain unclear, the ternary complex containing active eIF2 is definitely not required for this
interaction, nor for the subsequent scanning of the leader sequence [129]. Once the 40S in the “open”
conformation (with some still undefined eIFs) reaches the AUG initiation codon, it can stop to interact
with the stable hairpin loop that could bind to the ribosomal P site, inducing the “close” conformation.
This event would promote the joining of the 60S subunit to build-up the 80S ribosome competent to
translate this viral messenger. How the Met-tRNA is delivered to the ribosome in order to establish
the codon-anticodon based pairing remains unknown. The finding that other codons can replace AUG
to initiate translation of sgRNA, albeit with lower efficiency, makes it possible that aminoacyl-tRNAs
different from Met-tRNA can participate in this process [88,119]. Since active eIF2 is not required for
this initiation event, perhaps other cellular factors, including elongation factor eEF1, are responsible
for this event following a mechanism akin to that reported for cricket paralysis virus (CrPV) [174,175].
The similarities in the structure between the DSH and domain II of HCV IRES points to the possibility
that their functioning is also similar (Figure 3B) [163,164], since translation of HCV is independent of
active eIF2. Once the 80S ribosome has been built-up, it can initiate the elongation phase to synthesize
the polyprotein that contains the SINV structural proteins. A puzzling aspect of sgRNA translation is
that the 80S has to pass through the DSH, melting its structure. Clearly the DSH cannot be functional
during the translation of this hairpin because it would remain disorganized. After the ribosome passes,
the hairpin must reorganize to become functional on the 40S ribosomal subunit that is paused at the
start position. Therefore, the DSH is melted and reorganized each time that the ribosome translates
this sequence of the capsid protein. The obvious question that arises is why the DSH is located at
the coding region and not at the leader sequence. A possible reason could be that since the mRNA
is capped, the 40S ribosomal subunit could not melt this structure and necessarily should be placed
after the initiation codon at an optimal distance to exert its function. It must be considered that the
preinitiation complexes containing the small ribosome subunit are unable to melt the DSH hairpin,
and only 80S ribosomes have the potential to pass through this stem-loop.
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6. Translation of SINV sgRNA Bearing IRES Elements
The singular translation system represented by SINV-infected cells provides a good model to
analyze the requirements of some specialized mRNAs to direct protein synthesis. This is because
high amounts of sgRNA are present at late stages of infection and this is the only mRNA efficiently
translated after the abrogation of cellular protein synthesis. Against this background, the translatability
of sgRNAs bearing different IRES elements has been studied in mammalian cells using SINV replicons,
and a number of surprising results, some of them remaining unresolved, have been reported during
IRES-driven translation in SINV-replicating cells [89,176].
6.1. The Variety of Internal Ribosome Entry Site Elements
There is a great variety of IRES elements with regards to their structure and functioning,
and several have been analyzed in cellular and viral mRNAs [177–179]. In the case of animal viruses,
four major groups are known to contain mRNAs bearing IRES elements: picornaviruses, flaviviruses,
pestiviruses and retroviruses [178,180–183]. Picornavirus IRES elements can be classified into at least
two groups—IRES type I is typical of entero/rhinoviruses, with PV considered as the prototype,
whereas type II IRESs are present in cardio/aphtoviruses, with encephalomyocarditis virus (EMCV) as
the prototype [181,184,185]. IRES elements contain a rich secondary structure with several stem-loops,
which are crucial for their activity. Most IRES elements bear a tRNA-like motif that is involved
in binding to ribosomes [186–188]. The requirement for eIFs varies according to the IRES under
study. Thus, picornavirus IRESs do not require eIF4E and can be translated when eIF4G is cleaved
by some picornavirus proteases, such as PV 2Apro or foot-and-mouth disease virus (FMDV) leader
(L)pro [81,189,190]. Notably, HCV mRNA can be translated without the eIF4F complex and even in
the absence of eIF2 [187]. Perhaps most strikingly, the intergenic region (IGR) of CrPV mRNA directs
protein synthesis in the absence of all known initiation factors [182]. In addition to eIFs, a number of
cellular proteins known as IRES trans-activating factors (ITAFs) have the ability to interact directly
with IRESs and modulate their activity [183,191,192].
6.2. IRES-Driven Translation in Alphavirus Replicons
In the early days of research on alphavirus translation, it was discovered that gRNA only directed
the translation of the first ORF, whereas those proteins encoded by the second cistron were synthesized
from a second mRNA (sgRNA) [193]. The implication was that only the AUG initiation codon
nearest to the cap structure was functional, and not the internal AUG present in sgRNA. Therefore,
the leader sequence of sgRNA was thought to have no IRES activity. Indeed, transfection of uncapped
gRNA in mammalian cells failed to direct the translation of a reporter gene located in the second
cistron [176]. It is appreciated that mRNAs containing IRES elements are very efficiently translated,
both in cultured cells and in in vitro systems, and for this reason a number of viral vectors have been
developed bearing IRES elements to provide robust gene expression. In this regard, alphavirus vectors
are potentially useful tools to express heterologous genes and for the design of vaccines [194–196].
However, the use of IRES elements in alphavirus vectors results in poor gene expression [176,197].
Indeed, IRES elements belonging to picornaviruses HCV and CrPV perform poorly in SINV replicating
cells [89,176]. SINV constructs containing the leader sequence of sgRNA replaced by an IRES element
followed by the luciferase gene are able to synthesize luciferase protein when uncapped gRNA is
transfected into mammalian cells, demonstrating that internal initiation on gRNA occurs early after
transfection (Figure 3D). Notably, the translation is inhibited in the late phase of SINV replication.
Co-expression of different PV non-structural genes has revealed that PV 2Apro can increase translation
of sgRNAs containing the PV or EMCV IRESs, but not of those from HCV or CrPV. The Lpro protease
from FMDV also rescues translation, whereas a PV 2Apro variant deficient in eIF4G cleavage does
not increase picornavirus IRES-driven translation in SINV replicons. Overall, these findings suggest
that the replicative foci of SINV-infected cells, where sgRNA translation takes place, are deficient in
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components necessary to translate IRES-containing mRNAs. In the case of picornavirus IRES elements,
cleavage of eIF4GI by PV 2Apro or FMDV Lpro rescues this inhibition. The fact that translation of
picornavirus IRESs requires functional eIF2 at early stages of infection, but not later [198], suggested
that the lack of picornavirus IRES-driven translation in SINV-replicating cells was due to the
phosphorylation of eIF2. Indeed, PV IRES-driven translation can take place from SINV replicons if
eIF2α remains unphosphorylated in PKR−/− MEFS [89]. It was therefore concluded that these viral
proteases conferred eIF2-independent translation to picornavirus IRESs [89,189,190,199]. Thus far,
no explanation has been proposed for the failure of HCV or IGR CrPV IRES elements to direct protein
synthesis in SINV replicating cells. In the case of HCV IRES, it is independent of both the eIF4F complex
and eIF2, a situation similar to that described for sgRNA translation [200]. Even more intriguing is the
fact that IGR CrPV IRES, which does not require any eIF [175,201], is inactive in the context of SINV
replicons [176]. Perhaps these IRES elements require an ITAF that is not present in the replicating foci
of SINV-infected cells. Alternatively, it is possible that the redistribution of nuclear proteins to the
cytoplasm is inhibitory for the translation of these IRES elements. This latter possibility is more likely
given that all the viral IRES elements are functional on uncapped gRNA early after transfection.
7. Concluding Remarks and Future Perspectives
The study of the regulation of protein synthesis in SINV-infected mammalian and insect cells has
broadened our understanding of the basic translation mechanisms of viral mRNAs. In this regard, several
elements have been identified in SINV mRNAs that maximize their translatability in different host cells.
These viral messengers have thus exhibited functional plasticity during evolution to adapt to different
species and environments. Most probably, alphaviruses first appeared in marine vertebrates [2] and
expanded their host range by acquiring the ability to infect insects, which became effective vectors
for viral transmission to terrestrial vertebrates. In the adaptation to insects, alphaviruses recruited
a motif at their 3′-UTR, which is necessary for the powerful translation of their mRNAs in this host.
However, the precise functioning of this motif as regards to its interaction with cellular factors remains
enigmatic. Although we now comprehend the functioning of DSH and the leader sequence of these
mRNAs, additional efforts are needed to better understand their activity during the initiation of
translation. In particular, further work is necessary to address the mechanism of translation of SINV
gRNA, to discern if it follows the canonical pathway exhibited by cellular mRNAs, and also the explicit
eIFs involved in the initiation of protein synthesis. Finally, the abrogation of host protein synthesis
after infection of vertebrate cells by SINV would appear to be due to the redistribution of nuclear
proteins to the cytoplasm. However, we do not know which RNA-binding proteins interact with viral
and cellular mRNAs at late stages of infection. Comprehensive proteomic analysis will be essential to
identify which cellular (or viral) proteins interact with mRNAs and may shed more light on the control
of host cell translational machinery by SINV. If translational shut-off is indeed due to the accumulation
of nuclear proteins in the cytoplasm of infected cells, several questions will need to be addressed:
(1) Which nuclear proteins are able to interact with cellular mRNAs and, from those, which ones are
responsible for the inhibition of protein synthesis? (2) Why is this blockade selective for host cell
translation? (3) Is the presence of viral RNA sequences responsible for the relocalization of nuclear
proteins to the cytoplasm following the “sponge-like” mechanism and consequently for the inhibition
of host translation? Future work using the SINV infection model will answer some of these questions.
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